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Abstract
Structural eye defects are often caused by aberrant mechanisms during the early 
stages of eye development. The underlying mechanisms of these defects are currently 
not fully known. The optic vesicle, which gives rise to the mature eye, is patterned 
by asymmetrical gene expression. The T-box transcription factors, Tbx2, Tbx3, and 
Tbx5y which are members of the evo lu tionary  conserved family of T-box genes, are 
expressed in the dorsal region of the developing eye. The expression of these genes 
overlaps with the expression of the secreted signalling factor Bone morphogenetic 
protein (Bmp) 4. Together, they represent the earliest dorsally expressed genes in the 
developing mouse eye and are co-expressed in several other vertebrate species. This 
thesis investigates the regulation of T-box gene expression by Bmp4 in the 
developing mouse eye, and the importance of the regional expression of these genes 
for early eye development.
Bmp4 and Noggin coated bead implantation in combination with whole mouse 
embryo culture was performed to manipulate Bmp4 signalling during eye 
morphogenesis. Examination of gene expression revealed that manipulation of Bmp4 
signalling alters the expression of the T-box genes as well as the ventrally expressed 
Vax2 transcription factor, thus disrupting dorso-ventral (D-V) patterning. These 
changes resulted in reduced eye size and growth. Cell division was decreased 
globally and cell death induced in the dorsal neural retina. To directly investigate the 
role of Tbx2 in eye development, mice with a targeted mutation of Tbx2 were 
analysed, and gain of function experiments were carried out using in ovo retroviral 
gene delivery in the chick embryo. Tbx2 was selected for further analysis, as it 
showed the largest change in expression in Bmp4 manipulated eyes. Both strategies 
resulted in reduced eye size. In the loss of function approach, establishment of the 
expression of D-V patterning genes occurred in the absence of Tbx2, but the 
maintenance of the expression of several of these was affected. Within the normal 
dorsal site of Tbx2 expression, an increased trend in cell division was detected. 
Several abnormalities were also found outside of the Tbx2 expression domain, 
including delayed formation of the ventral region of the eye, and abnormal lens and 
hyaloid vasculature defects. These findings suggest that Tbx2 regulates eye
2
development both intrinsically and outside of its site of expression and that a Bmp- 
Tbx2 pathway regulates early growth and coordination of morphogenesis of the 
developing eye.
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CHAPTER 1 Introduction
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The eye develops through a series of interactions between distinct cell types. These 
give rise to several tissues which must acquire a precise size, shape, and orientation 
in relation to each other to collectively form the visual organ. Tissue interactions, 
which give rise to the eye, as well as the visual anatomy and function were already 
reasonably well-studied by developmental biologists and neuroanatomists half a 
century ago (Coulombre 1965). The genes and genetic interactions however, that 
direct tissue growth and interactions, as well as the crucial shaping of the different 
structures o f the eye, remain largely elusive.
Congenital eye defects, which are present at birth and often cause blindness due to 
structural and/or functional impairment o f the eye, are a significant cause of 
childhood blindness according to the World Health Organisation 
(www.who.int/blindness/causes). The underlying causes of congenital eye defects 
may be genetic and/or environmental. In particular, mutations in several genes 
encoding transcription factors and signalling molecules that are expressed during 
early eye development have been identified that cause structural congenital eye 
defects (see Table 1.1). However, the aetiology o f these genetic defects are largely 
unknown. Elucidation of the genetic basis o f eye development is therefore of great 
importance for the understanding of the mechanisms involved in the causation of 
congenital eye defects.
Visual impairment has devastating effects for children’s development and their 
educational, employment, and social prospects in life (Rahi et al. 1999). This 
realisation has prompted the World Health Organisation’s VISION 2020 initiative, 
which is a global partnership that aims to eliminate preventable blindness by the year 
2020 (www.who.int/pbd/blindness/vision_2020/en/). Although the step from 
identification of genes and mechanisms that cause abnormal eye development to the 
treatment or prevention of congenital eye defects is today large, better understanding 
of eye development is necessary, which coupled with the advancement of technology 
encourages development o f treatments or prevention o f such defects in the future.
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1.1 Overview of eye development and disease
The morphological descriptions that follow are based primarily on current 
knowledge o f the development of the mouse eye, which is the model organism used 
in the majority o f the experiments in this thesis. The corresponding chick and human 
eye developmental timelines are also given for comparative purposes. When 
appropriate, mouse eye development is contrasted to that of the chick embryo, which 
is the second model organism used in this thesis.
1.1.1 Optic cup formation
Three distinct cell types contribute to the formation of the eye: the neural ectoderm, 
the non-neural ectoderm, and mesenchymal cells, some of which are migrating 
cranial neural crest cells that originate from the dorsal portion of the neural tube, 
others originate from the paraxial mesoderm (Coulombre 1965; Gage et al. 2005). 
The morphogenetic processes involved in eye formation are generally believed to be 
conserved among vertebrate species. Eye formation initiates during neurulation, the 
process o f neural tube formation, from a population o f precursor cells situated in the 
anterior neural plate. The eye precursors extend bilaterally to form the optic pits on 
either side o f the developing forebrain. This process starts on day 22 in human 
gestation, at 8.5 days post coitus (dpc) in the mouse, and at Hamburger Hamilton 
(HH) stage 8 in the chick embryo (Larsen 2001; Kaufman 1992; Hamburger and 
Hamilton 1992). The optic pits continue to extend towards the non-neural surface 
ectoderm, where they initially form vesicle like structures (Fig. 1.1).
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Fig. 1.1 Schematic drawing from a dorsal view of the head of a 9.5 dpc 
mouse embryo
Schematic shows the optic vesicles (OV) as extensions of the developing forebrain.
Once the optic vesicle has formed (day 24 in human, 9.5 dpc in mouse, HH 10 in 
chick), invagination into a bilayered optic cup is initiated upon contact with the 
surface ectoderm (Fig. 1.2). In the rat embryo, a network of collagenous fibrils and 
cytoplasmic processes have been detected that mediate contact between the surface 
ectoderm and the neuroepithelium (neural ectoderm) in the optic vesicle (McAvoy 
1980). During invagination, the distal region o f the optic vesicle, which is in contact 
with the surface ectoderm, undergoes rapid proliferation, whereby it becomes thicker 
and forms the neural retina (Fig. 1.2 A,B). The proximal region, which is not in 
contact with the surface ectoderm, but instead is surrounded by extra-ocular 
mesenchyme, forms the retinal pigmented epithelium (RPE). The neuroepithelium 
that connects the invaginating optic vesicle to the ventral developing forebrain, 
narrows to form the optic stalk (Fig. 1.2 B). Concomitant invagination of the 
overlying surface ectoderm gives rise to the lens placode (Fig. 1.2 B), a hollow pit, 
which later separates from the surface ectoderm and fuses to form the lens vesicle 
(Fig. 1.2 C).
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Fig. 1.2 Schematic drawings of m ouse eye m orphology between 9.5-11.5 
dpc
A-C depict sections through the eye along the dorso-ventral axis. D depicts a whole 
mount view. (A) The optic vesicle at 9.5 dpc. The distal layer (Pre.NR) is in touch 
with the surface ectoderm. (B) The invaginating optic cup at 10.5 dpc. The dorsal 
region is more advanced than the ventral region. The distal layer is thicker than the 
proximal layer. The lens placode (LP) is undergoing concomitant invagination to 
give rise to the lens vesicle. (C) The optic cup at 11.5 dpc. Both the dorsal and the 
ventral regions have now invaginated. The lens vesicle is complete, having separated 
from the surface ectoderm. Dotted line demarcates the distal and the proximal 
boundaries. (D) The optic fissure, a temporary opening in the ventral region of the 
optic cup, is still present at this stage. The irregular shapes around the developing eye 
tissues represent mesenchymal cells that surround the eye and invade the vitreous 
chamber to contribute to the hyaloid vasculature.
Abbreviations: D, dorsal; Di, distal; OS, optic stalk; P, proximal; Pre-NR, 
presumptive neural retina; Pre-RPE, presumptive RPE; SE, surface ectoderm; V, 
ventral.
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At 10.5 dpc in mouse (day 31 in human, HH 14 in chick), the eye appears as a ‘half 
cup’ with the region dorsal to the optic stalk having acquired its near complete shape; 
there is as yet no sign o f a ventral invagination (Fig. 1.2 B). Exactly how the ventral 
eye forms is not entirely clear, but the ventral neural retina and RPE become evident 
by 11.5 dpc in the mouse embryo (day 32 in human, HH 17 in chick; Fig. 1.2 C). 
Cell labelling studies in the Xenopus embryo, using tritiated Thymidine, which is 
incorporated during the DNA synthesis phase o f the cell cycle, have shown that optic 
stalk cells migrate distally and contribute to the formation of the ventral portion of 
the eye (Holt 1980). A temporary opening present in the ventral region of the optic 
cup, referred to as the optic or choroid fissure, accommodates the entry of the 
embryonic blood vessels and exit of axons (Fig. 1.2 D). The completion of the optic 
cup is marked by the elimination of the optic fissure and positioning of the optic disc 
approximately in the centre of the eye globe.
The space between the lens vesicle and the neural retina, the vitreous chamber (Fig.
1.2 C), becomes gradually filled with a gelatinous matrix, rich in extra-cellular 
matrix proteins such as Collagen II. This is called the primary vitreous body (Larsen 
2001). The vitreous serves to support the structure of the eye and maintain its shape. 
The morphogenetic processes o f optic cup formation described here is reviewed in 
(Chow and Lang 2001; Mey and Thanos 2000; Romanoff 1960; Coulombre 1965).
Once the lens vesicle has formed by separation from the surface ectoderm, the 
posterior lens cells elongate and project into the lens lumen. These eventually 
obliterate the lens cavity, as they continue to elongate and become fibrous. As the 
lens grows and posterior cells elongate, the equatorial axis of the tissue is increased. 
The anterior rim o f the lens remains epithelial and retains mitotic activity. The zone 
of transition between lens epithelium and lens fibre is referred to as the equatorial 
zone. This zone is directly opposite the peripheral edge of the neural retina and is the 
place where proliferating lens epithelial cells initiate their differentiation process to 
form fibre cells. As each lens fibre elongates, its nuclei becomes positioned at the 
centre of the fibre causing the formation of a belt o f cell nuclei across the lens fibre 
mass in the posterior lens. As new fibres are added from the equatorial zone, the 
oldest fibres are found in the centre of the lens. Eventually, the nuclei of these cells
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disappear leaving anucleus cells, which is important for the transparency of the 
developed lens (Coulombre 1965).
Development o f  the anterior segment o f  the eye
The anterior segment of the eye which includes the cornea, the iris, the ciliary body, 
and ciliary muscles, starts to develop after the onset of differentiation of the initial 
structures of the optic cup. The lens is thought to be important for the development 
o f the anterior segment (Beebe and Coats 2000; Graw 2003). The cornea forms from 
the surface ectoderm, after lens vesicle formation, and is induced and maintained by 
the lens and the optic cup (Coulombre 1965), but as the migrating cranial neural crest 
cells reach the eye, further contributions are made towards the cornea from neural 
crest derived (and non-neural crest) mesenchymal cells (Gage et al. 2005). The iris 
and the ciliary body serve important functions in facilitating vision. The iris regulates 
the amount o f incoming light into the cup, while the ciliary body is important for 
supporting the lens and synthesising proteins o f the vitreous body, and later in 
maintaining the intra-ocular pressure. They both form from the peripheral most edges 
o f the neural retina and the RPE, towards the end o f gestation, when this region is 
distinct in terms o f gene expression from the rest of the neural retina. The genetic 
distinction o f the peripheral edge of the neural retina has become increasingly well- 
characterised with the identification o f a large number o f genes by numerous gene 
expression studies, most recently using large scale subtractive hybridisation (Kubota 
et al. 2004)
Development o f  the vasculature that supplies the embryonic eye 
During early stages of eye development, at 10.5 dpc in mouse, day 33 of gestation in 
human, components of the embryonic vascular system of the eye are detected in the 
optic cup (Schook 1980b). The embryonic vasculature serves to provide the 
developing eye with nutrients and oxygen during its growth and differentiation 
before the definitive retinal vasculature has formed in humans and mouse. This 
vascular network is therefore a transient structure, which regresses postnatally in 
mouse (Ito and Yoshioka 1999) and around 29 weeks of gestation in humans 
(Achiron et al. 2000), mainly by the process o f apoptosis as shown by electron 
microscopy studies (Mitchell et al. 1998; Ito and Yoshioka 1999).
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The embryonic vascular system of the eye appears to form by the mechanism of 
angiogenesis, which involves sprouting and growth of pre-existing vessels (Saint- 
Geniez and D'Amore 2004). A branch o f the ophthalmic artery, which itself is a 
branch o f the internal carotid artery that supplies the head, enters the optic cup 
through the optic fissure. Here, in the vitreous chamber which is between the lens 
and the inner layer o f the optic cup, the hyaloid artery grows and branches out to 
form a lattice which fills the vitreous chamber and surrounds the lens. The lattice of 
vessels that fill the vitreous chamber are called the vasa hyaloidea propria and the 
capillary network over the lens is referred to as tunica vasculosa lentis (TVL). A fate 
mapping study in the mouse has shown that both neural crest and mesoderm derived 
mesenchymal cells that enter the vitreous chamber contribute to the hyaloid vessels 
by forming pericytes and endothelial cells respectively (Gage et al. 2005). A group 
o f congenital defects collectively termed persistent hyperplastic primary vitreous and 
characterised by the failed regression o f the hyaloid vasculature (Reese 1955), have 
sparked a research interest in the mechanism and molecular control of hyaloid 
vasculature regression, but less is known about the molecular regulation of the 
formation o f the hyaloid vasculature.
Retinal cell differentiation
Soon after invagination, while some of the anatomical structures of the optic cup are 
still forming, such as the anterior segment and the hyaloid vasculature, the process of 
retinal cell differentiation initiates. This is soon after the formation of the optic cup at
11.5 dpc in the mouse embryo (day 47 in human, ~HH 17 in chick; (Graw 2003; 
McCabe et al. 1999; Prada et al. 1991). The mature neural retina arises from a 
population o f progenitor cells and is composed of six major types of neurons (retinal 
ganglion cells, amacrine, horizontal, bipolar, rod, and cone; Fig. 1.3) and one type of 
glia, Muller glia (Hatakeyama and Kageyama 2004). Each cell type has a specific 
function and together, they are necessary for the capture of light and transmission of 
the information to various processing centres in the brain. Upon differentiation of 
retinal cell types, the retina becomes laminated so that each specific cell type resides 
within a specific region. The retinal ganglion cells (RGCs) are the projection neurons 
o f the retina which send axons to the brain in a topographic manner.
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Fig. 1 3  Schematic representation of the six retinal neuronal cell types
The mature neural retina consists o f three cellular layers: The rod and cone 
photoreceptors are in the outer nuclear layer, closest to the RPE on the ventricular 
side, horizontal, bipolar, amacrine, and Muller glia (not depicted) are in the inner 
nuclear layer. Retinal ganglion cells (RGC) and displaced amacrine cells (not 
depicted) reside in the ganglion cell layer on the vitreal side o f the neural retina. 
Abbreviations: RGCs, retinal ganglion cells; RPE, retinal pigmented epithelium. 
Picture adapted from www.smartdraw.com
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In the mouse, the majority o f the RGCs from each eye project to the contralateral 
side o f the brain. A small proportion of the projections however, project to the same 
side o f the brain. These are called the ipsilateral projections (Drager 1985).
An extensive review o f the field of knowledge of the molecular control of retinal cell 
differentiation is beyond the scope of this thesis. Instead a brief overview of the key 
features o f retinal cell differentiation is provided. Extensive research by several 
laboratories have demonstrated that retinal progenitor cells are multipotent and that 
the different cell types are produced in a specific birth order which appears to be 
evolutionarily conserved (Cepko et al. 1996). The multipotency of retinal progenitors 
has been shown by lineage tracing studies using retroviruses and injection of tracers 
such as fluorescent dextran (Turner and Cepko 1987; Turner et al. 1990; Holt et al. 
1988; Wetts and Fraser 1988). The molecular basis for the genesis of the different 
cell types within the retina and how the progenitor population of cells in the 
presumptive neural retina can give rise to such diverse cell types is currently not 
fully uncovered. However, it is known that a set of basic helix-loop-helix (bHLH) 
transcriptional repressors maintain progenitors, while bHLH activators promote 
neuronal differentiation (reviewed by (Hatakeyama and Kageyama 2004). The bHLH 
factors (e.g. Math5, NeuroD, H esl) regulate neurogenesis in cooperation with 
various homeobox genes, namely Pax6, ChxlO , Six3, Crx, Otx2, Proxl, and Rax 
(Rx). Many of these genes are expressed by eye precursor cells in the eye field and 
later by all retinal progenitor cells prior to differentiation. As differentiation 
proceeds, their expression can be found in distinct laminar layers. Although all these 
genes appear important for retinal neurogenesis, not one of them is capable of 
inducing retinal neurons o f specific fates by themselves. Rather, a combination of 
factors are required to generate a specific cell type. Some of them however, can 
induce ectopic eyes when misexpressed and have collectively been dubbed as the eye 
specification genes.
The eye specification genes
Genes that belong to this class encode transcription factors, that have several aspects 
in common. They are expressed in the eye field, at the time when the specification of 
eye precursors occurs in the anterior neural plate (see Table 1.1 for Rx, Pax6, Six3, 
Optx2, Hesxl and their expression in the mouse). There is evidence for most of them
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being able to induce each other’s expression when misexpressed, and being able to 
induce ectopic eyes when misexpressed ectopically in the nervous system in 
vertebrates, while their homologues in the Drosophila fruit fly, do the same when 
misexpressed in the eye-antennal, as well as other imaginal discs (Chow and Lang 
2001; Dominguez and Casares 2005). The imaginal discs in Drosophila are the 
embryonic building blocks which give rise to the different structures of the fly body. 
The critical role of these genes in eye development is also highlighted by the number 
o f human or mouse mutations that result in severe eye phenotypes, such as the 
absence or severely reduced eyes (Table 1.1).
1.1.2 Ocular defects that affect the size or the shape of the eye; role of 
genetics, and known murine and human genes
Focusing o f incoming light onto the retina, where it is received requires that all 
components o f the eye are present and have the correct size to collectively function 
in a synchronous manner (Coulombre 1965).
Congenital eye defects such as microphthalmia (small eye), anophthalmia (no eye), 
and coloboma (failure of optic fissure closure) arise due to abnormal eye 
development during embryogenesis, which may include aberrant growth of the 
ocular primordia (Oyster 1999). The incidences of these defects depend on the 
population studied (Dolk et al. 1998; Gregory-Evans et al. 2004), but are relatively 
low in comparison to other types of visually impairing defects (~1 in 10,000 births). 
A genetic as well as an environmental basis for these defects have been identified 
(Graw 2003). They can occur in isolation or in association with other developmental 
abnormalities, are genetically heterogeneous, and show all three types of inheritance 
patterns (Gregory-Evans et al. 2004).
Several developmental^ expressed genes that cause isolated or syndromic cases of 
microphthalmia, anophthalmia, and coloboma have been identified in humans and 
mice. Table 1.1 shows some of the genes that cause these defects in humans or in 
mice when over-expressed or functionally disrupted. These genes are mainly 
transcription factors or signalling molecules that act at the top o f the hierarchy of eye 
development (Graw 2003). They are all expressed from very early stages of eye
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development; some are even expressed as early as the eye field stage. In mouse 
models that carry mutations of these genes, structural eye abnormalities are evident 
soon after the onset of the expression of the gene in the majority of cases, suggesting 
that the defects are due to aberrant development rather than later onset degeneration 
o f a normally developed eye. In addition to the genes listed in Table 1.1, 
microphthalmia and coloboma can arise due to mutations in genes that are primarily 
expressed in the lens vesicle (Graw 2003). However, the specific mechanism(s) by 
which these genes cause eye defects, when mutated, and how they may regulate eye 
development and growth normally, is currently poorly understood.
Other congenital eye defects with a genetic basis, which are less severe in terms of 
affecting the structure o f the eye, include anterior segment defects (ASDs) such as 
aniridia (absence or reduced iris), Peter’s anomaly (comeal opacity often involving 
adhesion o f the cornea to the lens), cataract (clouding of the lens), as well as 
conditions affecting the nerve fibre layer such as optic nerve hypoplasia and 
glaucoma.
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Gene 9.5-11.5 dpc 
expression in mouse
Human/mouse phenotype References
PAX6 Eye field. OV, SE. OS. 
OC. lens
Heterozygous, aniridia in human and mouse, macular hypoplasia in human, 
small eye in mouse.
Homozygous, anophthalmia and failure of nasal tissue formation, onset of 
lethality soon after birth.
(Walther and Gruss 1991; Inoue et al. 2000; 
Grindley et al. 1995; Hill et al. 1991; Glaser et 
al. 1992; Jordan etal. 1992)
SIX3 Eye field, OV, SE. NR, 
lens, OS
Heterozygous, microphthalmia, and iris coloboma associated with 
holoprosencephaly in humans. Mice are normal.
Homozygous, absence of forebrain including eyes in mice.
(Oliver et al. 1995; Wallis et al. 1999; Lagutin 
etal. 2003)
RX(RAX) Eye field. OV, NR Heterozygous, no phenotype.
Homozygous, anophthalmia in humans and mice.
(Furukawa et al. 1997; Mathers et al. 1997; 
Voronina et al. 2004)
SIX6 (Optx2; 
Six9)
presumptive ventral 
forebrain, ventral OV, 
OS, NR
Hemizygous: anophthalmia with optic nerve and chiasm defects in humans. 
Heterozygous: microphthalmia with cataract and nystagmus in humans. 
Homozygous: variable expressivity of retinal hypoplasia, analysed at P35, and 
absence of optic nerve and chiasm in mice.
(Jean et al. 1999; L6pez-Rfos et al. 1999; Toy 
and Sundin 1999; Gallardo et al. 1999; 
Gallardo etal. 2004; Li etal. 2002)
Hes1 (Hry) Eye field, OV, SE, OS, 
NR, RPE, lens
Heterozygous: Some indications of a dosage effect, particularly in the early 
onset of differentiation of retinal neurons has been reported in mice, although 
specific details of the structure of the eye was not reported.
Homozygous: microphthalmia with lens and comeal abnormalities in mice. No 
human mutations identified to date.
(Lee et al. 2005; Tomita et al. 1996; Lee et al. 
2005)
SOX2 SE, OV, NR, lens, OS Heterozygous: anophthalmia in humans. No eye phenotype reported in mice. 
Homozygous: pre-implantation lethal in mice.
(Kamachi etal. 1998; Furuta and Hogan 1998; 
Avilion et al. 2003; Fantes et al. 2003)
HESX1
(Rpx)
Anterior neural plate Heterozygous: mild septo-optic dysplasia in humans, which is characterised by 
forebrain, midline and pituitary abnormalities.
Homozygous: septo-optic dysplasia in humans. In mice, microphthalmia and 
anophthalmia are detected in addition to the human phenotypes.
(Thomas and Beddington 1996; Dattani et al. 
1998; Thomas et al. 2001)
SHH Prechordal plate, 
ventral forebrain
Heterozygous: holoprosencephaly which can involve anophthalmia, 
microphthalmia and coloboma, and colobomatous microphthalmia identified in 
humans. No phenotype in mice.
Homozygous: cyclopia in mice.
(Echelard et al. 1993; Roessler et al. 1996; 
Schimmenti et al. 2003; Chiang et al. 1996; 
Furimsky and Wallace 2005)
BMP4 Dorso-distal OV, SE, 
dorsal NR, extra­
ocular mesenchyme, 
OS
Heterozygous, microphthalmia, optic nerve hypoplasia, a range of ASDs and 
PHPV in mice. No mutations identified in humans.
Homozygous, embryonic lethal and failure of lens induction in mice.
(Furuta and Hogan 1998; Dudley and 
Robertson 1997; Dunn et al. 1997; Chang et 
al. 2001)
BMP7 Proximal OV, SE, OS,
RPE, extra-ocular 
mesenchyme
Homozygous: anophthalmia at birth in mice, though OC forms initially. No 
mutations identified in humans
(Dudley and Robertson 1997; Godin et al. 
1998; Dudley et at. 1995; Luo etal. 1995)
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MSX2 (Hox8, 
Hox8.1)
OV. SE. dorsal NR 
and lens placode
Transgenic mice that over-express Msx2 under its own promoter display 
microphthalmia.
Gain and loss of function mutations in humans have been reported in patients 
with skull malformations and craniosynostosis, but not eye defects.
(Monaghan et al. 1991; Wu et al. 2003; Wuyts 
et al. 2000; Wilkie et al. 2000)
OTX2 OV. RPE Heterozygous: anophthalmia, microphthalmia, and coloboma in humans. 
Craniofacial malformation in mice.
Homozygous lack of forebrain/midbrain in mice.
(Simeone et al. 1993; Ragge et al. 2005; Ang 
et al. 1996; Matsuo et al. 1995)
MITF OV, RPE Heterozygous: Waardenburg syndrome type II associated with hearing loss and 
pigmentation defects, including that of the eyes, in humans.
Homozygous: microphthalmia and pigmentation defects in mice.
(Hodgkinson et al. 1993; Steingrimsson et al. 
1994; Nguyen and Amheiter 2000; Tassabehji 
etal. 1994)
CHX10 OV, NR Homozygous: microphthalmia and cataracts in humans. Microphthalmia and 
absence of the optic nerve in mice.
(Liu et al. 1994; Burmeister et al. 1996; Ferda 
Percin et al. 2000; Bar-Yosef et al. 2004)
Cx43
(Connexin43; 
Connexin a; 
GJA1)
OV. SE, RPE. lens Heterozygous: oculo-dento-digital syndrome which is associated with 
microphthalmia, cataracts, and iris abnormalities in humans.
Homozygous: a 3 bp homozygous duplication reported in a oculo-dento-digital 
syndrome patient. No eye phenotype in mice.
(Yancey et al. 1992; White et al. 2001; 
Paznekas et al. 2003; Kjaer et al. 2004; Vitiello 
et al. 2005)
Vax1 Ventral OV, ventral NR 
(briefly); OS
Homozygous: coloboma and optic nerve dysgenesis as well as variable 
craniofacial and basal telencephalic defects in mice. No human mutations 
identified to date.
(Mui et al. 2005; Halionet et al. 1999; Bertuzzi 
etal. 1999)
Vax2 Ventral OV, ventral NR Homozygous: coloboma depending on genetic background and abnormal 
retinocollicular projections in mice. No human mutations identified to date.
(Mui et al. 2005; Barbeiri et al. 2002; Mui et al. 
2002)
PAX2 Ventral OV, ventral 
NR; OS
Heterozygous: renal-coloboma syndrome, associated with microphthalmia in 
some cases in humans.
Homozygous: coloboma, abnormal optic nerve development and lack of 
contralateral optic nerve fibre projections in mice.
(Nomes et al. 1990; Torres et al. 1996; Eccles 
and Schimmenti 1999)
Gas1 Dorsal OV, SE, NR, 
RPE, lens
Homozygous: microphthalmia with lens and comeal abnormalities in mice. No 
human mutations reported to date.
(Lee etal. 2001a)
Lhx2 (Ap, 
Lh2, Lh2A)
OV. NR, OS Homozygous: anophthalmia in mice. No human mutations identified to date. (Porter et al. 1997)
Bf1 (Foxgl; 
Hfh9. HfhbfD
Nasal OV, Homozygous: coloboma, reduction or absence of the OS, and small lens in mice. 
No human mutations identified to date............................
(Hatini etal. 1994; Huh etal. 1999)
The mouse phenotypes are a result of targeted loss of function mutations or naturally occurring mutations in genes.
Abbreviations: ASDs: anterior segment defects; NR, neural retina; OC, optic cup; OS, optic stalk; OV, optic vesicle; P, postnatal day; RGC, retinal ganglion cell; RPE, retinal 
pigmented epithelium; SE, surface ectoderm.
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Apart from the severe structural eye defects described earlier, more subtle alterations 
in eye size and shape can also have an impact on vision. For optimal perception of 
visual input, the axial length of the eye and the power of its optics, which include the 
cornea and the lens, controlled by the ciliary muscles, must correlate well 
(Coulombre 1965). Abnormal size or shape of the retina, or of the lens or the cornea, 
will compromise focusing of images onto the retina, resulting in myopia (short­
sightedness) or hyperopia (long-sightedness). Myopia occurs when the focused 
image falls in front o f the retina, while hyperopia occurs when the image is focused 
behind the retina. An elongation of 1 mm without other compensation results in a 
myopia of -2 to -2.5 diopters (Jacobi et al. 2005). This suggests that even slight 
differences in eye size and shape have a major impact on human visual acuity. A 
diopter is a unit of measurement of the optical power of the lens that is used to 
correct for a refractive error.
Various epidemiological studies have provided evidence which suggest a 
contribution to the development of myopia by visual factors such as intensive 
reading (Wallman and Winawer 2004). A genetic basis has however also been 
recognised (Jacobi et al. 2005; Wallman and Winawer 2004; Mutti et al. 2002). 
Although several chromosomal loci for pathological or juvenile-onset myopia have 
been identified by genetic linkage studies, to date, no particular gene has been 
identified. A genome-wide linkage study in a cohort of dizygotic twins identified 
strong linkage to the 3’ region of the PAX6 gene (Hammond et al. 2004). Another 
study has reported mutations in MFRP, which encodes a protein related to the Wnt 
receptor frizzled, in patients with extreme hyperopia (Sundin et al. 2005). It has been 
suggested that mutations in genes important for embryonic growth of the eye may 
also influence growth postnatally (Manson et al. 2005). Currently, little is known 
about the identity of genes that regulate eye shape and if developmentally expressed 
genes can have an impact on the shape of the adult eye.
Although rare in occurrence, microphthalmia, anophthalmia, and coloboma are the 
most severe forms o f structural eye defects and a cause of childhood blindness. It is 
therefore o f interest to identify the specific genes and mutations that cause these 
defects and to investigate the mechanisms at the cellular and tissue levels that are
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perturbed by such mutations. To do this, it is essential to understand how these genes 
normally regulate eye development and to characterise the cellular mechanisms that 
are impaired.
1.1.3 Mechanisms affecting eye size
Eye size is dependent upon several developmental events at the cellular level. It is 
dependent on the number of neural progenitor cells that are initially specified to form 
the optic vesicle. Evidence for this is provided by manipulations of eye field 
transcription factors, which define the progenitor population in the anterior region of 
the developing forebrain. For example, over-expression of, XOptx2 (Six6), one of the 
genes expressed in the eye field, in Xenopus embryos induces the formation of 
abnormally large eyes by increasing the eye field progenitor population shown by 
enlarged domains of expression of Rxl and Pax6 on the injected side and by 
increased proliferation o f these cells (Zuber et a l 1999). These experiments also 
demonstrate the role of cell proliferation in the control o f the size of the eye. An 
example where a change in cell fate alone results in an abnormally large eye, is when 
the R xl or Rx2 genes o f zebrafish are misexpressed. Misexpression of either induces 
eye formation at the expense of forebrain tissue (Chang Chuang and Raymond 2001).
Cell death as well as differentiation are two other mechanisms that if perturbed can 
cause changes in the size of a tissue. For example, the microphthalmia observed in 
H esl mutants is at least partly due to premature neuronal cell differentiation at 9.5 
dpc when the optic vesicles have not yet invaginated (Lee et al. 2005).
The major role of early expressed genes in controlling growth and development of 
the eye, is highlighted by the type of disease causing genes in Table 1.1. Currently, 
many genes have been identified that are expressed in the eye, the function of some 
have been well-characterised, but the overall picture o f how the genes fit into the 
network that controls formation of the eye is far from complete. Interestingly, over 
the past decade, genes with an asymmetrical expression pattern have been identified 
in the eye. This suggests that the eye, like the rest of the developing nervous system, 
is a highly patterned structure and may possess regional developmental programs 
acting synchronously to drive its development. In other parts of the nervous system
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such as the spinal cord, the significance of patterning is more apparent and much 
more is known about the regulation and outcome of patterning by distinct gene 
expression domains. In contrast, the structure of the eye, apart from the well-studied 
requirement of positional information for topographic mapping of RGC axons to the 
brain, offers little clues as to why distinct gene expression domains are needed, as it 
does not display profound spatial differences once fully formed. The significance of 
patterning is addressed in a later section, but first, the genes that display 
asymmetrical expression in the eye must be introduced. This description is mainly 
focused on patterning along one of the axes of the eye, the dorso-ventral (D-V) axis, 
which is the one investigated in this thesis.
1.2 Molecular patterning and regionalisation of the eye
The eye is patterned by localised gene expression along the three main axes of the 
embryonic body plan. These are the anterio-posterior, the D-V, and the proximo- 
distal (P-Di) axes. Although initially in line with the main body plan, due to the 
rotation of the embryo during gastrulation, these axes apply mainly to the developing 
eye. For example, the anterio-posterior body axis becomes the naso-temporal (N-T) 
axis of the eye. These are indicated in Fig. 1.2 in schematic drawings of the 
developing eye as it invaginates.
The first sign of patterning is along the P-Di axis with the specification of the neural 
retina versus the RPE in the optic vesicle. This event is first obvious in terms of 
differential gene expression in the proximal versus the distal layer of the optic 
vesicle, as will be described in more detail in section 1.2.1, and later by the 
differentiation of the pigmented cells of the RPE and thickening of the neural retina. 
Transplantation experiments, performed in the chick embryo, have suggested that the 
N-T and the D-V axes of the eye are also established at optic vesicle stage and during 
the period of optic vesicle invagination respectively, prior to retinal cell 
differentiation (DUtting and Thanos 1995; Uemonsa et al. 2002). The N-T axis is 
thought to be determined prior to the D-V axis. When optic vesicles are transplanted 
in reverse along the D-V axis in ovo at ss 8, by the removal of the optic vesicle 
including the surface ectoderm and surrounding mesenchyme from a donor embryo 
and placement of it in the reverse orientation along the D-V axis into a cavity created
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in a host embryo, the eye develops properly and expresses characteristic markers of 
the dorsal and ventral neural retina in the correct place with respect to the host axes 
(Uemonsa et al. 2002). Transplantations performed after ss 14 (HH 11) show that the 
optic cup forms properly but in the reverse orientation to the newly acquired plane 
with the optic fissure forming in the dorsal region (Uemonsa et al. 2002). This 
suggests that the D-V axis is specified some time between ss 8-14 and prior to optic 
cup invagination, which occurs at HH 14. Others have shown that the D-V axis can 
be re-specified according to the host environment up to HH 13 (Goldberg 1976).
Interestingly, although explant cultures are not ideal for examination of eye shape, 
optic vesicles truncated at ss 10 (HH 10), when the axes may not be established, and 
cultured for 2-3 days develop round-shaped optic cups, while those explanted at ss 
14-17 (HH 11-12) developed oval-shaped optic cups, suggesting that optic cup shape 
may be linked to the correct establishment o f D-V polarity (Uemonsa et al. 2002).
The question then arises as to which genes are involved in the molecular regulation 
of patterning o f these axes. Many candidates have been identified based on 
asymmetrical expression patterns, mostly at RNA level. Some have been 
experimentally proven to induce profound changes on eye development, by loss of 
function and/or gain of function studies. For the purpose of this thesis, I will mostly 
focus on the evidence in the chick and the mouse model systems.
1.2.1 Neural retina versus RPE specification
At optic vesicle stage, the distal and proximal layers o f the optic vesicle are equally 
thin in morphology but by 10.5 dpc in the mouse embryo, when invagination is 
underway, these layers become morphologically distinct with the distal layer 
becoming thicker in appearance in comparison to the proximal layer. Pigmentation of 
the proximal layer becomes apparent shortly after; it is initiated dorsally and spreads 
ventrally (Robinson 1991). Prior to any morphological manifestations however, the 
distal region of the optic vesicle becomes specified to form the future neural retina 
and the proximal region becomes fated towards RPE formation by differential gene 
expression.
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Several signalling molecules and transcription factors have been identified, which are 
involved in this event. Microphthalmia associated transcription factor  (Mitf) in the 
mouse, but not in the chick embryo, is initially expressed in the entire optic vesicle 
and later becomes restricted to the proximal layer (Nguyen and Amheiter 2000). In 
the chick embryo, it is detected proximally from the onset of its expression (Mochii 
et al. 1998). The retraction of M itf in mice, and the induction of neural retinal fate in 
the distal layer have been attributed to the effect of secreted factors from the surface 
ectoderm and the extra-ocular mesenchyme. Removal of the surface ectoderm results 
in a mosaic appearance of intermingled neural retina and RPE cells (Hyer et al. 
1998). Conversely, signals from the extra-ocular mesenchyme upregulate M itf 
expression, while repressing neural retina specific genes including ChxlO (Fuhrmann 
et al. 2000).
Members o f the fibroblast growth factor (FGF) family o f signalling molecules, which 
are expressed in the surface ectoderm overlying the optic vesicle, have been shown 
to possess neural retina inducing abilities. Although Fgfl and Fgf2 compound 
mutants do not exhibit eye abnormalities (Miller et al. 2000), FGF 1/2 treatment of 
the optic vesicle or newly formed RPE, induces the formation of a neural retina 
instead o f the RPE (Zhao et al. 1995; Pittack et al. 1997; Hyer et al. 1998). 
Furthermore, misexpression of either Fgf9, which is normally expressed in the neural 
retina, in the presumptive RPE region under the regulation of the Tyrpl RPE specific 
promoter, induces the formation of an ectopic neural retina in place of the RPE (Zhao 
et a l  2001).
Members o f the Hedgehog (Hh) family of signalling molecules also appear to be 
involved in RPE formation. Retroviral driven misexpression of sonic hedgehog 
(Shh), the vertebrate homologue of the Drosophila Hh gene, in the chick induces 
ectopic Otx2 expression, a transcription factor normally restricted to the RPE, and 
pigmentation in the periphery of the inner layer of the optic cup. Downregulation of 
Otx2 and neural retina formation is observed in the outer layer of the optic cup in the 
reverse experiment using a blocking antibody to decrease Shh activity (Zhang and 
Yang 2001).
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The onset o f ChxlO expression at 9.5 dpc in the distal optic vesicle in the mouse 
embryo is coincident with the retraction of M itf to the proximal region (Liu et al. 
1994; Nguyen and Amheiter 2000). Recently it was shown that a dose dependent 
antagonistic interaction between ChxlO and M itf exists, which is essential for the 
maintenance o f neural retina and RPE fates (Rowan et al. 2004; Horsford et al.
2004). In ChxlO homozygous null mice, the neural retina is progressively pigmented 
as M itf and its downstream targets are increasingly upregulated with developmental 
age in the neural retina (Horsford et al. 2004; Rowan et al. 2004). Mice harbouring 
various mutated M itf alleles exhibit a progressive RPE to neural retina transformation 
and show ectopic expression of ChxlO and other neural retina markers in the 
transformed RPE (Nguyen and Amheiter 2000; Bumsted and Barnstable 2000). 
These observations suggest that M itf and ChxlO are not required for the induction, 
but are essential for the maintenance of the two cell fates.
Interestingly, mice carrying several of the mutated M itf alleles display 
transdifferentiation of the dorsal RPE only (Scholtz and Chan 1987; Nguyen and 
Amheiter 2000; Bumsted and Barnstable 2000), suggesting that the specification of 
the RPE is differentially regulated along the D-V axis o f the eye. In further support 
of this idea, loss o f function of Growth arrest specific gene I (Gas I ), a Glycosyl- 
Phosphatidyl-Inositol (GPI)-anchored membrane protein, results in the 
transdifferentiation o f the ventral RPE into neural retina (Lee et al. 2001a). Fgf9 
homozygous null mutants show a slight expansion o f the RPE into the ventral and 
nasal neural retina only (Zhao et al. 2001). Transgenic misexpression of MITF in the 
neural retina on Chxl(PrJOrJ background induces a complete transformation of 
almost the entire neural retina into an RPE except the dorsal periphery (Horsford et 
al. 2004). Msx2, a homeobox encoding gene which is expressed in the dorsal region 
of the developing eye, can suppress the RPE fate when misexpressed in chick RPE 
cultures (Holme et al. 2000), suggesting that it may also do so in the dorsal neural 
retina during eye development. How or why the regulation of the neural retina and 
RPE boundaries are separately regulated in the dorsal and ventral regions of the eye 
is currently not known.
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1.2.2 Molecular regulators of dorso-ventral patterning
Signalling molecules, such as members of the Hh, Fgf, Bone morphogenetic protein 
(Bmp), and Wingless-related (the Wnts) factors, as well as retinoic acid (RA) 
signalling, are highly conserved in animal development and recur in the development 
o f many distinct tissues of the embryo. Signalling molecules that pattern the limb 
bud (Tickle 2002), the neural tube (Lee and Jessell 1999; Jessell 2000), or the 
somites (Hofmann 2003) for example, are also expressed in the developing eye, 
making it possible to correlate the expression o f these factors in relation to each other 
and compare their interactions within different tissues. The individual role of some of 
these signalling molecules in the eye is starting to emerge, but their concerted 
interactions is far less understood. To fully appreciate patterning of a system 
however, all contributing components and their interactions must ideally be 
considered. In this section, an overview of asymmetrically expressed genes along the 
D-V axis and their roles in patterning of the eye is provided. A schematic of the 
interactions between genes described in this section is given in Fig. 1.4
1.2.2.1 Signalling molecules in D-V patterning of the developing eye
As the optic vesicles are emerging from the developing forebrain, the tissue has 
already been exposed to various signals in the anterior neural plate, which are likely 
to affect patterning o f the optic vesicles. Shh is expressed in the prechordal plate as 
the optic pits evaginate (Echelard et al. 1993). Shh is later expressed in the ventral 
telencephalon and in the Xenopus embryo, double-labelling with Rx (eye field 
marker) has indicated that in fact they overlap in expression in the medial region of 
the eye field at neurula stage (Crossley et al. 2001; Zhang and Yang 2001; Furimsky 
and Wallace 2005; Lupo et al. 2005). Shh is a signalling molecule, shown to be 
acting as a morphogen in the vertebrate neural tube to pattern the ventral neural tube 
into distinct domains of gene expression and induce ventral cell fates including 
motor neurons (Briscoe et al. 2001). SHH  mutations have been identified in patients 
with holoprosencephaly (Roessler et al. 1996), which is a heterogeneous condition 
caused by midline defects in the embryonic forebrain including cyclopia (OMIM 
#142945). Mice with a targeted disruption of Shh also display cyclopia and ventral 
midline defects (Chiang et al. 1996). Analyses of mutants lacking ventral midline
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Shh expression in the forebrain, such as the cyclops mutant in zebrafish, which 
encodes a signalling factor related to the mouse Nodal (Feldman et al. 1998; 
Sampath et al. 1998; Rebagliati et al. 1998), or the Brain Factor1 (Bfl> Foxgl -  
Mouse Genome Informatics) mouse mutant, which specifically loses Shh expression 
in the ventral telencephalon by 10.5 dpc, have revealed that Shh is essential for 
establishing optic stalk fate, and the boundary between optic stalk and the neural 
retina. This is evident by the loss of optic stalk at the expense of neural retinal tissue 
and at the molecular level, it is obvious in the expansion of Pax6 at the expense of 
Pax2 expression (Macdonald et al. 1995; Huh et al. 1999). In a normal eye, Pax6 and 
Pax2 are reciprocally expressed in the optic cup and the stalk respectively. Injection 
of Shh RNA in zebrafish or misexpression in the chick eye via retroviral gene 
delivery induces optic stalk tissue at the expense of the ventral neural retina and a 
distal shift of the Pax6/Pax2 border into the neural retina (Macdonald et al. 1995; 
Zhang and Yang 2001). Shh signalling also positively regulates the expression of the 
ventral anterior homeobox containing (Vox) transcription factors. This has been 
shown by the expansion of Vox upon Shh RNA injections in zebrafish, and the 
reduction of Vox gene expression in smoothened mutants (Take-uchi et al. 2003). 
Smoothened is a transmembrane protein that mediates the Hh signal (Ingham and 
McMahon 2001). The same is likely to apply in the chick embryo, where application 
of a Shh blocking antibody to the optic vesicle at HH 10 abolishes cVax expression 
(Zhang and Yang 2001).
From both zebrafish and chick overexpression studies of Shh, it has been proposed 
that Shh may have a role in the establishment of the overall D-V axis of the eye and 
that it does so by repressing Bmp4, a member of the Bmp family of signalling 
molecules. Treatment of the chick optic vesicle by a Shh blocking antibody results in 
the expansion of Bmp4 expression ventrally, offering support for a naturally 
occurring antagonistic relationship between Shh and Bmp4 in the developing chick 
eye (Zhang and Yang 2001). The idea that Hh signalling is important for D-V 
patterning of the eye was further strengthened recently with overexpression 
experiments of Hh related factors in Xenopus, in which there was a dorsal shift of 
several markers namely Pax2, Pax6, and Vox genes, as well as Aldhla3 and ET 
(Lupo et al. 2005).
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Shh
Fig. 1.4 Interactions between genes along the D-V axis of the developing 
eye as described in text
The information is based on information from mouse mutants and chick 
misexpression studies. References were described in text. Bmp4 misexpression 
induces Tbx5 expression, which in turn induces the expression of the dorsally 
expressed ephrinBs and represses the ventrally expressed EphB2, which may be 
indirect via Vax2. Lack of Vax2 induces EphB2 expression, while cVax (chick 
homologue o f Vax2) represses dorsal genes when misexpressed. Bmp4 is antagonised 
by misexpression of the ventral genes Ventroptin and Shh. There is also mutual 
antagonism between Pax6 and the ventrally expressed Vaxl, Vax2y and Pax2y while 
Pax6 is thought to positively regulate Tbx5 expression. This picture highlights the 
antagonistic relationship between the genes in the dorsal eye and those in the ventral 
eye. The exact hierarchy in which these interactions occur is currently not fully 
known.
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Shh has also later roles in eye development and appears to be involved in cell 
differentiation, axon guidance within the retina and also at the chiasm, and has a 
mitogenic effect in the mammalian retina (Dakubo et al. 2003; Ingham and 
McMahon 2001). In summary, there is evidence that Shh regulates ventral eye fates 
and may regulate overall D-V patterning by antagonising Bmp4 from the dorsal eye 
(Fig. 1.4).
Other factors implicated in D-V axial patterning are RA and most recently, there has 
been evidence of a role for Fgfs. In Xenopus neurula stage embryos, RA and Fgfs are 
thought to influence patterning of the eye already at the eye field stage, when Fgf8 
and RA synthesising enzymes are expressed adjacent to the eye field (Lupo et al. 
2005). Misexpression studies of Hh-related signalling factors, RA, and an inducible 
form of Fgf receptor I (FgfrI) in the Xenopus eye suggests that these factors probably 
collaborate in a dose dependent manner to specify the optic stalk and ventral neural 
fates (Lupo et al. 2005).
Although the above described study suggests that Fgf signalling contributes to axial 
patterning of the developing eye, a similar role in the development of the eye in other 
species has not been investigated. Moreover, as will be addressed in Chapter 3, the 
pattern and identity of the Fgfs that are expressed in the eye differ among vertebrate 
species. As such, data cannot be easily extrapolated between species.
RA, which derives from Vitamin A, is synthesised by the action of retinaldehyde 
dehydrogenases (RALDH), (Duester 2000). RA activity is asymmetrically 
distributed along the D-V axis in the neural retina in vertebrate species, including the 
chick and the mouse. The highest levels of RA activity is detected in the ventral 
neural retina as compared to the dorsal region. This pattern of activity is established 
by the action of several RA synthesising and RA degrading enzymes, which are 
differentially expressed across the neural retina and also possess differing substrate 
range and enzyme kinetics (McCaffery et al. 1991; McCaffery et al. 1992; Grlin et 
al. 2000).
Using a RA-responsive lacZ reporter under the control of the retinoic acid receptor 
(RAR)B promoter, the striking pattern of RA responsive regions within the
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developing eye has been revealed, which corresponds to the expression patterns of 
A ld h la l (.Raldhl, Ahd2, A ld h l, E l -  Mouse genome informatics) in a dorsal domain 
and Aldhla3  (Raldh3, Aldh6f VI -  Mouse Genome Informatics) in a ventral domain, 
separated by a sharp middle domain without labelled cells, where members of the 
CYP26 family degrade RA (Wagner et al. 2000). This pattern of RA activity is also 
evident in the chick eye, with the same spatial expression of RA synthesising 
enzymes, although temporally they are expressed slightly later in the chick than in 
the mouse eye (Suzuki et al. 2000; Mey et al. 2001).
The CYP26 family of enzymes are cytochrome P450-linked oxidases which degrade 
RA. In the mouse embryo, Cyp26al is the only CYP26 expressed from 9.5 dpc until 
around 14.5 dpc, when the expression of Cyp26cl initiates (Sakai et al. 2004). 
Together they are expressed in a narrow stripe along the N-T meridian of the optic 
cup, slightly dorsal to the optic disc. This pattern of expression continues until birth 
after which it starts to decline and disappears by p l4  (McCaffery et al. 1999; Li et al. 
2000; Sakai et al. 2004).
A role for RA in D-V patterning has been proposed based on its asymmetrical 
activity along the D-V axis (Marsh-Armstrong et al. 1994; McCaffery et al. 1999). 
But investigation of D-V markers in higher vertebrates have until recently not 
provided any supporting evidence for this hypothesis. Very recently however it was 
shown that retroviral driven expression of a dominant negative form of RARa in the 
developing chick eye results in the loss o f the ventrally expressed Eph receptors and 
the dorsally expressed ephrinB2 (Sen et al. 2005). Other asymmetrically expressed 
genes however are not affected (Tbx5, Vax2). Neither are they affected when RA 
signalling is manipulated in mice with targeted disruptions of both A ldhla l and 
Aldhla3, which are the only RA synthesising enzymes expressed in the optic cup 
(Matt et al. 2005). This is in contrast to experiments in Xenopus and zebrafish where 
addition o f RA is reported to expand early ventral markers and abolish dorsal 
markers (Lupo et al. 2005; Hyatt et al. 1996).
The role o f RA in eye development appears to be dose-dependent and has been best 
demonstrated in zebrafish; excess RA causes the loss of dorsal markers and 
duplication of the neural retina due to proliferation of ventral RPE precursor cells
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(Hyatt et al. 1992; Hyatt et al. 1996), while RA deficiency, induced by citral 
treatment which is a competitive inhibitor of RALDH enzymes, results in failure of 
ventral neural retinal formation (Marsh-Armstrong et al. 1994). Interestingly, 
application of an RA-soaked bead anywhere around the developing eye induces the 
formation of an optic fissure (Hyatt et al. 1996). RA deficiency during gestation also 
often causes microphthalmia and anophthalmia (Kalter and Warkany 1959). These 
studies highlight the importance of D-V patterning for optic cup morphogenesis and 
growth and suggest that there may be cross-talk between all these signalling 
pathways or alternatively, that they converge by regulating the same downstream 
targets. Some of the genes that are affected by manipulations of these factors have 
already been mentioned. These are mainly transcription factors and other 
asymmetrically expressed genes, which are introduced more extensively in the 
following section.
1.2.2.2 Transcription factors and topographic guidance molecules
along the D-V axis of the eye
Vaxl and Vax2 are expressed in a dynamic and overlapping pattern in the ventral 
optic vesicle and optic stalk from 9.5 dpc in the mouse. By 11.5 dpc, their expression 
becomes complementary; Vax2 is expressed in the ventral neural retina while Vaxl is 
expressed in the optic stalk (summarised in Mui et al. 2005). In the chick embryo, 
only one Vox gene has been identified, cVax, which in protein structure is most 
closely related to the mouse V axl, but in terms of gene expression encompasses the 
areas covered by both Vaxl and Vax2. Moreover, its expression appears to be 
initiated after the onset of optic vesicle invagination, which is slightly later than the 
onset of Vox genes in the mouse, (Schulte et al. 1999). Gain of function studies of 
Vox genes in the chick and Xenopus embryos, as well as analysis of mice 
homozygous for a loss of function mutation in Vax2 or Vaxl genes, have revealed 
that they have a vital role in specifying ventral neural retinal cell identity and optic 
stalk fates and are implicated in topographic mapping. This is based on observations 
that mice with a targeted deletion of Vax2 display abnormal axonal projections of 
ventrally located RGCs (Barbeiri et al. 2002; Mui et al. 2002), while loss of function 
of both Vox genes simultaneously in the mouse, causes a gradual expansion of neural 
retinal tissue, so that by 12.5 dpc the neural retina has
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replaced the entire optic stalk all the way to the ventral forebrain. By postnatal day 
(P)7 it has differentiated to possess retinal cell types of a normal retina (Mui et al.
2005). This phenotype is suggested to be the result o f the absence o f the strong direct 
inhibitory action of the two Vax genes together on the expression of Pax6, shown by 
chromatin immunoprecipitation assays, co-transfection assays, as well as 
electromobility gel shift assays (Mui et al. 2005). In support of a role for Vax genes 
in repressing Pax6, Vaxl misexpression in Xenopus embryos can repress formation 
o f the optic cup by reducing the expression of Pax6 (Hallonet et a l 1999). This 
interaction seems to be reciprocal as in the absence of Pax6, Vaxl and Vax2 are 
expanded in the entire optic vesicle in the mouse (Baumer et al. 2002). Pax6 is 
expressed in the entire optic vesicle and stalk and the overlying surface ectoderm, 
and later in the optic cup and the lens (Walther and Gruss 1991; Grindley et al.
1995).
Targeted deletions o f either Vaxl or Vax2 result in coloboma with the loss of Vaxl 
causing a more severe coloboma than seen in the absence of Vax2 (Hallonet et al. 
1999; Barbeiri et al. 2002). Vax2 also plays a role in establishing the pattern of rod 
photoreceptor differentiation in the ventral neural retina, shown by retroviral 
misexpression studies in the chick embryo (Schulte et al. 2005).
Another ventrally expressed gene that has been well characterised is Pax2. Pax2 is a 
paired box transcription factor possessing a dynamic expression pattern during optic 
cup morphogenesis. It is expressed in the ventral optic vesicle and optic stalk, but 
later retracts to occupy the optic stalk alone (Nomes et al. 1990). Mice homozygous 
for a null allele o f Pax2 exhibit developmental defects affecting several organs in 
which Pax2 is expressed, including the eyes (Torres et al. 1996). Pax2 homozygotes 
have coloboma, due to failure of closure o f the optic fissure. They also exhibit 
abnormal optic nerve development, as the optic stalk differentiates into pigmented 
cells in the absence of Pax2, which surround the optic nerve fibres. Moreover, the 
optic nerve is reduced in thickness and all axons project ipsilaterally (Torres et al.
1996). Like the Vax genes, Pax2 and Pax6 also interact in a mutually antagonistic 
manner. This has been shown by in vitro assays as well as in vivo, by the expansion 
of the expression of one gene at the expense of the other (Schwarz et al. 2000). This
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interaction is important for the establishment of the optic cup versus the optic stalk 
boundary along the P-Di axis of the eye.
Pax6 is emerging as an important factor in the regulation of both the dorsal and the 
ventral neural retina, and may be the gene that coordinates the two regions. In the 
absence o f Pax6, while Vax gene expression is expanded, the dorsally expressed T- 
box gene, Tbx5 is not present in the optic vesicle (Baumer et al. 2002). A recent 
report, which studied these interactions using misexpression of Pax6 in the chick eye 
by electroporation, glutathione S-transferase (GST)-pull-down assays, and co­
transfection assays has suggested that Pax6 can regulate the expression of the dorsal 
markers Tbx5 and Bmp4 and that Tbx5 in turn can activate the Pax6 a-enhancer 
regulatory element as well as bind the full-length Pax6 protein (Leconte et al. 2004). 
Contradictory to the reporting of Pax6 regulating Bmp4, Bmp4 expression in the 
homozygous Pax6Sey ISeu mouse is normal. Pax6 expression is also normal in the 
Bmp4 loss o f function mutant (Furuta and Hogan 1998), suggesting that in the mouse 
at least, Bmp4 and Pax6 do not regulate each other’s expression.
The studies described so far highlight that the ventral neural retina is under tight 
regulation o f several signalling molecules and transcription factors and that there is a 
considerable amount of feed-back in place. When ventral genes are manipulated, 
conditions such as coloboma, optic nerve defects, and RGC axonal misprojections 
result. Some information regarding the role of dorsally expressed genes in patterning 
of the eye has been provided by chick misexpression studies. There is evidence, that 
manipulations of the dorsally expressed genes Bmp4 and Tbx5 in the chick embryo 
also cause abnormal RGC axonal projections (Koshiba-Takeuchi et al. 2000), though 
milder than those caused by Vax2, even though the expression of Vax2 is disrupted. 
Misexpression of Tbx5 and cVax in the chick repress each other’s expression 
(Koshiba-Takeuchi et al. 2000; Schulte et al. 1999), though an antagonistic 
interaction has not been observed in the loss of function Vax2 mutant (Barbeiri et al. 
2002). Both misexpression of Bmp4, as well as the Bmp antagonist, Ventroptin, in 
the chick eye have shown that Tbx5 is downstream of Bmp4 (Koshiba-Takeuchi et al. 
2000; Sakuta et al. 2001). The role of two other dorsally expressed T-box genes, 
Tbx2 and Tbx3 in amniotes have not been studied and much remains to be learnt 
about Bmp4 and Tbx5 in the regulation of eye development.
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The best characterised aspect of D-V patterning of the eye is topographic mapping of 
RGC axons to the brain. Normally, the medial colliculus in mouse or the medial 
tectum in chick are invaded by axons from the ventral neural retina, while the lateral 
colliculus or tectum are invaded by axons from the dorsal neural retina. Several 
Eph/ephrin molecules are asymmetrically expressed in a graded fashion in the neural 
retina and in a complementary pattern in the tectum/superior colliculus. As such, 
they have been subject to much attention as candidates involved in Sperry’s long­
standing chemoaffmity theory, which proposed that topographic mapping of axonal 
projections from the neural retina to the brain are facilitated by corresponding graded 
distribution o f molecules on the RGCs and their targets (Sperry 1963). The Eph 
proteins are transmembrane tyrosine kinase receptors and their ephrin ligands are 
either transmembrane proteins (ephrinBs) or membrane bound through a GPI linkage 
(ephrinAs) (Wilkinson 2001). The postulated role of the Eph/ephrin molecules in 
RGC axon guidance has been substantiated over recent years by in vitro and in vivo 
functional studies involving manipulation o f the Ephs/ephrins, or other upstream 
regulators. Progress was first made in identifying and understanding the function of 
the EphA receptors and ephrinA ligands in the regulation of RGC projections from 
the nasal and temporal regions of the neural retina to the anterio-posterior axis of the 
tectum/superior colliculus. The EphA receptors are collectively expressed in a 
temporal-high nasal-low gradient in the neural retina, while the ephrinA ligands are 
collectively expressed in a posterior-high, anterior-low pattern in the tectum. A 
combination o f in vitro studies of axonal behaviour from different parts of the retina, 
using the membrane stripe and growth cone collapse assays, and in vivo gain of 
function and loss o f function studies have shown that these molecules mediate 
topographic mapping o f axonal projections via repulsive interactions, such that 
RGCs from the temporal neural retina, which express high levels of EphA receptors, 
settle in the anterior region of the tectum, which expresses the lowest levels of 
ephrinA ligands, because further posteriorly, they are repulsed by the increasing 
ephrinA gradient (O'Leary et al. 1999).
The EphB receptors and ephrinB ligands are involved in topographic mapping of the 
D-V axis o f the neural retina along the medio-lateral (M-L) axis of the 
tectum/superior colliculus. Unlike the repulsive mechanism of topographic mapping
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mediated by the EphA/ephrinAs, the EphB/ephrinBs appear to operate on the basis of 
attraction in the visual system, so that dorsally derived RGCs from the neural retina, 
where ephrinBs are expressed at high levels, project to the lateral tectum/superior 
colliculus which expresses high levels of EphB receptors. Along the D-V axis of the 
neural retina, ephrinB2 and ephrinBl are expressed dorsally, while EphB2 and 
EphB3 are expressed in a ventral-high dorsal-low gradient, with EphB2 shown to be 
expressed on RGC axons (Holash and Pasquale 1995; Holash et al. 1997; Braisted et 
al. 1997; Connor et al. 1998; Birgbauer et al. 2000; Hindges et al. 2002).
In Xenopus, in vivo experiments that increase or decrease levels of ephrinB2 
signalling in the neural retina show that ephrinB2 signalling is important for 
targeting o f axons to the lateral tectum in a concentration dependent manner. For 
example when wild-type ephrinB2 is misexpressed in the ventral neural retina, RGC 
axons originating from this region project incorrectly to more lateral tectal locations, 
while overexpression o f ephrinB2 in the dorsal neural retina, which already is 
expressing ephrinB2, causes an even more lateral shift o f dorsally derived axons 
(Mann et al. 2002). Furthermore, evidence was provided for attraction of ephrinB 
expressing dorsal neurites to EphB 1 expressing substrate, using a stripe assay.
Analysis o f compound mutants with disrupted alleles of EphB2 and EphB3 has 
shown that the EphB receptors are important for correct projections of ventro- 
temporal RGC axons to the lateral superior colliculus, as these mutants possess 
ectopic termination zones in more lateral locations (Hindges et al. 2002). These 
mutants also exhibit intra-retinal pathfinding errors to the optic disc, with a higher 
percentage o f dorsal axons missing the optic disc compared to ventrally derived 
axons (Birgbauer et al. 2000).
The role o f ephrinBl in topographic mapping has been studied in the chick tectum. 
Retroviral mediated targeting of the tectum specifically results in ectopic patches of 
ephrinBl expression, which do not disrupt the primary axonal projection pattern to 
the tectum. They do however shift the secondary branching of axons more laterally 
down the endogenous ephrinBl expression gradient (McLaughlin et al. 2003b). In 
mice and chick, the final topographic map is fine-tuned by the extension of 
secondary branches after the primary axons originating from the same location of the
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neural retina initially project broadly along the M-L axis of the tectum/superior 
colliculus. It is these branches rather than the primary axonal projections that get
shifted when the endogenous pattern of ephrinBl is disrupted (McLaughlin et al.
2003b). However, this study does not investigate the role of ephrinBl that is 
expressed in the dorsal neural retina in topographic mapping. Mice with targeted
deletions o f the dorsally expressed ephrinB2 have been generated, but not yet
analysed for eye or retinocollicular mapping defects (Adams et al. 1999).
There are several expression studies in the chick embryo which show that these 
genes are asymmetrically expressed soon after optic cup formation (HH 17-18), prior 
to the peak o f RGC differentiation (Braisted et al. 1997; Peters and Cepko 2002). 
Expression analysis in the mouse eye has so far been reported for slightly older 
developmental ages, past 13 dpc and beyond. However, one report has demonstrated 
the existence o f ligands of EphB2 in the dorsal region o f the invaginating optic cup 
o f 10.5 dpc mouse embryos using an EphB2-Fc fusion protein, which reveals 
distribution o f proteins but does not distinguish between the different ephrinB 
ligands (Marcus et al. 1996). This suggests that some of these molecules are 
expressed in the early optic cup, prior to the onset of RGC differentiation, and may 
therefore have additional roles in the formation o f the eye, as has been suggested 
following the early expression study in the chick (Braisted et al. 1997). It is 
important to determine their expression pattern at the earlier stages, as the expression 
o f these molecules appear to undergo dynamic changes during development. For 
example, the initial expression of EphB2 at 12-14 dpc is uniform, but later becomes 
graded (Birgbauer et al. 2000). The pattern o f expression of ephrinB2 in the early 
optic cup of the mouse embryo is examined in Chapter 3 of this thesis. These 
molecules have been shown to be regulated by Vax2/cVax (Schulte et al. 1999; 
Barbeiri et al. 2002; Mui et al. 2002) and Tbx5 (Koshiba-Takeuchi et al. 2000). It 
may therefore be a commonality that the Eph/ephrin molecules are downstream of 
asymmetrically expressed transcription factors.
Functional studies have revealed that the eye is patterned by a complex interaction of 
the genes mentioned in this section, and undoubtedly other as yet unidentified genes. 
These interactions not only occur at the RNA level but also at the protein level, and
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there appears to be feedback loops which add to the level o f  complexity that controls 
overall axial patterning o f the eye.
In the next sections, some aspects of eye development which either occur regionally 
or appear to require positional information, but the underlying mechanisms of which 
are not understood, are outlined in order to emphasise the importance of studying 
patterning o f the eye.
1.2.3 Significance of regional gene expression in eye development
Despite evidence of polarised gene expression in the neural retina, it does not display 
a striking distinction, morphologically or qualitatively in terms of differentiated cell 
types. There is a distinct centre to periphery temporal advancement of cell 
differentiation, with differentiation initiating centrally and expanding peripherally 
(Coulombre 1965; Drager 1985). But the end result is differentiation of the same cell 
types in all region o f the neural retina. A closer examination of the distribution of 
these cell types however, have revealed more subtle quantitative differences.
It is known that the RGCs form topographic maps in the brain, and require positional 
information to project correctly to their target sites (McLaughlin et a l 2003a). In the 
mouse, uncrossed or ipsilateral RGC axonal projections originate from the temporal 
and the ventral neural retina (Drager 1985). As described earlier, when certain 
asymmetrically expressed genes are manipulated, RGC axonal misprojections are 
observed (see section 1.2.2.2). The distribution of certain neuronal cell types can 
quantitatively differ along the different retinal axes. The density of cones and rods in 
the human retina is not uniform. For example, the central region of the human fovea, 
important for high acuity vision, lacks rods and cone density is higher in the nasal 
than the temporal retina (Curcio et al. 1990). The density of S (blue) and M (green) 
opsins, which are the visual pigments of the cones, is different along the D-V axis of 
the mouse retina, with M opsins present only dorsally and S opsins most abundant 
ventrally (Szel et al. 1992). In the chick, there is a rod-free zone within the area 
centralis, which is homologous to the human fovea, and the rod density of the dorsal 
neural retina is lower in comparison to the ventral region (Bruhn and Cepko 1996). 
Recently it was shown that the rod pattern in the chick retina is established at the
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optic vesicle stage by spatially restricted gene expression, including cVax (Schulte et 
al. 2005). These studies together with transplantation and rotation experiments of the 
optic vesicle, which disrupt early patterning of the eye and the RGC projections, 
suggest that early patterning, prior to the differentiation of retinal cell types, is 
important for the correct distribution of cells of the mature retina.
Further evidence that the eye is differentially regulated across its axes comes from 
discoveries o f the occurrence of region-specific defects. When RA signalling is 
manipulated in the zebrafish, only the ventral eye is affected (see section 1.2.2.1). 
Patients with superior segmental optic nerve hypoplasia display regionalised defects. 
This condition is characterised by several abnormalities of the superior (dorsal) 
region o f the eye including a more superior entry of the central retinal artery into the 
cup, a decrease in the superior optic nerve fibre layer, and loss of inferior visual 
fields (Unoki et al. 2002; Oster et al. 2004). In the next section, evidence for regional 
differences in cell proliferation and cell death during early optic cup formation is 
discussed.
1.2.4 Regional differences in proliferation and the pattern of cell death 
in the early optic cup
The morphogenesis of the optic cup and its growth can be divided into two 
overlapping phases. In the first phase, the optic vesicle invaginates and the distal and 
proximal layers become distinct in terms of thickness and cellular morphology. 
There is a dramatic shape change and modest growth. In the second phase, after optic 
cup formation, there is more profound growth but much less change in the shape of 
the eye. Analyses in this thesis have been carried out during the first phase and 
therefore a description of the pattern of cell death and proliferation during the period 
of optic cup morphogenesis is given here.
Spatio-temporal dynamics o f  the pattern o f  cell death during optic cup 
morphogenesis
During optic cup morphogenesis, the pattern of cell death is highly dynamic and 
regionalised. In the chick embryo, Tdt-mediated dUTP nick end labelling (TUNEL) 
of apoptotic cells and Feulgen staining of DNA has revealed that at optic vesicle
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stage (HH 13) cell death occurs in the optic stalk and extends to the central region of 
the optic vesicle. At HH 14, when the optic vesicle has started to invaginate, cell 
death is still localised to the optic stalk and the central region of the invaginating 
optic vesicle. By HH 16, cell death is detected in the optic stalk, in the ventral and 
central regions o f the optic cup in both the neural retina and the RPE, and a new area 
of cell death in the dorsal neural retina is apparent. By HH 18, the heavily labelled 
patch in the dorsal optic cup can no longer be detected, and labelling is seen in only a 
few spots within the central neural retina and in the optic stalk (Crossley et al. 2001; 
Trousse et al. 2001; Schook 1980a). At HH 17, cell death is also detected in the 
invaginating lens vesicle which has yet to separate from the surface ectoderm 
(Schook 1980a).
During optic cup morphogenesis in the mouse embryo, the pattern of cell death is 
also highly dynamic and regionalised. It appears to be concentrated in the optic stalk 
region just as invagination starts, but then spreads to the central neural retina by 10.5 
dpc. Apoptosis in the invaginating lens vesicle is localised to the tips that are to meet 
and fuse. Some apoptosis can also be detected in the dorsal neural retina between
10.5 -  11.5 dpc. However, the dorsal cell death in the mouse optic cup is distinctly 
less abundant than that in the chick embryo (Trousse et al. 2001).
Differential rates ofproliferation across the D-V axis
The process o f optic cup formation is coincident with a proliferative burst of the 
distal neuroepithelium, the presumptive neural retina, which becomes much thicker 
in comparison to the proximal neuroepithelium, the presumptive RPE, as the optic 
vesicle invaginates. Similar to the interkinetic movements of proliferating cells 
across the laminar axis of the developing chick neural tube, first recognised by Sauer 
(reviewed in Watterson 1965), proliferating retinal progenitors migrate to the 
ventricular edge during the M-phase of the cell cycle, when they divide, and migrate 
away from the ventricular edge during the S- and G-phases of the cell cycle (Sidman 
1961). As such dividing cells (in M-phase), which contain phosphorylated histone 
H3 (pH3), are observed on the ventricular edge o f the neural retina when immuno- 
labelled with a pH3 antibody.
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In the literature, the growth of the eye is often described as non-uniform, referring to 
the centre (proximal) to periphery (distal) gradient of development, which is apparent 
in terms of neurogenesis during early development, with the first bom neurons being 
detected in the central neural retina, but also later in terms of cell addition, when the 
central neural retina ceases to proliferate and proliferation becomes localised to the 
periphery o f the optic cup only, resulting in localised cell addition (Robinson 1991). 
In the mouse, localisation of proliferation to the peripheral optic cup only, occurs one 
week after birth shown by 3H-Thymidine labelling of proliferating cells (Sidman 
1961). Prior to this stage, proliferating cells are detected throughout the neural retina. 
In the chick embryo, it has been demonstrated that the ventral neural retina possesses 
a higher proliferative density, measured as the number of mitotic cells per unit area, 
than the dorsal neural retina at HH 13-14. This is when the optic vesicle has just 
invaginated. This trend continues also at HH 17-18, although the difference in 
mitotic activity between the two regions are less marked at this stage (Calvente et al. 
1988). Differential proliferation has also been reported along the D-V axis in the 
mouse RPE (Lee et al. 2001a).
1.3 The T-box gene family
1.3.1 Discovery of the T-box gene family
The evolutionarily conserved T-box gene family encode transcription factors, which 
are characterised by a highly conserved DNA binding domain. Brachyury (T- Mouse 
Genome Informatics), a mouse mutation that causes a short tail in heterozygous 
mice, was the first member of this family to be cloned in 1990 (Herrmann et al. 
1990). Shortly after, the Drosophila optomotor blind (omb) gene was cloned and 
found to bear sequence homology to Brachyury (Pflugfelder et a l 1992a). 
Subsequently, members of the mouse Tbx2 subfamily were identified and the 
existence of a gene family was established (Bollag et al. 1994). There are currently 
17 members identified in mammals (Naiche et al. 2005). The DNA binding domain 
was named the T-box after T which was the first identified member. Various animal 
mutants o f the T-box genes are now emerging and functional studies are providing 
information about the role of these genes in development. In man, there are six 
conditions that are known to date to be caused by mutations in various T-box genes
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(Naiche et al. 2005), two of which occur in T-box genes that are expressed in the eye 
and will be discussed in the following sections.
1.3.2 DNA binding, transcriptional activity, and binding partners
The protein structure of Brachyury, the prototype and the most studied of all T-box 
genes, contains an N-terminal DNA binding domain (180-200 amino acids) and a C- 
terminal domain containing two repression and two activation sites, suggestive of a 
role as a transcriptional repressor as well as an activator. Like other transcription 
factors, it also contains nuclear localisation domains (Fig. 1.5).
Nuclear localisation domain
T-box DNA binding domain repression/activation sites ~ C
Fig. 1.5 Schematic representation of the Brachyury protein structure
The crystallographic structures of Xenopus and human Brachyury, and human TBX3 
bound to a palindromic DNA sequence in vitro have been determined and although 
the T-box genes are highly conserved, T binds DNA as a dimer (Papapetrou et al. 
1997; Muller and Herrmann 1997) but TBX3 binds as two separate monomers to the 
palindromic sequence, called the T-site (Coll et al. 2002). It has also been reported 
that TBX2, like TBX3, interacts more efficiently with only a T-half site (Sinha et al.
2000). Furthermore, different T-box proteins show preference for different 
combination, orientation, number, and spacing of T-half sites in vitro (Conlon et al.
2001). Hence regardless of their highly conserved DNA binding domain, T-box 
proteins have differing DNA binding properties, which may partly account for their 
ability to regulate different downstream targets.
There is evidence that T-box proteins regulate gene expression in combination with 
other transcription factors. The investigation and identification of T-box protein 
partners is most advanced for those acting in the developing heart, where cooperative 
binding of promoters with several heart specific transcription factors have been
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identified in vitro (Naiche et al. 2005). There is evidence for the T-box proteins in 
both activating and repressing gene expression. For example Tbx5 has been reported 
to act as an activator (Hiroi et al. 2001), while Tbx3 has been reported to act a 
repressor (Lingbeek et al. 2002). Tbx2 has been reported to act both as an activator 
and as a repressor depending on promoter context (Carreira et al. 1998; Habets et al. 
2002; Paxton et al. 2002; Hiroi et al. 2001). Microarray analysis of differentially 
expressed genes in several different cell lines following transfection of Tbx2 confirm 
that a context-dependent upregulation and downregulation of gene expression can be 
achieved by Tbx2 (Chen et al. 2001). Although this does not differentiate between 
gene expression changes caused by Tbx2 directly and those caused indirectly.
Comparatively less is known about the transcriptional activity and potential partners 
in other tissues and there is currently no knowledge of potential partners or targets 
for T-box genes in the developing eye. Two factors that may be of relevance to the 
eye are Connexin43 (Cx43) and Mitf. Cx43 is a gap-junctional protein which is 
expressed in several tissues in which Tbx2 is expressed, including the chamber 
myocardium of the developing heart, developing rat coronal sutures, and in the eye 
of several vertebrate species (Yancey et al. 1992; Janssen-Bienhold et al. 1998; 
Borke et al. 2003). The Cx43 promoter contains T-sites and in transfection assays is 
repressed by Tbx2 (Borke et al. 2003; Chen et al. 2004). Though not a target, in 
melanocytes, Mitf has been shown to regulate Tbx2 expression (Carreira et al. 2000).
1.3.3 Functions in development
T-box genes have been isolated from all metazoan species examined so far and are 
expressed in a variety of tissues during development in spatio-temporally distinct, 
but also overlapping patterns (Papaioannou 2001). Although they are expressed in 
structurally and functionally different tissues and undoubtedly are implicated in 
tissue specific developmental events, there are some similarities that can be drawn 
regarding the function of T-box genes in development.
As no unicellular organisms express these genes, it has been speculated that they 
may be important in cell interaction, tissue specification, and differentiation 
decisions during development (Papaioannou 2001). There is some strong evidence
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that supports these hypotheses. For example, Xbra (Xenopus orthologue of mouse 
Brachyury) is essential for ventral mesoderm induction (Cunliffe and Smith 1992) 
and heterozygous Brachyury mice have a short tail while homozygotes die before 
birth due to a lack of notochord and posterior mesodermal defects (Tada and Smith
2001). Tbx6 is expressed in paraxial and presomitic mesoderm in mouse embryos 
and in Tbx6 null mice, caudal somites are converted into neural tubes, indicative of a 
requirement for Tbx6 in promotion of mesodermal tissues (Chapman and 
Papaioannou 1998). In mab-9 mutants (C.elegans orthologue of human TBX20) two 
posterior blast cells that are precursors of the hindgut take on the properties of their 
anterior neighbouring blast cells, causing abnormal male tail development (Woollard 
and Hodgkin 2000).
Moreover, there is an emerging role for T-box genes in tissue patterning and regional 
specification within tissues. Mice homozygous for a mutation of Tbxl8 have 
revealed that Tbxl8y which is expressed in the anterior region of somites, is required 
for the maintenance o f the separation of anterior and posterior somite compartments. 
These mutants display rib and vertebrae defects (Bussen et al. 2004). In the 
developing heart, Tbx2 is thought to spatially define the atrioventricular canal (AVC) 
region, where it is expressed. In mice with a targeted mutation of Tbx2 A VC 
differentiation is lost at the expense of chamber myocardium so that the developing 
left ventricle becomes connected to the atria and no longer separated by the A VC 
(Harrelson et al. 2004). Conversely, misexpression of Tbx2 in chamber myocardium 
blocks chamber differentiation (Christoffels et al. 2004).
1.3.4 T-box genes expressed in the developing eye
The vertebrate Tbx2 subfamily contains four members, Tbx2/3/4/5, that are also 
collectively referred to as the omb-related genes due to their high resemblance in 
both DNA and protein structure to the omb gene of Drosophila than to any other 
vertebrate T-box gene (Bollag et al. 1994). A model has been proposed in which the 
vertebrate om^-related genes have evolved as a result of an unequal crossing event of 
an ancestral Tbx2/omb gene prior to the divergence of the vertebrate and invertebrate 
lineages. This has given rise to the Tbx2/3 and Tbx4/5 primordial genes, which by 
undergoing a further duplication have resulted in four distinct but highly related T-
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box genes (Agulnik et al. 1996) (Fig. 1.6). This model does not explain why there are 
no orthologues of Tbx4 or Tbx5 in the nematode or arthropod lineages. But as no new 
studies addressing this issue have been carried out, the theory of Agulnik et al 
remains.
Tbx2/3
Fig. 1.6 The current divergence model of members of the Tbx2 subfamily
in mouse.
An unequal crossing event of an ancestral Tbx2/omb gene gave rise to the Tbx2/3 and 
Tbx4/5 primordial genes, which then by undergoing a further duplication followed by 
a dispersion event have resulted in four distinct but highly related T-box genes 
(Agulnik et al 1996).
During mouse eye development, TbxS, Tbx2, and Tbx3 are detected in the optic 
vesicle in an overlapping pattern in the distal layer (Chapman et al 1996; Holt 
2003). Tbx20 has also been detected in the dorsal region of the mouse eye (Kraus et 
al. 2001) and is the only non o/w&-related T-box gene to be expressed during optic 
cup morphogenesis. No other T-box orthologues were identified in a 15.5 dpc mouse 
retinal cDNA library screen specifically aimed at detecting T-box genes within the 
developing mouse eye (Sowden et al. 2001).
Currently, very little is known about the function of the T-box genes in eye 
development. Eye abnormalities in human patients with conditions caused by 
mutations in the o/wZ>-related T-box genes are unusual, most probably due to their 
overlapping expression pattern in the eye. Mutations in TBX3 and TBXS cause the 
human conditions Ulnar mammary and Holt-Oram syndromes respectively
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(Bamshad et al. 1997; Basson et al. 1997; Li et al. 1997). Ulnar-mammary syndrome 
patients suffer from limb, breast, teeth, and genital abnormalities, which are tissues 
in which Tbx3 is expressed during mouse development (Packham and Brook 2003). 
No ocular abnormalities have so far been reported in these patients. Holt-Oram 
syndrome is mainly associated with cardiac and skeletal defects, however, in a study 
involving 66 patients, 16 wore glasses for a refractive error, five had squint, and two 
had Duane anomaly (Newbury-Ecob et al. 1996).
Targeted mouse mutants for these genes do exist, though none have been analysed 
for eye defects. Omb null mutants have defects in wing development but they also 
have defective optomotor behaviour caused by severe optic lobe abnormalities 
including the absence of lobula-plate giant nerve fibres leading to visual impairment 
(Pflugfelder et al. 1992b). Misexpression studies have been performed in the 
developing chick eye for TbxS, and in Xenopus for Tbx2 and Tbx3. Although there 
are some differences in the temporal and the spatial expression of these genes 
between species, all express Tbx2, Tbx3 and TbxS in the dorsal region of the early 
optic cup (Takabatake et al. 2002; Gibson-Brown et al. 1998; Chapman et al. 1996; 
Sowden et al. 2001). Ectopic expression of TbxS in the chick eye leads to disruption 
of D-V patterning and retinotectal projections as described earlier (Koshiba-Takeuchi 
et al. 2000). Misexpression of Tbx2 and Tbx3 in the Xenopus embryo are reported to 
cause similar effects to each other, which is not unexpected given the homology of 
these genes. Misexpressions were performed by injection of capped synthetic RNA 
into the animal hemisphere of two-cell stage embryos and therefore, defects as a 
result o f non-specific expression of these genes may have resulted. The defects 
reported include a loss o f ventral eye pigmentation, medial displacement of the optic 
cup (shortened distance between eyes and brain), and fused eyes in the most severe 
cases (Takabatake et al. 2002). These defects are reminiscent of ventral midline 
defects and hard to reconcile with the dorsal expression of the T-box genes in the 
eye.
The early onset of T-box gene expression in the optic vesicle prior to the 
specification of the neural retina versus the RPE, suggests that they may have a role 
in this specification event. This idea is also supported by the role of several T-box 
genes in delineating tissue boundaries as discussed earlier. Their asymmetrical
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expression pattern in the dorsal eye suggests their early involvement in the 
specification o f the dorsal eye and perhaps overall D-V patterning of the eye. 
Moreover there is an emerging role for Tbx2 in cell cycle control and 
tumourogenesis.
1.3.5 Role of Tbx2 in cell cycle control and cancer
The cell cycle, which in eukaryotic cells has been divided into two major phases with 
gaps in between according to the events of DNA replication and partition, is 
controlled by proteins belonging to the families of cyclins, cyclin-dependent kinases 
(CDK)s, and cyclin-dependent kinase inhibitors (CDKI)s (Nurse 2000).
Much of the current knowledge of the role of Tbx2 in cell cycle control comes from 
in vitro studies which were sparked by the discovery that TBX2 can immortalise 
B m ir '  mouse embryo fibroblasts by downregulating p l9 ARF, and that TBX2 is 
amplified in a subset of primary human breast cancer tumours (Jacobs et al. 2000). 
Since then, more studies have reported the amplification of TBX2 in human breast 
tumours and pancreatic cancer cell lines (Barlund et a l  2000; Sinclair et al. 2002; 
Mahlamaki et al. 2002) and its overexpression in melanoma cell lines (Vance et al. 
2005). There is evidence that TBX2, and TBX3, have anti-senescence properties; 
both can rescue senescence in mouse embryonic fibroblasts (Carlson et al. 2001; 
Jacobs et al. 2000) and a dominant negative form of Tbx2 can induce senescence in a 
melanoma cell line (Vance et al. 2005). Furthermore, both can repress the p l4 ARF 
promoter in vitro (Lingbeek et al. 2002). TBX2 can also repress other CDKIs such as 
p21 (Prince et al. 2004).
The mouse p l9 ARF, which is homologous to the human p l4 ARF, together with 
p l6 INK4a, are transcribed from the Cdk2a (INK4a/ARF) locus and are CDKIs which 
block cell cycle progression via two different routes (Chin et al. 1998). pl9ARF 
traps the oncoprotein MDM2 and thereby stabilises p53. This leads to accumulation 
of p53, which blocks cell cycle progression or induces apoptosis. p l6 INK4a on the 
other hand causes G1 arrest by preventing the inactivation of RB (retinoblastoma 
protein). Hence both proteins work to prevent cell proliferation.
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A similar role for these T-box genes in regulating the expression of cell cycle genes 
and regulating cell proliferation in developing embryos is currently sparse. Recently, 
it was shown that Tbx2 represses the expression of Nmyc, in mice with a targeted 
deletion of Tbx20, in which Tbx2 is ectopically expressed (Cai et al. 2005).
1.4 BMP4 and patterning in embryogenesis
Previous studies have shown that Bmp4 is expressed in the dorsal region of the 
developing eye and is essential for mouse eye development (Furuta and Hogan
1998). Bmps belong to the evolutionarily conserved super family of TGF-p 
signalling molecules. Members of this family play fundamental roles during 
development as well as serving roles in adult tissues (Mehler et a l 1997; Botchkarev 
2003). The basic signal transduction pathway o f the TGF-p superfamily involves two 
receptor serine/threonine kinases, receptor type I and receptor type II, and the Smad 
family of intracellular receptor substrates as well as the co-mediator Smad. Smad 
stands for sma/mothers against dpp related, which are the names given to their 
c.elegans and Drosophila homologues. Each ligand assembles a certain complex of 
transmembrane type I and type II receptors, which phosphorylate different Smad 
proteins in the cytoplasm. These activated Smads form multisubunit complexes and 
are translocated into the nucleus where they either activate or repress gene 
expression (Massague and Chen 2000).
Phosphorylation of Smads occurs upon binding to a homo or hetero dimeric unit of 
Bmps to a Bmp receptor type I (Bmprl)/Bmp receptor type II (Bmprll) complex. 
Smad4, the co-Smad, is a crucial partner of phosphorylated Smads in inducing gene 
regulation once translocated into the nucleus. A complex of receptor activated Smads 
and Smad4 alter gene expression by binding to Smad binding sites upstream of 
promoter elements (Fig. 1.7). The interaction of the Smad complex with DNA is of 
low affinity and is strengthened by additional cofactors. It is thought that these 
cofactors also confer the mode of regulation of gene expression by the pathway. Both 
coactivators and corepressors have been identified (Massague and Chen 2000).
This signalling pathway is complex and interactions with other signalling pathways 
have been demonstrated. There is also some evidence that Bmps and TGF-B1 may
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also act via a mitogen-activated protein kinase (MAPK) pathway in which 
stimulation of TAK1 (TGFB-activated kinase 1) activates the p38 and c-Jun N- 
terminal kinase (JNK) pathways (Yamaguchi et al. 1995; Moriguchi et al. 1996; Atfi 
et al. 1997; Botchkarev 2003; Massague and Chen 2000).
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Fig. 1.7 Bmp signal transduction.
A) Homo or hetero dimeric complexes of Bmps bind Type I receptors with high affinity, after which 
Type II receptors are recruited to form a complex. Type II receptors phosphorylate the Type I 
receptors, which in tum phosphorylate various intracellular Smad proteins, the receptor activated 
Smads (R-Smads). R-Smads and Smad4, the co-Smad, undergoes continuous nucleocytoplasmic 
shuttling. Upon activation, phosphorylated Smads accumulate in the nucleus where they associate 
with Smad4 and other cofactors to alter gene expression by binding to Smad-binding sites present 
upstream of gene promoters. Antagonists of this pathway act at multiple levels and include antagonists 
of the ligands (represented by Noggin in figure), antagonist of the receptors (BAMBI) and antagonists 
of the Smads within the cytoplasm. B) Alternatively, the Bmp signal activates various members of the 
MAPK family via TAK1 (Shi and Massague 2003). PM, plasma membrane; P, phosphorylation.
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It has for example been suggested that BMP2 may induce apoptosis via the TAK1- 
p38 pathway, based on in vitro transfection studies in which kinase inactive TAK1 
prevented BMP2 induced apoptosis (Kimura et al. 2000).As well as the presence of 
intracellular inhibitory Smad proteins, this pathway is antagonised by various extra 
cellular proteins (Table 1.2) out of which Noggin, Chordin, and the most recently 
identified Ventroptin bind Bmp4 with high affinity and prevent its association with 
receptors (Zimmerman et al. 1996; Piccolo et al. 1996; Sakuta et al. 2001).
Table 1.2: List of Bmps expressed in the developing eye or its surroundings and proteins
involved in the Bmp signalling pathway
Bmps Smad proteins Inhibitory Smad proteins
Bmp
antagonists
Bmp
receptors
Bmp2 Smad 1 (R) Smad 6 Noggin Bmprla
Bmp3 Smad 5 (R) Smad 7 Dan Bmprlb
Bmp4 Smad 8 (R) Ventroptin Actrl
Bmp5 Smad 4 (Co) Bmprll
Bmp6 Actrl I a
Bmp7 Actrl lb
Actr, activin receptor; Bmp. bone morphogenetic protein; Bmpr, bone morphogenetic protein receptor; 
Co, co-Smad; R, receptor activated.
1.4.1 Bmp signalling in the developing eye
Several Bmps are expressed in an overlapping pattern in the dorsal forebrain and 
surface ectoderm during forebrain development (Furuta et al. 1997), including Bmp2, 
Bmp4 and Bmp7 that are later also expressed in the eye. Bmps are secreted factors in 
the extracellular environment that trigger intracellular responses via the signal 
transduction pathway described earlier. As such, the expression of Bmp receptors 
and factors that modify this pathway is of relevance towards understanding the 
spatial distribution of Bmp signalling in a tissue.
Expression o f  Bmps during early eye development
In the developing mouse eye, Bmp4 is expressed in the entire distal optic vesicle and 
the overlying surface ectoderm at around ss 14 -  16 (9.5 dpc) (Furuta and Hogan 
1998; Dudley and Robertson 1997; Liu et al. 2003). At the time when the lens 
placode is forming, Bmp4 becomes restricted to the dorsal region of the distal optic 
vesicle and continues to be dorsally restricted throughout optic cup formation. The
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expression in the surface ectoderm disappears during lens placode formation (Furuta 
and Hogan 1998). The expression of Bmp4 in the chick eye is similar to the mouse, 
with the exception that at optic vesicle stage, Bmp4 is only detected in the surface 
ectoderm and not the optic vesicle itself (Trousse et a l 2001).
At the optic vesicle stage in the mouse, Bmp7 is detected in the surface ectoderm and 
in the optic vesicle, with the strongest expression in the proximal layer, 
complementary to Bmp4. Bmp7 expression levels in the surface ectoderm decrease 
gradually and at the optic cup stage, Bmp7 is still expressed at low levels in the 
surface ectoderm. At this stage, it becomes restricted to the RPE and the optic stalk 
(Dudley and Robertson 1997). In the chick embryo, Bmp7 is only detected in the 
proximal layer of the optic vesicle and later in the RPE, but not in the surface 
ectoderm as detected in the mouse embryo (Trousse et a l  2001). In the chick optic 
cup, detection of Bmp6 and Bmp5 in the RPE have also been reported (Belecky- 
Adams and Adler 2001b).
In summary, there are differences detected in Bmp expression between the two 
species, mainly at the optic vesicle stage when in the mouse Bmp4 is expressed at 
high levels in the dorsal optic vesicle and at low levels in the surface ectoderm, while 
in the chick it is expressed at high levels in the surface ectoderm and only after optic 
cup formation, it is localised dorsally in the neural retina. Bmp7 is expressed at high 
levels in the mouse surface ectoderm at optic vesicle stage, but not in the chick. In 
both mouse and chick, Bmp4 and Bmp7 are expressed in a complementary fashion to 
each other in the optic vesicle (Dudley and Robertson 1997; Golden et a l 1999). 
These expression data emphasise the existence of some differences which must be 
taken into account when studying the function of Bmps and their regulation of 
downstream targets in the two species.
At the optic cup stage, two other Bmps are detected in the eye. Bmp2 is expressed in 
the RPE and Bmp3 is strongly expressed in the mesenchyme surrounding the optic 
stalk (Dudley and Robertson 1997). In the chick embryo, Bmp2, Bmp4, Bmp5, Bmp6 
have been detected in the extra-ocular mesenchyme at optic cup stage (Belecky- 
Adams and Adler 2001b).
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Targeted disruption of Bmp4 or Bmp7 have identified an important role for these 
genes in lens induction (Furuta and Hogan 1998; Jena et al. 1997; Wawersik et al.
1999). Bmp7 null mice are bom and show a variable expressivity of the aberrant lens 
induction phenotype depending on genetic background. They also exhibit 
microphthalmia and anophthalmia at birth (Dudley et al. 1995; Luo et al. 1995; Jena 
et al. 1997). Heterozygous Bmp4 mutants are viable and display variable expressivity 
of several phenotypes including a low incidence of microphthalmia as well as a range 
of anterior segment defects detected postnatally (Dunn et al. 1997; Chang et al. 
2001). Misexpression studies in the chick embryo, o f the Bmp antagonists Noggin 
and HtrAl, result in several defects of the eye including microphthalmia, coloboma, 
pecten agenesis, and expression of optic stalk markers in the ventral neural retina. 
HtrAl is a relatively recent addition to proteins that inhibit Bmps, but is not normally 
expressed in the eye (Adler and Belecky-Adams 2002; Oka et al. 2003). The chick 
misexpression studies indicate that Bmp signalling is important for optic cup 
morphogenesis and development beyond the period of lens formation, though they 
cannot differentiate between the roles that each Bmp, that is expressed during early 
eye development in the chick embryo, is playing in this process and which 
mechanisms are responsible for these abnormalities.
Bmp receptor expression
A combination o f a type I and a type II receptors is vital for Bmps to mediate their 
signal to the cytosol and eventually to the nucleus. Bmp4 binds with high affinity to 
Bmprla (also referred to as Alk3), a type I receptor that is ubiquitously expressed in 
the optic vesicle and cup including the lens vesicle and the surrounding mesenchyme 
(Furuta and Hogan 1998; Liu et al. 2003). It also binds to Bmprlb (also referred to as 
Alk6), another type I receptor that is expressed in a complementary fashion to Bmp4 
in the proximo-ventral optic vesicle and later in the ventral neural retina and optic 
stalk (Furuta and Hogan 1998; Liu et al. 2003). Bmp7 binds more efficiently to 
Bmprlb and Activin receptor-I (Actr-I, also referred to as Alk2) (Yamashita et al. 
1996). Actr-I is expressed in the lens placode and in the overlying surface ectoderm 
after lens vesicle formation (Yoshikawa et al. 2000).
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There are currently only two studies reporting the expression of the Bmp type II 
receptor in the developing mouse eye. Study one utilised immunohistochemistry to 
show that at optic vesicle stage, the Bmprll protein is present in both the proximal 
and distal layers of the dorsal optic vesicle in a domain wider than Bmp4 as well as 
in the surface ectoderm. But at the optic cup stage it is confined to the RPE and the 
anterior rim of the optic cup and in the lens vesicle (Faber et al. 2002). The second 
study utilises in situ hybridisation and reports that Bmprll is barely detectable until 
the 15 dpc stage where it is expressed in the entire D-V axis of the neural retina, 
mainly confined to the retinal ganglion cell layer (Liu et al. 2003). As Bmp4 has not 
been shown to bind to any activin type II receptors, the expression reported so far for 
Bmprll suggests that there may be other unidentified type II receptors that have a 
more closely matched expression pattern to Bmp4 in the eye.
In the chick embryo, Bmprla transcripts are ubiquitous in the optic vesicle and the 
entire optic cup including the lens. Bmprlb is very weak at optic vesicle stage but is 
expressed throughout the optic cup, with highest levels in the ventral region (Trousse 
et al. 2001; Hyer et al. 2003). Data regarding the expression of Bmprll is conflicting, 
with one study reporting expression only in the ventral optic cup by in situ 
hybridisation (Hyer et al. 2003), while another reports ubiquitous expression in the 
optic cup and the lens by both in situ hybridisation and RT-PCR (Trousse et al. 
2001).
Heterozygous mouse mutants for Bmp and activin type I receptors appear normal, 
while homozygotes (all except Bmprlb) fail to survive past 9.5 dpc (Gu et al. 1999; 
Mishina et al. 1995). Bmprlb homozygous null mutants do not display any major eye 
phenotype. Except for a ventral retinal ganglion cell axonal guidance defect, there is 
no change in the expression of D-V markers of the eye or genes involved in retinal 
proliferation and differentiation such as ChxlO and MathS (Liu et al. 2003). This 
suggests that many of the effects of Bmp signalling can be mediated by other type 
one receptors such as Bmprla which is ubiquitously expressed in the retina. Bmprll 
heterozygotes appear normal while homozygotes die before 9.5 dpc (Beppu et al. 
2000).
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Expression o f Bmp antagonists
Several inhibitors of the Bmp signalling pathway have been identified. At the optic 
cup stage, Noggin has been reported to be expressed in a small region of the dorsal 
neural retina and lens in the chick embryo (Trousse et al. 2001; Belecky-Adams and 
Adler 2001a), but no such pattern has been reported in the mouse (McMahon et al. 
1998). Dan, which is another Bmp antagonist (Hsu et al. 1998), is present in the 
ventral neural retina and the surface ectoderm overlying the lens vesicle in the chick 
embryo (Ogita et al. 2001). No such expression has been reported for its mouse 
homologue (Stanley et al. 1998). Ventroptin, the most recently identified Bmp4 
antagonist, is expressed in a naso-ventrally high gradient in the neural retina in the 
chick embryo (Sakuta et al. 2001).
A few studies have described the phenotypes of mouse with targeted disruptions of 
Bmp antagonists, but these phenotypes are related to the early involvement of these 
antagonists in neural induction and patterning and therefore their effect on eye 
development specifically cannot be examined. Noggin null mice undergo normal 
gastrulation but have been reported to exhibit skeletal and neural defects later in 
development (McMahon et al. 1998). The neural defects comprise failure of neural 
tube closure in cranial regions, which contributes to the disruption of eye 
development, and ventral patterning defects in the posterior neural tube (McMahon 
et al. 1998). Chordin null mice undergo normal neural development but display ear, 
pharyngeal, and cardiovascular abnormalities (Bachiller et al. 2000). Double null 
homozygotes for both Chordin and Noggin die before birth with severe anterior 
forebrain truncations and some reveal phenotypes similar to embryos lacking Shh 
including cyclopia (Bachiller et al. 2000).
1.4.2 Bmp4 and link to T-box genes
Of particular relevance to the study of the T-box genes in the eye is Bmp4, as it is 
expressed in the dorsal region of the developing eye (see previous section), where T- 
box gene expression has been detected during early eye development. Moreover, 
Bmps have been shown to regulate T-box gene expression in various tissues and 
species.
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The Omb gene of Drosophila is the homologue of Tbx2 and Tbx3 in vertebrates 
(Bollag et al. 1994). Besides the high amino acid sequence similarity within the T- 
box region of these genes, they are expressed in many homologous tissues in the 
Drosophila and the mouse embryos. For example, Omb is expressed in the wing disc 
in the fly embryo, and Tbx2 and Tbx3 are expressed in the limb buds in the mouse 
embryo (Grimm and Pflugfelder 1996; Bollag et al. 1994; Chapman et al. 1996). 
Omb is expressed in the optic lobe anlagen and in the eye imaginal disc in the fly 
embryo, and Tbx2 and Tbx3 are expressed in the eye primordia of the mouse embryo 
as described earlier (Poeck et al. 1993).
Overexpression of dpp, the Drosophila homologue of the vertebrate Bmp2/Bmp4 
signalling factors, in the wing disc using an enhancer trap line that drives higher 
levels of dpp expression, induces ectopic omb gene expression. Indirect down- 
regulation o f dpp by inactivation of Hh, which has been shown to regulate dpp 
expression in the wing disc, results in a decrease in omb expression (Grimm and 
Pflugfelder 1996; Nellen et al. 1996; Lecuit et al. 1996). Studies in vertebrates have 
also yielded evidence for the regulation of several T-box genes by members of the 
Bmp family. In the chick embryo, rhBMP2 soaked heparin beads placed lateral to the 
anterior neural plate of Hamburger Hamilton (HH) stage 5 chick embryos induces 
strong Tbx2 and weaker Tbx3 expression in the close vicinity of the bead (Yamada et 
al. 2000). Beads placed in the wing bud induce ectopic Tbx3 expression (Tumpel et 
al. 2002) In the chick optic vesicle, forced expression of Bmp4 by electroporation 
induces ectopic TbxS expression in the entire optic cup while cVax is repressed 
(Koshiba-Takeuchi et al. 2000). Xbra expression in Xenopus has also been shown to 
be regulated by Bmp4 (Jones et al. 1996).
These data indicate that Bmp regulation of at least members of the Tbx2 subfamily, 
and maybe members of other T-box subfamilies, may be evolutionarily conserved 
among species and also within species in the formation of different organs. In this 
thesis, regulation of the T-box genes in the eye by the dorsally expressed Bmp4 was 
investigated in mouse eye development.
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1.4.3 Evidence of a Bmp4 signalling gradient in development
Patterning is a fundamental process in embryogenesis and allows the distinction and 
specialisation of groups of cells during development. This is the basis for 
development of distinct organs from the initial pool of unspecified cells of the 
embryo (Wolpert and Kerszberg 2003). Early patterning is often established by 
signalling molecules which induce different patterns of expression of transcription 
factors or other signalling molecules. The concept of morphogen gradients was 
introduced in developmental biology as a mechanism by which pattern formation 
could be achieved. A morphogen is the term given to a signal that fulfils two criteria: 
1) it acts directly at a distance, and 2) it induces distinct cellular responses at 
different concentrations (Vincent and Briscoe 2001). Lewis Wolpert proposed that 
positional information establishes spatial patterning by the action of morphogens 
emanating from a localised source which diffuse away to introduce a concentration 
gradient across a field of cells (Wolpert 1969). These cells acquire a positional value 
with respect to the morphogen gradient and as such become patterned or distinct 
from each other. This can translate into unique gene expression, a difference in cell 
behaviour such as growth, or cell differentiation (Wolpert and Kerszberg 2003). A 
pattern can therefore be morphologically visible, but in some systems it may also 
exist even though it is not initially morphologically obvious, such as the topography 
of the RGCs in the developing eye.
In more recent years, candidate morphogens have been identified based on their 
concentration-dependent activity, but to prove that they act directly at a distance has 
been more challenging. Strong evidence has been provided for Dpp acting as a long- 
range morphogen in the wing imaginal disc on the basis of the following 
experiments: when a constitutively active form of the type I Dpp receptor thick veins 
(tk\') was misexpressed in a patch distinct from the endogenous dpp expression 
domain and that of its downstream targets, omb and spalt, which are normally 
expressed in a wider domain than dpp, omb and spalt were autonomously induced 
within cells that misexpressed tkv only. But when dpp was misexpressed in a similar 
manner, omb and spalt were induced in cells expressing dpp, but also in a circle of 
neighbouring cells of up to at least 20 cell diameters away from the source of dpp 
expression in the case of omb. Inactivation of tkv in a few cells within the normal
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omb expression domain resulted in the absence of omb expression in those cells 
alone, indicating that cells must directly receive the Dpp signal to express omb 
(Nellen et al. 1996). The finding that direct Dpp signal transduction is necessary for 
omb and spalt gene expression was corroborated by an independent group who 
however also provided results which suggested that Dpp induction of omb expression 
far away from the dpp source may not always occur (Lecuit et al. 1996). Findings of 
a third group have shed some light on this contradiction by showing that Dpp is 
sufficient to induce ectopic omb expression in the hinge region of the wing disc but 
that in the wing pouch, it requires the presence of Wingless, which is another 
secreted signalling factor (Grimm and Pflugfelder 1996). Nevertheless, these 
findings together with the Dpp responsive spalt expression nested within the 
naturally broad expression domain of omb in the wing disc, which are both abolished 
in the absence of dpp (Lecuit et al. 1996), suggest that direct long-range Dpp 
signalling induces distinct gene expression in the Drosophila wing.
In vertebrates, although there is evidence that Bmps also induce concentration 
dependent responses, such as specification of distinct cell types in the neural tube 
(Barth et al. 1999; Nguyen et al. 2000), evidence for a direct action at a distance in 
vivo has so far not been achieved. Moreover, it has not been possible to directly 
visualise an endogenous morphogen protein gradient in an in vivo system, perhaps 
due to the inadequate sensitivity provided by current methods of in situ protein 
detection. Though visualisation of secretion of activin from a bead in Xenopus 
animal cap explants showed that exogenous activin, which like Bmp4 belongs to the 
TGFC super family, can form a concentration gradient in an in vivo environment 
(McDowell et al. 1997).
In contrast to the long-range actions of Dpp in Drosophila and of activin in Xenopus, 
it has been suggested, though not proven, that Bmp4 is a short-range signalling 
molecule. However, the experimental data on which this is based are not strong and 
include mRNA injections of Bmp4 in one half of Xenopus animal cap conjugates 
(made o f two animal cap aggregates) and the detection of Xbra in close vicinity of 
injected cells only (Jones et al. 1996). As only Xbra expression was analysed, these 
experiments cannot clarify the diffusion range of Bmp4. Detection of phosphorylated 
Smad proteins in response to Bmp4 signalling in the same type of experiments do
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however show that the Bmp4 diffusion range is shorter than that of activin in animal 
caps (Ohkawara et al. 2002).
It has been suggested that the establishment of a concentration gradient of a putative 
morphogen can be established by other means than just the diffusion of the molecule 
itself. These include the effect of the distribution of receptors and antagonists, and 
the affinity of the protein for other extracellular matrix molecules and their 
availability (Wolpert and Kerszberg 2003). The action range of Bmp2, Bmp4 and 
Dpp is dependent on a positively charged N-terminal amino acid core which has been 
shown to restrict the Bmp action range in the mouse neural tube and Xenopus animal 
cap assays in comparison to when a mutation is introduced in this region. It is 
thought to act by enhancing the affinity of these proteins for extracellular matrix 
including heparan sulphate proteoglycans (Ohkawara et al. 2002; Hu et al. 2004). 
Despite the above described experiments, the actual diffusion range of the Bmp4 
protein during in vivo development in vertebrate tissues remains unknown.
1.4.4 Conserved regulatory interactions between the Shh, Fgf, and 
Bmp signalling pathways?
Several groups of signalling molecules involved in the initial patterning of 
developing tissues have been identified, but the interaction between these molecules 
are less well understood. In several tissues in vertebrate embryos, antagonistic 
interactions between Shh and members of the Bmp family of signalling molecules 
have been demonstrated (see below). Furthermore, the interaction of these signalling 
factors appear to facilitate an optimal pattern of Fgf expression which drives growth 
of the tissue. The mRNA expression pattern of these signalling molecules are often 
detected in juxtaposed or opposite sites in developing tissues. As they are mostly 
secreted factors, it is thought that they interact to drive tissue growth by creating a 
pattern across the tissue and either regulate each other’s expression or common 
downstream targets across the range of cells between their sites of expression. These 
interactions have been best studied during chick limb bud development and in the 
development of the forebrain, as well as and more caudal regions of the neural tube.
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In the chick limb buds, which consist of undifferentiated mesenchymal cells encased 
in ectoderm, Shh is expressed in the polarizing region (posterior region), while 
several Fgfs are expressed in the apical ectodermal ridge (AER) and members of the 
Bmp family are detected in the anterior and the posterior mesenchyme as well as in 
the AER (Fig. 1.8; reviewed in (Tickle 2002). The expression of Bmp2 and Bmp4 in 
the developing limb is dynamic (Francis et al. 1994) and although the interaction 
between Shh and Bmps differ in the anterior region of the limb bud compared to the 
posterior region (Tickle 2002), it is thought that optimal Fgf expression is achieved 
in the AER by antagonism of Bmp signalling by Shh in the polarising region (Zuniga 
et a l 1999; Khokha et al. 2003). Shh positively regulates Fgf4 expression in the 
AER, which in turn feeds back to maintain Shh in the polarising region (Niswander 
et al. 1994; Laufer et al. 1994). Bmp signalling on the other hand negatively 
regulates the expression of Fgfs in the AER (Pizette and Niswander 1999) and it has 
been shown that the positive effect of Shh on the AER is mediated via inhibition of 
Bmp signalling. Furthermore, Bmps and Fgfs can antagonise each other’s effects on 
limb growth and chondrogenesis (Niswander and Martin 1993; Buckland et al. 
1998). Together, interplay between these pathways maintains an optimal level of Fgf 
expression in the AER which is essential for limb bud growth. The chick limb bud 
becomes truncated if the AER is removed, while growth can be rescued by 
implantation of Fgf coated beads (Niswander and Martin 1993; Tickle 2002).
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Fig. 1.8 Interaction between the Shh, Bmp, and  Fgf pathways in the 
an terio r neural plate and in the limb bud
(A) Bmp, Shh, and Fgf expression in an early limb bud. (B) Shh from the polarising 
region (orange) in the posterior region of the limb bud maintains Fgf expression in 
the apical ectodermal ridge (AER; green) by indirectly antagonising Bmps in the 
mesenchyme. Bmps repress Fgf expression in the AER. Fgfs feed-back to maintain 
Shh expression in the polarising region. (C) In the developing anterior neural plate, 
Shh from the prechordal mesendoderm (orange) and Bmps from the lateral region of 
the neural plate (arrows) act antagonistically. Shh maintains FgfS expression in the 
anterior neural ridge (green), while Bmps repress Fgf8. (D) Summary of the 
interactions between these pathways.
Abbreviations: ANR, anterior neural ridge; C, caudal; D, distal; P, proximal; Pre, 
presumptive; R, rostral;
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In the developing anterior neural plate a similar scenario is evident. Bmps from the 
lateral (becomes dorsal in the neural tube) non-neural and neural ectoderm (Furuta et 
al. 1997; Dudley and Robertson 1997; Crossley et a l  2001) and Shh from the 
prechordal mesendoderm, an axial mesendodermal structure rostral to the notochord 
in the medial (becomes ventral in the neural tube) neural plate (Echelard et al. 1993; 
Crossley et al. 2001), pattern the medio-lateral axis of the anterior neural plate, 
which later becomes the dorso-ventral (D-V) axis of the developing forebrain. FgfS 
is expressed in the anterior neural ridge (ANR), the rostral-most limit of the anterior 
neural plate, and in the presumptive midbrain-hindbrain boundary (Crossley and 
Martin 1995; Crossley et al. 2001); it extends between the medial Shh and lateral 
Bmps (Fig. 1.8). BMP2 coated beads placed against the ANR in cephalic mouse 
explants suppress Fg/8 and reduce Shh (Anderson et al. 2002). Likewise, in the chick 
developing prosencephalon, implantation of BMP4 coated beads in the anterior 
neuropore represses the expression of Fg/8 in the anterior neural ridge, and the 
expression o f Shh in the ventral midline tissue, while in Shh homozygous targeted 
mutants, Fg/8 expression is not maintained in the commissural plate (rostral-most 
region o f the developing forebrain) and the expression o f Bmp responsive genes, 
M sxl and Msx2, are reported to be expanded (Ohkubo et al. 2002). In mice that are 
compound homozygous for a targeted deletion of Chordin and heterozygous for a 
targeted deletion of Noggin, Shh expression in the ventral midline underlying the 
developing forebrain is absent and Fgf8 expression in the ANR is reduced to a 
midline domain rather than two bilateral domains at 8 dpc. This is presumably 
caused by increased Bmp signalling due to the lack of antagonism exerted by Noggin 
and Chordin on Bmps and is followed by reduced cell proliferation in the forebrain 
(Anderson et al. 2002). Finally, Fgf8 coated bead implantation next to the optic 
vesicle in the chick embryo represses Bmp7 expression in the presumptive RPE, 
which results in its conversion into neural retina (Vogel-Hopker et al. 2000). This 
demonstrates that an antagonistic interaction between an Fgf and a Bmp can also 
occur in the ocular tissues.
Evidence so far suggests that a pattern in which Shh by antagonising Bmps enables 
the expression of Fg/8 resulting in a high proliferation zone that drives forebrain 
development, reminiscent of limb development (Ohkubo et al. 2002). The authors
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suggest that the expression of Bmp4, Shh, and Fg/8 are interdependent and together 
create an environment where optimal growth of the forebrain can proceed (Fig. 1.8). 
Based on the presence of these same factors also in the chick eye, similar interactions 
have been proposed, although much less is known about them in the eye in 
comparison to the limb and the forebrain. In the developing mouse eye, the 
expression pattern o f the dorsally expressed Bmp in the eye, Bmp4, in relation to Shh 
has not been carefully described, neither has the expression of suitably juxtaposed 
members of the Fgf family. In Chapter 3 of this thesis, an expression analysis for this 
purpose is undertaken and a putative interaction between Bmp4 and a suitably 
positioned Fgf as well as the effect of the lack o f that Fgf on D-V patterning of the 
eye is investigated.
1.5 Summary
More is currently known about the function of factors that are expressed in the 
ventral eye than the dorsal eye. It is known for example that disruptions of the 
ventral genes Pax2 and Vaxl/2 cause coloboma and optic nerve abnormalities. On 
the contrary, the importance of genes that are expressed dorsally for optic cup 
formation is unresolved. With the lack of specialised structures in the dorsal neural 
retina, such as the optic fissure and the optic disc, a specific role, one that is 
restricted to the dorsal eye alone, for the dorsal genes in the development of the eye 
is not easy to envisage. Bmp4 null mutants display a lack of lens induction, showing 
that Bmp4 is essential for eye development (Furuta and Hogan 1998), but the 
embryonic lethality o f this allele, which sets in at mid-gestation (Winnier et al. 
1995), precludes further analysis of what might be the role of Bmp4 in retinal 
development. Heterozygous mice are viable and display variable expressivity of 
several phenotypes including a low incidence of microphthalmia as well as a range of 
anterior segment defects postnatally (Dunn et al. 1997; Chang et al. 2001). This 
suggests that Bmp4 may play several important functions in eye development, one 
being regulation of the growth of the eye. The anterior segment defects are most 
likely reflecting a late role of Bmp4 in eye development, when the anterior segment 
is developing. The incidence of microphthalmia on the other hand could potentially 
represent an early function of Bmp4 in the eye. Further support for a role in eye 
growth for Bmp4 comes from chick misexpression studies where Noggin, the Bmp
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antagonist was misexpressed in the optic vesicle by retroviral delivery, which 
resulted in microphthalmia (Adler and Belecky-Adams 2002). The mechanisms by 
which Bmp4 can control the growth of the eye, the downstream genes that could 
mediate such an effect, and crucially, how a dorsally expressed gene may be 
implicated in the regulation of eye size and whether it does so by controlling regional 
growth or exerts an effect globally, remain unanswered. Evidence of T-box gene 
regulation by Bmps in several tissues and species supports the hypothesis that this 
may also be the case in the developing eye. In the chick embryo, such regulation has 
been demonstrated for Tbx5 by Bmp4. In the Xenopus embryo, Tbx2 and Tbx3 are 
ectopically induced by Bmp4. In this thesis, the mouse model system was used to 
investigate the regulation of the T-box genes by Bmp4 in the developing mouse eye 
and the implication of manipulations of Bmp4 as well as the T-box genes for early 
eye development. The mouse model was used for majority of experiments as it 
provides a model of mammalian eye development, which is relevant for 
understanding formation of the human eye. When manipulations were not feasible in 
the mouse embryo, the chick embryo was utilised, as it offers a more accessible 
system for somatic cell manipulations.
1.6 Manipulation of gene expression or protein distribution in 
vivo
Manipulation of gene expression during embryogenesis has proved a vital tool in 
elucidating roles of single or combination of genes at organ or even cellular levels 
during embryonic development. There are several methods by which the spatial 
distribution of a gene product can be manipulated in an embryo and the method of 
choice is often governed by the research question as well as the model organism.
In developmental biology, the chick embryo is a classical model for in vivo 
manipulation studies and widely used for its ease of culture and accessibility in 
comparison to the mouse embryo for example. There are now several established 
means to achieve genetic manipulation in the chick embryo including electroporation 
and retroviral mediated gene delivery. The use of retroviruses for genetic 
manipulation of the embryo precedes the use of electroporation. The two approaches 
differ significantly and offer different advantages. For example, retroviral mediated
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gene delivery offers integration and inheritance of foreign DNA into the host cell and 
its progeny (Morgan and Fekete 1996), but takes longer to express the transgene due 
to the time needed for the virus to integrate into the host genome and express. 
Moreover, the size of the transgene that can be inserted into the viral backbone is 
restricted and often it is not possible to express more than one transgene in the same 
cell. Electroporation on the other hand offers a means to deliver more than one 
transgene to the same cell and poses no limits on insert size (Momose et al. 1999). 
Moreover, it can be used to deliver viral DNA, in which case the transgene is 
integrated and inherited (Yasuda et a l  2000). The disadvantage of electroporation is 
the damage it can cause to a tissue as current is applied to make transient openings in 
cell membranes to allow uptake of foreign DNA.
In the mouse embryo, which is a well characterised mammalian model organism for 
human development, these types of manipulations are more challenging due to 
restrictions imposed by development of mouse embryos in utero. An ex utero culture 
technique has been developed but is currently restricted to gastrula and early neurula 
stage embryos, as culture beyond these developmental stages is currently not 
possible (Cockroft 1990). Delivery of genetic material in combination with the whole 
mouse embryo culture system is in its infancy and will be addressed in Chapter 6.
With the advent of technological advances such as the creation of mouse chimaeras 
and targeted mutagenesis by homologous recombination in ES cells, the first mouse 
‘knockouts’ were produced in the 1980’s (Papaioannou 1998). This technique has 
provided a powerful tool for the study of gene function in the mouse. Functional 
analysis in mice with a germ line mutation benefit from reproducibility of the 
mutation in future offspring; an advantage lost in approaches involving genetic 
manipulations in somatic cells of the embryo. Although once germline transmission 
is achieved, stably inherited genetic manipulations offer the best reproducibility and 
therefore a more homogenous population for analysis, these approaches are initially 
more time and cost consuming in comparison to somatic manipulations. Embryonic 
lethality in knockouts can also be a problem although this can be circumvented by 
tissue specific gene targeting. Furthermore, spatial regulation of the expression of a 
gene or dosage control is limited by the availability of tissue specific and dosage 
specific promoters.
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The use of these techniques in understanding the function of a gene and genetic 
pathways have been demonstrated throughout this introduction. These techniques 
complement each other and provide necessary tools for genetic studies and ultimately 
the understanding of genetic pathways in driving tissue development. But the 
restrictions they each pose highlight the need for further refinements.
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1.7 Aims of thesis
The aim of this thesis was to investigate the role of the dorsally expressed genes, 
Bmp4, and the T-box genes in D-V patterning and early development of the eye.
Bmp4 and members of the Tbx2 subfamily, Tbx2, Tbx3, and Tbx5 are expressed 
in the dorsal region of the developing eye of several vertebrate species. This is 
suggestive of a highly conserved function for these genes in eye development. 
Previous functional studies in the chick and analysis of heterozygous Bmp4 
mutants suggest that Bmp4 may be regulating eye growth. Furthermore, Bmp4 
regulates T-box gene expression in several vertebrate as well as invertebrate 
species. The following hypotheses were therefore tested in this thesis:
1. Bmp4 signalling regulates the expression of the dorsal T-box genes in the 
developing mouse eye and a Bmp-Tbx genetic pathway is required for the 
formation and growth of the optic cup.
2. Tbx2 is required for optic cup morphogenesis and is implicated in the 
regulation o f the expression of molecular and morphological asymmetries during 
this process;
a) Tbx2 regulates the expression of other asymmetrically expressed genes 
across the D-V axis
b) Tbx2 regulates growth of the dorsal optic cup
In C hapter 3, RNA in situ hybridisation was used to compare the expression 
pattern of Tbx2, Tbx3y and Tbx5 in the mouse optic vesicle and newly formed 
optic cup. This study also aimed to compare the expression of these genes to the 
expression of signalling molecules, including Bmp4, and other asymmetrically 
expressed genes in the eye. This analysis served to identify potential interactions 
between signalling molecules that are expressed during early eye development, 
their relation to the T-box genes, and putative downstream targets of the T-box 
genes.
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In C hapter 4, bead implantation in combination with whole mouse embryo 
culture was employed to manipulate Bmp4 signalling during optic cup 
morphogenesis. This approach allowed the investigation of T-box gene 
regulation by Bmp4. It also allowed the effect of manipulation of Bmp4 
signalling to be assessed on eye size and shape. The whole embryo culture 
system provided excellent preservation of the morphogenetic process of optic 
cup formation.
In C hap ter 5, the role of Tbx2 in early eye development was investigated by 
analysing mouse embryos with a targeted mutation of Tbx2 (provided by 
Professor V.E. Papaioannou, Columbia University, USA). O f the three T-box 
genes, Tbx2 was selected for further analysis because o f the availability of the 
Tbx2 mutants and because Tbx2 was found to be most responsive to Bmp4 
manipulations in Chapter 4. RNA in situ hybridisation, immunohistochemistry, 
and histological analyses were carried out to examine whether loss of expression 
of Tbx2 affected optic cup formation, the expression of Tbx3, Tbx5, and the 
spatial distribution of other D-V patterning genes.
In C hapter 6, retroviral mediated gene delivery was used to misexpress Tbx2 in 
ovo in the developing chick eye. This study investigated the consequence of the 
loss of the normal dorsal restriction of Tbx2 expression in eye morphogenesis 
and growth, as well as early retinal cell differentiation.
This thesis presents novel findings on the role of Bmp4 in regulating D-V 
patterning and growth of the optic cup and on the function of Tbx2 in regulating 
early optic cup growth and morphogenesis.
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CHAPTER 2 Materials and Methods
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2.1 General solutions, media, and laboratory equipment
2.1.1 General laboratory equipment
Petri dishes, pipettes, eppendorfs and Falcon tubes were supplied by Costar, UK. 
Pipette tips were supplied by VWR, UK. Pipette tips and eppendorf tubes were 
autoclaved prior to use. Centrifugations were either performed in a bench-top 
Sigma 1-15 microfuge (Philip Harris Scientific Ltd., UK) or in a Sorvall SS-34 
Rotor (Du Pont Company, USA), as indicated in text. Dissections were carried 
out under a Stemi SV11 Zeiss microscope (Zeiss, Germany).
2.1.2 General solutions and reagents
Components of solutions made were purchased from Sigma, UK or BDH, UK 
unless stated otherwise. Basic solutions commonly used in experiments are 
outlined below. Solutions were autoclaved prior to use.
Diethylpyrocarbonate (DEPC) dH20  1% v/v DEPC (Sigma,UK) in dH20 , shaken
vigorously until dissolved, incubated at 37®C, 
and autoclaved prior to use
1x Phosphate buffered saline (PBS) pH 7.4 0.15 M NaCI, 8 mM Na2P04,17 mM NaH2P0 4
1 x PBT (PBS+Tween) 0.1 % Tween-20 (Sigma,UK)
dissolved in PBS. DEPC treated if required
4% paraformaldehyde (PFA) 4% w/v PFA (Sigma,UK) dissolved in DEPC
PBS, heated until ~60®C while stirring until 
dissolved. Aliquoted and stored at -20 9C until 
used.
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2.2 DNA preparation and purification
2.2.1 Culturing of bacteria
All bacterial culture media were autoclaved as soon as prepared. To obtain single 
colonies, Escherichia coli (E. coli) bacterial cells were cultured on selective agar 
plates. All plasmids used in this thesis contained either the Kanamycin or the 
Ampicillin resistance genes. Therefore, stock solutions of 50 mg/ml of 
Ampicillin (Sigma, UK) or 30 mg/ml of Kanamycin (Sigma, UK) in dH20 were 
added in a 1 in 1000 dilution to the culture media. Agar plates were prepared by 
pouring 25 ml of freshly prepared and autoclaved LB Agar (1% w/v Peptone 
140, 0.5% w/v Yeast Extract, 85 mM NaCl, 1.2% Agar, Invitrogen, UK) plus the 
appropriate antibiotic into 100 x 20 mm Petri dishes. Once set at room 
temperature, bacterial cells were plated onto the agar and the dish was cultured 
upside down at 37°C overnight in a Heraeus Instruments horizontal incubator.
Single colonies were picked from the overnight culture on LB Agar and scaled 
up by inoculation in a starter volume of 5 ml LB Broth (1% w/v Peptone 140, 
0.5% w/v Yeast Extract, 85 mM NaCl, Invitrogen, UK) containing the 
appropriate antibiotic in a flask that was approximately 5 times larger in volume 
than the broth volume. The culture was inoculated overnight at 37°C while 
shaking in an Innova 4300 shaking incubator at 200 revolutions per minute 
(rpm). If the culture was to be further expanded (large-scale culture), the initial 
starter culture was diluted 1:500 in fresh LB Broth with antibiotic and cultured 
for an additional overnight period.
2.2.2 Production of chemically competent bacterial cells
This procedure was performed as described by Inoue et al. (Inoue et al. 1990). 
Chemically competent bacteria, DH5a E. coli cells were streaked on a non- 
selective agar plate (no antibiotics) and incubated overnight at 37°C. Twelve 
colonies were picked and inoculated in 50 ml SOB (2% w/v Bacto peptone, 0.5% 
w/v Yeast extract, 10 mM NaCl, 2.5 mM KC1, 10 mM MgCL, 10 mM MgS0 4 ) 
and cultured while shaking vigorously at room temperature on a bench-top
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orbital shaker. Optical density (od) at 600 nm was measured using a Pharmacia 
Ultraspec III UV/visible spectrophotometer. Once the od reached 0.6, indicative 
of the exponential growth phase of the culture, the culture was poured into pre­
chilled Polypropylene tubes (Becton Dickinson and Co., UK) and incubated on 
ice for 10 min and then spun at 5000 rpm (1949 g) in a Sorvall SS34 rotor 
centrifuge for 10 min at 4°C. The supernatant was discarded and the pellet was 
resuspended by careful pipetting in 16 ml of filter sterilised and pre-chilled TB 
(10 mM Pipes, 15 mM CaCh, 250 mM KC1, pH adjusted to 6.7 with KOH, 55 
mM MnCh), in which they were incubated on ice for 10 min and then 
centrifuged at 5000 rpm (1949 g) for 10 min at 4°C. After discarding the 
supernatant, the pellet was again dissolved in 4 ml ice-cold TB by gentle 
pipetting and incubated for 10 min on ice. Then 0.3 ml (7.5 % v/v) dimethyl 
sulphoxide (DMSO) was added to the cell suspension and cells were incubated 
for another 10 min on ice before being aliquoted into cryotubes (VWR 
International Ltd, UK) and snap frozen in liquid nitrogen. The aliquots were 
stored at -80°C until used.
To ensure that DH5a cells were not resistant to Ampicillin or Kanamycin, an 
aliquot of competent cells was plated on Kanamycin and Ampicillin agar plates 
each, which were incubated at 37°C overnight. No colonies were observed on 
either plate.
The transformation efficiency of these cells was determined by transforming 50 
pi aliquots of competent cells with a 1:1 and a 1:100 dilution of 20 ng of plasmid 
DNA (see section 2.2.3). Overnight culture at 37°C of transformants on agar 
plates with the appropriate antibiotic yielded single colonies, which were counted 
to determine the transformation efficiency expressed as number of colonies per 
jig of DNA used in transformation. This was found to be ~2 x 106 colonies/pg 
DNA.
2.2.3 Transformation of plasmid DNA in bacteria
DNA transformation was achieved by the heat-shock method. 50-100 ng of DNA 
was placed in a pre-chilled Polypropylene tube (Becton Dickinson, UK). A 50 pi
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aliquot of competent DH5a cells was thawed on ice and gently added to the 
DNA and mixed by gentle swirling. The mix was incubated on ice for 30 min 
followed by 45 sec in a 42°C water bath before being put pack on ice for 2 min. 
950 /xl of LB Broth was then added to the mix which was incubated for 1 hr at 
37°C with horizontal shaking. 200 jri of this culture was spread on a selective 
agar plate, which was cultured at 37°C in order to obtain single colonies.
2.2.4 Purification of plasmid DNA from bacteria
The Qiagen min-prep and midi-prep kits (QIAGEN Ltd., UK) were used for 
isolation of plasmid DNA from small scale and large scale overnight cultures 
respectively according to the manufacturer’s protocol. For the purpose of making 
RNA probes for in situ hybridisation, templates in plasmids containing cDNA 
were purified with the QIAGEN mini-prep kit. For in vivo transfection in mouse 
and chick embryos (Chapter 6), plasmid DNA was purified using the QIAGEN 
midi-prep kit which yields DNA of a higher purity. The basis of these kits is 
quite similar with the exception of the column-bound membranes used to bind 
plasmid DNA during the purification procedures. As such the buffers used to 
allow DNA binding and elution from each column differed. The mini-prep 
membrane binds DNA in high salt conditions and releases DNA in no or low salt 
conditions. The midi-prep column is an anion-exchange resin which binds DNA 
on the basis of the affinity of negatively charged DNA phosphate backbone to 
positively charged diethylaminoethyl (DEAE) groups on the membrane.
Apart from the initial spin, mini-prep centrifugations were carried out at 
maximum speed in a bench-top microfuge, while midi-preps were centrifuged in 
a Sorvall SS-34 rotor at the speeds and durations described in the QIAGEN 
protocol.
Briefly, for a small-scale preparation, transformed bacteria were cultured 
overnight in 5 ml of selective LB broth while shaking horizontally at 37°C (see 
section 2.2.1). The overnight culture was then centrifuged for 15 min at 2800 g 
and 4°C in a Sorvall SS-34 rotor to obtain a pellet of bacterial cells. For large- 
scale preparations, an initial overnight starter culture of 5 ml was further
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expanded by a 1:500 dilution of the overnight inoculation in 25 ml of selective 
LB broth, which was cultured for an additional overnight period and then 
centrifuged in the same manner as the small-scale culture to obtain pelleted 
bacterial cells. Pelleted bacteria were resuspended in Buffer PI (50 mM Tris- 
HC1, pH 8.5, 10 mM EDTA, 100 pg/ml RNase A). Cells were then lysed in the 
alkaline Buffer P2 (200 mM NaOH and 1% w/v sodium dodecyl sulphate [SDS]) 
by inversion of the tube 4-6 times. Then Buffer N3 was used for mini-preps and 
Buffer P3 for midi-preps (3 M potassium acetate, pH 5.5) to precipitate cellular 
debris and denatured proteins and chromosomal DNA while plasmid DNA, 
which is smaller in size, remained in solution. The lysate was centrifuged to 
remove the precipitated material and to isolate the supernatant, which was then 
applied to a QIAprep column containing a silica gel membrane (mini-prep) or a 
QIAGEN-100 tip containing an anion-exchange resin (midi-prep). All elutions 
from mini-prep columns were done by centrifugation, while elutions from midi- 
prep columns occurred by gravity flow.
While membrane-bound, DNA was washed in Buffer PE (mini-prep: contains 
ethanol) or Buffer QC (midi-prep: 1 M NaCl, 50 mM MOPS, pH 7.0, 15% v/v 
isopropanol). DNA from the mini-prep column was eluted in 50 pi Buffer EB 
(10 mM Tris-HCl, pH 8.5) and stored at -20°C. DNA from the midi-prep column 
was eluted with Buffer QF (1.25 M NaCl, 50 mM Tris-HCl, pH 8.5, 15% v/v 
isopropanol) and then precipitated with 0.7 volumes of isopropanol followed by 
centrifugation. The supernatant was discarded and pelleted DNA was washed 
with 2 ml of 70% ethanol followed by centrifugation. The supernatant was 
discarded after centrifugation and the DNA pellet allowed to air-dry before being 
dissolved in 50 pi Buffer EB (10 mM Tris-HCl, pH 8.5) or dH2 0 . The 
concentration of DNA was estimated by agarose gel electrophoresis alongside a 
known quantity of a molecular weight marker (section 2.2.7). The concentration 
and purity of DNA was further quantified in a GeneQuant spectrophotometer 
(Pharmacia Biotech, UK). The absorbance measured at 260nm gave the 
concentration of DNA while the 260nm/280nm ratio indicated the purity of DNA 
from proteins. A ratio higher than 1.8 indicated satisfactory purity.
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2.2.5 Characterisation and linearisation of plasmids
All restriction enzymes and buffers were purchased from Promega, UK. For 
characterisation purposes, double digests of plasmid DNA were set up in a final 
volume of 30 pi. For these digests, two enzymes with compatible buffer 
conditions were chosen in order to cut out a fragment of known size. For 
linearisation purposes, single digests were set up in a final volume of 100 pi as 
follows:
Table 2.1 Com position of characterisation and linearisation d igests of plasmid DNA
C haracterisation Linearisation
dH20 to a final volume of 30 pi to a final volume of 100 pi
10 x Buffer 3 pi 10 pi
DNA 0.6-0.7 Mg 10-12 pg
enzyme 1 1 pi 9 pi
enzyme 2 1 Ml n/a
n/a: not applicable.
The digests were mixed by vortexing and then spun for 6 sec in a bench-top 
microfuge to ensure that the entire volume was at the bottom of the eppendorf 
tube. Digests were then incubated for 2 hrs (characterisation digests) or 5 hrs 
(linearisation digests) in a 37°C water bath. 4 pi of the characterisation digests 
and 2 pi of the linearisation digests were run on an agarose gel next to 0.5 pi of 
uncut DNA and 5 pi of a molecular weight marker to ensure that all DNA was 
cut in the linearisation digests and to check that the size of the fragments
produced in the double digests corresponded to those expected according to
plasmid maps.
2.2.6 Phenol/chloroform extraction of plasmid DNA
Linearised DNA (l 00 pi) was purified from proteins using the
phenol/chloroform method. 100 pi of a mixture of 25:24:1
phenol/chloroform/isoamyl alcohol solution (Sigma, UK) was added to 100 pi of 
the linearisation digest and mixed by vortexing. The mixture was spun for 5 min 
at 13,000 rpm in a microfuge, which resulted in the separation of the mix into an 
aqueous and an organic layer. The aqueous layer (top layer) was removed and
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put in a fresh eppendorf tube. To this was added 100 pi of chloroform in order to 
remove any traces of phenol. The solution was mixed by vortexing and 
centrifuged for 5 min at 13,000 rpm. The top layer, containing the DNA, was 
removed and put into a fresh eppendorf tube. DNA was precipitated overnight at 
-20°C by the addition of 10 pi 3 M sodium acetate (pH 5.3) and 500 pi 100% 
ethanol to the 100 pi volume of DNA. The next day the solution was centrifuged 
at 13,000 rpm at 4°C for 30 min. The liquid was decanted and the pellet was 
washed in 200 pi of 70% ethanol, centrifuged for 10 min at 4°C and 13,000 rpm, 
and then the DNA pellet was allowed to air-dry before being dissolved in an 
appropriate volume of DEPC treated dH20  in order to obtain a concentration of 1 
pg/pl. The purified DNA solution was checked by agarose gel electrophoresis.
2.2.7 Agarose gel electrophoresis
This method allows the visualisation and separation of nucleic acid according to 
size. An appropriate volume of DNA or RNA (as stated under relevant sections) 
were diluted in dH20  and 5 x loading buffer (Bioline,UK). The agarose gel was 
prepared by dissolving agarose powder (Flowgen, UK) in lxTAE (Tris-acetate 
EDTA; 0.04 M Tris-acetate, 1 mM EDTA, pH 8.0) and heating the mix in a 
microwave oven until no powder or bubbles remained. The heating period 
differed between approximately 2 min for mini-gels of 50 ml and 1% w/v to 12- 
15 min for maxi-gels of 300 ml and 2% w/v. The concentration of agarose gels 
depended on the size of the genetic material to be analysed. To check digests of 
plasmids and linearised probes, a 1% w/v agarose gel was used. For the low 
molecular weight PCR products obtained from genotyping of Tbx2~ ' embryos, a 
2% w/v gel was used. Ethidium bromide, which intercalates into the DNA 
backbone was added to the gel at a final concentration of 0.5 fig/ml. The gel was 
then allowed to set at room temperature in a gel cast with an inserted comb in 
order to make wells that could hold the loaded volume. Once set, the gel was 
submerged in lxTAE in an appropriately sized gel tank (Gibco BRL, UK). The 
previously prepared dilutions of the DNA or RNA were loaded into the wells. 
For quantification purposes, 5 pi of a DNA molecular weight marker (ladder) 
was also loaded onto the gel. The DNA ladder used for quantification purposes 
during agarose gel electrophoresis were the 2-Log DNA ladder (New England
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Biolabs Inc., USA), the Hyperladder I (Bioline, UK), or the GenRuler 
(Fermentas) all of which contain fragments of plasmid DNA ranging from 
100/200 bp to 10,000 bp in size. At 5 /ri, the quantity of each fragment in the 
ladder was known. Current was applied at approximately 60 V for mini-gels and 
130 V for maxi-gels in order to allow the migration of DNA fragments across the 
gel. After completion, the gel was visualised under ultra violet (UV) light and 
images were captured using a UVitec camera and the Alphalmager Programme.
2.3 Mouse models; obtaining and genotyping embryos
The mouse models used in different Chapters of this thesis include the inbred 
CBA/Ca wild-type strain in Chapters 3 and 4, the Fgf 15 knock-in allele on a 
mixed genetic background (A. Battersby, University of Wales Cardiff) in 
Chapter 3, the Tbx2mIPa allele on a mixed Sv/C57/ICR background (Harrelson et 
al. 2004) in Chapter 4, and the spontaneous Chxl0OrJ allele (Burmeister et al. 
1996) on a 129/Sv background in Chapter 4. The CBA/Ca strain used in the 
embryo culture experiments in Chapter 4 is a widely used strain in research due 
to good breeding performance and litter size (Mouse Genome Informatics). It is a 
pigmented strain, suitable for studies of eye development.
2.3.1 Maintenance of adult animals
Mice were maintained in a barrier facility on a daily cycle of 12 hours (hrs) 
artificial light and 12 hrs darkness. Caging, feeding, breeding, and general 
maintenance were according to Home Office (UK) regulations
2.3.2 Timed mating
Mice reach breeding age around six weeks after birth (Hetherington et al. 2000). 
Matings were set up between three or four females and a male per cage 
overnight. In the morning, females were checked for vaginal plugs with a blunt 
metal probe. The plug, which is a white coagulate, forms in the opening of the 
vagina after mating has occurred. Upon identification of a plug, the female was
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removed from the breeding cage and kept separately. Mice usually mate in the 
middle of the dark period (Hetherington et al. 2000). The age of the litter at 
midday of the day of the detection of a vaginal plug was therefore designated 0.5 
days post coitum (dpc).
2.3.3 Obtaining homozygous embryos
To obtain homozygous embryos for the Tbx2,mlPa and the Fgfl5-Egfp alleles, 
timed matings were set up between heterozygous animals as described in Section
2.3.2. Chxl(PrJ/° rJ homozygous embryos were obtained from timed matings of 
homozygous breeding pairs of adult mice, as the Chxl0OrJ/OrJ mice are viable and 
fertile.
2.3.4 Dissection of embryos from pregnant females, fixation, and 
storage
Pregnant animals were killed by cervical dislocation and embryos were dissected 
out of the uterus in PBS if they were to be fixed, and in Dulbecco’s modified 
Eagle’s medium (DMEM, Gibco BRL, UK) containing 10% heat inactivated 
fetal calf serum (FCS, Sigma, UK) if they were to be cultured, using No5 
Watchmakers forceps (Interfocus, UK).
The uterus was removed through a horizontal incision across the mouse abdomen 
and washed in PBS. The decidual swellings were taken out of the uterus 
individually by carefully teasing open the uterus from one end, at the 
mesometrial surface until a decidual swelling was visible. Keeping the forceps 
close together and working with small motions, the tear in the uterine wall was 
made larger until more of the decidua was visible. The decidual swelling was 
then freed from the uterine wall by gentle squeezing with the forceps. This was 
repeated until all decidual swellings were out. The decidua, trophoblast, and 
Reichert’s membrane were carefully trimmed around the ectoplacental cone until 
the yolk sac and the embryo were completely revealed. Then, a small hole was 
made in the yolk sac, where it meets the placenta. This hole was made in an 
avascular region, taking great care not to rupture any of the yolk sac vessels. The
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hole was then made bigger by making small tears while going around the 
placenta with the forceps. The yolk sac, together with the amnion, were pulled 
over the head of the embryo and positioned under its tail, exposing it for 
manipulations. This allowed easy access to the eye for bead implantation 
purposes.
Embryos that were to be fixed immediately after dissection were freed from all 
extra-embryonic layers. For genotyping purposes of mutant litters, the yolk sac 
of each embryo was dissected with great care in order to avoid tissue 
contamination between embryos or between embryo and the placenta; forceps 
were often wiped clean and flamed between the dissection of each embryo. 
Isolated yolk sacs were rinsed in PBS and kept for genotyping at -20 °C. 
Embryos were fixed overnight in 4% w/v PFA in DEPC treated PBS at 4 °C. 
After fixation, they were rinsed twice in DEPC treated PBT, and dehydrated to 
100% methanol through an increasing concentration series of methanol : DEPC 
PBT (25%, 50%, 75%, 100%) while rocking gently at 4 °C. 9.5-10.5 dpc 
embryos were washed for 20  min in each solution, while older embryos were 
washed for 25 min. After the last wash embryos were put in fresh 100% 
methanol, in which they were stored until further use at -20°C.
2.3.5 Genotyping of embryos by Polymerase Chain Reaction (PCR)
2.3.5.1 Isolation of genomic DNA
To obtain genomic DNA from embryos for genotyping, yolk sacs were digested 
overnight at 55 °C with 0.1 mg/ml Proteinase K (Sigma, UK) in 200 fi\ “lysis 
buffer” (50mM Tris pH 8.0, 100 mM NaCl, 100 mM EDTA, 1% SDS). Lysates 
were shaken for 5 min on a horizontal shaker, after which 100 jd of saturated 
(6M) NaCl was added to each tube. Samples were again shaken for 5 min on a 
horizontal shaker and then spun for 10 min at 13,000 rpm in a microfuge to pellet 
proteins at the bottom of the eppendorf tube. Supernatants were gently poured 
into new eppendorf tubes and 250 /d of 2-isopropanol was added to each sample 
to precipitate DNA. Tubes were inverted 3-5 times to mix all components and 
were then spun for 10 min at 13,000 rpm to pellet DNA. Supernatants were
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carefully poured out and DNA pellets were washed with 250 pi of 70% ethanol 
followed by centrifugation at 13,000 rpm. The ethanol was poured out and pellets 
were left to dry with each eppendorf tube tilted upside down on a clean sheet of 
paper. Once dry (~10 min), pellets were re-suspended in 100 pi TE buffer (10 
mM Tris pH 8 , 1 mM EDTA) and kept at -20 °C until used.
2.3.5.2 PCR amplification
E/nbryos from matings of Tbx2lmlpa heterozygous mice were genotyped using a 
three-primer system (Table 2.2) as described in (Harrelson et al. 2004). Each 20 
pi PCR reaction contained the following: 2 pi genomic DNA as template, 200 ng 
forward primer one, which was specific for an intronic region between exons two 
and three and was present in the wild-type allele but absent in the mutant allele, 
200  ng of forward primer two, which was specific to a region introduced by the 
insertion of the loxP sites in the mutant allele and remained intact after the cre- 
mediated excision of PGK-neo, 200 ng of reverse primer three, which was 
specific for an intronic region between exons two and three in both alleles. To 
these components were added 0.2 mM of each deoxyribonucleotide triphosphate 
(dNTP; Bioline, USA), lx  buffer (10 mM Tris-HCL pH 8.0, 50 mM KCL, 2.5 
mM MgSC>4, 0.5% v/v DMSO, 0.2 mM spermadine, 0.1% v/v Tween-20), and 1 
unit of Taq DNA polymerase (Invitrogen, USA). Positive controls for each allele 
were included in each PCR run using DNA templates of known genotypes. A 
water control, in which the DNA template was substituted for dH20  was also 
included to control for DNA contamination. Each reaction volume was made up 
to 20 pi with dH20  and tubes were sealed with caps.
Reactions were incubated in a thermal cycler (Biorad MyCycler) at 94°C for 10 
sec for the initial denaturing step of double stranded DNA template, followed by 
36 cycles of amplification with 10 sec at 94°C to denature, 30 sec at 61°C to 
allow annealing of primers, and 30 sec at 72°C for extension. At the end of the 36 
cycles, reactions were incubated at 72°C for another 5 min, to ensure complete 
synthesis of all PCR products, and then held at 4°C. A sample of 10 pi of each 
PCR reaction was run on a 2% agarose gel as described in Section 2.2.7, to 
separate the amplified products.
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Table 2.2 Details of PCR Primers and the expected amplified products
Primer Sequence
1-T2F1 5’-CC AGCC AGGGAACAT AAT GAGG-3’ ■P
2- T2m4F 5’-CCT GCAGGAATT CCT CGACC-3’ b T C
3- T2R1 5'-CT GTCCCCT GGCATTT CT GG-3' -  VC
Product size wild-type allele: 180 bp 
mutant allele: 80 bp
Fgf 15 {wt)p11 5'-GACTT GAT GCAATT AGGAGG-3' 5 S'C
Fgf 15 (wt) p55 5’-CAGCCGT AGAGAAAGAGT G-3*
Fgf 15 (mt) p50 5’-GT AACC ATT AT AAGCT GCAAT-3’
Fgf 15 {mt) p5 5'-T GCAAGCTTT CCTT GAT GGCAATCGT C-3’
Product size wild-type allele: 388 bp 
mutant allele: 513 bp
Each F gf 15 PCR reaction consisted of: 1 pi genomic DNA, 0.75 pi of each 
primer (10 pmol/pl solution), lx NH4 Reaction Buffer (16 mM (N H ^SC^, 67 
mM Tris-HCL pH 8 .8 , 0.1% v/v Tween-20; Bioline, UK) either 1.5 mM MgCh 
solution (for primer pair pi l+p55 recognising the wild-type F gf 15 locus) or 2.5 
mM MgCh solution (for primer pair p50+p5 recognising the excised locus), 3 
mM dNTP solution, 1.5 unit of BIOTAQ DNA Polymerase (Bioline, UK) in 25 
pi H2O (Sigma, UK). The PCR reaction consisted of an initial 2 min at 96°C 
followed by 30 cycles of: 95°C for 30 sec (denaturation), either 50°C (primer pair 
pi l+p55) or 55°C (primer pair p50+p5) for 30 sec (annealing), and 72°C for 1 
minute (extension). A single 5 min elongation step at 72 °C was added at the end 
of the 30 cycles.
2.4 Mouse whole embryo culture
2.4.1 Preparation of rat serum
Blood was withdrawn from the abdominal aorta of ether-anesthetised male 
Sprague-Dawley rats, decanted gently into a 15 ml centrifuge tube and 
centrifuged immediately at 1000 g for 5 min. This separated the plasma from red 
blood cells. The plasma was allowed to clot at room temperature and serum was 
squeezed out with forceps and transferred to a fresh tube, taking care not to mix 
with the blood. The serum was centrifuged again at 1000 g  for 5 min and
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transferred to a fresh tube, to ensure that no remnants of blood remained. It was 
then heat-inactivated at 56 C° for 30 min and stored at -20 C° until used.
2.4.2 Culture of embryos
The whole mouse embryo culture system has successfully been used to study 
many aspects of embryogenesis, for example neural tube closure (Greene and 
Copp 1997). It has been demonstrated that mouse embryos can grow and develop 
as in utero, in culture conditions first established by David Cockroft (Cockroft 
1990; Martin and Cockroft 1999).
Plugs were obtained and conceptuses dissected out of the uterus as described in 
Sections 2.3.2 and 2.3.4. Unless embryos were in exceptional health (strong 
blood circulation) they were put in ‘recovery culture’ for approximately one hour 
before further manipulations took place. Embryos were cultured in 30 ml 
Universal tubes (Nalgene Nunc, USA) at 37°C in a roller incubator (30-40 rpm) 
for approximately 15-18 hours (hrs) in 3 ml medium containing 25% rat serum in 
culture saline (0.12 M NaCl, 4 M KC1, 0.4 mM MgS04.7H20, 0.25 mM 
MgCl2.6H20 , 0.60 mM NaH2PO4.2H20, 1.8 mM CaCl2.2H20 , 11 mM Glucose, 
24 mM NaHCOj). Prior to incubation, embryos were manually gassed for 
approximately 1 min with 95% 0 2/ 5% C 0 2 (Cryoservice Ltd, UK). The rim of 
the tubes were smeared with silicone grease to create a gas-tight seal. 
Assessment of health and growth of embryos after culture are described in 
Chapter 4.
2.5 Obtaining chick embryos
Handling of eggs and chick embryos were carried out as described in the 
‘Essential Developmental Biology’ book (Stem 1993). For electroporation 
experiments in Chapter 6 with the pIRES2-EGFP vector, brown eggs were used. 
For electroporations with the RCAS-AP or retroviral delivery, pathogen-free
white were used to avoid viral interference from possible
previous infections, which would prevent new infection.
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2.5.1 Egg incubation
Fertile eggs were purchased from Henry Stewart & Co Ltd, Lincolnshire, UK. 
They were stored at 15°C for up to 4 days prior to incubation. To initiate 
development, eggs were placed horizontally in a humidified (Curfew incubators 
model 747) incubator at 38°C. Manipulations were carried out on day 1.5 of 
incubation, when most embryos reached Hamburger and Hamilton stage (HH) 9- 
10, which is the stage when the optic vesicles form (Hamburger and Hamilton 
1992).
2.5.2 Preparation of the egg for manipulation
Eggs were placed horizontally, in the same orientation that they had been 
incubated in, in an egg tray under a dissecting microscope (Stemi SV11, Zeiss, 
Germany) with transmitted light. The surface of the egg was wiped with 70% 
ethanol. With the tip of a pair of sharp scissors, the pointy end of the egg, which 
does not contain the air sac, was gently tapped to make a small hole. A 19 G 
needle (Becton Dickinson, UK) attached to 5 ml Luer tip syringe (BD, 
Biosciences, UK) was inserted through the hole and ~3 ml of albumin was 
removed to lower the embryo from the upper surface of the egg, in order to avoid 
damaging the embryo when opening the egg. A large part of the upper surface of 
the egg was then covered with one piece of cellotape and using a pair of fine 
scissors, an oval-shaped piece of the shell was cut and removed to reveal the 
embryo. The cellotape helped to minimise cracks and to prevent egg shells to fall 
on the yolk and the embryo. If large pieces of the shell fell inside the egg, they 
were gently removed with forceps.
2.5.3 Staging of chick embryos
Embryos were staged according to the Hamburger and Hamilton descriptions of 
morphology. For younger embryos, staging was based on assessment of the 
shape of the optic vesicles and the number of somite pairs. After optic cup 
formation, staging was based on limb morphology and the appearance of the 
branchial arches.
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2.5.4 Explanting embryos from the egg
Using a pair o f sharp scissors, four cuts were made in the vitelline membrane 
around the embryo. For younger embryos (until HH 20) it was possible to lift out 
the embryo from the egg by grabbing two opposing comers of the cut membrane 
using watchmakers’ forceps. Older embryos (above HH 20) were lifted out in a 
spoon as they were too heavy to be lifted out with the membrane.
If embryos were to be processed for RNA in situ hybridisation, they were rinsed 
and cleansed from membranes in DEPC treated PBS, but otherwise non-treated 
PBS was used. Once the vitelline membrane and the yolk sac were removed, 
embryos were rinsed in fresh (DEPC) PBS and then fixed overnight at 4 °C in 
4 % PFA. If not processed further immediately after fixation, embryos were 
dehydrated in an ascending concentration of methanol involving 20-25 min 
washes in 25, 50, 75, and 100 % methanol in (DEPC) PBT, which was performed 
at 4 °C. Embryos were kept in 100 % methanol at -20 °C until used.
2.6 Manipulation of the embryo
Many of the experiments described in this section required pulled glass capillary 
needles. Borosilicate glass capillaries (Clark electromedical instruments, UK), 
were prepared by Katy Gardner (Institute of Child Health) on a P-87 
Flaming/Brown micropipette puller (Sutter Instrument Co.).
2.6.1 Protein delivery by bead implantation
Human BMP4 is initially translated as a pro-protein of 408 amino acids, which is 
post-translationally cleaved into an active 116 amino acid peptide. The rhBMP4 
used in this study was produced in a mouse myeloma cell line and is a 
homodimeric form of two 116 amino acid human peptides crosslinked by a 
disulfide bond (R&D Systems, UK). The human and mouse homologues share 
98% amino acid sequence similarity (Botchkarev 2003).
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The application of a concentration range of rhBMP4 coated beads [1-100 pg/ml] 
in the anterior neuropore in chick embryos was previously reported to cause a 
range of abnormalities with the degree of severity corresponding to the 
concentration of rhBMP4 protein (Ohkubo et al. 2002). In another study where 
rhBMP4 coated beads at [1-5 pg/ml] were applied to wild-type mouse optic 
vesicle explant cultures, no effects were observed on eye development, but the 
application of the same concentration of rhBMP4 to Bmp4 ' optic primordia, 
which lack the ability to form a lens, was reported to rescue lens formation. 
(Furuta and Hogan 1998). Therefore, in order to achieve an effect on eye 
development, a 100 pg/ml rhBMP4 solution containing 0.1 % w/v BSA in PBS 
was used in experiments described in Chapter 4.
The Noggin protein used is a homodimeric form of a chimeric protein consisting 
of amino acid residues 20-232 of mouse Noggin fused to the Fc region of human 
IgGj via a polypeptide linker. It was produced in a mouse myeloma cell line 
(R&D Systems, UK). A stock solution of 1 mg/ml was made by dissolving the 
Noggin powder in PBS containing 0.1% BSA. The concentrations^ Noggin used 
are stated in the description of relevant experiments in Chapter 4. As a control 
for the surgical procedure, implantations were performed with beads soaked in 
0.1% w/v BSA in PBS.
Affi-Gel Blue beads made of cross-linked agarose gel with covalently attached 
Cibacron blue (a blue dye) were used as protein carriers (Biorad, USA). 10 pi 
beads in sodium azide solution with a diameter of 80-150 pm were first washed 
with embryo water (Sigma, UK) three times and centrifuged to remove the 
sodium azide. They were then incubated for a minimum of one hour at 37 C° in 
5 pi of either rhBMP4 or Noggin protein of concentrations stated.
Bead implantation into the eye was performed with the embryo resting on its side 
in explanting saline (0.12 M NaCl, 4 M KC1, 0.4 mM MgS04.7H20, 0.25 mM 
MgCl2.6H20 , 0.60 mM NaH2PO4.2H20, 1.8 mM CaCl2.2H20 , 0.83 mM Glucose, 
0.6 mM NaHCCb) in a Petri dish. Prior to bead implantation, the location in 
which the bead was to be inserted was pierced using a sharpened tungsten wire.
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A bead was then placed in the pierced location using a pulled glass needle (see 
section 2.6.2.3) and a mouth pipette. The specific locations of beads are stated in 
the description of the results.
In experiments where high concentration rhBMP4 was used, the uptake of 
protein by beads, rather than the concentration of protein solution was increased 
(Lee et al. 2001b). Beads were incubated in an initial 5 pi volume of 100 pg/ml 
stock solution and allowed to airdry for 2 hrs. They were then incubated in 
another 5 pi o f the protein stock solution but this was done in cycles of ~2 pi 
volumes in between which the beads were allowed to dry for 2 hrs. This 
increases the amount of protein uptake by the beads and therefore, more protein 
can be delivered.
2.6.2 Gene delivery by electroporation
Electroporation is the method whereby the lipid bilayer of the plasma membrane 
of cells is briefly permeabilised by the application of a single or multiple electric 
pulses. In ovo electroporation in the chick embryo has been employed to 
misexpress various genes in the developing eye (Koshiba-Takeuchi et al. 2000; 
Sakuta et al. 2001; Kubo et al. 2003) as well as in other tissues (Itasaki et al. 
1999; Swartz et al. 2001).
2.6.2.1 Vectors used and preparation of the DNA solution
pIRES2-EGFP
The pIRES2-EGFP vector (BD Biosciences Clontech), which expresses 
enhanced green fluorescent protein (EGFP) when taken up by cells, and the 
RCASBP-AP vector (here referred to as RCAS-AP), which expresses the human 
placental alkaline phosphatase (AP) enzyme were used in electroporation 
experiments. The expression of EGFP can be directly assessed by fluorescence 
microscopy and the expression of AP can be histochemically assessed at the end 
of the experiment to visualise plasmid uptake in the eye. Since the chick embryo 
offered a system, in which retinal cell differentiation and RGC axonal projections 
could be studied due to the possibility of longer culturing of embryos after
102
manipulation, a strategy that allowed long term expression of the transgene was 
desirable. The pIRES2-EGFP vector was not suitable for this purpose but was 
extremely useful for visualising the targeted cells in live embryos during the 
experiment and was therefore used in conjunction with the RCAS-AP plasmid 
(proviral form), which offers long term expression. In this manner, stable 
transgene expression and direct visualisation of transfected cells could be 
achieved.
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Fig. 2.1 Schematic diagram of the pIRES2-EGFP vector
cDNA inserted into the multiple cloning site (MCS) is driven by the CMV 
promoter in conjunction with EGFP (BD Biosciences Clontech, UK)
pIRES2-EGFP (Fig. 2.1) contains a multiple cloning site downstream of the 
constitutively active cytomegalovirus (CMV) promoter, followed by an internal 
ribosomal entry site (IRES), the EGFP gene, and an SV40 polyadenylation 
signal. It is constructed so that the cDNA of interest, inserted into the multiple 
cloning site, is transcribed in conjunction with EGFP as a bicistronic mRNA. But 
the two proteins are translated separately due to the IRES fragment. The 
advantage of this vector is that it drives the expression of EGFP and the protein 
of interest in the same cell, allowing direct detection of the site of plasmid uptake 
and protein expression. In comparison to other types of vectors, which lack the 
IRES and tag the protein of interest to a fluorophore or a chromophore, the risk 
of a conformational change to the protein structure is minimised.
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RCAS-AP
The RCASBP (replication-competent, avian leukemia virus long terminal repeat, 
splice acceptor, Bryan high-titre, polymerase) vectors are derived from the Rous 
sarcoma virus and encode genes vital for viral replication, production, and 
integration into the host cell genome but lack the src oncogene normally carried 
by this virus (Fig. 2.2). RCAS-AP encodes a retroviral backbone (RCASBP 
subtype A) with the gag, pol, and env viral genes (see Fig. 2.2) as well as the 
full-length AP cDNA. It produces a replication competent virus, which is capable 
of infecting avian cells and integrating into their genome.
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Fig. 2.2 Schematic diagram of the important features of the RCASBP 
retroviral vector
The pro virus (double stranded DNA form) contains two identical untranslated 
regions called the long terminal repeats (LTR) that contain the viral transcription 
regulatory regions, which drive transcription of viral genes as well as the inserted 
gene. The proviral genome also consists of gag, which encodes viral protease, 
nucleocapsid, capsid, and matrix proteins, pol, which encodes reverse 
transcriptase and integrase, and e/zv, which encodes viral envelope glycoproteins. 
The desired cDNA is inserted in the Cla I site (blue box). The splice donor and 
splice acceptor sites enable the production of three different transcripts one of 
which encodes the inserted cDNA alone. The RSCH probe used for detection of 
the virus in infected tissue is depicted by a stripy pink box.
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Plasmids were amplified in DH5a bacterial cells and midi-prepped as described 
in Sections 222-2 .2A . DNA was dissolved in buffer EB (lOmM Tris, pH 8.2) 
and quantified as described in 2.2.7 and characterised by restriction enzyme 
digests as described in 2.2.5. At the start of each experiment, in order to make the 
DNA more viscous, DNA was dissolved in a 16% w/v final concentration of 
sucrose in embryo water (Sigma, UK), and to make it visible, in a final 
concentration of 0.05% fast green (Sigma, UK).
Table 2.3 Information about vectors used for electroporation
Vector 
(size, bp)
Promoter Antibiotic
resistance
Restriction 
enzyme used for 
characterisation
Expected 
bands (bp)
Supplier of 
vector
plRES2-
EGFP
(5,308)
CMV Kanamycin Hind III 5,039 + 
269
Dr. C Beesley; 
(ICH, London, 
UK; originally 
purchased 
from BD 
Biosciences 
Clontech)
RCAS-AP
(13,842)
LTR Ampicillin C/a I 11,657 + 
2,185
Dr J Chan 
(ICH, London, 
UK)
Enzymes and buffers were purchased from Promega, UK
2.6.2.2 Preparation of the injection needle
Glass needles (1 mm) pulled with a micropipette puller to create an injection tip 
were used as injection needle for all injection and bead implantation experiments 
described in this thesis. The tip of a pulled glass needle was gently removed by 
fine forceps under the view of a dissecting microscope. The tip of the injection 
needle had to be wide enough for fluid to pass through it, but small enough for it 
to penetrate the embryonic tissue without causing extensive damage. The blunt 
end of the glass needle was attached to a mouth pipette, which was attached to a 
pipette tip at the other end for mouth aspiration. A 0.5 pi aliquot of the prepared 
DNA solution was placed on cling film. The sharp tip of the needle was carefully 
placed inside the DNA drop at an almost horizontal angle to avoid damage to the
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tip of the needle by the surface of the bench. DNA was then sucked up into the 
needle, avoiding formation of bubbles.
2.6.2.3 Description and preparation of electrodes
Gold electrodes (5 mm thickness) were purchased from Qbiogene,UK. Silver 
electrodes were prepared from 5 mm thick silver wire, which was insulated by 
insertion into a glass pasteur pipette (Volac, 230 mm). Tungsten electrodes were 
prepared from 0.5 mm thick tungsten wire (Agar scientific), also inserted inside 
pasteur glass pipettes. The tip of the glass pipette was heated in order to melt the 
glass around the tungsten or silver wire to hold it firmly in place. The tip of the 
tungsten wire that was to be inserted into the embryo was sharpened in hot 
sodium nitrite until satisfactory sharpness was obtained. It had to be sharp 
enough to pierce through the embryonic tissue without causing extensive 
damage. Gold and Gold/tungsten electrodes were placed ~0.4 mm apart.
2.6.2.4 Mouse electroporation followed by whole embryo culture
Dissection and preparation of embryos for embryo culture were carried out as 
described in 2.4.2. Embryos at 11.5 dpc were prepared for embryo culture with 
the yolk sac and the amnion carefully cut open and pushed beneath the embryo to 
reveal it for ease of access. Prior to electroporation, healthy embryos were 
cultured for one hour, in order for them to recover from the stress of being 
explanted from their uterine environment.
Basic setup
The basic electroporation setup consisted of a dissecting microscope (Stemi 
SV11, Zeiss, Germany) with incident light. Although the earlier preparation of 
the embryo required transmitted light for clear visibility of the embryo and 
membranes, incident light from above was sufficient for the purpose of injection 
of DNA and electroporation of 11.5 dpc embryos. Several agarose gel covered 
medium sized Petri dishes were prepared by pouring 1.5 % agarose in autoclaved 
dfbO  into the Petri dish and allowing the gel to set. The agarose gel facilitated
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positioning of the embryo and in some experiments also accommodated the 
electrode. One or both electrodes were held in position by an electrode holder, 
which was attached to a micromanipulator. Electrodes were connected to an 
ECM 830 Square Wave Pulse Generator (Qbiogene, UK) via connection cables. 
The site of DNA injection, the strength of current, and the number and duration 
of pulses varied and are given for each experiment in Chapter 6 . All experiments 
were carried out with the embryo rested in an agarose covered petridish 
containing explanting saline (0.12 M NaCl, 4 M KC1, 0.4 mM MgS04.7H20, 0.25 
mM MgCl2.6H20 , 0.60 mM NaH2PO4.2H20, 1.8 mM CaCl2.2H20 , 0.83 mM 
Glucose, 0.6 mM NaHCC^). After current was delivered, the build-up of material 
on electrodes was cleaned in dH20  using a brush. In the following subsections, 
the modified setups and the procedure are described.
Electroporation with gold plated electrodes
Straight gold plated electrodes (Qbiogene,UK), were held in place by the 
micromanipulator. The embryo was rested on its tail inside a pocket in the 
agarose bed in explanting saline. The electrodes where positioned on either side 
of the head of the embryo. The DNA solution was then mouth pipetted into the 
vitreous chamber of the optic cup with a plasmid DNA filled glass needle 
(2 .6 .2 .2 ) and current was delivered immediately.
Electroporation with gold-tungsten combination electrodes 
Tungsten electrode insertion into the embryo was first reported in a study where 
a lacZ reporter driven by the CAG promoter was targeted to the chick optic 
vesicle (Momose et al. 1999) and shown to provide a better transfection 
efficiency than platinum electrodes, which are the predominant type of electrodes 
used in mouse electroporation studies reported so far. A straight gold plated 
electrode was fastened to the micromanipulator via a holder. It was connected to 
the cathode and placed dorsal of the head of the embryo, while the embryo was 
rested on its side on the agarose bed with one eye facing up. A straight tungsten 
electrode was then connected to the anode and the sharpened tip was inserted 
into the extra-ocular mesenchyme directly opposite the cathode. The DNA 
solution was injected into the eye and current was delivered immediately after 
injection.
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Electroporation with silver electrodes
The tips of the silver wire electrodes were bent into an L-shape. The bent part of 
the cathode was placed inside a fitting pocket in the agarose cover of the Petri 
dish in which the embryo was to be rested, so that it was level with the surface of 
the agarose gel. The embryo was rested on its side with the optic cup positioned 
directly on top of the cathode. The DNA solution was mouth-pipetted into the 
optic cup (injection sites varied as described in Chapter 6 ) facing up, the L- 
shaped anode was held manually over the injected optic cup in parallel to the 
cathode and current was delivered. The distance between these electrodes were 
subject to variability as one was held manually over the optic cup, but 
approximately, this distance was the same as the width of an 11.5 dpc mouse 
head.
After electroporation, embryos were returned to culture in the same media as 
they had been cultured in for one hour prior to electroporation. Embryo culture 
was described in section 2.4.2.
2.6.2.5 In ovo electroporation of the chick embryo
Setup
In contrast to mouse electroporations, all chick electroporations were carried out 
with the same experimental setup, regardless of electrodes used. The electrodes 
were fastened in the holder, which was held in place and manoeuvred by a 
micromanipulator. The current was supplied by an ECM 830 Square Wave Pulse 
Generator (Qbiogene, UK), to which the electrodes were connected. DNA 
injection and electroporation were carried out with the egg placed in an egg 
holder under a dissecting microscope (Stemi SV11) with incident light.
Procedure
Electroporation was performed on HH 9-10 embryos, when the optic vesicle was 
forming or had just formed. Eggs were prepared and opened as described in 
section 2.5. Prior to DNA injection, electrodes were put in a suitable position. If 
a pair of gold plated electrodes were used, they were placed on either side of the
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head of the embryo where they covered the optic vesicles. When using the 
gold/tungsten combination electrodes, the gold plated electrode was connected to 
the anode and placed lateral to the injected optic vesicle, while the tungsten 
electrode was connected to the cathode and inserted into the embryonic tissue in 
close proximity to the injected optic vesicle. DNA was injected into the right 
optic vesicle lumen with a mouth pipette. The volume injected was variable, but 
never exceeded 0.5 ul, which was the initial volume of DNA filled into the 
needle prior to injections. DNA injected into the optic vesicle lumen spread also 
into the brain vesicles and sometimes poured out through the anterior neuropore, 
although care was taken to avoid this as much as possible. Preparations of the 
DNA solution, electrodes, and the injection needle were described in sections 
2.6 .2.2 -  2.6 .2.3. After electroporation, the opening of the egg shell was sealed 
with cellotape and eggs were returned to the humidified incubator at 38 °C for 
further culture (as indicated in Chapter 6).
2.6.3 Gene delivery by retroviral vectors
Retroviruses use RNA as their genetic material and the mechanism of retroviral 
gene delivery to the embryo is based upon the natural ability of the retrovirus to 
enter a cell via cell surface receptors. Therefore, the host range of each retrovirus 
is determined by the availability of cell surface receptors on the host cell that can 
interact with its coat protein. Once inside the host cell, the RNA genome of the 
retrovirus is converted into double stranded DNA, the provirus, which is then 
integrated into the host DNA during the S-phase of the cell cycle, when the host 
DNA is being replicated (Morgan and Fekete 1996). In this manner, the host cell 
and its future progeny inherit the viral genome. The retrovirus is also capable of 
infecting neighbouring cells, which together with its heritability by progeny can 
lead to a widespread infection across a proliferating tissue.
The method used for viral injection into the chick optic vesicle was based on the 
experimental set-up and procedure reported for targeting of chick limb buds with 
some adaptations (Logan and Tabin 1998).
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The viruses used were produced from an RCAS-AP construct, encoding the 
human placental alkaline phosphatase, as a control for retroviral delivery, and the 
type A RCASBP virus containing the full length sequence of chick Tbx2 
(RCASBP-cTbx2y here referred to as RCAS-cTbxI).
2.6.3.1 Preparation of retroviral stock
The viral stocks were kindly provided by Dr M. Logan (National Institute for 
Medical Research [NIMR], London, UK) and were prepared by Dr C. Rallis as 
described in Logan and Tabin (Logan and Tabin 1998). The titre of the viral 
stocks were estimated to 1 x 108 colony forming units (c.f.u)/ml.
2.6.3.2 Injection of virus
Set-up
Pulled borosilicate glass capillary needles were prepared for injection under a 
dissecting microscope by using forceps to break off the sealed end in order to 
make an opening with a desired diameter. Several needles were prepared prior to 
the start o f the experiment as they had to be frequently replaced due to clogging. 
A 0.1 ml Luer tip Hamilton syringe was attached to a 19 gauge needle (1.1 x 40 
mm, BD, Biosciences, UK) and both needle and syringe were filled with heavy 
mineral oil (Sigma, UK), making sure that air-bubbles were excluded. The oil 
allowed for better control over the volumes injected, while the presence of air- 
bubbles resulted in build-up of unwanted pressure, which prevented controlled 
injections. The Hamilton syringe was mounted in a micromanipulator. Then a 2 
cm piece of Tygon tubing (Saint Gobain) was used to attach the pulled capillary 
needle to the 19 G needle on the Hamilton syringe. Under a dissecting 
microscope, mineral oil was slowly pressed out from the Hamilton syringe so 
that the Tygon tubing and the capillary needle were also filled with mineral oil to 
the tip. The viral stock was then thawed on ice and for visualisation purposes, 0.2 
% v/v Fast Green (Sigma, UK) was added to the viral stock. A small volume (3 
pi) of the viral solution was placed on a piece of cling film. The tip of the 
capillary needle was inserted just beneath the surface of the bubble of viral 
solution that formed on the cling film. The capillary needle was then loaded
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gently with viral solution by lightly lifting the plunger of the Hamilton needle to 
generate a slight negative pressure. Before lifting the needle out of the viral 
solution, it was ensured that the negative pressure was no longer present, as 
otherwise air-bubbles would be sucked in when the tip of the needle was 
removed from the solution.
Procedure
White Leghorn eggs were incubated until HH 9-10 and were prepared for 
injection as described in 2.5.1 and 2.5.2. The tip of the capillary needle was 
inserted in the embryo so that it touched the neuroepithelium of the left optic 
vesicle. Viral solution was injected into the lumen of the left optic vesicle, but 
since this is continuous with the right optic vesicle via the developing 
telencephalic vesicle, the injected volume appeared to spread equally to both 
optic vesicles. When possible, virus was also injected into the neuroepithelium 
itself. Injection was repeated three to four times. Eggs were then sealed with 
cellotape and returned to the humidified incubator for further incubation. Injected 
embryos were monitored every day for heart beat and blood circulation. 
Unhealthy embryos were discarded and at day 5 of incubation (HH 23-25) only 
healthy embryos with clear presence of heart beat and circulation were analysed 
further.
2.7 Preparation of tissue sections and histology
For the collection of wax and frozen sections, slides were pre-treated with 3- 
aminopropyltriethoxysilane (TESPA) in order to increase the adhesion of 
sections to slides. Slides (BDH, UK) were dipped for 30 seconds in the following 
solutions in the given order: (1) 10% HCL/ 70% ethanol/ DEPC H2O, (2) DEPC 
H2O, (3) 95% ethanol/ DEPC H2O. They were then incubated overnight at 65 C° 
and again dipped for 30 seconds in the following solutions: (1) 2% v/v TESPA 
(Sigma, UK), (2) acetone (twice), (3) DEPC H20 . Slides were then allowed to 
dry at 37 C°.
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2.7.1 Vibratome embedding and sectioning
PFA fixed embryos were incubated overnight at 4°C in embedding mix (0.45% 
w/v gelatin, 28% w/v egg albumin, 18% w/v sucrose in PBS, all from Sigma, 
UK). They were then positioned in disposable embedding moulds (L.I.P Ltd, 
UK) containing fresh embedding mix to which was added 25% glutaraldehyde 
(Sigma, UK) at 1/10 of the volume of the embedding mix. The embryo was 
orientated quickly under a Stemi SV11 dissecting microscope (Zeiss, Germany). 
The block was allowed to harden at room temperature for one hour. Vibratome 
sections o f 50 pm thickness were prepared using a ‘Vibratome series 1000 
sectioning system’ (Agar scientific Ltd, UK). Sections were collected in PBS 
using a fine brush, mounted onto slides and covered with 50% glycerol in PBS. 
Slides were sealed with a cover-slip (Agar Scientific).
2.7.2 Wax embedding and sectioning
PFA fixed embryos were dehydrated in an increasing series of ethanol in PBS 
(25%, 50%) until 70% ethanol in water. Embryos were normally stored in this 
solution until used. The embedding continued with further incubations in 85%, 
95%, and twice in 100% ethanol. The ethanol was then gradually replaced first 
with a ratio of 1:1 Histoclear (Nation Diagnostics, UK): ethanol followed by 
incubation in 100% Histoclear at 60 C°. The samples were then incubated in 1:1 
pre-warmed wax (Raymond Lamb, UK) : Histoclear, followed by two more 
incubation^, in wax alone, all at 60 C°. Embryos were placed in disposable 
embedding moulds and held in the desired orientation in fresh wax until the wax 
solidified. Wax blocks were trimmed with a razor blade and cut at a thickness of 
10 pm using a microtome (Microm HM 330). Strips of adjoined sections were 
transferred onto pools of distilled water on TESPA coated slides, which were 
heated on a slide dryer until creases in the wax disappeared. The water was then 
gently removed and slides were incubate vertically at 25 C° overnight.
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2.7.3 Cryo embedding and sectioning
Fixed embryos were first incubated in 20% w/v sucrose in DEPC (if to be used 
for in situ hybridisation) PBS at 4°C in order to cryoprotect the tissue. The 
embryo was orientated in OCT compound (BDH, UK) under a dissecting 
microscope. The block was allowed to freeze on dry ice in a dish containing iso­
propanol (Sigma, UK). Sections of 12-20 pm thickness were cut on a cryostat 
machine (Bright 5040 Model OTF, UK) and the sections were picked up with 
TESPA coated slides. Slides were allowed to dry at room temperature overnight 
and stored at -70 C° until used.
2.7.4 Haemotoxylin and Eosin staining
This staining procedure was performed on wax sections. All steps were carried 
out for five minutes unless stated otherwise. Wax sections were first de-waxed in 
Histoclear (Nation Diagnostics, UK) twice followed by two 100% ethanol 
washes. Sections were then rehydrated to water by going through 95% and 70% 
ethanol washes. Haemotoxylin and Eosin staining was carried out in a series of 
steps outlined below. However, the length of time given for each step is 
approximate and had to be adjusted for samples individually.
Haemotoxylin (BDH, UK) 5 min
dHiO 1 min
Running tap water 5 min
10% HCL in 70% ethanol 10 sec
Running tap water 5 min
Eosin (BDH, UK) 3 min
Running tap water 5 min
Sections were then dehydrated again in an ascending series of ethanol 
concentrations (70%, 95%, 100%) and washed twice in Histoclear. Slides were 
finally mounted with DPX .
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2.7.5 Methyl green staining
Frozen sections were stained with methyl green solution (0.5% w/v methyl 
green, BDH UK, 0.1 M NaAc in d ^ O ) after immunohistochemistry experiments 
when a DAB colourimetric reaction was used for detection of the antibody 
signal. Slides were immersed in a coplin jar containing methyl green solution for 
5 min, followed by three washes in dH20 for 10 min each. Sections were then 
dehydrated in 100% butanol for 5 min followed by Histoclear (Nation 
Diagnostics, UK) for 5 min. Slides were mounted in DPX (BDH, UK) and cover- 
slipped.
2.8 Detection of gene and protein expression
2.8.1 Immunohistochemistry
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2.8.1.1 Antibody specificity and dilutions
Table 2.4: List of antibodies
1° antibodies
Antibody
[conc.]
Working
dilution
Type specificity Supplier References
Connexin43 1:100 mouse
MC
against the cytoplasmic loop of 
mouse connexin43 at aa 131-142. 
Recognises a 43 kDa protein by 
western blotting and sites of 
connexin43 expression in tissue 
sections.
Kindly 
provided by 
Dr D Becker 
(UCL)
(Wright e t al. 2001)
RMO270 
[0 5 mg/ml]
1:1500 mouse
MC
against the carboxy domain of the 
160 kDa intermediate neurofilament. 
Crossreacts to most vertebrates and 
invertebrates. In chick, it has been 
shown to label differentiating RGC 
bodies during their laminar migration 
from the ventricular surface to the 
RGC layer and their processes.
Zymed, USA (McCabe et al. 
1999)
VC 11 
[0.6 mg/mfj
1:100 mouse
MC
against the HNK-1 antigen which is 
found in many glycoproteins 
including NCAM. In the retina, 
shown to react with differentiated 
amacrine and horizontal cells as well 
as a subset of retinal progenitors. 
Majority of the mitotic progenitors 
positive for VC1.1 during early 
development adopt amacrine and 
horizontal fates.
Sigma, UK (Naegele and 
Barnstable 1991; 
Alexiades and 
Cepko 1997)
pH3
[1mg/ml]
1:100 Rabbit
PC
against aa 7-20 of phosphorylated 
human histone H3. Recognises 
phosphorylated histone H3 at serine- 
10 during the M-phase of the cell 
cycle.
Upstate,
USA
PECAM1 
[0 5mg/ml]
1:150 Rat
MC
against 129/Sv mouse-derived 
endothelial cell line tEND. 
Recognises endothelial cells of 
blood vessels.
Pharmingen,
USA
(Vecchi et al. 1994)
Blll-tubulin 
[1 mg/ml]
1:1000 Mouse
MC
against a peptide at the C-terminus 
of pill tubulin. During early retinal 
development, shown to label RGCs 
and their processes -
Promega,
UK
(Snow and Robson 
1995)
Secondary antibodies
Antibody [conc.] Working dilution Supplier
FITC-conjugated goat anti mouse [1.4 mg/ml] 1:100 Jackson
Immunoresearch
laboratories,
USA
FITC-conjugated goat anti rabbit [1.5 mg/ml] 1:100 Jackson
Immunoresearch
laboratories,
USA
FITC-conjugated goat anti rat [1.5 mg/ml] 1:100 Jackson
Immunoresearch
laboratories,
USA
HRP-conjugated rabbit anti mouse [1.3 mg/ml] 1:100 Dako, Denmark
HRP-conjugated goat anti rat [0.8 mg/ml] 1:1000 Jackson
Immunoresearch
laboratories,
USA
Abbreviations: aa, amino acid; Cone., concentration; FITC, fluorescein isothiocyanate; HRP, horseradish 
peroxidase; kDa, kilo Daltons; MC, monoclonal; NCAM, neural cell adhesion molecule; PC, polyclonal; 
PECAM1, platelet endothelial cell adhesion molecule-1; pH3, phospho histone H3; RGC, retinal ganglion cell.
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2.8.1.2 Whole mount immunohistochemistry
At the starting point of this procedure, embryos had already been fixed in 4% 
w/v PFA overnight and dehydrated in a methanol series and stored at -20°C 
according to descriptions in Section 2.3.4. In a methanol based solution 
containing methanol: DMSO: H2O2 in a 4:1:1 ratio, embryos were washed at 
room temperature for 5 hrs while gently rocking. Each wash (throughout the 
procedure) was in a 1.5 ml volume and the solution was changed once an hour. 
This step was crucial for permeabilisation and bleaching o f whole mount tissue. 
Embryos were then rehydrated while rocking at room temperature through a 
series of 50% then 25% methanol in PBT washes for 20 min each and finally 
three PBT washes for 10 min each. This was followed by incubation of embryos 
in blocking solution.
For PEC AM -1 immunohistochemistry of mouse embryos (Chapter 5), the 
blocking solution consisted of PBSMT (2% w/v non-fat milk, Nestle, USA, 0.5% 
v/v Triton X-100, 0.2% w/v BSA in PBS). For Blll-tubulin
immunohistochemistry of whole neural retinae (Chapter 6), the blocking solution 
consisted o f PBS with 10% v/v FCS, 1% w/v BSA, and 0.5% v/v Triton X-100. 
Embryos were blocked while gently rocking at room temperature in washes 
consisting of two times 5 min, then three times 15 min, and finally two times 1 
hr. The primary antibody was appropriately diluted (see Table 2.4) in fresh 
blocking solution and incubated with embryos overnight while rocking gently at 
4°C. From this step onwards, all washes were carried out at 4°C while gently 
rocking. The next day, embryos were washed in freshly made blocking solution 
twice for 5 min to eliminate excess unbound antibody. Three more washes for 15 
min each and then three to four washes of 1 hour each followed. Embryos were 
then placed in secondary antibody diluted appropriately in fresh blocking 
solution and incubated (at 4°C) overnight. The next day, excess secondary 
antibody was washed off in a series of 5 min (three times), then 15 min (three 
times), and finally 1 hour (four times) washes in blocking solution. When an 
FITC-tagged secondary antibody was used (Chapter 6 ), washes were continued 
overnight, followed by a few one hour washes in PBS with 0.5% v/v Triton X- 
100 before retinae were flat mounted on slides and covered in CITIFLUOR
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(Citifluor Ltd., UK) and a coverslip. Embryos incubated with a horseradish 
peroxidase (HRP)-tagged secondary antibody were washed in PBS containing 
0.5% v/v Triton-X 100 a few times and then incubated in PBS with 0.5% v/v 
Triton X-100, 0.08% w/v NiCh (Sigma, UK), and 250 /xg/ml diaminobenzidine 
tetrahydrochloride (DAB, Sigma, UK) while gently rocking at room temperature 
for 10 min. To this solution was added 0.03% v/v H2O2. The enzymatic colour 
reaction was stopped with PBS when satisfactory labelling was detected. Whole 
mounts were photographed and stored at 4°C in PBS containing 0.018% w/v 
Thimerosal (Sigma, UK).
2.8.1.3 Section immunohistochemistry
A list of antibodies and dilutions is given in Table 2.4. The detergent used to 
allow penetration of antibody to access their epitopes was 0.1% v/v Tween-20 
(Sigma, UK) for the pH3 antibody and 0.1% TritonX-100 for all other primary 
antibodies. All section immunohistochemistry described in this thesis were 
performed on 12 or 15 /xm frozen sections prepared from 4% PFA fixed tissue 
embedded in OCT. Samples were prepared and sectioned as described in Section
2.7.3. Twenty minutes prior to the start of the procedure, sections were removed 
from -80°C and thawed at room temperature. The OCT medium was washed off 
with two washes of PBS for 5 min each. After the first wash, each section was 
encircled with a PAP pen (Sigma, UK), which repulses water and therefore 
allows the sections to be submerged in a small quantity of liquid. As well as 
minimising the amount of media needed during the entire experiment, this also 
enables sections on the same slide to be treated differently. From this step 
onwards, each section was submerged in no more than 60 /xl of liquid.
If the primary antibody was to be detected with an HRP-tagged secondary 
antibody, endogenous peroxidase activity was quenched with 3% H2O2 in PBS 
containing 0.1% detergent for 10 min at room temperature, otherwise this step 
was omitted. Sections were then washed three times for 5 min in PBS containing 
0.1% detergent and then incubated in a blocking solution (10% v/v heat- 
inactivated FCS (Sigma, UK), 1% BSA (Sigma, UK) in PBS containing 0.1% 
detergent). The blocking solution was replaced with the appropriate dilution of
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the primary antibody (as given in Table 2.4) in fresh blocking solution. Sections 
were incubated in primary antibody overnight at 4°C. The next day, sections 
were washed three times 10 min in PBS containing 0.1% detergent and then 
incubated in blocking solution containing an appropriate dilution of a secondary 
antibody (see Table 2.4 for specific details of the secondary antibodies used to 
detect each primary). This incubation was carried out at room temperature for 1 
hour.
Secondary antibody tagged with fluorophore
After incubation with the secondary antibody, sections were washed three times 
10 min in PBS with 0.1% detergent. For nuclear counterstaining, sections were 
incubated in either a 1:1500 dilution of Hoechst 33258 (Molecular Probes, UK) 
or 1 Mg/ml propidium iodide (Sigma, UK) in PBS with 0.1% detergent for 30 
min at room temperature. Finally, sections were washed twice for 10 min in PBS 
with 0.1% detergent and then mounted in CITIFLUOR (50% glycerol in PBS, 
Citifluor Ltd., UK), and cover-sliped (Marienfeld, Germany). To avoid 
evaporation of the mounting media, coverslips were sealed with nail varnish.
Secondary antibody tagged to HRP
After incubation with the secondary antibody, sections were washed three times 
in PBS with 0.1% detergent. The chromogenic colour reaction was developed 
with PBS containing 250 /xg/ml diaminobenzidine tetrahydrochloride (DAB, 
Sigma, UK) and 0.03% v/v H2O2. The reaction was stopped by washing the 
sections in dfLO when satisfactory colour was detected. To counterstain, 
sections were dipped in 0.5% w/v methyl green (BDH, UK) for 5 min followed 
by three washes in dH20 for 1 min each. Sections were then dehydrated in 100% 
butanol for 5 min, before being cleared in Histoclear for 5 min. Sections were 
mounted with DPX mounting media containing 80% Xylene (BDH, UK) and 
then cover-slipped. Slides were allowed to dry horizontally in a fume hood.
2.8.2 RNA in situ hybridisation
In situ hybridisation was carried out essentially as described by D.G. Wilkinson 
(Wilkinson 1992). Chick and mouse embryos were treated similarly. RNA is
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highly susceptible to degradation by ribonucleases. Therefore, most solutions 
were DEPC treated, which inactivates ribonucleases, prior to autoclaving. 
Solutions that could not be autoclaved, such as sodium dodecyl sulphate (SDS), 
were made with DEPC treated H2O instead. RNAse-free pipette tips and sterile 
tubes were used until at least after the hybridisation step.
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2.8.2.1 Probe templates
Table 2.5: Details of templates used for probe synthesis
Gene Antibiotic Vector sense 
(enzyme/ 
RNA Pol)
a-sense 
(enzyme/ 
RNA Pol)
insert size (bp) References/supplier
Jaggedl Ampicillin Hindlll/T7 EcoRI/T3 1800 (Mitsiadis etal. 1997)
ephrinB2 Ampicillin pBS SK Hindlll/T3 3800 Kindly provided by Dr D. Wilkinson (NIMR, 
London)
Fgf15 Ampicillin pGEMT Ncol/Sp6 Notl/T7 806 (McWhirter etal. 1997)
Tbx2 (m) Kanamycin pBK CMV Xhol/T3 EcoRI/T7 2200 Sowden lab
Shh Ampicillin pB(ll)KS Pstl/T7 Hindlll/T3 640 (Echelard etal. 1993)
Tbx3 Ampicillin pB(ll)KS EcoRV/T7 Pstl/T3 1000 (Chapman etal. 1996)
Tbx5 Ampicillin pB(ll)KS BamHI/T3 EcoRV/T7 1000 (Chapman etal. 1996)
Tbx2(c) Ampicillin pBS SK Notl/T3 Sall/T7 2500 Kindly provided by Dr Logan (NIMR,London)
Msx2 Ampicillin
Kanamycin
pCR2.1 Notl/Sp6 BamHI/T7 1000 Kindly provided by Prof. P Sharpe (King’s 
College, London)
Bmp4 Ampicillin pSP72 Smal/T7 EcoRI/Sp6 1000 (Furuta etal. 1997)
Vax2 Ampicillin pBS SK Kpnl/T7 EcoRI/T3 700 (Schulte etal. 1999)
RSCH Ampicillin pBS SK Clal/T7 Sall/T3 900 Kindley provided by Dr Logan (NIMR, London)
Silver Ampicillin modified 
pBS (3)
Kpnl/T3 (Baxter and Pavan 2003)
Fgf8 Ampicillin pBS SK BamH1//T7 875; full coding sequence plus 16 bp 
of 5’UTR
(Crossley and Martin 1995)
2 8 .2 .2 Probe synthesis
In order to obtain single stranded RNA probes, in vitro transcription was 
performed using cDNA templates in plasmid vectors (see Table 2.5). To obtain 
DNA template, plasmids were purified using the miniprep method 2.2.4. Then 
10-12 pg o f the template was linearised as described in 2.2.5 and the linearised 
template was purified by phenol-chloroform extraction. The in vitro transcription 
reaction contained the following: 1 pg/pl linearised template, 4 ul 10 x dNTP 
mix (10 mM each of ATP, CTP, and GTP; 6.5 mM UTP; 3.5 mM digoxigenin or 
fluorescein-UTP; Roche, Germany), 2 ul lOx buffer (Roche, Germany), lul 
RNasin ribonuclease inhibitor (Promega, UK), 2 pi T3, T7, or SP6 RNA 
polymerase (Roche, Germany) in a final volume of 20pl DEPC dH20. The 
reaction was incubated for 2hrs in a 37°C water bath. Labelled probe was 
precipitated with 100 pi 2.5 M ammonium acetate in DEPC dH20 and 300 pi 
100% ethanol overnight at -20°C. The next day, this was spun for 30 min at 4°C, 
13000 rpm, in a bench-top microfuge. The supernatant was gently poured out and 
the pellet washed with 100 pi 100% ethanol. The pellet normally dislodged at 
this step and the eppendorf tube was carefully flicked to wash the pellet, which 
was spun again for 10 min at 4°C, 13000 rpm. The supernatant was discarded and 
the pellet air-dried before being dissolved in 20 pi DEPC dH^O. One pi was 
taken out to run on an agarose gel, as described in 2.2.7, then 20 pi formamide 
and lp l RNasin were added. The solution was vortexed, spun and stored at - 
20°C.
If examination o f the probe on an agarose gel showed a thick band, 
approximately 10 x brighter than the DNA template, which was still present, the 
probe was sufficiently good to proceed with in situ hybridisation.
2.8.2.3 Single and double whole mount in situ hybridisation
Samples were prepared in advance by fixation overnight in 4% PFA and 
dehydrated in an increasing series of methanol in PBS (25%, 50%, 75%, 100%)
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on ice. All steps o f this procedure were earned out in 5 ml polystyrene round- 
bottom tubes (Beckton Dickinson, UK). Samples were stored in 100% methanol 
until the day of the procedure. Each dehydration step was performed for 15-30 
min on ice depending on the size of the sample. Mouse embryos at 9.5-10.5 dpc 
were washed for 15 min, while older embryos and chick embryos were washed 
for 25-20 min. Washes throughout this procedure were performed in a 5 ml 
volume o f solution.
Rehydration and H2O2 treatment
All steps were carried out on ice. Embryos were rehydrated through a decreasing 
series o f methanol in PBT (75%, 50%, 25%), each step being performed for 15- 
30 min on ice depending on the size of the sample as indicated in the previous 
section. After the last rehydration step, samples were washed twice in PBT, for 5 
min each, and treated then with 6% H2O2 (Sigma, UK) for 1 hr.
Permeabilisation
The concentration and length of proteinase K (Sigma, UK) treatment was 
adjusted according to the size and age of the tissue. Table 2.6 gives the 
approximate times used for different samples. Embryos were treated with 
proteinase K in order to permeabilise cells and degrade proteins surrounding the 
mRNA, hence maximising probe penetration.
Table 2.6: Approxim ate length of time of pro teinase K treatm ent of tissu e  according
to s tag e  and size
Stage of em bryo/tissue [Proteinase K] Length of treatm ent
HH 23-25 chick embryos 20 pg/pl 15 min
HH 9-16 chick embryos 10 pg/pl 12 min
HH 23-25 optic cups 10 pg/pl 15 min
11.5 dpc (post-culture mouse embryos, 45-53 s) 10 pg/pl 15 min
11.5 dpc (pre-culture mouse embryos, 40-45 s) 10 pg/pl 12 min
10.5 dpc mouse embryos (34-40 s) 10 pg/pl 7 min
10.5 dpc mouse embryos (26-34 s) 5 Mg/pl 5 min
10.5 dpc mouse embryos (20-26 s) 3 pg/pl 3 min
Dpc, days post coitum; S, somite pairs.
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Proteinase K digestion was stopped with 2mg/ml glycine in PBT, followed by 
two 5 min PBT washes. Embryos were refixed in 0.2% glutaraldehyde/4% PFA 
in PBS for 20 min at 4°C. The fixative was washed away with two 5 min washes 
in PBT.
Hybridisation
Embryos were incubated in pre-warmed (70°C) pre-hybridisation mix 
(hybridisation mix without probe: 50% formamide; 5X sodium chloride/sodium 
citrate buffer (SSC) pH 4.5: 0.75 M NaCl, 0.075 M NaCi; 50 jig/ml yeast t-RNA; 
1% SDS, 50 pg/ml Heparin). Incubation in this solution was performed at 70°C 
for 2 hrs in a water bath to equilibrate embryos and block non-specific 
hybridisation. This solution was then replaced with 1 ml hybridisation buffer 
containing a 1:100 or 1:200 dilution of labelled sense or anti-sense probes (-0.5- 
1 pg/ml), depending on the strength o f the probe. For probe details please see 
Table 2.5. For double in situ hybridisation experiments, both probes, one 
conjugated with Fluorescein (fl) and the other with Digoxigenin (DIG), were 
added at the same time. For single in situ hybridisations, DIG-conjugated probes 
were used as these give a cleaner result. Samples were hybridised overnight at 
70°C.
Washing
After the overnight hybridisation step, embryos were washed twice with solution 
I (50% formamide; 5X SSC pH 4.5: 0.75 M NaCl, 0.075 M NaCi; 1% SDS) at 
70°C and twice with solution II (50% formamide; 2X SSC pH 4.5: 0.3 M NaCl, 
0.03 M NaCi) at 65°C, each wash lasting 30 min. These formamide based 
washes, which have a less concentrated salt composition than the hybridisation 
mix, helped to reduce non-specific hybridisation.
Blocking
After post-hybridisation hot washes, embryos were washed in TBST (137 mM 
NaCl, 2.7 mM KC1, 0.25 M Tris.HCl pH 7.5, 1% Tween-20, 2 mM Levamisol) 
three times for 5 min at room temperature and then incubated in 10% v/v heat 
inactivated sheep serum (Sigma, UK) in TBST for 90 minutes, while rocking.
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Antibody solution
Alkaline phosphatase tagged antibodies (sheep polyclonal Fab fragments) were 
used to detect probes by a colourimetric reaction. To minimise non-specific 
binding by the anti-DIG (0.75 Units of enzyme activity/pl, Roche, Germany) or 
anti-fl (0.75 Units of enzyme activity/pl, Roche, Germany) antibodies, they were 
pre-blocked with embryo powder. Embryo powder was produced by 
homogenising embryos (9.5-11.5 dpc) in a small volume o f PBS, mixing with 4 
volumes of ice-cold acetone and incubating the homogenate on ice for 30 min. It 
was then spun at 10 000 g for 2 hours. Some acetone was added to the pellet 
which was pulse spun and then grinded on a sheet of filter paper, allowed to air- 
dry, and stored at -20°C until used. For the preparation of every 5ml of final 
antibody solution, 7.5 mg embryo powder was first incubated with 1.2 ml TBST 
in an eppendorf tube at 70°C for 30 minutes. This mix was then vortexed and 
spun at 3000 rpm for 1 min in a bench-top microfuge. The supernatant containing 
embryo-derived lipids was discarded and the pellet was mixed in 1.2 ml of fresh 
TBST. To this was added 125 pi heat inactivated sheep serum (Sigma, UK) 
together with 2.5 pi antibody. The mixture was incubated for approximately 3 
hrs rocking at 4°C, then centrifuged at 3000 rpm in a bench-top microfuge for 10 
min and the supernatant was removed and diluted to 5ml with 10% v/v heat 
inactivated sheep serum in TBST.
Antibody incubation
For detection o f bound probe in single in situ hybridisation experiments, samples 
were incubated in 2 ml o f pre-blocked anti-DIG solution while rocking at 4°C 
overnight. For double in situ hybridisations, the fl-conjugated probe was detected 
first with 2 ml o f pre-blocked anti-fl. This is because the fl tag is less stable than 
the DIG tag.
Washing
Samples were first washed three times for 5 min and then five times for 1 hr in 
TBST, rocking at room temperature to wash away unbound antibody.
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Development o f  the colour reaction
Before being developed, embryos were equilibrated with NTMT (0.1 M NaCl, 
0.1 M Tris-buffer pH 9.5, 0.05 M MgCl2, 1% Tween-20, 2 mM Levamisol) three 
times for 10 min at room temperature. Then 0.2 mM Nitro blue tetrazolium 
chloride, 0.2 mM 5-bromo-4-chloro-3-inodyl-phosphate, toluidine salt stock 
solution (NBT/BC1P, Roche, Germany) was added to the NTMT and the colour 
reaction was allowed to develop until satisfactory colour was observed. BCIP is 
the substrate o f alkaline phosphatase, which becomes de-phosphorylated and 
then reacts with NBT in a redox reaction step to give a dark blue colour.
Detection o f  the second probe in double in situ hybridisation 
After development o f the first colour reaction, o f the fl-tagged probe with 
NBT/BCIP, embryos were washed five times in TBST for 10 min while rocking 
at room temperature. The alkaline phosphatase o f the anti-fl antibody was heat- 
inactivated in TBST by incubation at 65°C in a water bath for 30 min. Samples 
were washed again in TBST, twice for 5 min at room temperature, and blocked 
in TBST containing 10% heat inactivated sheep serum for 1 hr, while rocking at 
room temperature. 2 ml of pre-blocked anti-DIG was added per tube and samples 
were incubated at 4°C overnight while rocking. The next day, unbound antibody 
was washed off with three times 5 min, followed by five times 1 hr washes at 
room temperature. Samples were then equilibrated in NTMT with three times 10 
min washes before being incubated in NTMT containing 0.2 mM 2-[4- 
iodophenyl]-3-[4-nitrophenyl]-5-phenyl-tetrazolium chloride and 0.2 mM 5- 
bromo-4-chloro-3-inodyl phosphate, toluidine salt (INT/BCIP). The colour 
reaction was developed at room temperature until satisfactory colour was 
observed. This substrate produces a red colour via a redox reaction of the 
dephosphorylated BCIP by alkaline phosphatase.
Usually, the strongest probe was the one developed with INT/BCIP as the 
product of this solution is weaker than that produced by NBT/BCIP. When both 
colour reactions were complete, embryos were stored at 4 °C in PBT containing 
0.018 % w/v Thimerosal (Sigma, UK)
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2.8.2.4 Section in situ hybridisation
Glassware used for this procedure were baked at 280°C for 5 hrs. Frozen sections 
were cut at 20 pm, as described in 2.7.3, and allowed to dry at room temperature 
for 2 hrs. Alternatively, previously prepared sections stored at -80°C were taken 
out to dry at room temperature for 30 min.
Hybridisation
An aliquot o f hybridisation buffer (50% formamide; lx  ‘salts’: 0.2 M NaCl, 5 
mM NaH2P 0 4.H20 , 5 mM Na2H P 04, 5 mM EDTA, 10 mM Tris pH 7.5; 0.1 
mg/ml yeast t-RNA; 10% w/v dextran sulphate, Sigma UK; lx  Denhardt’s 
solution, Sigma UK) was warmed at 70°C. Probe was added to the pre-warmed 
hybridisation buffer (-0.5-1 pg/ml), heated at 65°C for 5 min to denature probes, 
and 200 pi was added per slide. Slides were covered with cover-slips and 
incubated at 65°C in a humidified incubation chamber (Grant Boekel SM30, 
Grant Instruments Ltd., England) overnight.
Posthybridisation washes
The next day, slides were washed in 35 ml of pre-warmed wash solution (50% 
formamide, lx  SSC pH7.5, 0.1% Tween-20) in a glass coplin jar in a 65°C water 
bath for 30 min. Usually cover-slips separated from slides during this wash and 
could easily be removed without causing damage to sections. Slides were then 
washed twice more in fresh wash solution for 30 min each at 65°C. This was 
followed by three times 30 min washes in MABT (0.1 M Maleic acid, 0.15 M 
NaCl, pH 7.5, 0.1% Tween-20) at room temperature.
Blocking and antibody incubation
Slides were removed from coplin jars, sections were circled with a PAP pen 
(Sigma, UK) to reduce the amount of solution needed, and incubated in 50 pi per 
section of blocking solution (2% blocking reagent, Roche UK; 10% heat 
inactivated sheep serum; 0.1 M Maleic acid, 0.15 M NaCl, pH 7.5, 0.1% Tween- 
20) at room temperature for 1 hr. This was replaced by blocking solution 
containing 1:500 anti-DIG (Roche, Germany) and section were incubated 
overnight at 4°C in a slide chamber.
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Washes and colourimetric reaction
Unbound antibody was washed away in three times 10 min MABT washes, 
followed by three times 10 min NTMT (same as used for whole mount in situ 
hybridisation but with 0.1% Tween-20) washes at room temperature. The 
alkaline phosphatase reaction was developed with 0.2 mM NBT/ 0.2 mM BCIP 
(Roche, Germany) at room temperature until satisfactory colour was observed. 
Slides were washed in dH20 for 30 min and the dehydrated in 100% butanol for 5 
min, followed by Histoclear (Nation Diagnostics, UK) for 5 min, and then 
mounted with DPX (BDH, UK) and covered with a cover-slip.
2.8.3 Whole mount in situ hybridisation followed by 
immunohistochemistry
This procedure was performed on isolated chick optic cups in Chapter 6. After 
fixation overnight at 4 °C in 4% w/v PFA in PBS, embryos were rested on their 
side in a Petri dish containing PBS. Using No. 5 Watchmakers forceps (Raymond 
Lamb, UK), the lens was carefully dissected out making sure not to tear away 
any part o f the retina. In removing the lens, the surface ectoderm was ruptured, 
which facilitated the peeling of the rest o f the surface ectoderm and the 
underlying extra-ocular mesenchyme in the distal portion of the eye. When the 
distal region o f the eye was cleaned, the forceps were pierced through the extra­
ocular mesenchyme nasal or temporal to the eye, and the eye globe was separated 
from the head mesenchyme by gentle squeezing o f forceps around the globe. 
Once separated, the globe together with the optic nerve were pulled away from 
the head. The eye was then further cleaned from all surrounding mesenchyme 
and when possible, which was in the majority o f eyes, the RPE layer was also 
removed.
Combined whole mount in situ hybridisation with immunohistochemistry was 
performed according to a protocol by Sterit and Stem 2001 with some 
modifications (Streit and Stem 2001). Whole mount in situ hybridisation was 
carried out as described in 2.8.2.3. Samples were then washed extensively in 
PBT, 5ml solution, three to five lhr washes at room temperature, to adjust the
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basic pH of the NTMT solution used to develop the colour reaction of in situ 
hybridisation. Samples were fixed in 4% w/v PFA for 1 hr at 4°C, washed in PBT 
twice for 5 min. The rest o f the procedure, which was immunohistochemistry, 
was carried out as described in 2.8.1.2 (from second paragraph).
After completion of both in situ hybridisation and immunohistochemistry, the 
retina was flat mounted by making 4-6 cuts from the periphery of the retina to its 
centre. It was then transferred onto a glass microscope slide using a plastic 
pipette, which had previously been cut at the tip in order to minimise contact 
between the retina and the pipette tip and hence damage to the retina. The fluid 
that followed onto the microscope slide was dried using clean tissue and the 
peripheries o f the retina were gently straightened with forceps so that the retina 
rested flat on the slide. One drop of Citifluour was put on the retina and finally a 
cover-slip was positioned on top of the retina.
2.8.4 Detection of exogenous alkaline phosphatase activity in 
whole embryos
Human placental alkaline phosphatase (AP) is heat stable. Therefore, to detect its 
activity in transfected embryos (Chapter 6) and to differentiate it from 
endogenous AP, which is heat labile, PFA (4%) fixed embryos in PBT were 
incubated in a 65 °C water bath for 45 min to inactivate endogenous AP. 
Embryos were then equilibrated in NTMT (0.1 M NaCl, 0.1 M Tris-Base pH 9.5, 
0.05 M MgCE, 1% v/v Tween-20, 0.05% w/v Levamisol) for 30 min at room 
temperature, during which time, the NTMT solution was replaced three times. 
The colour reaction was developed by 2 ml o f NTMT containing 0.2 mM NBT 
0.2 mM BCIP solution (Roche, Germany) The colour reaction was developed by 
rocking at room temperature until satisfactory colour was evident. During and 
after development of the colour reaction, embryos were kept in dark. The colour 
reaction was stopped by several washes in PBT, in which embryos were kept 
until photographed. Embryos were stored at 4 °C in PBT containing 0.018 % w/v 
Thimerosal (Sigma, UK).
129
2.9 Detection of cell death by apoptosis
Apoptosis was detected using the method of in situ labelling of single strand 
DNA breaks, which occurs during cell death by apoptosis. A deoxynucleotidyl 
transferase-mediated dUTP nick end labelling (TUNEL) kit (Roche, UK) was 
used for this purpose according to the manufacturer’s protocol. Briefly, frozen 
sections of 12-20 /tm thickness were allowed to thaw at room temperature and 
were washed twice in PBS. The tissue was permeabilised with 0.1% Triton X- 
100 in PBS for two min and then incubated at 37°C for one hour with a mixture 
of enzyme (deoxynucleotidyl transferase) and labelling solution (containing 
fluorescein dUTP) as described in the manual. Afterwards, sections were washed 
twice in PBS (5 min) and the cell nuclei were counterstained by adding 200 jil 
per section of Propidium Iodide (Sigma, UK) at 1 /tg/ml in PBS for 20 min. 
Finally, sections were washed three times ten min in PBS, mounted with 
CITIFLUOR (50% glycerol in PBS, Citifluor Ltd., UK) and covered with a 
cover-glass (Marienfeld, Germany). Sections were photographed as described in 
section 2.10.
2.10. Microscopy
Whole mounts
Images of whole embryos following in situ hybridisation were captured with a 
Leica MZ FLIII microscope (Leica, Germany) fitted with a Leica DC500 camera 
(Leica, Germany). The Leica IM1000 Image manager V I.20 software was used 
to operate the camera and import images, which were saved as Tiff files. Some 
pictures were captured with a 35 mm film camera (MC 100, Zeiss, Germany) 
attached to a Stemi SV 11 dissecting microscope (Zeiss, Germany). Photos were 
digitised using a scanner (FilmScan 200, Epson Ltd., UK) and imported into 
Adobe Photoshop (6.0) as JPEG files. For comparison purposes, the objects were 
always photographed using the same set-up.
Sections
Images of fluorescently labelled tissue sections were captured using an Axioplan 
2 microscope (Zeiss, Germany) attached to a ProgRes C14 camera (Jenoptik Jena,
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Germany) operated with the Openlab 4.0.4 software (Improvision Ltd., UK). 
Images were saved in Openlab Liff format for measurement purposes or in 
Photoshop Tiff format for presentation purposes.
Images of vibratome or frozen sections following in situ hybridisation were 
captured using an Axiophot 2 microscope (Zeiss, Germany) fitted with 
Differential Interference Contrast (DIC) objectives and a Leica DC500 camera 
(Leica, Germany). Captured images were imported into Photoshop and saved in 
Tiff format.
In Chapter 5, some images were taken using a Leica TCS SP Confocal Laser 
Scanning microscope (Leica, Germany).
Retinal fla t mounts
Images o f retinal flat mounts (Chapter 6) were captured with the set-up described 
for whole mounts.
2.11 Analysis of eye size and shape
2.11.1 Estimation of retinal volume
First, 50 pm thick vibratome sections of eyes were prepared as described in 
Section 2.7.1 and images were digitally captured as described in Section 2.10. 
Only specimen with a complete set of sections through both rhBMP4 treated and 
BSA treated eyes (Chapter 4), or with a complete set o f sections through a 
mutant or a wild-type eye (Chapter 5) were included. Moreover, if the thickness 
of all sections through an eye was not consistent, which was apparent by the 
colour o f the embedding mix, the whole eye (and its contralateral control in 
Chapter 4) was excluded from analysis. Using the “area tool” in the OpenLab 
programme, which was pre-calibrated to measure in mm2 units, the area of the 
neural retina was measured on each section. The retinal area values were 
multiplied by the thickness of the section and then summed for each eye to obtain 
the retinal volume expressed in mm3. In Chapter 4, data were compared with the
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paired t-test, while in Chapter 5, they were compared with the independent 
samples t-test (see Sections 2.12.3 and 2.12.4)
2.11.2 Estimation of retinal area
This was performed in Chapter 6 as an estimate o f the size of the eye in chick 
embryos. Retinae were flatmounted as described in the first paragraph of section
2.8.3 without disturbing the optic fissure by making incisions in dorsal regions of 
the retinae after isolation o f the optic cup from the head mesenchyme. Digital 
images were taken o f each retinae and stored as a Liff file in the OpenLab 
programme. Using the Tine measure’ tool, calibrated to measure in millimetres, 
retinal area was measured by following the outline of the tissue.
2.11.3 Estimation of the length of the optic fissure
The optic disc and the optic fissure walls were clearly visible in all flat mounted 
retinae. Digital images were taken of each retinae and stored as Liff files in the 
OpenLab programme. Using the Tine measure’ tool, calibrated to measure in 
millimetres, the length o f the fissure wall from the optic disc to the peripheral 
most edge o f the ventral neural retina was measured. The line followed exactly 
the fissure wall and is therefore a measure o f the optic fissure length.
2.11.4 Estimation of D-V and N-T axial length of the 
embryonic eye
Axial length measurements were carried out on high power whole mount images 
of 11.5 dpc post-culture embryos (Chapter 4), captured with a 35 mm film 
camera (MC 100, Zeiss, Germany) attached to a Stemi SV 11 dissecting 
microscope (Zeiss, Germany) and digitally scanned. In Photoshop, the ‘measure 
tool’ was used to measure the longest distance o f the eye along the D-V and N-T 
axes as illustrated in Figs. 4.11 and 4.12. Each treated eye was compared to the 
non-treated control eye o f the same embryo. The percent decrease/increase in 
axial length for each pair of eyes in rhBMP4 treated, BSA treated, and non­
treated but cultured embryos were calculated as follows:
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C-T xlOO
l/2(C+T)
C= control eye (or eye two in non-treated control) 
T= treated eye (or eye one in non-treated control)
Data was analysed with the paired t-test (see Section 2.12.3).
2.11.5 Estimation of the P-Di axis of the embryonic eye
Serial 50 pm thick transverse vibratome sections o f eyes were prepared as 
described in Section 2.7.1 and images were digitally captured as described in 
Section 2.10. Only specimens with a complete set of sections through both 
rhBMP4 treated and BSA treated eyes (Chapter 4) were included in analysis. 
Moreover, if the thickness of all sections through an eye was not consistent, 
which was apparent in the colour of the embedding mix, the whole eye (and its 
contralateral control) was excluded from analysis. Using the “area tool” in the 
OpenLab programme, which was pre-calibrated to measure in mm units, the 
longest distance from the ventricular edge o f the neural retina (proximal) to the 
surface ectoderm (distal) was measured on sections. Measurements were carried 
out in four embryos and values from equivalent sections were plotted as mean ± 
1 s.d. according to the position of the section from each eye with section one in 
each eye being the dorsal-most and section five or six being the ventral-most. 
The graph revealed the average shape of the eyes in each treatment group.
2.12 Statistical analysis
Analysis o f data and production of graphs were facilitated by the use of SPSS 
12.0.1 for Windows statistical programme.
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2.12.1 Tests of normality of data
Prior to performing a statistical test, the distribution of data was analysed with 
the construction o f a normal plot to determine whether normal distribution could 
be assumed. The normal plot is constructed by arranging the data set in an 
ascending order and plotting the values on the x-axis against the corresponding 
normal score on the y-axis, which is the number of standard deviations away 
from the mean that each value is expected to fall within. Data were assumed to 
be adequately normal if the points were close to linear. Normality of data was 
also assessed by Shapiro-Wilk’s test of normality. Data with a P-value > 0.05 
were considered to be normally distributed and were analysed with parametric 
tests.
2.12.2 Logarithmic transformation of data
Non-normal data sets were transformed logarithmically by Loge (Ln), which 
helped to bring values closer together. Ln transformed data were checked for 
normality after transformation as described in 2.12.1.
2.12.3 Paired t-test
Data collected from differentially treated left and right eyes in each embryo were 
considered paired and were analysed with consideration to their paired nature. 
The paired t-test examines the difference in means between two groups and 
therefore requires that data is normally distributed and that the variance around 
the mean is equal between groups. Variability in the paired t-test is estimated 
from the differences between paired values. This test was used to compare the 
axial length and retinal volume in treated versus non-treated pairs of eyes in 
Chapter 4.
2.12.4 Independent samples t-test
Measurements performed on separate embryos were regarded as independent and 
were analysed accordingly with the independent samples t-test if only the 
difference between treated and non-treated specimens were of interest. Like the
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paired t-test, this test is based on the difference in means o f two groups, therefore 
requiring data to be normally distributed with equal variance around the mean 
between groups. This test however estimates variability from the within group 
variability. The analysis of retinal volumes and head length measurements 
between embryos o f different genotypes in Chapter 5, section 5.3 and in the 
differences in eye size between two groups in Chapter 6 were analysed with this 
test.
2.12.5 One-Way Analysis of Variance (ANOVA)
For the analysis o f differences between more than two groups of specimens, 
which were differentiated from each other by only one factor, the One-Way 
ANOVA test was employed. This test is based on the differences in means 
between various groups and was used in Chapter 6 for the comparison of eye size 
between embryos o f four developmental stages. An example of a One-Way 
ANOVA table produced by SPSS is illustrated in Table 2.7 and the mathematical 
formulae explained.
Table 2.7: Example of a One-Way ANOVA table produced by SPSS
Sum of S quares df Mean Square F Sig.
Between
Groups
£  (^observed 
values in a 
treatment group)2 
-  (^observed 
values)2/
n.groups “1 sum of
SquareSbe tween 
groups /  dfbetween 
groups
mean
Squarebe tween
groups/ mean 
squarewithin
groups
P-value for 
difference 
between 
groups
Within
Groups
n. observations
£  (observed 
value)2-  £  
(^observed 
values in a 
treatment 
group)2)
n -observations' 
n. groups
sum of 
squareswithm
groups/ dfwithin 
groups
Total £  (observed 
value)2-  
(^observed 
values)2 / n.
observations
n. observations" 1
Key: n, number of; df, degrees of freedom; Sig. significance.
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2 .12.6 Two-Way Analysis of Variance (Two-Way ANOVA)
For the analysis o f differences between more than two data sets, differentiated by 
two grouping factors, the Two-Way ANOVA test was employed. This analysis 
was used in Chapter 4 to test for significant differences in cell division and 
apoptosis in data sets representing several sections from paired eyes of 4-5 
embryos, which had been differentially treated. The Two-Way ANOVA allowed 
the comparison between treated and non-treated pairs of eyes (treatment) within 
embryos and across embryos (embryo or section). Embryo and treatment were 
the two grouping factors. Table 2.8 shows an example of a Two-Way ANOVA 
table produced by SPSS.
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Table 2.8 Example of a Two-Way ANOVA table produced by SPSS and formulae for the
calculation of the value in each cell
Source Type III Sum of 
S quares
df Mean
Square
F Sig.
Corrected
Model
£  (observed valued -  
(^observed values)2 
n. observations
dftreatment "*" 
dfembryo
sum of 
s q u a re s ^
ected model 1
dfcorrected
model
mean
Squarecorrected 
model / mean 
squareerror
P-value for 
model
Intercept 1 sum of
S CJ U 3  T© Si nter 
cept / 1
mean
squareinteroept 
/ mean 
squareerror
treatment £  (^observed values in 
a treatment group)2 - 
tTobserved values)2 
n. observations
n. treatments ”1 sum of 
squarestreat 
ment / 
dftreatment
mean
Squaretreatment 
/ mean 
squareerror
P-value for 
difference 
between 
treatments
Embryo X (observed value)2 -  £  
(^observed values in a 
treatment group)2)
n. observations- "I sum of 
squaresemb
ryo ! dfembryo
mean
squareembryo /
mean
squareerror
P-value for 
difference 
between 
embryos
Error
(residual)
^(observed -  
predicted)2
n.observations sum of 
squareserror
/ dferror
Total df intercept"*" df 
treatment"*" df 
embryo"*" df error
Corrected
Total
n-1
Key: n. number of; df, degrees of freedom; Sig, significance.
This test is based on the differences in means of observed values and predicted 
values. Each predicted value is calculated from the means of the groups into which 
the observed value falls and the overall mean of all observed values and therefore 
incorporates the overall variation o f values. As the Two-Way anova has two 
grouping factors, there are two group means that apply to each observed value. 
Therefore, a predicted value is calculated as:
(mean of group 1 + mean of group 2) -  overall mean
The difference between the observed value and the predicted value gives the 
residual value. The sum of squares of these residual values are illustrated as ‘Error’ 
in Table 2.8.
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The ‘corrected model’ shows the total sum of squares based on observed values and 
is calculated as:
X (observed value)2 -  (Y all observed values)2
n. observations
The sum of ‘sum of squares’ of all grouping factors add up to the total sum of 
squares:
sum of squares of ‘corrected model’ = sum of squares of embryo + sum of
squares of treatment
The degrees of freedom (df) for each grouping factor are derived as illustrated in 
Table 2.8. The mean squares are the sum of square values divided by the df in each 
row. Finally, the F-ratio is calculated as the mean square of each grouping factor 
divided by the residual mean square. The bigger the F-ratio, the more significant the 
P-value, which is given under ‘Sig’ in ANOVA tables produced by SPSS.
2.12.7 Analysis of co-variance (ANCOVA)
The ANCOVA test is an ANOVA with the incorporation of the effect of other 
continuous variables that are known to correlate with the main test variable. The 
effect of the covariate(s) are incorporated by ANOVA when deriving the predicted 
values. This test was employed in the analysis of the number of mitotic cell divisions 
in Chapter 4 and Chapter 5. The programmed cell death was also analysed with this 
test in Chapter 4. It allowed the examination of the effect of total cell number/surface 
area on the observed number of dividing/dying cells, otherwise accounted for in 
many studies by the calculation of the mitotic/apoptotic index ad the comparison of 
the indices. The ANCOVA table is similar to the ANOVA table with the result of the 
covariate added as an extra row.
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CHAPTER 3 Expression analysis of the T-box genes and 
their putative upstream regulators and downstream targets 
along the D-V axis of the developing mouse eye
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3.1 Introduction
The first step towards understanding the function of a gene and its position within the 
genetic cascade in a developing tissue, is to carry out an analysis of its expression 
pattern within the tissue of interest. Members o f the Tbx2 subfamily have previously 
been reported to be expressed in the dorsal region of the mouse optic cup (Chapman 
et al. 1996; Sowden et al. 2001), but their expression pattern during optic cup 
morphogenesis has not been reported. This Chapter describes the expression pattern 
of Tbx2, Tbx3, and Tbx5 during early eye development in the mouse embryo, and 
provides the foundation for the functional experiments presented in subsequent 
Chapters. Also examined, are the expression patterns o f several signalling molecules, 
and other genes along the D-V axis o f the eye, some o f which have previously been 
described during optic cup morphogenesis, others not, in order to place the T-box 
genes in the context o f a molecular network during optic cup formation.
Evidence described in Chapter 1.4.4 regarding the antagonistic interactions between 
Bmps with the Shh and the Fgf pathways, demonstrated in several developing tissues 
including the limb bud and the developing forebrain, suggest that the same 
interactions may also occur in other developing tissues where these signalling 
molecules are expressed in juxtaposed or close sites. The expression of these factors 
in close proximity of each other have been described in the developing chick eye 
(Crossley et al. 2001). In literature, several Fgfs are reported to be expressed in the 
neural retina during eye development. During early stages o f eye development in the 
mouse eye, only Fgf9 and F gf 15 have been detected (Colvin et al. 1999; McWhirter 
et al. 1997), whereas in the chick neural retina Fgf3, Fgf8, and F gf 19 have been 
detected (Martinez-Morales et al. 2005; Vogel-Hopker et al. 2000; Crossley et al. 
2001; Kurose et al. 2004). Fg/S is expressed juxtaposed to the dorsal Bmp4 in the 
developing chick eye (Crossley et al. 2001). To find an Fgf that is suitably close to 
the dorsally expressed Bmp4 in the early mouse optic cup, the expression patterns of 
Bmp4, Fg/8, and F gf 15 were examined in relation to each other and to Shh during 
mouse eye morphogenesis. Because Fgf9 is reported to first be expressed at 10.5 dpc 
(Colvin et al. 1999), which is later than when Bmp4 (Furuta and Hogan 1998) or the 
T-box genes (Holt 2003) are first detected, it was not included in the analysis. Upon
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identification o f Fgfl5 as a suitable candidate to interact with Bmp4 based on its 
expression, a putative interaction between Bmp4, F g f 15, and a role for Fgfl5 in D-V 
patterning in the mammalian eye was explored by examining the expression of 
Bmp4y Tbx2, and Vax2 in mice carrying an enhanced green fluorescent protein 
(EGFP) expression cassette within the F g f 15 coding region.
This mouse line has been created by homologous recombination in an embryonic 
stem (ES) cell line, with EGFP targeted to exon 1 of the F gfl5  allele, which resulted 
in the deletion of a 100 bp region of exon 1 and the insertion o f the EGFP coding 
sequence at the site o f the deletion (A. Battersby, University o f Wales Cardiff, UK). 
Mice homozygous for the mutated allele (referred to as Fgf15'/') are viable until at 
least birth when embryos appear at the expected Mendelian ratio. Fgfl5'A embryos 
form optic cups and are currently being analysed for eye defects by Dr A. Battersby 
(University o f Wales Cardiff).
This Chapter aims to compare the pattern o f expression o f the T-box genes in 
relation to putative upstream effectors and downstream targets along the D-V axis of 
the mouse eye, and to examine a possible interaction between Bmp4/Fgf signalling in 
the developing eye. This study is novel because it aims to identify sites of mutually 
exclusive expression between Tbx2y Tbx3, and Tbx5 in the developing mouse eye. It 
also examines the expression of Tbx2, Vax2, and Bmp4 in the absence of a specific 
FGF.
3.2 Results
Whole mount and section RNA in situ hybridisations were performed to detect gene 
expression patterns using previously published probes as described in Chapter 2.8.2. 
The described gene expression patterns are based on at least 3 embryos per probe. 
Sense probes were made for most genes examined here and showed no specific 
hybridisation signal. Examples are shown in Fig. 3.1 (A-D) of embryos hybridised 
with sense probes o f Tbx2 and Tbx5. Further details of expression are given in the 
following sections. All genes examined showed expression in tissues as described in 
previous literature.
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Fig. 3.1 Comparisons of in situ hybridisation with sense and antisense 
probes
(A 3 )  10.5 dpc embryos hybridised with a Tbx2 sense probe (A), showing no specific 
expression. The Tbx2 antisense probe (B), revealed a specific expression pattern as 
expected. ( C 3 )  10.5 dpc embryos hybridised with a Tbx5 sense probe (C), and Tbx5 
antisense probe (D), showing that detection of Tbx5 expression with the antisense 
probe is specific and differs from that detected by the Tbx2 probe.
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The nomenclature used for orientations of whole embryo views and section views of 
eyes were described in Fig. 1.2 of Chapter 1 and are again illustrated in Fig. 3.2 
(optic vesicle stage) and Fig. 3.3 (optic cup stage). These apply throughout the thesis
3.2.1 Expression of secreted signalling molecules along the D-V axis 
of the developing mouse eye
At 10.5 dpc (somite stage, ss, 29), just before optic cup invagination, Bmp4 was 
expressed in the dorsal region of the optic vesicle (Fig. 3.2 A). It was confined to the 
distal region o f the optic vesicle, which later differentiates into the neural retina (Fig. 
3.2 B,C). Shh expression at 10.5 dpc (ss27) was detected in a localised domain in the 
proximal region o f the optic stalk, close to the Shh expression domain in the 
prechordal plate (Fig. 3.2 D,E). This site o f expression is more clearly seen in a 
dorsal view o f the head (Fig. 3.2 E). The optic vesicle itself lacks Shh transcripts 
(Fig. 3.2 E) in agreement with previous reports (Dakubo et al. 2003).
Whole mount in situ hybridisation was carried out for FgfS on the basis of its 
reported expression in a central patch within the developing chick and zebrafish 
retinae (Vogel-Hopker et al. 2000; Crossley et al. 2001; Reifers et al. 1998; 
Martinez-Morales et al. 2005). Using a probe against the C-terminal coding sequence 
shared by all FgfS isoforms, expression was not detected in the optic vesicle (Fig. 3.2 
F,G) in agreement with previous reports (Crossley and Martin 1995).
In the limb bud and developing forebrain, members o f the Fgf family are expressed 
in domains in between or in close proximity to Bmps and Shh. The expression of 
Fgf 15 was analysed in order to examine its spatial distribution to Bmp4 in the dorsal 
optic vesicle and Shh in the proximal optic stalk. At ss27, Fgfl5  was expressed in 
two distinct stripes in the central region of the mouse optic vesicle (Fig. 3.2 H-J). Its 
expression was confined to the distal neuroepithelium (Fig. 3.2 I, arrow) and 
excluded from the dorsal-most and ventral-most regions o f the optic vesicle (arrows 
in Fig. 3.2 J). It was positioned between the Bmp4 domain in dorsal and Shh 
emanating from the optic stalk in the ventral region of the optic vesicle.
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Fig. 3.2 W hole m ount in situ hybridisation analysis of the expression of 
Bmp4, Shh and Fgfs in the mouse eye a t optic vesicle stage (10.5 dpc)
The depicted orientations (D-V; R-C, P-Di) are relative to the optic vesicle and 
illustrated in the schematic. The plane of coronal sections is illustrated by the dotted 
line in the schematic. (A) Whole mount view of an embryo at ss29, showing the 
expression of Bmp4. Expression in the optic vesicle was confined to the dorsal region 
(arrow). (B) Dorsal view of the head of the embryo in A, showing Bmp4 transcript 
localisation to the distal layer (arrow) of the optic vesicle (highlighted in dotted 
circle). (C) Coronal vibratome section through the eye in A-B, confirming Bmp4 
expression in the dorso-distal optic vesicle (arrow). (D) Shh expression in a whole 
mount view of an embryo at ss27, expressed in the notochord along the body axis 
(grey arrow) and in the prechordal plate in the forebrain region (white arrow). (E) 
Dorsal view of the head of the embryo in D, revealing Shh expression in two patches 
in the ventral forebrain at the proximal region (arrows) of the optic stalks 
(highlighted by the dotted lines). (F) Whole mount view of an embryo at ss27 
hybridised with the Fgf8 probe, which was clearly expressed in the isthmus and the 
apical ectodermal ridge of the forelimb bud, but not the optic vesicle. (G) Coronal 
vibratome section of the embryo in F. Fgf8 transcripts were present in the surface 
ectoderm of the presumptive nasal region (arrow) but absent in the optic vesicle. (H) 
Whole mount view of an embryo at ss27 showing F gf 15 expression in the optic 
vesicle. (I) Dorsal view of the head in H. F gflS  was confined to the distal optic 
vesicle (arrow). (J) Enlarged view of the head in H. F gf 15 transcripts were detected 
in two stripes within the central region of the optic vesicle (marked by dashed lines). 
The dorsal-most and ventral-most regions of the optic vesicle are indicated by 
arrows. Scale bars: 0.5 mm in all except C and G where 0.1 mm.
Abbreviations: AER, apical ectodermal ridge; C, caudal; D, dorsal; Di, distal; FL, 
forelimb bud; 1ST, isthmus; OV, optic vesicle; P, proximal; Pre-NR, presumptive 
neural retina; Pre-RPE, presumptive RPE; R, rostral; V, ventral
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The expression of these genes were also compared at 11.5 dpc, when the optic 
vesicle has invaginated. At ss45, Bmp4 was expressed in a restricted domain within 
the dorsal neural retina (Fig. 3.3 A,B). At ss42, Shh was not detected within the optic 
cup (Fig. 3.3 C,D). In the inset in Fig. 3.3 D the floor plate o f the neural tube in the 
same embryo is displayed, confirming positive detection o f Shh elsewhere. Apparent 
expression in the optic stalk lumen is trapping; Shh is not expressed in this region, 
which was also confirmed by (Dakubo et a l  2003).
In similarly aged embryos (~ss41), F gf 15 was expressed throughout the central 
region of the eye in a gradient. Expression was never detected in the distal-most tip 
of the dorsal neural retina or the ventral region o f the neural retina (Fig. 3.3 E,F). The 
highest level o f F g f 15 signal (arrow in Fig. 3.3 F) appeared to be proximal to the 
Bmp4 expression domain in the dorsal neural retina (Fig. 3.3 F). From its strongest 
site of expression, F g f 15 expression decreased towards the dorsal distal tip and 
towards the ventral neural retina in a graded fashion.
Examination o f FgfS expression at this stage, showed the absence of transcripts in 
the mouse optic cup (Fig. 3.3 G), confirming that FgfS is not expressed in the 
developing mouse eye. The combined expression patterns of Bmp4 and Fgfl5  are 
summarised in schematic 3.3 H.
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Fig. 3 3  Com parative analysis of the expression of Bm p4 , Shh  and Fgfs in 
the mouse em bryo detected by whole m ount in situ hybridisation a t optic cup 
stage (11.5 dpc)
A,C,G,E are whole mount views of the head of embryos. B,D,F are coronal 50 fim  
thick vibratome sections of eyes. The plane sections is illustrated by the dotted line in 
the schematic diagram of an 11.5 dpc embryo. The proximo-distal orientation of 
sections is illustrated in the schematic in H. (A) Embryo at ss45, hybridised with the 
Bmp4 probe, showing expression in the dorsal optic cup (arrows) and in the 
maxillary and mandibular processes of the first branchial arch. (B) Bmp4 expression 
was restricted to the distal region of the dorsal neural retina (arrow). Bmp4 
expression in the roof plate of the same embryo is shown in the inset as a positive 
control for the signal. (C) Embryo at ss42 showing the notochordal Shh expression in 
the tail. Signal in OF is trapping. (D) Section of the eye in C, showing lack of Shh 
expression in the optic cup. Signal in OS is trapping. Inset shows the floor plate 
expression of Shh in the neural tube of the same embryo and confirms detection of 
signal. (E) Embryo at ss41 showing F gfl5  expression. In the optic cup, Fgfl5  
expression was strongest in the dorso-temporal region. Signal intensity in the dorso- 
nasal region was slightly weaker. Its expression was excluded from the dorsal and 
ventral-most regions of the optic cup. (F) F gfl5  expression was detected in a 
gradient with the highest signal intensity in the dorsal proximal region of the retina 
(arrow), decreasing towards the dorsal distal tip of the neural retina (highlighted by 
the dotted line) and towards the ventral region of the eye. FgflS  expression did not 
extend beyond the optic stalk boundary into the ventral neural retina. (G) Embryo at 
ss42 showing lack of Fgf8 expression in the optic cup. (H) Schematic diagram of a 
coronal section summarising F gfl5  and Bmp4 expression. F gfl5  is shown in a 
gradient of blue, with the highest levels of expression in the central neural retina, 
dorsal to the optic stalk, which decreases towards the dorsal tip of the optic cup and 
towards the ventral neural retina. Bmp4 is shown in dotted red, occupying the dorsal 
distal region of the neural retina. Scale bars: 0.5 mm in A, C, E, G, 0.1 mm in B, D, 
F. Di, distal; L, lens; MN, mandibular process of the first branchial arch; MX, 
maxillary process of the first branchial arch; N, nasal; NR, neural retina; P, proximal; 
OF, optic fissure; OS, optic stalk; RPE, retinal pigmented epithelium; T, temporal.
148
whole mount view
149
3.2.2 Expression of Tbx2subfamily members in the developing mouse 
eye
The expression o f Tbx2, Tbx3, and Tbx5 were analysed prior to optic vesicle 
invagination as well as in the early optic cup. Their expressions were compared to 
the signalling molecules described in the previous section.
At 10.5 dpc, prior to optic vesicle invagination (ss25-28), Tbx2, Tbx3, and Tbx5 were 
expressed in overlapping domains in the presumptive dorsal neural retina (Fig. 3.4). 
Tbx2 had the broadest expression of the three T-box genes (Fig. 3.4 A,B). Tbx2 
transcripts were also present in the extra-ocular mesenchyme, ventral to the optic 
vesicle (Fig. 3.4 B, arrowhead). The expressions of Tbx3 and Tbx5 were more 
restricted than that of Tbx2 within the dorsal optic vesicle (Fig. 3.4 B,D,F). At this 
stage, the Tbx3 expression domain was more restricted than Tbx2 also in the nasal 
primordia (Fig. 3.4 B,D).
Comparison o f the expression of Bmp4 with that o f the T-box genes in an embryo of 
comparable age (ss24) highlights their overlapping pattern within the dorsal optic 
vesicle (Fig. 3.4 B,D,F,H). The expression of Tbx2 was larger than all the other 
genes.
At 11.5 dpc, after optic vesicle invagination, all three T-box genes continued to be 
expressed in the dorsal neural retina. At ss44, Tbx2 was expressed in the dorsal optic 
cup (Fig. 3.5 A). Transcripts were also detected in mesenchymal cells between the 
ventral neural retina and the surface ectoderm (arrowhead in Fig. 3.5 A). At ss42, 
Tbx3 was detected in the dorsal optic cup and was seen to extend further temporally 
than nasally (Fig. 3.5 B, arrows). At ss39, Tbx5 was also detected in the dorsal optic 
cup in a region more restricted than both Tbx2 and Tbx3 (Fig. 3.5 C). Comparison of 
the expression o f the T-box genes with Bmp4 in embryos of comparable age showed 
that also at the optic cup stage, Tbx2 expression was broader than that of Bmp4, 
which was spatially most similar to Tbx5 expression (Fig. 3.5 D).
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Fig. 3.4 T-box gene expression in the mouse embryo a t optic vesicle stage 
(10.5 dpc) detected by whole m ount in situ hybridisation
(A) Whole mount view of an embryo at ss26 hybridised with a probe for Tbx2, 
showing Tbx2 expression in the dorsal region of the optic vesicle (arrow). Other sites 
of expression in the head at this stage included a thin stripe in the nasal region, the 
maxillary and mandibular processes of the first branchial arch, and the otic vesicle.
(B) Higher magnification of the head region in A. As well as the dorsal expression 
domain in the optic vesicle (arrows), Tbx2 transcripts were detected in the extra- 
ocular mesenchyme, immediately ventral to the optic vesicle (arrowhead). (C) Whole 
mount view of an embryo at ss25 showing Tbx3 expression also in the dorsal optic 
vesicle (arrow). (D) Higher magnification of the head in C. Tbx3 transcripts were 
found in a smaller region of the dorsal optic vesicle than covered by Tbx2 expression 
(arrows). The nasal process expression of Tbx3 was also narrower than that of Tbx2. 
Unlike Tbx2, Tbx3 was not expressed in the extra-ocular mesenchyme ventral to the 
optic vesicle. (E) Tbx5 expression in an embryo at ss27. Tbx5 was expressed in the 
dorsal optic vesicle (arrow) and was not detected at any other site within the 
developing head. But more caudally, Tbx5 transcripts were detected in the sinus 
venosus/atrium, and in the forelimb bud. The blue colour in the hindbrain region is 
due to trapping of the colour reaction product. (F) Higher magnification of the head 
region in E. Tbx5 expression was confined to the dorsal region of the optic vesicle 
(arrows). (G) An embryo at ss24 showing Bmp4 expression. (H) Bmp4 transcripts 
within the optic vesicle closely matched that of the T-box genes. Scale bars: 0.5 mm.
Abbreviations: A, atria; D, dorsal; FL, forelimb bud; MN, mandibular process of the 
first branchial arch; MX, maxillary process of the first branchial arch; NP, nasal 
process; OT.V, otic vesicle; V, ventral.
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Fig. 3.5 Comparison of the expression of the T-box genes in the mouse 
optic cup a t 11.5 dpc by whole m ount in situ hybridisation
(A-C) Whole mount views of the head of embryos showing Tbx2, Tbx3, and Tbx5 
expression in the optic cup respectively. Arrows show the extent of the expression 
domains. Tbx2 had the largest expression domain. The Tbx3 domain extended further 
ventrally on the temporal side of the optic cup than on the nasal side (arrow). Tbx5 
had the smallest expression domain restricted to the dorsal-most region of the optic 
cup (compare arrows in A-C). The arrowhead in A shows Tbx2 expression in cells 
between the lens vesicle and the ventral neural retina. (D) Bmp4 expression in the 
dorsal optic cup most resembles that of Tbx5. (E-G) Lateral view of whole eyes in 
A-C after dissection. Tbx2 and Tbx3> but not Tbx5, expression extended past the 
dorsal curvature marked by a grey arrowhead in E and white arrowheads in E-G. 
Tbx3 expression past the dorsal curvature appeared weaker and more graded than 
Tbx2. White arrowhead in D shows the ventral extra-ocular mesenchyme. Stars in F 
show non-ocular tissue that were used to support the optic cup during photography. 
(H-K) Schematic representation of the spatial pattern of expression of Tbx2, Tbx3, 
Tbx5, and Bmp4 in the dorsal optic cup as indicated. Scale bars: 0.5 mm in A-D, 0.1 
mm in E-G.
Abbreviations: D, dorsal; Di, distal; L, lens; MN, mandibular process of the first 
branchial arch; MX, maxillary process of the first branchial arch; N, nasal; NP, nasal 
process; NR, neural retina; OS, optic stalk; P, proximal; SE, surface ectoderm; T, 
temporal; V, ventral.
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Eyes were dissected out of the head mesenchyme and isolated from the RPE in order 
to examine the three-dimensional expression of the T-box genes in the neural retina. 
The lens and its overlying surface ectoderm were left intact, to avoid causing damage 
to the neural retina and the shape of the eye globe, and also to preserve mesenchymal 
cells that exist between the surface ectoderm and the optic cup. It was then possible 
to view the expression of each gene along the proximo-distal (P-Di) axis, as well as 
the D-V axis. The region where the dorsal neural retina curves is here referred to as 
the dorsal curvature and marked in Fig. 3.5 E with a grey arrowhead and in F,G with 
white arrowheads. To pinpoint this site, a vertical line, serving as a reference point, 
was drawn between the dorsal-distal and the ventral-distal tips of the neural retina, 
connecting the two points (Fig. 3.5 D-F solid grey lines). A second line (dashed 
white), perpendicular to the solid line, was drawn and placed tangentially on the 
dorsal-most edge of the neural retina. The point at which the outline of the neural 
retina no longer followed the dotted line was marked as the initiation of the dorsal 
curvature.
Tbx2 expression reached into the proximal region of the neural retina, past the dorsal 
curvature, and was graded across the P-Di axis. It was not detected in the ventral 
neural retina but was expressed in mesenchymal cells between the surface ectoderm 
and the ventral neural retina (Fig. 3.5 E, white arrowhead). Tbx3 expression also 
extended into the proximal region o f the dorsal neural retina, past the dorsal 
curvature, but its highest level of expression was within the distal region. Tbx3 
expression decreased in a gradient more proximally (Fig. 3.5 F). The expression of 
Tbx5 did not extend beyond the dorsal curvature and unlike Tbx2 and Tbx3, Tbx5 
expression did not appear graded along the P-Di axis (Fig. 3.5 G). At this stage, Tbx5 
expression was more confined than that of both Tbx2 and Tbx3.
Of particular importance to the functional studies presented in subsequent chapters of 
this thesis is the identification of sites of exclusive Tbx2 expression. Along the D-V 
axis of the distal neural retina, seen in whole mount views, Tbx2 expression extended 
further ventrally than Tbx5 on the temporal side, and further ventrally than both Tbx5 
and Tbx3 on the nasal side (Fig. 3.5 A-C). Tbx2 expression also extended more 
proximally into the neural retina than either Tbx3 or Tbx5 (Fig. 3.5 E-G). Another 
site of exclusive Tbx2 expression was in the mesenchymal cells ventral to the optic
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cup (Fig. 3.5 E, white arrowhead). The expression of each gene in the dorsal optic 
cup is depicted schematically in Fig 3.5 H-K.
3.2.3 Expression of other asymmetrically expressed genes along the 
D-V axis of the developing mouse eye
The expression of several asymmetrically expressed genes, which could be potential 
T-box gene targets, were examined in order to compare their spatial pattern of 
expression to those of the T-box genes in the developing eye, in particular to that of 
Tbx2 which is the main T-box gene investigated in this thesis. Genes included in this 
section where chosen on the basis of previous reports that describe their 
asymmetrical expression pattern along the D-V axis in the developing eye and or 
reports that have linked them to Tbx5 or Bmp4 in the eye (Vax2, ephrinB2, Msx2\ see 
Chapter 1.2.2). The expression of ephrinB2 has previously been reported to be 
dorsally confined in the developing mouse eye from 13 dpc onwards (Marcus et al. 
1996; Birgbauer et al. 2000), but its expression in the early optic cup at 10.5 dpc has 
not been described. Jagged 1 which has not been studied in relation to the T-box 
genes or Bmp4 previously was also examined. Of all Notch pathway genes reported 
so far to be expressed during early eye development in the rat embryo {Notch 1-3, 
and their ligands Deltal-2 and Jaggedl), the expression of Jaggedl most closely 
resembled that of the T-box genes in the dorsal optic vesicle (Lindsell et al. 1996; 
Bao and Cepko 1997), suggesting a possible regulatory interaction between the 
Notch pathway and the T-box genes. Both dorsal and ventral genes were selected as 
Tbx2, Tbx3, and Tbx5 have been reported to act both as repressors and activators of 
gene expression in vitro and in vivo (see Chapter 1.3.2).
At 11.5 dpc (ss45), Vax2 was expressed in the ventral region of the optic cup (Fig. 
3.6 A). Double labelling with the Tbx2 and the Vax2 probes revealed a patch of non- 
expression in between the dorsal Tbx2 and the ventral Vax2 domains along the D-V 
axis of the optic cup (Fig. 3.6 B).
At 10.5 dpc (ss 33-35), ephrinB2 was expressed in the dorsal optic cup and at this 
stage, resembled the expression of Tbx2 in the neural retina (Fig. 3.6 C,D). EphrinB2 
was also detected in the lens vesicle (Fig. 3.6 D).
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Fig. 3.6 Expression of a  selected group of asymmetrically expressed genes 
and Tbx2 in the mouse em bryo a t optic cup stage by whole m ount in situ 
hybridisation
Pictures represent whole mount lateral views of the embryonic head. (A) Embryo 
hybridised with the Vax2 probe at ss45 (11.5 dpc). Vax2 was expressed in the ventral 
optic cup. (B) An 11.5 dpc embryo hybridised simultaneously with the Vax2 and 
Tbx2 probes. Tbx2 transcripts, detected in red, were expressed in all regions 
described in earlier figures, including the dorsal optic cup (grey arrows) and in the 
ventral extra-ocular mesenchyme (arrowhead). Vax2 expression, detected in blue, 
was separated from Tbx2 expression by a group of cells (between grey and white 
arrows) in which neither gene was expressed. The overall blue appearance of the 
head is due to high levels of non-specific trapping of the reaction product. The Vax2 
signal in the eye however is specific as it is localised ventrally as in A. (C) Tbx2 
expression in a 10.5 dpc embryo, just after optic cup invagination. (D) A 10.5 dpc 
embryo hybridised with an ephrinB2 probe. Transcripts were localised to the dorsal 
optic cup (arrows) and in the anterior rim of the lens vesicle (L). (E) A late 10.5 dpc 
embryo hybridised with an Msx2 probe. Transcripts in the eye were confined to the 
dorsal-most region of the optic cup. (F) A 10.5 dpc embryo showing Jaggedl 
expression, which was expressed widely in the optic cup except the dorsal most and 
the ventral most regions (arrows). Scale bars: 0.5 mm
Abbreviations: D, dorsal; L, lens; LE, lens epithelium; MX, maxillary process of the 
first branchial arch; NP, nasal process; V, ventral.
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Msx2 expression, shown in an embryo at ss37, was present in the dorsal most region 
of the neural retina, in a domain that resembled that of Tbx5, and Bmp4 and appeared 
located within the Tbx2 domain, (Fig. 3.6 E). Msx2 expression was also detected in 
the dorsal lens vesicle.
At ss 35 Jaggedl was expressed in the nasal and temporal neural retina (Fig. 3.6 F). 
Interestingly, it was excluded from the dorsal-most region of the optic cup, where 
Msx2, Tbx5, and Bmp4 are expressed. It was also excluded from the ventral-most 
region (Fig. 3.6 F, arrows). Jaggedl expression was also detected in the lens vesicle.
3.2.4 Analysis of D-V patterning of the eye in mice carrying a null 
mutation in the Fgf15$ex\&
Analysis of the expression o f Fgfl5  and Bmp4 in section 3.2.1 of this Chapter 
revealed that their expressions are juxtaposed with some overlap in the developing 
mouse eye. To investigate a putative interaction between the two signalling pathways 
during eye development, the expression of Bmp4, Tbx2, and Vax2 was analysed in 
F gfl5"  embryos and their wild-type littermates. If there is a mutually antagonistic 
interaction between Fgfl5 and Bmp4, one would expect the expression of one gene 
or its target genes to expand in the absence of the other. In other words, in the 
absence of Fgfl5, Bmp4 expression, or the expression of its targets, should expand.
Embryos were collected at 10.5-11.5 dpc and their genotype determined by PCR 
(Fig. 3.7). In F g fl5 "  embryos, Bmp4 expression was similar to somite matched wild- 
type littermates at 10.5 dpc (n= 3 per genotype, Fig. 3.8 A,B). The expression 
patterns of Tbx2 (Fig. 3.8 C-F) and Vax2 (Fig. 3.8 G-J) were also indistinguishable 
between mutant and wild-type somite matched littermates (n= 3 per genotype and 
probe). This suggests that the lack of Fgfl5  has no effect on Bmp4 expression and 
that D-V patterning of the eye is correctly maintained.
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Fig. 3.7 Genotyping PCR products of Fgfl5'/' and wild-type mouse yolk 
sac DNA
Examples of 2% agarose gels showing the PCR products obtained from the 
genotyping reactions of Fgfl5'A and wild-type DNA. Genotypes are indicated on the 
bottom gel. The 388 bp product shows the existence of the wild-type allele, while the 
513 bp product indicates the existence of the transgenic allele.
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Fig. 3.8 Expression of D-V m arkers of the optic cup in F g f l ^ '  mice at
10.5 dpc detected by whole m ount in situ hybridisation
Pictures represent either whole mount lateral views of the embryonic head or coronal 
vibratome sections through the eye. (A) Wild-type (+/+) embryo hybridised with the 
Bmp4 probe. (B) Somite matched mutant (-/-) embryo showing normal Bmp4 
expression in the optic cup. (C) Wild-type embryo hybridised with the Tbx2 probe. 
(D) Somite matched mutant embryo showing normal Tbx2 expression in the dorsal 
optic cup. (E,F) Coronal vibratome sections through the optic cups of the wild-type 
and mutant embryos shown in C and D respectively, confirming comparable Tbx2 
expression between genotypes. (G) Vax2 expression in a wild-type embryo. (H) 
Somite matched mutant embryo showing normal expression of Vax2 in the ventral 
optic cup. ( I J )  Coronal vibratome sections through the wild-type and mutant eyes in 
G and H respectively showing normal Vax2 expression in the ventral neural retina. 
Scale bars: 0.5 mm in A-D, G, H, 0.1 mm in E, F, I, J.
Abbreviations: D, dorsal; L, lens; NR, neural retina; OS, optic stalk; RPE, retinal 
pigmented epithelium; V, ventral
161
162
3.3 Discussion
3.3.1 Summary of analysis
1) Tbx2, Tbx3, and Tbx5 were expressed in overlapping domains in the dorsal optic 
vesicle, at 10.5 dpc, and in the dorsal optic cup at 11.5 dpc, with Tbx2 being 
expressed in the largest domain.
2) Tbx2 is the only T-box gene of the three examined, which was expressed in the 
ventral extra-ocular mesenchyme.
3) Tbx2, Tbx3, and Tbx5 expression coincided with Bmp4, ephrinB2, and Msx2 in the 
dorsal region o f the developing eye; Tbx5, Bmp4, and Msx2 appeared to overlap 
completely, while Tbx2, Tbx3, and ephrinB2 were broader.
4) The ventral Vax2 expression domain did not meet the dorsal Tbx2 expression 
domain, at least not at 11.5 dpc.
5) Jaggedl and F gfl5  were excluded from the dorsal-most region of the developing 
eye; they therefore appeared complementary to the T-box genes and Bmp4.
6) Bmp4 and Fgfl 5 were suitably expressed in the developing eye to interact.
7) FgfS expression detected in chick and zebrafish eyes was not conserved in the 
mouse.
8) Tbx2, Vax2, and Bmp4 expression was normal in the early optic cup of Fg/75v' 
embryos.
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3.3.1 The optic cup is divided into distinct domains of gene expression 
along the D-V axis
Expression analysis of members of the Tbx2 subfamily, including Tbx2, Tbx3, and 
Tbx5y during optic cup formation showed that they are expressed in overlapping 
domains in the dorsal neural retina. Several sites where transcripts of the T-box 
genes were differentially distributed in the developing mouse eye were identified. 
Along the D-V axis o f the optic cup, Tbx2 expression extended more ventrally and, 
along the P-Di axis, it extended more proximally than both Tbx3 and Tbx5. Tbx5 
expression was the most restricted, both along the D-V and the P-Di axes of the optic 
cup. Along the D-V axis of the optic cup, the expression of the T-box genes was 
restricted in sharp domains, while along the P-Di axis, the expression of Tbx2 and 
Tbx3 appeared graded.
It has been proposed that the developing chick eye is divided into four compartment­
like domains of gene expression based on analysis of the expression of several 
asymmetrically expressed genes along the D-V axis. These include some of the genes 
analysed in this Chapter in the mouse embryo, namely ephrinB2, Tbx5, and Bmp4 in 
the dorsal-most region of the chick eye and Vax2 in the ventral most region (Peters 
and Cepko 2002). Retroviral driven lacZ labelling of cells and their progeny within 
the described domains in the chick embryo showed that approximately 80% of the 
cells originating in these domains respect the boundaries of gene expression and do 
not cross into the next domain, while 57% o f cells cross an arbitrary border within a 
domain. This has led to the suggestion that the eye possesses multiple compartment­
like units marked by restricted gene expression along the D-V axis, although these 
units do not possess the full characteristics of absolute lineage compartments due to 
the observation that some clonal cells do indeed cross the boundaries. Further 
support for the eye being composed of units at the cellular level along the D-V axis 
has come from labelling of a population of cells in the optic stalk region which 
contribute to the ventral-most domain of the neural retina and form a sharp domain 
with more dorsally located unlabelled cells in the Xenopus embryo during optic cup 
morphogenesis (Holt 1980).
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In addition to the genes analysed by Peters and Cepko in the chick embryo, I have 
incorporated Tbx2 and Tbx3 into the model and confirmed the presence of such 
distinct gene expression domains also in the mouse eye. The early optic cup of the 
mouse embryo can be divided into at least four domains of restricted gene expression 
along the D-V axis (Fig. 3.9). In the dorsal-most domain, dorsal domain 1 (Dl), 
Tbx5, Bmp4, Msx2, were expressed. Tbx2 was expressed in almost the entire dorsal 
half of the eye, in dorsal domain 2 (D2) together with ephrinB2. Tbx3 was expressed 
in Dl and on the temporal side also extended into D2. Double-labelling of Tbx2 and 
Vax2 expression demarcated yet another domain of non-labelled cells, ventral 
domain 3 (V3), as Vax2 in the ventral-most domain, ventral domain 4 (V4), was 
separated from the Tbx2 domain by a group of non-labelled cells. The expression of 
Jaggedl can be described as occupying D2 and V3, but not Dl or V4. It is possible 
that these domains of gene expression can be further subdivided by the borders of 
expression of other as yet unidentified genes. Some differences do appear to exists 
between the developing chick and the developing mouse eyes, notably in the chick 
eye, the expression of ephrinB2 was described to be more restricted than Tbx5 and 
Bmp4 (Peters and Cepko 2002), but in the developing mouse eye, ephrinB2 
expression appears similar to Tbx2 expression.
Fig. 3.9 The division of the mouse neural retina into distinct domains of 
gene expression based on genes examined in Chapter 3
Frontal view of an optic cup. Tbx5, Bmp4, Msx2 are expressed in dorsal domain 1 
(Dl; light blue). Tbx2 and ephrinB2 are expressed in D2 (dark blue). Tbx3 is 
expressed in Dl and in the temporal neural retina, also extends into D2. Vax2 is 
expressed in V4 (pink). V3 demarcates the existence of a domain between Tbx2 and 
Vax2.
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Attempts have been made to identify further genes expressed asymmetrically along 
the D-V axis. Shintani and colleagues have recently published a large-scale screening 
of differentially expressed genes in the dorsal, ventral, nasal, and temporal chick 
retina, based on comparisons o f signal intensities o f a display o f restriction digested 
cDNA fragments synthesised from RNA that was isolated from the above mentioned 
regions in a 2-dimensional gel (Shintani et al. 2004). O f 47 clones (20 genes) 
identified to be asymmetrically expressed, none possessed a smaller expression 
domain than that o f ephrinB2 (D l). In fact all genes identified in the dorsal eye 
showed expression domains similar to that o f  Tbx2 (D2) or to genes confined to D l.
The functional significance o f these early divisions is currently not fully understood. 
However, as described in Chapter 1.2.3-4, there are several manifestations of 
morphological asymmetries during optic cup morphogenesis. Later, some neuronal 
cell types display a non-uniform distribution in the mature retina. One aspect of 
asymmetry in the eye at the cellular level that has been studied extensively is the 
regulation o f the topographic map o f RGC axons. M anipulation o f the expression of 
Vax2/c Vax, Tbx5, Bmp4, EphB2 and EphB3 have all resulted in axonal mis- 
projections in the brain (Schulte et al. 1999; Mui et al. 2002; Barbeiri et al. 2002; 
Koshiba-Takeuchi et al. 2000; Sakuta et al. 2001; Birgbauer et al. 2000). Recently, 
retroviral driven misexpression o f cVax was shown to result in an increase in the rod 
density in infected areas in the chick retina, leading to suggestions that the 
asymmetrical expression o f cVax at the optic vesicle stage sets the ventral rod-dense, 
dorsal rod-sparse pattern obvious in late development in the chick eye (Schulte et al. 
2005). In the same study, misexpression o f a retrovirus encoding an engrailed-tagged 
Tbx5 insert, which acts in a dominant negative manner, also disrupted the rod 
pattern. Some o f the genes described here and in the study o f Peters and Cepko 
(2002) retain their expression pattern seen in the early optic cup as the retina grows, 
while others are switched off or expanded. How these domains o f restricted gene 
expression are established or maintained in the eye, whether they mark cells that are 
synchronous in development in terms o f proliferation and differentiation, and how 
the early pattern o f  these genes in the optic vesicle and during optic vesicle 
invagination relates to the final topography and shape o f the expanded adult retina, 
the bulk o f which is produced after the molecular division o f the early optic cup, is
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unknown. In Chapter 4 o f  this thesis, I have attempted to examine the role of Bmp4 
in regulating these gene expression domains, specifically those o f the T-box genes, 
along the D-V axis o f the mouse optic cup and examined the growth and the 
formation o f the early optic cup after manipulation o f Bmp signalling.
3.3.2 Shh, Bmp4, Fgf signalling network in the eye and their function
By analogy to the interaction between Bmp4, Shh, and Fgfs in for example the limb 
bud, the developing forebrain or the developing chick eye, it has been proposed that 
this tripartite signalling network may play generalised roles in growth and patterning 
of embryonic tissues (Crossley et al. 2001).
In the chick and zebrafish embryos, FgfS is dynamically expressed in the central 
region o f the neural retina and in the optic stalk (Reifers et al. 1998; Crossley et al. 
2001; Martinez-Morales et al. 2005). There are seven FgfS mRNA isoforms 
expressed during mouse embryogenesis (Crossley and Martin 1995), all o f which 
share the same C-terminal coding region but differ in their N-terminal region. Here, 
using a probe specific for the C-terminus o f  Fgf8, it was confirmed that unlike in the 
chick and zebrafish embryos, Fgf8 is not expressed in the central presumptive neural 
retina at the optic vesicle stage or in the neural retina at the optic cup stage in the 
mouse embryo. This is in agreement with the initial expression study o f Fgf8 in the 
mouse (Crossley and M artin 1995). Comparative analysis, described in this Chapter, 
o f the expression o f F g f 15, Bmp4, and Shh, both at the optic vesicle and at the optic 
cup stages, revealed that F g fl5 is expressed in between the dorsal Bmp4 domain and 
ventral neural retinal tissue that has previously been exposed to Shh emanating from 
the ventral forebrain. The pattern o f expression o f these signalling molecules in the 
developing mouse eye is therefore similar to the relative expression o f Shh, Bmp4, 
and multiple Fgfs in other tissues described earlier. Therefore, it is possible that 
similar interactions also occur between these factors during mouse eye development.
The above mentioned idea o f a putative interaction between the Bmp4 and F gfl5 
signalling pathways, was tested by analysing the expression o f Bmp4, and other 
asymmetrically expressed genes along the D-V axis o f the eye in F gfl5 7 mice. 
These mice form optic cups and are currently being analysed for eye defects by Dr.
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A. Battersby (University of Wales Cardiff). The expression of all genes were similar 
in mutant and wild-type embryos, suggesting that F g fl5 alone does not regulate 
Bmp4 ex p ress io n ^  the molecular composition of the eye along the D-V axis. An 
interaction between the Bmp4 and the Fgfl 5 pathways in the eye is nevertheless still 
possible, as Bmp4 could be upstream of F g fl5. Evidence for this was recently 
provided by demonstration of the lack of F g fl5 expression in the optic vesicle in 
mice homozygous for a non-functional Bmp4 allele (Murali et al. 2005). Although, 
this suggests that unlike other developing systems where Bmp4 antagonises Fgfs, in 
the developing mouse eye, Bmp4 is required for F g fl5 expression in the presumptive 
neural retina.
The expression analysis carried out here cannot completely exclude a role for Fgf 
signalling in D-V patterning of the eye. First of all, Fgfs may functionally 
compensate for each other, hence it is possible that the loss of function of one Fgf 
does not reveal the true role of Fgf signalling in a tissue. Evidence that corroborates 
this idea comes from studies in zebrafish, where loss of function of Fgf8/ace or 
Fgf3/lia alone has no profound effect on eye development, whereas loss of function 
of both prevents the onset of retinal cell differentiation (Martinez-Morales et a l 
2005). Recent evidence that provides support for a role for Fgf signalling in D-V 
patterning, comes from misexpression of an inducible Fgf receptor I (FgfrI) in the 
developing Xenopus eye, which induces the expansion of ventral retinal and optic 
stalk markers (Lupo et al. 2005). Noggin treatment o f the chick optic cup, which 
antagonises Bmp signalling, causes an expansion of the Fg/S neural retinal 
expression domain (Adler and Belecky-Adams 2002). The Fgf8 expression in the 
chick central neural retina is juxtaposed to the dorsal Bmp4 expression domain, in a 
similar pattern to F g fl5 in the mouse neural retina. The necessity of Bmp4 for F gfl5 
induction in the mouse eye compared to the antagonistic effect of Bmp signalling on 
Fgf8 in the chick optic cup could be either due to species differences or differences 
in the experimental approach, including the developmental time points studied; in the 
mouse, the induction of F g fl5 was examined in the absence of Bmp4 at optic vesicle 
stage, while in the chick, Noggin was misexpressed only after the induction of FgfS 
expression in the neural retina at the optic cup stage, and therefore the expansion of 
the FgfS domain, could reflect an antagonistic relationship that may exist also in the
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mouse between Bmp4 and Fgfs during maintenance rather than the induction of Fgfs 
in the central neural retina.
Manipulations o f Shh, Fg/8, and Noggin in the chick eye are accompanied by 
morphological abnormalities such as microphthalmia and abnormal optic stalk 
development (Zhang and Yang 2001; Crossley et al. 2001; Adler and Belecky- 
Adams 2002). The mechanism o f these morphological defects or how the three 
signalling pathways interact are currently not clear. Although the Shh expression 
domain is distant from the optic cup in 10.5-11.5 dpc mouse embryos, it has been 
shown that Patched, the Hh receptor which is a transcriptional target o f Shh 
signalling in all tissues examined and therefore considered to be an indicator o f Shh 
receptive cells (Marigo et al. 1996; Ingham and McMahon 2001), is expressed in a 
graded fashion along the optic stalk (Zhang and Yang 2001; Dakubo et al. 2003). 
Misexpression o f Shh in the developing chick, zebrafish, and Xenopus eyes has a 
ventralising effect and induces optic stalk and ventral neural retina at the expense of 
dorsal neural retina at the molecular level. By contrast, antagonism of endogenous 
Shh, causes suppression o f optic stalk and ventral neural retinal fates (Macdonald et 
al. 1995; Zhang and Yang 2001; Take-uchi et al. 2003; Lupo et al. 2005). This 
shows that Shh signalling is important for D-V patterning o f the eye, even though its 
site o f expression is a distance away in the ventral forebrain.
In conclusion, the peripheral optic cup can be divided into at least four distinct 
domains o f gene expression along the D-V axis. The T-box genes occupy D l and 
D2. The signalling molecule that most closely overlaps in expression pattern with the 
T-box genes is Bmp4, which is expressed in D l. Bmp4, F g fl5, and Shh expression 
along the D-V axis o f the mouse eye is reminiscent o f the expression pattern of Shh, 
Bmp4, and Fgfs in multiple other tissues where they have been shown to interact to 
regulate tissue growth. However, data presented here has excluded Fgfl5 as a 
regulator o f Bmp4 expression in the neural retina, and shown that in the absence of 
F gfl5, the molecular composition of the eye along the D-V axis is not disrupted.
In the next Chapter, the effect o f manipulation o f Bmp4 signalling is analysed with 
respect to optic cup formation, growth, and regulation o f the four domains of distinct 
gene expression, with emphasis on the T-box genes, along the D-V axis.
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CHAPTER 4 Investigation of the role of Bmp4 signalling in 
T-box gene regulation, D-V patterning and growth of the 
mouse eye
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4.1 Introduction
Analysis o f the expression o f Bmp4 and members o f the Tbx2 subfamily during optic 
cup morphogenesis (Chapter 3) revealed a high degree of overlap in the dorsal region 
of the developing eye. Preliminary observations in the Sowden laboratory had 
indicated that ectopic Tbx5 and Tbx2 expression could be induced by BMP4 in the 
presumptive RPE at optic vesicle stage (J. Holt and J. Sowden, unpublished). In this 
Chapter, experiments that investigated the regulation of Tbx2, Tbx3, Tbx5, as well as 
the ventrally expressed Vax2 gene by Bmp4 in the mouse optic cup are presented and 
the affect of manipulation o f Bmp4 signalling on early optic cup morphology is 
analysed.
Previous work in the chick embryo has demonstrated that electroporation o f Bmp4 
into the ventral optic cup can repress ventral retinal genes including cVax, the 
homologue o f mouse Vax2, and induce Tbx5, ephrinBl, and ephrinB2, which are 
normally restricted to the dorsal optic cup (Koshiba-Takeuchi et al. 2000), 
suggesting that Bmp4 induces dorsal characteristics. The Bmp4 homologue in 
Drosophila, Dpp, acts as a long-range morphogen in wing disc development 
(Chapter 1.4.3) The possibility o f Bmp4 setting up a long range signalling gradient 
along the D-V axis o f the newly formed optic cup across which the four domains of 
restricted gene expression are set up as described in Chapter 3, was explored here by 
assessing the spatial alteration of the four domains upon manipulation of Bmp4 
signalling. This was tested by providing an ectopic source o f Bmp4 or Noggin in 
such a way that the putative natural dorsal-high, ventral-low Bmp4 signalling 
gradient would be enhanced (by ectopic Bmp4) or decreased (by ectopic Noggin).
Analysis o f D-V patterning, or growth and development o f the eye in mice that are 
homozygous for a targeted disruption o f Bmp4 has been precluded by the resulting 
embryonic lethality around mid-gestation (Winnier et al. 1995; Furuta and Hogan 
1998). In the heterozygous state on a C57BL/6 genetic background however, 
embryos are bom and manifest microphthalmia at a three-fold higher incidence than 
observed in wild-type mice (Dunn et al. 1997). This is corroborated by the recent 
finding that Bmp4 heterozygous mutants crossed to mice homozygous for a disrupted
171
allele o f twisted gastrulation (Tsg), a Bmp binding protein which in the mouse eye 
has been suggested to boost Bmp4 signalling, exhibit anophthalmia (Zakin and De 
Robertis 2004). To gain insight into the mechanism(s) by which Bmp4 regulates eye 
growth, eye size was measured after manipulation o f Bmp signalling in experiments 
described here. The pattern o f cell proliferation and cell death were analysed in 
relation to the distinct gene expression domains along the D-V axis o f the eye, and 
changes in proliferation and apoptosis in Bmp manipulated eyes were correlated to 
alterations in the gene expression domains along the D-V axis o f the optic cup.
To manipulate Bmp signalling in the mouse optic cup, the mouse whole embryo 
culture system, described by Martin and Cockroft (Martin and Cockroft 1999) was 
utilised to allow further development o f mouse embryos ex-utero after manipulation. 
Exogenous recombinant human BMP4 (rhBMP4) and Noggin protein were delivered 
by agarose beads, which have previously been shown to be suitable delivery media 
for these proteins to embryonic tissues (Furuta et al. 1997; Lee et al. 2001b). The 
whole embryo culture system in combination with bead implantation is ideal for 
local delivery o f proteins such as signalling factors. It is more accessible for such 
surgical manipulations o f embryos than in-utero manipulations. Furthermore, in 
comparison to explant cultures o f eyes, which is another method often used for the 
study o f eye development, it offers superior preservation o f eye morphology and 
allows the analysis o f eye size and shape within the embryonic head.
4.2 Results
4.2.1 Optic cup formation and eye development in whole embryo 
culture
To assess the suitability of the mouse whole embryo culture system for the study of 
eye development, embryos were cultured for a period o f 15-18 (hours) hrs, here 
referred to as overnight culture, as described in Chapter 2.4.2. The state o f health and 
growth of embryos were assessed according to the following criteria, which are 
commonly used to assess developmental stage (Brown 1990) and viability . The heart 
beat and the rate o f circulation in the large cranial vessels were examined as a
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measure o f viability and were given a score for each embryo before (pre) and after 
(post) culture (Table 4.1; scoring criteria are described in table). Growth of embryos 
was assessed by measuring the head length as illustrated in Fig. 4.1. Head length, 
like crown-rump length, increases with developmental age and is commonly used as 
a measure of growth, although neither show a simple linear nor logarithmic increase 
with developmental age (Brown 1990). The post-culture head length was compared 
to the pre-culture head length for each embryo. The number o f somite pairs pre- and 
post-culture were also counted. Table 4.1 illustrates examples o f these records for 
some o f the 263 embryos cultured for the experiments reported in this Chapter.
Table. 4.1: Examples of health check records for cultured embryos before (pre) and after (post)
15-18 hrs in culture
no. Heart beat Circulation Somite pairs Head length (mm)
Age Pre Post Pre Post Pre Post Pre Post
11.5 dp c 1 +++ ++ +++ + 42 51 3.0 3.5
2 +++ +++ +++ +++ 46 52 3.1 3.6
3 +++ +++ +++ +++ 42 48 3.0 3.3
4 +++ +++ +++ ++ 4 6 50 3.0 2.8
5 +++ +++ +++ +++ 4 0 50 2.6 3.5
10.5 d pc 6 ++ +++ +++ +++ 31 37 1.7 2.2
7 ++ - ++ - 25 30 1.4 1.4
8 ++ +++ +++ +++ 25 32 1.4 2.1
9 ++ ++ +++ ++ 20 29 1.2 1.7
10 ++ +++ +++ +++ 22 29 0.9 1.7
Heart beat: none; +, slow; ++, moderately fast; +++, very fast.
Circulation: none; +, few circulating blood cells; ++, many circulating blood cells and moderately fast 
rate of blood flow, +++, many circulating blood cells with very fast rate of blood flow.
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Fig. 4.1 Schematic dem onstration of the measurement of head length
Head length was measured from the anterior groove o f the forebrain to the posterior 
most point o f the hindbrain, using a 10 mm graticule positioned beneath a petridish 
containing the embryo rested on its lateral side.
In all experiments presented in this Chapter, post-culture embryos were analysed if 
they passed the minimum criteria o f heart beat = +, circulation = + and showed an 
increase in the number o f somite pairs and an increase in head length compared to 
their pre-culture state. Embryos lacking circulation after culture but having grown 6 
or more somite pairs and showing an increase in head length as well as possessing a 
more advanced morphology and appearing generally healthy after overnight culture 
were also included in the analysis. For example, embryos numbered 4 and 7 in Table
4.1 were regarded as unhealthy and therefore excluded from analysis.
Eye development in embryo culture was assessed morphologically and compared to 
non-cultured embryos. Fig. 4.2 shows examples o f eye morphology of cultured 
embryos in comparison to the eye morphology in embryos equivalent to their pre­
culture and post culture states. Overnight cultures o f 10.5 dpc embryos in possession 
o f optic vesicles prior to culture (Fig. 4.2 A-C), resulted in the formation of optic 
cups, in which the neural retina was thick, the RPE layer was thin but still non- 
pigmented, and the lens vesicle was in most cases completely separated from the 
overlying surface ectoderm (Fig. 4.2 D-H). Overnight cultures o f 11.5 dpc embryos 
resulted in growth o f the optic cup, pigmentation o f the RPE, and apposition of the 
walls o f the optic fissure (Fig. 4.2 I-N), which were features also observed in stage
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matched non-cultured embryos (Fig. 4.2 O-T). Thus, optic vesicle invagination and 
further growth and development o f the optic cup occur in whole embryo culture with 
conditions described and closely resemble in vivo development.
Eye development in embryo culture was assessed morphologically and compared to 
non-cultured embryos. Fig. 4.2 shows the eye morphology o f cultured embryo in 
comparison to the eye morphology o f an embryo equivalent to its preculture state. 
Overnight cultures o f 10.5 dpc embryos in possession o f optic vesicles prior to 
culture (Fig. 4.2 A-C), resulted in the formation o f optic cups, in which the neural 
retina was thick, the RPE layer was thin but still non-pigmented, and the lens vesicle 
was in most cases completely separated from the overlying surface ectoderm (Fig.
4.2 D-H). Thus, optic vesicle invagination and growth o f the optic cup occurs in 
whole embryo culture with conditions described
The age o f each embryo is described as its age at the time o f explantation from the 
uterus plus information about its culture state. For example, an embryo dissected at
11.5 dpc and cultured overnight is described as 11.5 dpc post-culture.
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Fig. 4.2 Development and morphology of the ocular tissues in cultured 
embryos a t 10.5 -11.5 dpc
Rows show serial transverse vibratome sections through eyes with the dorsal most 
section displayed at the top and the ventral most section displayed at the bottom of 
each row. (A-C) State of eye development in a non-cultured early 10.5 dpc embryo, 
still in possession of an optic vesicle. Sections show Tbx5 expression in the optic 
vesicle. (D-H) State of eye development in an early 10.5 dpc embryo cultured 
overnight, which prior to culture possessed optic vesicles and was at the same ss as 
the embryo shown in A-C. Sections show an invaginated optic cup with a tick neural 
retina and an almost complete lens vesicle. Dorsal sections (D,E) show the 
expression of Tbx5 in the dorsal neural retina. (I-N) State of eye development in an
11.5 dpc embryo (ss 44) after overnight culture showing further growth of the optic 
cup, formation of the lens vesicle, pigmentation of the RPE, and alignment of the 
walls of the optic fissure in close proximity (arrow in N). Prior to culture, this 
embryo possessed approximately the same number of somite pairs as the embryo 
shown in D-H. (O-T) State of eye development in a non-cultured 11.5 dpc embryo 
(ss 44), showing similar features as the cultured embryo in I-N. Scale bars: 0.1 mm.
Abbreviations: L, lens; NR, neural retina; OS, optic stalk; OF, optic fissure; P-NR, 
presumptive neural retina; P-RPE, presumptive retinal pigment epithelium; RPE, 
retinal pigment epithelium
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4.2.2 T-box gene expression and D-V patterning in eyes treated with 
rhBMP4 coated beads
To test the hypothesis that Bmp4 regulates the expression o f members of the Tbx2 
subfamily in the developing mouse eye, an ectopic source o f BMP4 was provided to 
the optic cup in 11.5 dpc embryos by beads soaked in [100 fig/ml] rhBMP4 protein 
(see Chapter 2.6.1). Beads were implanted into the lens vesicle o f one eye, keeping 
the contralateral eye either as a non-implanted control or implanted with a BSA- 
soaked bead. It was reasoned that implantation o f the rhBMP4 bead within the optic 
cup would provide an equal source o f Bmp4 to the entire D-V axis o f the optic cup, 
hence elevating the putative signalling gradient. The lens was the only feasible site 
for bead implantation at this stage. After overnight culture, gene expression was 
analysed by whole mount in situ hybridisation in healthy embryos that met the 
criteria described in Section 4.2.1.
In BSA treated eyes, gene expression was never altered in comparison to 
contralateral non-treated eyes (Fig. 4.3 A,B). By contrast, Tbx5 expression, usually 
confined to the dorsal most domain D1 extended further ventrally in rhBMP4 treated 
eyes in comparison to contralateral non-treated eyes (Fig. 4.4 A,B). Interestingly, 
although induced in a wider domain, Tbx5 expression was never seen to extend into 
the ventral half o f the optic cup. It was noted that the ectopic Tbx5 expression 
induced in rhBMP4 treated eyes was very similar to the normal spatial expression of 
Tbx2 in dorsal domain D2 in non-treated eyes with physiological levels of Bmp4 
(Fig. 4.4 B,C). In contrast to the lack o f expansion o f Tbx5 expression in the ventral 
neural retina in rhBMP4 treated eyes, Tbx2 expression was expanded into ventral 
territories. It was also induced in the lens vesicle (Fig. 4.4 C,D). Tbx3 expression was 
also expanded into the ventral neural retina in rhBMP4 treated eyes, but unlike Tbx2 
it was not induced in the lens vesicle (Fig. 4.4 E,F).
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Fig. 4.3 Com parison of gene expression between BSA-treated and non- 
treated control eyes in an 11.5 dpc post-culture em bryo by whole m ount in situ 
hybridisation
Pictures depict lateral views of the head of the embryo. (A) An 11.5 dpc post culture 
embryo (overnight culture) showing localisation of Tbx5 transcripts to the dorsal 
optic cup (arrows). (B) The contralateral eye of the embryo in A implanted with a 
BSA bead (asterisk), showing similar pattern of Tbx5 expression (arrows). Scale 
bars: 0.5 mm.
Abbreviations: BSA, bovine serum albumin; D, dorsal; MN, mandibular process of 
the first branchial arch; V, ventral.
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Fig. 4.4 Gene expression along the D-V axis of the optic cup by whole 
m ount in situ hybridisation upon rhBM P4 treatm ent
Somite stages of each embryo are indicated next to their pictures with the post­
culture somite count outside of the brackets followed by the pre-culture somite count 
within brackets. Beads are indicated with asterisks. All pictures show lateral views of 
the head of the embryos. (A) Control eye of a cultured embryo showing Tbx5 
expression in a non-manipulated eye. (B) The rhBMP4 treated eye of the embryo 
shown in A. Tbx5 expression was detected in a wider domain of the dorsal optic cup, 
extending beyond the dorsal curvature (arrows). (C) An eye implanted with a BSA 
bead showing normal Tbx2 expression in the dorsal optic cup (arrows). Arrowhead 
indicates Tbx2 expression in the extra-ocular mesenchyme within the ventral optic 
cup. (D) The rhBMP4 treated eye of the embryo in C. Tbx2 expression was detected 
in almost the entire optic cup including the lens. Arrows point to the ventral limit of 
Tbx2 expression. (E) An eye implanted with a BSA bead showing normal Tbx3 
expression in the dorsal optic cup (arrows). (F) The contralateral eye to E implanted 
with an rhBMP4 bead and showing Tbx3 expression in the entire neural retina. (G) 
Lateral view of an eye implanted with a BSA bead and showing normal Vax2 
expression (arrows). (H) Contralateral eye of G implanted with an rhBMP4 bead 
showing absence of Vax2 expression was absent in this eye. Arrows are replicas of 
those in G and indicate the region in which Vax2 would normally be expressed. (I) 
Schematic representation of the expression of Tbx2, Tbx5, and Vax2 relative to each 
other in a lateral view of a non-treated neural retina in a cultured embryo. (J) 
Schematic representation of the ventral shift of gene expression along the D-V axis 
in rhBMP4 treated eyes. Scale bars: 0.5 mm.
Abbreviations: D, dorsal; MN, mandibular process of the first branchial arch; MX, 
maxillary component of the first branchial arch; V, ventral.
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These data show that rhBMP4 bead implantation in the lens vesicle is capable of 
affecting gene expression in both the lens and the neural retina. rhBMP4 treatment 
induced a differential response in T-box gene expression along the D-V axis of the 
optic cup, as all three T-box genes were ectopically induced in a unique manner. The 
ventral neural retina was capable o f expressing Tbx2 and Tbx3, but not Tbx5 in 
response to rhBMP4 treatment, suggesting that the ventral neural retina is capable of 
expressing T-box gene expression.
To further investigate the effect o f ectopic rhBMP4 on the distinct domains of gene 
expression (D l, D2, V3, V4) along the D-V axis o f the mouse optic cup, the 
expression o f Vax2 was analysed in treated embryos. As described in Chapter 3.2.3, 
Vax2 expression is normally confined to the ventral neural retina (V4). In rhBMP4 
treated eyes however, it was completely absent, but was present in BSA treated 
contralateral eyes (Fig. 4.4 G,H). The observed change in transcription factor gene 
expression upon rhBMP4 treatment is illustrated in Fig. 4.4 I-J. rhBMP4 induced a 
ventral shift in the expression o f these genes resulting in an expansion of Tbx5 
expression into D2, the region normally occupied by Tbx2 transcripts, an expansion 
of Tbx2 expression further ventrally into V3 and V4, though not completely covering 
V4, and repression o f Vax2 expression in the ventral optic cup. Tbx3 showed the 
widest expansion in response to rhBMP4 beads within the neural retina, where its 
expression encompassed the region normally expressing Vax2 in V4.
To better examine the shift in transcription factor gene expression along the D-V axis 
o f the optic cup at 11.5 dpc, double in situ hybridisation with the Tbx2 and Vax2 
probes were performed on embryos with rhBMP4 coated bead in one eye and BSA 
coated bead in the contralateral eye. In BSA treated eyes, Tbx2 expression in the 
dorsal neural retina was separated from Vax2 expression in the ventral neural retina 
by a small area o f unlabelled cells in V3 (Fig. 4.5 A), as previously demonstrated in a 
non-treated 11.5 dpc embryo in Chapter 3 (Fig. 3.6 A). rhBMP4 treatment induced 
ectopic Tbx2 expression within this region and abolished Vax2 expression in V4 (Fig.
4.5 B). Serial sections through the eyes confirmed the expansion o f Tbx2 expression 
further ventrally but showed that it was never induced in the ventral most region of 
the optic cup (V4), where Vax2 is normally expressed. Hence the expansion of Tbx2 
did not encompass the normal Vax2 expression domain, yet Vax2 was abolished (Fig.
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4.5 C-H). The number o f times altered gene expression was observed for each gene 
are indicated in Table 4.2.
These experiments suggested that elevated Bmp4 signalling induced molecular 
changes in the optic cup in the form o f ectopic T-box gene expression and repression 
of Vax2 expression in the ventral eye. A further set o f experiments were conducted, 
which started at the earlier stage o f 10.5 dpc prior to optic cup formation, to test 
whether alterations in Bmp4 signalling disrupted the formation o f the optic cup.
In these experiments, rhBMP4 beads were implanted close to the optic vesicle in the 
extra-ocular mesenchyme as the lens vesicle had not yet formed, and embryos were 
cultured through the optic vesicle invagination period. Implantations were performed 
in several locations around the eye in order to enhance the endogenous Bmp4 
signalling. To assess the effect on eye morphology, vibratome sections were 
prepared, and to assess a disruption o f D-V patterning by rhBMP4 beads implanted 
in these new locations, the expression o f Tbx2 and Tbx5 were analysed in post­
culture embryos.
In a total o f 12 embryos examined, optic cup formation proceeded normally 
regardless o f bead location; in all 10.5 dpc post-culture embryos the optic cup and a 
lens vesicle had formed. Examination o f gene expression did not show the 
reproducible changes observed at 11.5 dpc. rhBMP4 bead implantation in the ventral 
extra-ocular mesenchyme did not induce ectopic Tbx5 expression and had no 
apparent effect on the dorsal expression o f Tbx5 (n= 0/2; Fig. 4.6 A,B). Implantation 
o f the bead temporal to the optic vesicle also failed to induce ectopic Tbx5 
expression (n= 0/1; Fig. 4.6 C,D). In eyes where beads were implanted nasal to the 
optic vesicle, Tbx5 expression appeared stronger within its normal domain and was 
slightly extended (n= 2/2; Fig. 4.6 E-G ). Sections through the eyes showed that Tbx5 
was also induced in the RPE next to the bead (Fig. 4.6 H,I, arrow). Finally, 
implantation o f beads dorsal to the optic vesicle resulted in an apparently stronger 
expression o f Tbx5 within the dorsal neural retina in 1/3 treated eyes compared to 
non treated contralateral eyes in each embryo (data not shown as similar to the set in 
Fig. 4.6 E-G).
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Fig. 4.5 Tbx2 and Vax2 expression in the optic cup by whole m ount double 
in situ hybridisation upon rhBM P4 treatm ent
Beads are highlighted by asterisks. (A) Lateral view of the eye of a cultured embryo 
implanted with a BSA bead, showing normal Tbx2 expression in red and Vax2 
expression in blue. Arrows indicate the limits of the expression of each gene. 
Arrowhead point to Tbx2 expression in the extra-ocular mesenchyme in the ventral 
optic cup. The strong expression of Tbx2 in the maxillary and mandibular processes 
of the first branchial arch is also visible in red. (B) The contralateral eye of A, 
implanted with an rhBMP4 bead. Tbx2 expression was detected in almost the entire 
optic cup, but Vax2 expression was absent. (C-H) Serial transverse vibratome 
sections through the BSA treated and the rhBMP4 treated eyes, showing the 
expansion of Tbx2 and loss of Vax2 expressions. Sections start in the dorsal optic cup 
at the level of the dotted lines indicated in A and B and continue into the ventral 
optic cup. The red staining indicated by arrowheads in G and H show Tbx2 
expression in the ventral extra-ocular mesenchyme. Arrows indicate the optic fissure 
walls. Scale bars: 0.5 mm in A,B; 0.1 mm in C-F.
Abbreviations: D, dorsal; L, lens; MN, mandibular process of the first branchial arch; 
MX, maxillary process of the first branchial arch; NR, neural retina; OF, optic 
fissure; V, ventral
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Fig. 4.6 Tbx5 expression in eyes treated  with rhBM P4 from various 
locations p rio r to optic vesicle invagination (10.5 dpc)
Gene expression was detected by whole mount in situ hybridisation. The locations of 
beads are marked by asterisks. (A) Lateral view of a non-treated control eye of a 
cultured embryo showing Tbx5 expression (arrows). (B) The contralateral eye to the 
eye shown in A with an rhBMP4 bead implanted in the ventral extra-ocular 
mesenchyme. Tbx5 expression was not affected (arrows). (C,D) Lateral views of 
control and rhBMP4 treated eyes of a cultured embryo respectively. Implantation of 
the bead in the temporal extra-ocular mesenchyme had no effect on the expression of 
Tbx5 in the dorsal optic cup. (E) Dorsal view of the head of an embryo with an 
rhBMP4 bead implanted in the nasal extra-ocular mesenchyme of one eye (asterisk). 
Tbx5 expression was stronger on the treated side. (F,G) Lateral views of the control 
and treated eyes respectively of the embryo shown in E. Tbx5 expression was also 
slightly extended on the treated side (H,I) Transverse sections through the control 
and treated eyes respectively at the level of the dotted lines in F,G. Arrow shows 
ectopic induction of Tbx5 expression in the RPE. (arrows). Scale bars: 0.5 mm in A- 
G, 0.1 mm in H,I.
Abbreviations: D, dorsal; L, lens; N, nasal; NR, neural retina; RPE, retinal pigmented 
epithelium; T, temporal, V, ventral.
187
Tbx5
control rhBMP4
188
The expression o f Tbx2 was also examined after rhBMP4 bead implantation dorsal to 
the optic vesicle. In one out o f three embryos the bead was found proximal to the 
optic cup after culture and Tbx2 expression was extended ventrally in comparison to 
the non-treated contralateral eye (n= 1/3; Fig. 4.7 A-H; Table 4.2).
Table 4.2 Summary of the number of embryos that showed gene expression alterations upon
rhBMP4 treatment
Protein Stage Gene
Gene
expression
altered
No change 
in gene 
expression
Total Ratio
rhBMP4 11.5 dpc Tbx5 10 2 12 10/12
Tbx2 6 0 6 6/6
Tbx3 3 0 3 3/3
Vax2 4 0 4 4/4
10.5 dpc Tbx5 3 5 8 3/8
Tbx2 1 2 3 1/3
BSA 11.5 dpc Tbx5 0 5 5 0/5
Tbx2 0 6 6 0/6
Tbx3 0 1 1 0/1
Vax2 0 6 6 0/6
10.5 dpc Tbx5 0 2 2 0/2
Tbx2 0 2 2 0/2
Although at low incidence, the ectopic expression o f Tbx2 in 1/3 eyes, and Tbx5 in 
3/8 eyes in 10.5 dpc embryos suggests that T-box gene expression is also likely to be 
controlled by Bmp4 signalling during optic vesicle invagination. The variable effect 
on gene expression may be due to the reduced ability o f rhBMP4 to reach the neural 
retina from the extra-ocular mesenchyme. The morphogenetic movements that take 
place during this period in eye development may also have contributed to the 
variable outcome. The concentration o f rhBMP4 used in these experiments was 
identical to that used at the optic cup stage, where D-V patterning was successfully 
disrupted, and a higher concentration may have induced more reproducible changes.
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Fig. 4.7 Tbx2 expression upon rhBM P4 bead im plantation prior to optic 
vesicle invagination (early 10.5 dpc)
Gene expression was detected by whole mount in situ hybridisation. Location of 
bead is marked by asterisk. The D-V axis, as indicated, refers to the orientation of A 
and B, while the indicated N-T axis shows the orientation in C-H (A) Lateral view of 
a non-treated control eye of a cultured embryo showing Tbx2 expression. (B) Lateral 
view of the contralateral eye of the one in shown in A with an rhBMP4 bead 
implanted proximal to the optic cup (asterisk). Wider Tbx2 expression was observed. 
(C-H) Serial transverse vibratome sections of each eye. Sections start from the dorsal 
region of the eye displayed at the top of each row (C,D) and continue serially to the 
ventral region of each eye, displayed at the bottom of each row (G,H). Tbx2 
expression was stronger in the dorsal neural retina and reached further ventrally in 
the rhBMP4 treated eye. Scale bars: 0.5 mm in A,B; 0.1 mm in C-H.
Abbreviations: D, dorsal; L, lens; MN, mandibular process of the first branchial arch; 
MX, maxillary process of the first branchial arch; N, nasal; NP, nasal process; NR, 
neural retina; OS, optic stalk; T, temporal; V, ventral
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4.2.3 D-V patterning in the mouse eye in response to an ectopic 
source of Noggin protein
As mentioned in previous sections, the change in gene expression along the D-V axis 
of the optic cup upon rhBMP4 bead implantation is reminiscent o f changes in gene 
expression during manipulations o f systems where morphogen gradient models have 
been proposed (see introduction 4.1). To further investigate Bmp4 regulation of T- 
box gene expression and the consequences o f changes in Bmp4 signalling on D-V 
patterning and optic cup morphology, endogenous Bmp signalling was manipulated 
by an exogenous source o f mouse Noggin. Noggin binds Bmp4 with high affinity 
and antagonises Bmp4 signalling by preventing receptor ligand interactions 
(Zimmerman et al. 1996).
As Bmp4 is expressed in the dorsal neural retina and therefore endogenous Bmp4 
protein concentration is most likely to be highest in this region, Noggin soaked beads 
were placed in the extra-ocular mesenchyme dorsal to the optic vesicle of early 10.5 
dpc embryos. After bead implantation, embryos were cultured through the process o f 
optic vesicle invagination and gene expression was compared between Noggin 
treated, non-treated or BSA treated contralateral eyes in each embryo. Beads soaked 
in [1 mg/ml] Noggin have previously been reported to cause craniofacial 
abnormalities in the chick embryo (Lee et al. 2001b). In the experiments described 
here, Noggin was used at [1 mg/ml].
In Noggin treated eyes, Tbx5 expression was abolished (n= 6/6; Fig. 4.8 A,B). In 
contrast Tbx2 expression was never completely abolished, but restricted to a smaller 
region o f the dorsal neural retina than in control eyes (n= 4/4; Fig. 4.8 C,D). Tbx2 
expression in Noggin treated eyes resembled Tbx5 expression in D1 in non-cultured 
embryos o f the same age (Fig. 4.8 A,D), much in the same way Tbx5 expression 
resembled normal Tbx2 expression in rhBMP4 treated optic cups (Section 4.2.2, Fig. 
4.4 B and C). No changes were observed in the expression o f either Tbx2 or Tbx5 in 
BSA treated eyes (n= 0/4; Fig. 4.8 E-H) or non-treated control eyes in cultured 
embryos (n= 0/14).
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Fig. 4.8 T-box gene expression upon Noggin bead im plantation prio r to 
optic vesicle invagination (early 10.5 dpc)
Gene expression was detected by whole mount in situ hybridisation. Location of 
bead is marked by asterisk. Pictures show lateral views of the head of embryos. (A) 
A non-treated control eye of a cultured embryo showing the expression of Tbx5 in 
the dorsal optic cup (arrows). (B) The Noggin treated eye of the embryo in A, 
showing absence of Tbx5 expression in the optic cup. Arrows are replicas of those in 
A, highlighting the area where Tbx5 would be normally expressed. (C) Non-treated 
control eye of a cultured embryo hybridised with the Tbx2 probe. Tbx2 expression in 
the eye is marked by arrows. (D) Noggin treated eye of the embryo in C, showing 
reduced expression of Tbx2 within the dorsal optic cup (arrows). (E,F) Non-treated 
and BSA treated eyes respectively of a cultured embryo hybridised with the Tbx5 
probe. (G-H) Non-treated and BSA treated eyes respectively of a cultured embryo, 
showing Tbx2 expression. (I) Schematic representation of normal Tbx2, Tbx5 and 
Vax2 expression in a lateral view of the optic cup. (J) Schematic representation of 
the observed dorsal shift of T-box gene expression upon Noggin bead implantation in 
the dorsal extra-ocular mesenchyme. Scale bars: 0.5 mm.
Abbreviations: D, dorsal; MN, mandibular process of the first branchial arch; MX, 
maxillary process of the first branchial arch; NP, nasal process; V, ventral
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The shift in T-box gene expression induced by exogenous Noggin is summarised in 
Fig. 4.8 I-J. Beads soaked in [lOOug/ml] o f Noggin had been tried initially, but did 
not yield a consistent reduction in T-box gene expression (n= 2/6 Tbx5\ data not 
shown). Data is summarised in Table 4.3
The effect o f Noggin was also examined at 11.5 dpc by Noggin coated bead 
implantation in the lens vesicle, as had been done with rhBMP4 beads. Beads were 
soaked in [1 mg/ml] Noggin which had successfully perturbed T-box gene expression 
during optic vesicle invagination. However, no effect was seen on the expression of 
Tbx5 (n = 0/2), Tbx2 (n = 0/3), or Vax2 (n = 0/2) in 11.5 dpc embryos (data not 
shown). It may be that Noggin bead implantations in the lens vesicle at 11.5 dpc 
were ineffective due to Noggin not reaching the optic cup from the lens, or that 
inhibition o f endogenous Bmp4 no longer affects gene expression at this stage.
Table 4.3 Summary of the num ber of em bryos showing alteration in T-box gene
expression upon Noggin bead implantation
stage gene
gene
expression
altered
no change 
in gene 
expression
Total Ratio
Noggin 11.5 dpc Tbx5 0 2 2 0/2
Tbx2 0 3 3 0/3
Vax2 0 2 2 0/2
10.5 dpc Tbx5 6 0 6 6/6
Tbx2 4 0 4 4/4
4.2.4 Eye morphology upon manipulation of Bmp signalling
In 10.5 dpc embryos implanted with Noggin beads, as T-box gene expression along 
the D -V  axis o f the neural retina had clearly been altered, it was possible to 
investigate the hypothesis that normal D-V patterning may be required for optic cup 
formation. In Noggin treated eyes, the optic vesicle invaginated into an optic cup, 
suggesting that correct D-V patterning is not required for optic cup formation. 
However, the morphology o f the optic cup in Noggin treated eyes was abnormal as 
the optic stalk had expanded dorsally (n = 6/8, Fig. 4.9) in comparison to non-treated 
control eyes.
195
Fig. 4.9 Morphology of the ventral optic cup and stalk upon Noggin bead 
implantation prior to optic vesicle invagination (early 10.5 dpc)
Images in each column show serial vibratome sections through the transverse plane 
of a Noggin treated eye (A-D) and its contralateral control (E-H) in an embryo 
cultured through the optic cup invagination process. The ventral most sections 
obtained from each eye are at the bottom of the columns and the consecutive sections 
placed in order towards the top of each column. Each row shows equivalent sections 
through the treated and the non treated eyes. Pictures were acquired as described 
previously, but were converted to black and white due to aesthetic reasons as embryo 
was sectioned after an unsuccessful in situ hybridisation experiment. In the Noggin 
treated eye, optic cup invagination (arrows) and retinal thickening is observed in 
section A but not further ventrally (B-D), while in the control eye, invagination of 
the cup has advanced further ventrally and is observed in sections E and F (arrows). 
Compare eye morphology in B versus F. Scale bars: 0.1 mm.
Abbreviations: D, dorsal; NR, neural retina; OS, optic stalk, V; ventral
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Based on the thickness of the sections (50 /zm), from which eye morphology was 
analysed in these embryos, the Noggin treated eyes contained between 50-100 /zm 
extra optic stalk region without evidence of invagination or thickening of the distal 
neuroepithelium (compare Fig. 4.9 B,C with F,G). This apparent expansion of the 
optic stalk was at the expense of the optic cup as the number of sections obtained 
from each eye was either similar or one less in Noggin treated eyes. What appears to 
be a dorsal shift of the optic stalk corresponds well with the dorsal shift of gene 
expression along the D-V axis described in Section 4.2.3. At this stage no further 
abnormalities were detected.
In 11.5 dpc cultured embryos which showed the ventral shift in gene expression upon 
rhBMP4 treatment, haemotoxylin and eosin (H&E) staining of coronal wax sections 
revealed a thinner neural retina in rhBMP4 treated eyes compared to non-treated eyes 
(Fig. 4.10 A,B). Moreover, the size of the optic cup appeared smaller and its shape 
altered in the ventral aspect as the ventral neural retina appeared shorter and less 
curved. The size and shape differences were analysed in more detail in Sections 4.2.5 
- 4.2.6. The hyaloid vasculature, which normally fills the vitreous chamber upon 
entry of the hyaloid artery from the posterior region of the optic cup, was present and 
apparently normal in treated optic cups, where it extended into the anterior region of 
the vitreous chamber (Fig. 4.10 B, arrowheads).
4.2.5 Eye size and shape in rhBMP4 and Noggin treated embryos
To examine the effect of rhBMP4 on eye size, neural retinal volume was estimated 
from neural retinal area measurements performed on 50 /zm thick vibratome sections 
of rhBMP4 treated and BSA treated eyes in 11.5 dpc post-culture embryos as 
described in Chapter 2.11.1. These measurements were performed blind and they 
were paired, as the treated eye was compared to the BSA treated contralateral eye in 
each embryo. The measurements revealed that neural retinal volume in rhBMP4 
treated eyes was smaller than in BSA treated contralateral counterparts (n= 4 
embryos; mean rhBMP4 eye= 7.35x10’3 mm3 ± 2.3x10"3 s.d.; mean BSA eye= 
10.90xl0‘3 mm3± 1.95xl0'3 s.d.; P= 0.033 by paired t-test; Fig. 4.10 C).
198
Fig. 4.10 Eye morphology and size in rhBMP4 treated optic cups
(A,B) H&E stained coronal wax sections (7/xm) of rhBMP4 treated and contralateral 
non-treated control eyes, as indicated, after overnight culture of 11.5 dpc embryos. 
rhBMP4 bead implantation in the lens vesicle resulted in a thinner retinal 
morphology, an overall smaller eye size, and altered the shape of the cup most 
apparent in the ventral region. The hyaloid vasculature appeared normal in the 
treated eye as it had extended into anterior regions of the cup (arrowheads). Asterisk 
marks the bead. (C) Bar chart represents estimated mean retinal volume ± s.d. in 
rhBMP4 treated and BSA treated eyes. The P-value was calculated with the paired t- 
test. Retinal volumes were measured on 50 /xm vibratome sections. Scale bars: 50 
/xm.
Abbreviations: BSA, bovine serum albumin; D, dorsal; V, ventral.
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The relationship between the shape o f the embryonic and the adult eye is not well 
established. However, the idea that early embryonic events, particularly during the 
formation o f the optic cup and the early growth o f the optic cup, affect the shape of 
the mature eye is plausible. Few studies have attempted a quantitative analysis of the 
shape and size o f the embryonic eye. In view o f the changes in gene expression 
across the D-V axis in response to altered Bmp4 signalling, quantitative analysis o f 
treated embryonic eyes was carried out to investigate whether there was evidence of 
a change in the shape o f the eye. In human patients, the axial length o f the adult eye 
globe, measured from the posterior comeal surface to the inner limiting membrane of 
retina or to the RPE, is a measure o f myopia or hyperopia, and is correlated with the 
refractive error o f the eye. Even small differences in the axial length and shape of the 
eye impact human vision. In mice, this axis corresponds to the P-Di'axis of the eye. In 
order to examine the impact o f rhBMP4 on the axial length o f the embryonic mouse 
eye at 11.5 dpc, measurements along the D-V and N-T axes o f the optic cup were 
carried out on whole head views as described in Chapter 2.11.4 and illustrated in 
Figs. 4.11 and 4.12. Measurements o f the P-Dfaxes were carried out on transverse 
vibratome sections as described in Chapter 2.11.5. A previous study has reported 
quantification o f the P-D| axial length in adult mice eyes by measurements performed 
on transverse sections (Tejedor and de la Villa 2003).
First, the natural difference between the right and the left eyes o f cultured, but not 
treated embryos, was examined to determine the extent o f natural variation and to 
control for any impact o f the embryo culture procedure on the difference found 
between two eyes o f an embryo. No significant difference was found in this group, 
suggesting that there is no significant natural variation in D-V axial length between 
the left and right eyes in non-treated but cultured 11.5 dpc embryos (Fig. 4.11 A, 
Table 4.4). In rhBMP4 treated eyes however, the D-V axis was significantly smaller 
than in contralateral non-treated eyes (Fig. 4.11 B, Table 4.4). In embryos with a 
BSA coated bead in one eye and no bead in the contralateral eye, the variation in eye 
size was not found to be significant (Fig. 4.11 C, Table 4.4).
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Fig. 4.11 D-V axial length in non-treated and rhBM P4 treated eyes in 11.5 
dpc cultured embryos
P-values were calculated with the paired t-test with the raw data set for pairs of eyes. 
Scatter plots illustrate the percentage difference in D-V axial length between the two 
eyes in each embryo, calculated as described in Section 4.3.5. (A) Difference 
between left and right eyes in cultured but not treated embryos, representing the 
natural variation between eyes. (B) Difference between rhBMP4 treated and non- 
treated control eyes in cultured embryos. In all cases, the rhBMP4 eye was smaller 
than the contralateral non-treated eye. (C) Difference between BSA treated and non- 
treated control eyes in cultured embryos. BSA treated eyes were sometimes smaller 
and sometimes bigger than their contralateral non-treated counterparts.
Abbreviations: BSA, bovine serum albumin
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Table 4.4: Percentage difference in eye size between differentially treated pairs of eyes in
11.5 dpc post-culture em bryos and P-values by the paired t-test___________________________
Treatm ent
Group
n. Mean percentage difference ± l.s.d. P-value
D-V axial length none 10 98.1% ± 3.50 0.108
rhBMP4 25 92.33% ±3.83 <0.0001
BSA 8 95.26% ±7.77 0.07
Noggin 6 99.97% ±0.10 0.436
N-T axial length none 10 99.97% ± 2.92 1
rhBMP4 25 96.66% ± 4.93 0.001
BSA 8 97.87% ±3.50 0.147
Noggin 6 99.95% ± 0.07 0.133
Although the difference in the D-V axial length in BSA treated embryos was not 
significant, there appeared to be several embryos that showed similar differences to 
those detected in rhBMP4 embryos, and because the rhBMP4 treated group was 
larger than the BSA treated group, it was important to investigate whether a 
significant difference would be found if the groups were equal in number. Therefore, 
the rhBMP4 treated group was randomly reduced to eight specimens to match the 
BSA treated group in the number of observations, and the data was again analysed by 
the paired t-test and unlike the BSA treated group, was found to be significantly 
different with n= 8 (P= 0.002).
Comparison of the N-T axial length in a similar manner in cultured embryos revealed 
no significant naturally occurring differences between left and right eyes of non- 
treated but cultured embryos (Fig. 4.12 A, Table 4.4). However, significant 
differences were found along the N-T axis between rhBMP4 treated and non-treated 
eyes (Fig. 4.12 B, Table 4.4). Eyes implanted with BSA coated beads showed no 
significant change in the N-T axis compared to non-treated contralateral eyes (Fig. 
4.12 C, Table 4.4). In comparison to the difference in D-V axial length, a decrease in 
N-T axial length in rhBMP4 treated eyes was less frequently observed as not all 
rhBMP4 treated eyes exhibited a smaller N-T axis, whereas all eyes examined 
showed a smaller D-V axial length.
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Fig. 4.12 N-T axial length of in non-treated and rhBM P4 treated eyes in
11.5 dpc cultured embryos
P-values were calculated with the paired t-test with the raw data set for pairs of eyes. 
Scatter plots illustrate the percentage difference in N-T axial length between two 
eyes in each embryo, calculated as described in Section 4.3.5. (A) Difference 
between left and right eyes in cultured but not treated embryos, representing the 
natural variation between eyes. (B) Difference between rhBMP4 treated and non- 
treated control eyes in cultured embryos. In majority of embryos, the rhBMP4 eye 
was smaller than the contralateral non-treated eye, with the overall difference being 
significant between the two groups. (C) Difference between BSA treated and non- 
treated control eyes in cultured embryos. BSA treated eyes showed less variation 
than rhBMPP4 treated eyes.
Abbreviations: BSA, bovine serum albumin
205
903
O" 03
18-
% difference in N-T axial length
8 S o o o o S
■ ■____ I____ I -----1------J-------1—
♦
♦
ZJ♦ OZJ
_l_
3'
♦  M -0
♦
o> -  ♦ °  (D
O C L
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
8a
% difference in N-T axial length 03
8 8 o o o o
I I I ■ I I i
♦
♦
♦
♦
♦ ♦
♦
♦♦ 3
♦ II
♦ ro __
♦ w 8  -o
-o 3-II 03o  P-
% difference in N-T axial length <->
8 8 0 0 0 0 0
w “ ♦ 03
TJ C/3
J  * - * I  p  |CT 00 O
J  ♦ 5  2.o ^
Comparisons were also made between eyes implanted with a Noggin coated bead in 
the lens vesicle in 11.5 dpc post-culture embryos, in which gene expression changes 
were not observed (see Table 4.3), and their contralateral non-treated eyes. No 
significant differences were found between Noggin treated eyes and their 
contralateral non-treated counterparts in either the D-V or the N-T axes, again 
supporting the conclusion that changes in axial length were associated with changes 
in gene expression and not bead implantation alone (Fig. 4.13, Table 4.4).
P-Di axial length measurements were performed on serial vibratome sections through 
the entire optic cup in four embryos implanted with an rhBMP4 bead in one eye and 
a BSA bead in the contralateral eye as described in Chapter 2.11.5. When all values 
were plotted against the position of the section per eye, the plots revealed the relative 
shape of the eye along the P-Di axis, which in agreement with previous observations 
on sections, appeared altered in rhBMP4 treated eyes in comparison to BSA treated 
contralateral eyes (Fig. 4.14 A,B). In particular, this graph demonstrated that the 
ventral region of the optic cup was especially affected, appearing shorter, hence 
altering the shape of the optic cup. This was also frequently observed in embryos 
where one eye was treated with rhBMP4 and the other kept as a non-treated control 
(Fig. 4.14 C,D).
Together, these data show that addition of exogenous rhBMP4 to the newly formed 
optic cup reduces eye size (neural retinal volume) and the eye’s D-V and N-T axial 
lengths while altering the P-Di axial length in the ventral region of the eye, thus 
inducing a change in size and shape of the optic cup.
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Fig. 4.13 D-V and N-T axial length in Noggin treated and control eyes in
11.5 dpc cultured embryos
Scatter plots represent the percentage difference in axial length calculated as 
described in Section 4.3.5. P-values were calculated with the paired t-test with the 
raw data set for pairs of eyes. (A) Difference in D-V axial length in Noggin treated 
and contralateral non-treated eyes in embryos (n= 6) represented by yellow squares.
(B) Yellow diagonal squares show the percentage difference in N-T axial length 
between Noggin treated and contralateral non-treated eyes.
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Fig. 4.14 Representation of P-Di axial measurements in rhBMP4 treated 
and BSA treated eyes in 11.5 dpc post-culture embryos
(A) Schematic drawing of a coronal section through the eye with orientations as 
indicated. Dotted lines indicate levels of serial transverse sections corresponding to 
the x-axis on the graph in B. The P-Di axis (arrow in A) was measured on each 
transverse vibratome section (50 /im) through the eye. (B) Graph shows mean P-Di 
axial length ± 1 s.d. for four eyes starting from the dorsal most section (x= 1) to the 
ventral most section obtained from each eye. Note that the number of sections 
obtained from rhBMP4 treated eyes is less than BSA treated contralateral eyes in all 
embryos (5 versus 6). (C-D) Coronal frozen sections (12 /rm) stained with propidium 
iodide showing the non-treated and the contralateral rhBMP4 treated eyes in a 
cultured embryo. The ventral region (marked by dotted lines) of the rhBMP4 treated 
optic cup (D) is shorter and has an altered shape compared to the contralateral non 
treated eye (C). Scale bars: 0.1 mm
Abbreviations: P-Di, proximo-distal
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4.2 .6  Cell division in rhBM P4 trea ted  e y e s
To investigate the mechanisms that may underlie the observed alteration in eye size 
and shape in rhBMP4 treated optic cups, cell division and apoptotic cell death were 
examined in rhBMP4 treated and contralateral non-treated neural retinae in 11.5 dpc 
cultured embryos. Specifically, this study investigated the possibility that 
regionalised abnormal cell death or cell division may be associated with the observed 
alterations in gene expression. A role in regional control of cell proliferation in the 
developing mouse heart was recently discovered for Tbx20 and Tbx2 (Cai et al. 
2005).
Cell division was detected by phospho-SerlO-histone H3 (pH3) labelling of mitotic 
cells on frozen sections as described in Chapter 2.8.1 (Fig. 4.15 A,B). When 
comparing cell division between different treatment groups, it is important to also 
take into account a measure that correlates with the size of the area in which mitotic 
cells were counted. For this purpose, the number of pH3 positive cells and the total 
number of cells in the retina were counted and retinal surface area measured in 3-4 
propidium iodide labelled midline sections per eye in four embryos and mitotic 
indices were calculated (Table 4.5).
Table. 4.5: Total cell number and mitotic indices in rtiBMP4 treated and contralateral non-treated
eyes in 11.5 dpc post-culture embryos
Embryo 
post(pre) ss
n. sections Treatment
per eye rhBMP4 Control
n.pH3
cells
pH3 
cells/ 
total 
cells (%)
pH3
cells/
mm2
n.pH3
cells
pH3 
cells/ 
total 
cells (%)
pH3
cells/
mm2
1. 48(40) ss 4 70 4.6% 556 118 7.2% 879
2. 52(42) ss 3 36 2.0% 294 74 4.5% 598
3. 50(42) ss 4 37 2.1% 268 45 2.6% 315
4. 48(42) ss 4 34 1.5% 227 42 1.8% 295
ss, somite stage. The somite stage of each embryo, pre-culture is given in brackets, and post­
culture outside of the brackets.
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All data analysed in this section were Ln transformed to acquire normal distribution 
and normality was checked as described in Chapters 2.12.1-2. First the difference in 
the number of pH3 positive cells between rhBMP4 treated and contralateral non- 
treated eyes were analysed with a Two-Way ANOVA test, which allows the 
comparison of the paired data within groups (rhBMP4 treated and non-treated 
contralateral), and also compares the data between embryos and therefore takes into 
account that data is collected from different embryos, as there was variability in the 
number of pH3 positive cells between embryos (Fig. 4.15 C; Table 4.5 and 4.6; n= 
30 sections in 4 embryos, P= 0.003). The ANOVA table suggested that there is a 
significant difference between the treatment groups (P= 0.003) and also highlighted 
the variability between embryos (Table 4.6; P= 0.004). The between embryo 
variability was also evident in the mitotic indices (Table 4.5) and could be due to a 
number of potential differences between embryos including differential uptake and 
release of rhBMP4 protein by implanted beads and differences in somite stages and 
litters.
In each embryo the number of pH3 cells per total retinal cells or per mm2 in the 
rhBMP4 treated eye was lower than in the contralateral non-treated eye (Table 4.5; 
Fig. 4.15 D) suggesting that there is less cell division in rhBMP4 treated eyes. The 
total number of cells in each section, or the retinal surface area, was incorporated as a 
co-variate into the Two-Way ANOVA which analysed the per section data and 
distinguished between embryos, and the mitotic indices were hence analysed with an 
ANCOVA to test for the effect of the area counted on the number of pH3 labelled 
cells. The ANCOVA Table 4.7 suggests that the total number of cells per section had 
no significant effect on the number of observed mitotic cells (P= 0.966). When the 
effect of total cell number was adjusted for with the ANCOVA test, the effect of 
rhBMP4 treatment was still significant (P= 0.005; Table 4.7). The same result was 
obtained with Ln surface area as a covariate (P= 0.005; data not shown). These 
analyses show that cell division was reduced in rhBMP4 treated eyes compared to 
non-treated contralateral eyes. Analysis of the number of pH3 labelled cells was also 
undertaken in a larger data set consisting of mitotic cell counts from 112 sections in 
five embryos, and further supported this conclusion (Fig. 4.16; Tables 4.8 and 4.9; 
Two-Way ANOVA P<0.001). In this analysis, all intact sections obtained from each 
eye were included and as such the number of sections counted per eye varied
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Fig. 4.15 Cell division in rhBMP4 treated and control eyes 
(A) Frozen section through the coronal plane of a non-treated control eye in a 
cultured embryo, showing mitotic cells at the ventricular edge of the neural retina by 
pH3 immuno-labelling (green) and counterstained with propidium iodide (red). (B) 
Approximately equivalent section of an rhBMP4 treated eye, contralateral to the eye 
in A counterstained with propidium iodide (red). pH3 labelled cells (green) were 
detected on the ventricular edge of the neural retina in sparser numbers. (C) Scatter 
plot of Ln transformed number of pH3 labelled cells per section per eye as indicated, 
in four embryos. P-value is for the between treatment groups comparison and was 
calculated by the Two-Way ANOVA test. (D) Scatter plot of Ln transformed mitotic 
indices per section per eye. P-value calculated by ANCOVA, with the number of 
cells per section incorporated as a covariate and the number of pH3 cells as the main 
variable.
Abbreviations: D, dorsal; L, lens; NR, neural retina; V, ventral
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Fig. 4.16 Cell division in rhBMP4 treated and control eyes (larger data set)
Scatter plot of Ln transformed number of pH3 labelled cells per section in a total of 
112 sections in five embryos. rhBMP4 eyes contain significantly smaller number of 
pH3 labelled cells in comparison to contralateral non-treated control eyes. P-value by 
Two-Way ANOVA, P<0.001
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Table 4.6: Two-way ANOVA table for the comparison of pH3 labelled cells In four 11.5 dpc post­
culture embryos
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 6.660(a) 15 .444 5.053 .002
Intercept 200.293 1 200.293 2279.534 .000
treatment 1.082 1 1.082 12.311 .003
Sections 5.578 14 .398 4.534 .004
Error 1.230 14 .088
Total 208.183 30
Corrected Total 7.890 29
a R Squared = .844 (Adjusted R Squared = .677)
Table 4.7 ANCOVA table for the comparison of pH3 labelled cells with n.Total cell number as a
covariate in four 11.5 dpc post-culture embryos
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 6.660(a) 16 .416 4.399 .005
Intercept .006 1 .006 .063 .806
treatment 1.067 1 1.067 11.281 .005
Sections 5.183 14 .370 3.913 .009
Ln (total cell number) .00018 1 .00018 .002 .966
Error 1.230 13 .095
Total 208.183 30
Corrected Total 7.890 29
a R Squared = .844 (Adjusted R Squared = .652)
Table 4.8: Total number of pH3 labelled cell counts per eye in rhBMP4 treated and contralateral
non-treated eyes in five 11.5 dpc post-culture embryos
Embryo post(pre) ss n. sections per eye n. pH3 cells
rhBMP4 Control
1. 48(40) ss 18 341 519
2. 52(42) ss 12 199 309
3. 50(42) ss 13 110 133
4. 48(42) ss 7 63 81
5. 48(39) ss 6 64 162
Total 56 777 1,204
ss, somite stage. The somite stage of each embryo, pre-culture is given in brackets, and 
post-culture outside of the brackets.
Table 4.9: Two-way ANOVA, (larger data set)
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 27.093(a) 56 .484 4.577 .000
Intercept 837.917 1 837.917 7926.877 .000
treatment 4.716 1 4.716 44.613 .0001
Sections 22.377 55 .407 3.849 .0001
Error 5.814 55 .106
Total 870.823 112
Corrected Total 32.907 111
a R Squared = .823 (Adjusted R Squared = .643)
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The ANCOVA test indicated a significant difference in cell division due to rhBMP4 
treatment of eyes, which was corroborated by analysis of pH3 labelled cells in a 
larger data set. These data were therefore further analysed to investigate whether the 
reduction in the number of mitotic cells was regional or global along the D-V axis of 
the neural retina. Sections were divided into dorsal and ventral domains with respect 
to the boundary of the optic stalk and the normal expression of Vax2 as illustrated in 
Fig. 4.17 A. pH3 labelled cells per mm2 were counted in each region. As division of 
the neural retina was based upon the morphological boundary of the optic stalk, only 
sections containing the optic stalk were included in this analysis. The total number of 
pH3 labelled cells, cells per mm , and the number of sections counted per eye for 
each region are shown in Table 4.10.
Table 4.10 Total number of pH3 labelled cell counts in sections indicated, divided in dorsal and 
ventral regions per rtiBMP4 treated and contralateral non-treated eyes in four 11.5 dpc post-culture 
embryos
Embryo n. Treatment
post(pre) ss sections
/ey e
rtiBMP4 Control
Dorsal Ventral Dorsal Ventral
pH3 pH3/mm* pH3 pH3/mm* pH3 pH3/mm* pH3 pH3/mm*
1. 48(40) ss 6 79 601 26 951 102 738 58 666
2. 52(42) ss 3 27 350 9 211 45 520 29 700
3. 50(42) ss 9 38 169 33 238 52 241 39 640
4. 48(42) ss 4 19 203 16 410 23 253 17 348
ss, somite stage. The somite stage of each embryo, pre-culture is given in brackets, and post-culture 
outside of the brackets.
The number of pH3 labelled cells in dorsal and ventral domains per section were 
compared separately between embryos by the Two-Way ANOVA test (Fig. 4.17 B-
C). The ANOVA tables produced for each region showed that the number of pH3 
labelled cells were significantly less in rhBMP4 treated eyes as compared to the non- 
treated contralateral eyes in both the dorsal and the ventral neural retina (Tables 4.11, 
4.12).
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Fig. 4.17 Investigation of regional changes in cell division along the D-V 
axis of the eye in rhBMP4 treated and control eyes
P-values for comparisons between the number of Ln transformed pH3 labelled cells 
in different treatment groups were calculated by the Two-Way ANOVA test. (A) 
Schematic illustration of the division of the neural retina into dorsal and ventral 
regions. The dorsal wall of the optic stalk was used as a morphological border. The 
region of the neural retina above this border was considered as dorsal whereas the 
region below this border was considered as ventral neural retina. (B) Scatter plot of 
Ln transformed number of pH3 labelled cells in the dorsal neural retina per section 
per eye in four cultured embryos. The number of pH3 labelled cells in rhBMP4 
treated eyes were significantly lower than in contralateral non-treated control eyes.
(C) Scatter plot of Ln transformed number of pH3 labelled cells in the ventral neural 
retina of same sections analysed for the dorsal comparison. The number of pH3 
labelled cells were also significantly lower in the ventral region of rhBMP4 treated 
eyes compared to contralateral non-treated eyes.
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Table: 4.11 Two-Way ANOVA table for the comparison of pH3 labelled cells between dorsal 
regions of rhBMP4 treated and non-treated contralateral eyes
Dependent Variable: Ln (pH3 labelled cells in dorsal retina)_______________________________
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 13.823(a) 22 .628 5.972 .000
Intercept 179.515 1 179.515 1706.238 .000
Treatment .939 1 .939 8.922 .007
Sections 12.884 21 .614 5.832 .00008
Error 2.209 21 .105
Total 195.547 44
Corrected Total 16.033 43
a R Squared = .862 (Adjusted R Squared = .718)
Table: 4.12 Two-Way ANOVA table for the comparison of pH3 labelled cells between ventral 
regions of rhBMP4 treated and non-treated contralateral eyes
Dependent Variable: Ln (pH3 labelled cells in ventral retina)
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 13.965(a) 22 .635 1.754 .102
Intercept 86.261 1 86.261 238.300 .000
Treatment 2.384 1 2.384 6.586 .018
Sections 11.528 21 .549 1.516 .174
Error 7.602 21 .362
Total 110.395 44
Corrected Total 21.567 43
a R Squared = .648 (Adjusted R Squared = .278)
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These analyses revealed that addition of an exogenous source of BMP4 protein, 
resulted in a decrease in cell division in the neural retina. This decrease was not 
regionally restricted but was induced globally along the D-V axis of the neural retina.
4.2.7 Investigation of apoptotic cell death in rhBMP4 treated eyes
As stated in the previous section, apoptosis was analysed in order to investigate 
factors that may underlie the changes in eye size and shape induced by rhBMP4 
treatment, and to investigate whether there are changes in the pattern of apoptosis in 
these eyes in relation to the changes in gene expression.
During the analysis of cell division, when sections of eyes were counter-stained with 
propidium iodide, small granular staining, characteristic of apoptotic nuclei were 
often observed. These granules were mainly seen in the central retina, in the area of 
the optic disc, in non-treated control eyes, but in rhBMP4 treated eyes, the 
predominant site of apoptosis appeared to be in the dorsal neural retina (Fig. 4.18 A-
D). To verify that these granules were apoptotic cells, the TUNEL assay which labels 
fragmented DNA by fluorescein tagged dUTP nick-end labelling was used (Chapter 
2.9). In non-treated control eyes of 11.5 dpc post-culture embryos, very little TUNEL 
labelling was detected in the dorsal optic cup, as previously noted with propidium 
iodide staining (Fig. 4.18 E). In rhBMP4 treated eyes however, increased apoptosis 
was detected in the dorsal neural retina (Fig. 4.18 F). A high dose of Bmp4 
signalling, provided by implantation o f beads soaked in a larger amount of rhBMP4 
protein than used in experiments described earlier (see Methods 2.6.1), resulted in a 
more dramatic increase in dorsal apoptosis in rhBMP4 treated eyes in comparison to 
embryos implanted with the low dose of rhBMP4 (Fig. 4.18 compare F and H). 
Although increased cell death was also observed in the central and ventral regions of 
the neural retina, as well as in the anterior region of the lens vesicle, the most 
dramatic change in cell death was regionally restricted to the dorsal eye, confirming 
that rhBMP4 treatment can induce a profound regionalised cell death response in the 
optic cup. Gene expression analysis in previous sections were carried out in embryos 
treated with the low dose, which triggered a milder apoptotic response.
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Fig. 4.18 Pattern of cell death in rhBMP4 treated and control eyes of 
cultured 11.5 dpc embryos
(A) Propidium iodide stained coronal section (frozen) of a control eye of a cultured 
embryo showing a few granules of intense staining (arrowheads), characteristic of 
apoptotic nuclei, in the central neural retina. (B) An equivalent section to A through 
the rhBMP4 treated contralateral eye of the same embryo showing one granule of 
intense propidium iodide staining in the region where the optic stalk appears in later 
sections of the eye, but lots of granular staining in the dorsal neural retina 
(arrowheads). (C,D) Higher magnifications of the dorsal neural retina of A and B 
respectively. Intense propidium iodide stained granules in the rhBMP4 treated eye 
are marked with arrowheads. (E) Coronal section of a control non-treated eye 
labelled with TUNEL (green). Very few apoptotic cells were detected in this 
particular section. (F) An equivalent section to E, through the coronal plane of the 
rhBMP4 treated contralateral eye of the same embryo. A large amount of TUNEL 
labelling was detected in the dorsal neural retina. (G,H) Control and contralateral 
rhBMP4 treated eye with the high dose of rhBMP4. Increased TUNEL positive 
nuclei detected in the dorsal neural retina of the rhBMP4 treated eye (H, arrow). 
Labelling was also detected in the ventral neural retina and in the lens vesicle. Scale 
bars: 0.1 mm.
Abbreviations: D, dorsal; L, lens; NR, neural retina; V, ventral.
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For quantification purposes, only embryos treated with the lower dose of rhBMP4 
were analysed. Because the pattern of cell death in the early optic cup is normally 
highly regionalised to separate clusters in the dorsal, and the central neural retina 
(see Chapter 1.2.4), and the elevated cell death in rhBMP4 treated eyes was 
regionalised to the dorsal-most neural retina (in D l), the neural retina was divided 
into dorsal-most, central, and ventral regions as indicated in Fig. 4.19 A and TUNEL 
labelled nuclei were counted in each region (Table 4.13). In comparison to the 
divisions used for analysis of mitosis, the dorsal domain used there was further 
subdivided into the dorsal-most (equivalent to D l) and central domains for the 
analysis of apoptosis here. The ventral domain still corresponds approximately to the 
region of normal Vax2 expression.
Table 4.13 Total number of apoptotic cells per eye, divided in dorsal, central and ventral regions,
in rtiBMP4 treated and contralateral non-treated eyes in five embryos
Embryo 
post(pre) ss
sections 
per eye rhBMP4 Control
D C V Total
D
C V Total
TUNEL positive cells
1. 52(42) ss 3 13 1 2 16 3 3 1 7
2. 48(40) ss 3 5 56 12 73 5 6 9 20
3. 53(44) ss 2 37 19 13 69 4 27 14 45
4. 51(41) ss 3 16 10 10 36 6 31 11 48
5. 52(40) ss 2 8 16 4 28 8 6 9 23
Total 13 79 102 41 222 26 73 44 143
TUNEL positive cells/mm*
1. 52(42) ss 3 289 21 67 377 94 45 26 165
2. 48(40) ss 3 190 1390 454 2034 181 196 344 721
3. 53(44) ss 2 2313 471 650 3434 222 725 591 1538
4. 51(41) ss 3 667 224 367 1258 354 1071 306 1731
5. 52(40) ss 2 527 510 182 1219 500 162 500 1162
Total 13 3986 2616 1720 8322 1351 2199 1767 5317
D, dorsal; C, central; V, ventral; ss, somite stage. The somite stage of each embryo, pre-culture 
is given in brackets, and post-culture outside of the brackets.
Table illustrates the total number of cells counted in 2-3 midline sections (as indicated) per eye.
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Fig. 4.19 Investigation of regional occurrence of apoptotic cell death along 
the D-V axis of the eye in rhBMP4 treated and control eyes
P-values for comparisons between the number of Ln transformed TUNEL labelled 
cells in different treatment groups were calculated by the Two-Way ANOVA test 
and with the ANCOVA test with the effect of surface area incorporated. (A) 
Schematic illustration of the criteria for division of the eye used in quantitative 
analysis. The dorsal region of the neural retina until the dorsal curvature was 
regarded as the dorsal region. The area below the dorsal curvature, but above the 
dorsal wall of the optic stalk was regarded as central neural retina. The area below 
the dorsal wall of the optic stalk was regarded as ventral neural retina. (B) Scatter 
plot of Ln transformed number of TUNEL labelled cells in the dorsal neural retina in 
2-3 sections per eye in five embryos. Overall, sections through rhBMP4 treated eyes 
contained more TUNEL labelled cells in comparison to non-treated control 
counterparts. (C) Scatter plot of Ln transformed number of TUNEL labelled cells in 
the ventral neural retina of same sections as counted in B. The number of TUNEL 
labelled cells did not differ significantly in the ventral neural retina of rhBMP4 and 
non-treated control eyes. (D) Scatter plot of Ln transformed number of TUNEL 
labelled cells in the central neural retina of sections used in B and C. The number of 
TUNEL labelled cells did not differ significantly in the central neural retina of 
rhBMP4 and non-treated control eyes. (E-G) Scatter plots of apoptotic indices 
calculated as number of TUNEL positive cells per surface area in the dorsal, ventral, 
and central neural retina respectively.
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Both Table 4.13 and the scatter plot illustrating Ln transformed number of apoptotic 
nuclei per section, reveal that the number of apoptotic cells in the dorsal-most region 
of rhBMP4 treated eyes were larger than apoptotic cells detected in the equivalent 
region of their contralateral non-treated eyes (Fig. 4.19 B). The Two-Way ANOVA 
test shown in Table 4.14 suggests that this difference is statistically significant (P=
0.036). Moreover, in agreement with the observation that apoptosis is only regionally 
increased upon rhBMP4 treatment, there were no significant differences in central or 
ventral regions of the neural retina between rhBMP4 treated and non-treated 
contralateral eyes (Fig. 4.19 C,D; ventral neural retina, P= 0.886; central neural 
retina, P= 0.382; Tables 4.15, 4.16).
In contrast to the variation detected between embryos in the analysis of mitotic cells, 
the Two-Way ANOVA tests performed on the data set of the apoptotic cells detected 
no significant between embryo differences (dorsal, P= 0.369; ventral, P= 0.421; 
central, P= 0.586). To correct for the effect of potential differences in the different 
regions analysed between rhBMP4 treated and non-treated contralateral eyes, the 
surface area of each region was measured per section and incorporated into the Two- 
Way ANOVA as a covariate. The ANCOVA results for these analyses are shown in 
Tables 4.17-4.19 and the programmed cell death indices per section are illustrated by 
scatter plots in Figs. 4.19 E-G. The adjustment of surface area did not alter the 
previous interpretation of results; the ANCOVA tests suggest that there is a 
significant difference in TUNEL positive cells in the dorsal neural retina of rhBMP4 
treated and non-treated contralateral eyes (Table 4.17; P= 0.044), but not in the 
ventral (Table 4.18; P= 0.838) or the central regions (Table 4.19; P= 0.302).
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Table: 4.14 Two-Way ANOVA table for the comparison of TUNEL labelled nuclei between dorsal 
regions of rhBMP4 treated and non-treated contralateral eyes
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 13.017(a) 13 1.001 1.552 .227
Intercept 25.667 1 25.667 39.794 .000
sections 9.423 12 .785 1.217 .369
treatment 3.594 1 3.594 5.572 .036
Error 7.740 12 .645
Total 46.424 26
Corrected Total 20.757 25
a R Squared = .627 (Adjusted R Squared = .223)
Table: 4.15 Two-Way ANOVA table for the comparison of TUNEL labelled nuclei between ventral
regions of rhBMP4 treated and non-treated contralateral eyes
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 12.229(a) 13 .941 1.040 .476
Intercept 16.687 1 16.687 18.443 .001
treatment .019 1 .019 .021 .886
sections 12.210 12 1.017 1.125 .421
Error 10.857 12 .905
Total 39.774 26
Corrected Total 23.087 25
a R Squared = .530 (Adjusted R Squared = .020)
Table: 4.16 Two-Way ANOVA table for the comparison of TUNEL labelled nuclei between central 
regions of rhBMP4 treated and non-treated contralateral eyes
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 15.725(a) 13 1.210 .876 .594
Intercept 45.150 1 45.150 32.681 .000
treatment 1.138 1 1.138 .824 .382
sections 14.587 12 1.216 .880 .586
Error 16.578 12 1.382
Total 77.454 26
Corrected Total 32.303 25
a R Squared = .487 (Adjusted R Squared = -.069)
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Table 4.17 ANCOVA table for the comparison of TUNEL labelled nuclei between dorsal regions 
of rhBMP4 treated and non-treated contralateral eyes with Ln surface area as covariate
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 13.062(a) 14 .933 1.334 .320
Intercept .012 1 .012 .017 .897
treatment 3.637 1 3.637 5.199 .044
section 8.384 12 .699 .999 .504
Ln Surface Area .046 1 .046 .065 .803
Error 7.694 11 .699
Total 46.424 26
Corrected Total 20.757 25
a R Squared = .629 (Adjusted R Squared = .158)
Table 4.18 ANCOVA table for the comparison of TUNEL labelled nuclei between ventral regions 
of rhBMP4 treated and non-treated contralateral eyes with Ln surface area as covariate
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 12.664(a) 14 .905 .955 .541
Intercept .557 1 .557 .587 .460
treatment .042 1 .042 .044 .838
section 12.644 12 1.054 1.112 .434
Ln Surface Area .434 1 .434 .458 .512
Error 10.423 11 .948
Total 39.774 26
Corrected Total 23.087 25
a R Squared = .549 (Adjusted R Squared = -.026)
Table 4.19 ANCOVA table for the comparison of TUNEL labelled nuclei between central regions 
of rhBMP4 treated and non-treated contralateral eyes with Ln surface area as covariate
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 19.520(a) 14 1.394 1.270 .358
Intercept 2.805 1 2.805 2.555 .141
treatment 1.303 1 1.303 1.187 .302
section 16.218 12 1.352 1.231 .376
Ln Surface Area 2.291 1 2.291 2.087 .179
Error 10.977 10 1.098
Total 77.454 25
Corrected Total 30.497 24
a R Squared = .640 (Adjusted R Squared = .136)
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4.3 Discussion
4.3.1 Summary of findings
The following conclusions can be drawn from this study, which aimed to manipulate 
Bmp4 signalling during optic cup morphogenesis, using bead implantation as a 
means of protein delivery, in combination with whole mouse embryo culture.
1. All three T-box genes in the dorsal eye are regulated by Bmp4 signalling.
2. Increased Bmp4 signalling induced a differential pattern of ectopic expression of 
Tbx2, Tbx3, and Tbx5. Together with the loss of Vax2 in the ventral eye, the 
molecular composition along the D-V axis of the eye was shifted ventrally.
3. Decreased levels of Bmp signalling, by the addition of Noggin, shifted T-box gene 
expression dorsally.
4. Perturbation of Bmp4 signalling and T-box gene expression altered eye size and 
shape; a reduction in eye size was revealed by measurements of the D-V and N-T 
axial lengths as well as retinal volume in rhBMP4 treated eyes as compared to BSA 
treated or non-treated contralateral eyes. Measurements along the P-Di axis provided 
indications of a shape change in rhBMP4 treated eyes in the form of a reduction of 
the ventral neural retina.
4.3.2 T-box genes in the eye show differential responsiveness to 
Bmp4 signalling
In Chapter 3, it was shown that while Tbx5 was expressed in the same region of the 
neural retina as Bmp4, Tbx2 and Tbx3 expression domains were broader than that of 
Bmp4 in the optic cup. Data presented in this Chapter show that all three T-box genes 
are responsive to manipulations of Bmp signalling and in the same way that normal 
Tbx2 and Tbx3 expression domains are broader than Tbx5, the ectopic patterns of 
Tbx2 and Tbx3 induced by rhBMP4 were also broader than Tbx5. Although there
232
may be some variability in the amount of protein uptake and release from the beads, 
the results obtained were extremely consistent in that Tbx5 was induced in D2 and 
never in the ventral neural retina, Tbx3 was induced in the entire neural retina, while 
Tbx2 was induced in V3 and also in the lens vesicle.
The question arises as to how these genes are differentially regulated. Data presented 
here suggest that Bmp4, which is transcribed in D l, regulates gene expression 
outside of its expression domain. The way in which gene expression was altered 
upon manipulation of Bmp4 signalling is reminiscent of systems where the action of 
morphogen gradients have been proposed or demonstrated. The similarity lies in 
several genes being differentially induced or repressed at a distance from the site of 
expression of a secreted factor (Gurdon et al. 1995; Lecuit et al. 1996; Nellen et al. 
1996; Ericson et al. 1997; Briscoe et al. 2000). Interpretation of results obtained here 
according to such a model would predict that Bmp4 protein or signalling present in a 
dorsal-high, ventral-low gradient, with the highest levels of signalling in the dorsal 
neural retina induces unique domains of expression of the different T-box genes in a 
concentration dependent manner.
Considering the experimental approach used in this Chapter more closely, in 
experiments where an rhBMP4 bead was placed in the lens vesicle, a site at an 
equivalent distance from both the dorsal and the ventral neural retina, it is likely that 
Bmp4 levels were elevated equally across the D-V axis of the optic cup. Therefore, 
the dorsal neural retina with high endogenous Bmp4 protein levels would have an 
even higher concentration of Bmp4, while the ventral neural retina which may or 
may not be exposed to Bmp4 protein naturally, would have a low level of Bmp4 
signalling due to the exogenously provided rhBMP4. The lens which also does not 
express Bmp4 normally, would also be exposed to Bmp4 signalling due to the 
rhBMP4 bead. As described in Chapter 1.4.1, the Bmp4 signal transduction 
machinery are present in both the lens and the ventral neural retina (BmprI, Bmprll) 
in order to mediate the signal.
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Fig. 4.20 The envisaged Bmp4 signalling gradient before and after bead 
implantation
Bmp4 is expressed in the dorsal neural retina. As such, Bmp4 signalling is likely to 
be highest in this region (red circles). Implantation of the rhBMP4 bead is thought to 
provide equal amounts of protein to both dorsal and ventral regions, resulting in an 
enhancement of the putative endogenous Bmp4 signalling gradient, while 
implantation of a Noggin bead reduces it.
Abbreviations: D, dorsal; V, ventral
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As outlined in Chapter 1.4.3, the first criterion for a morphogen is that it must induce 
different responses at different concentrations. The results presented here provide 
indirect evidence in support of the existence of a dorsal-high, ventral-low 
concentration gradient of Bmp4 signalling along the D-V axis of the eye, across 
which distinct domains of Tbx2, Tbx3, and Tbx5 are expressed. In support of this 
idea, Tbx5 which is expressed at the highest concentration of the putative Bmp4 
signalling gradient was completely abolished when Bmp4 signalling was reduced 
with Noggin bead implantation, while the Tbx2 domain was only reduced to D l. In 
the reverse experiments, when rhBMP4 beads were placed in the lens vesicle, Tbx2 
was induced in the ventral neural retina and also adjacent to the bead in the lens 
vesicle, while Tbx5 was only expanded within the dorsal half of the neural retina. 
Moreover, Tbx3 was expanded in the ventral neural retina while Vax2 was abolished 
in what appears to be a ventral shift of transcription factor domains in adjustment to 
the new Bmp4 signalling gradient. The acquired pattern of expression of the genes 
examined in rhBMP4 eyes is consistent with the ventral regions acquiring the 
properties of more dorsal regions.
The second criterion for a morphogen is that it must act directly at a distance. Here, 
indirect evidence for endogenous Bmp4 signalling acting at a distance was provided 
by Noggin bead implantations which lead to repression of the endogenous Tbx2 
expression domain in the D2 region, when the bead was placed dorsal to the eye. 
Tbx2 expression was not abolished but reduced, suggesting that Noggin acts by 
reducing the endogenous Bmp4 levels in the dorsal eye, which results in the 
reduction of the Tbx2 domain. As Bmp4 and Tbx2 are not co-expressed in D2, this 
response has occurred at a distance. Moreover, there was a dorsal expansion of the 
optic stalk, which is normally located in the ventral region of the eye at 10.5-11.5 
dpc, in Noggin treated eyes. That Tbx5 and Tbx3 were ectopically induced, while 
Vax2 expression in the ventral eye was abolished at a distance away from rhBMP4 
beads implanted in the lens, further support that Bmp4 can induce a response at a 
distance in the developing eye. Whether Bmp4 acts directly or indirectly across a 
distance to induce these changes cannot be determined based on data presented here. 
The alternative possibility is that these changes are indirect and instead caused by a 
relay mechanism in which Bmp4 induces other genes in neighbouring cells and so 
forth. Examination of gene expression within a shorter period after bead implantation
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could help to determine the likelihood of a direct response in gene expression to 
rhBMP4 treatment; if a relay mechanism is involved, changes in gene expression 
would be expected to take longer to occur, due to the time needed for the expression 
and action of intermediaries to take place.
Other mechanisms that could account for the observed changes in the pattern of gene 
expression, would include changes in cell proliferation/cell death or cell migration. 
Two aspects of the data directly argue against gene expression domains being altered 
because of cell proliferation/cell death. Firstly, although cell division was decreased 
in rhBMP4 treated eyes, expression of the T-box genes were expanded, suggesting 
that these changes are due to induction of gene expression rather than proliferation of 
cells that already express the T-box genes. Secondly, in the domain where Vax2 was 
abolished, no differences were found in the level of cell death, suggesting that Vax2 
expression rather than Vax2 expressing cells was abolished. The possibility of cell 
migration also appears inconsistent with the data, as the loss of Vax2 expression was 
not accompanied by displacement of Vax2 expressing cells elsewhere, and rhBMP4 
treated eyes still possessed a ventral optic cup region indicated by the presence of the 
optic fissure. Conversely, there was no evidence of displaced Tbx5 expressing cells 
in Noggin treated eyes where Tbx5 was abolished.
In Drosophila, tethered proteins have been used to experimentally show whether a 
suspected morphogen acts over a distance (Zecca et al. 1996). This approach could 
potentially be used in the mouse embryo in future experiments. For example a 
transmembrane domain of a transmembrane protein could be attached to Bmp4 and 
this hybrid protein expressed in the lens vesicle under the regulation of a lens 
specific promoter, such as the a-crystallin promoter. If it failed to induce the ventral 
shift in gene expression, this could demonstrate whether exogenous Bmp4 diffuses 
and acts directly on neural retinal cells to cause gene expression changes.
Other mechanisms or additional factors, apart from interpretation of a Bmp4 
signalling gradient, may also contribute to the observed differential response in gene 
expression. It is for example possible that additional factors predispose certain 
regions of the optic cup to express a particular T-box gene in response to Bmp4. It is 
simplest to consider the lens alone when contemplating this idea. That Tbx2, but not
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Tbx3 or Tbx5, are induced in the lens vesicle suggest that Tbx2 requires the lowest 
level o f Bmp4 signalling to be switched on. However, Tbx3 which according to this 
model needs higher levels of Bmp4 than Tbx2, is induced in the ventral neural retina 
but not in the lens. It is unlikely that the lens, containing an rhBMP4 bead, would 
have lower levels o f Bmp4 than the ventral neural retina which is further away from 
the source, yet expresses ectopic Tbx3. Instead, it is likely that the lens is permissive 
to Tbx2 expression only, while the ventral most region o f the neural retina (V4) is 
more permissive to Tbx3 than to Tbx2 expression. This points towards the existence 
of differences in the regulatory elements o f the T-box genes, other than those that 
enable each gene to sense a Bmp4 signalling gradient. These could be the existence 
of binding sites for cofactors which together with phosphorylated Smad complexes 
may be needed to induce different T-box genes; the expression o f these cofactors 
would then provide a limiting step in the regulation o f each T-box gene in response 
to the Bmp4 signalling pathway. In support for the idea o f other factors also being 
involved, in the Drosophila wing, there is evidence that omb is induced by the 
combined actions o f Dpp and Wingless (Grimm and Pflugfelder 1996).
Regardless of other differences in the regulation o f the T-box genes, Bmp4 signalling 
is likely to play a significant role in their regulation in eye development. This finding 
in the mouse embryo is similar to findings in the Xenopus embryo, where all three T- 
box genes were induced in the ventral optic cup in response to Bmp4 RNA 
electroporations into the eye field. Although one difference was that all three were 
reported to show a similar expansion in the Xenopus study, which is likely to be due 
to the different experimental approach (Sasagawa et al. 2002). Moreover, the 
absence of Tbx5 expression recently reported in the optic vesicle of Bmp4 null mice 
demonstrates the absolute requirement o f Bmp4 for the induction of Tbx5 at least 
(Murali et al. 2005). Data presented here, suggest that this requirement is likely to be 
concentration dependent.
Ventroptin is a Bmp antagonist with high affinity for Bmp4 and no affinity for 
Bmp7, that is suitably expressed in a ventral and nasal high gradient in the chick 
neural retina, in order to counteract Bmp4 signalling and create a dorsal-high, 
ventral-low Bmp4 signalling gradient. It has also been isolated in the mouse, but its 
expression has not yet been reported (Sakuta et al. 2001). Misexpression of
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Ventroptin in the chick optic vesicle by electroporation, abolishes Bmp4 and Tbx5 
expression and induces a complete expansion of cVax expression into the dorsal eye. 
This study suggests that cVax is only expressed when Bmp signalling is antagonised. 
In further support of this idea, an expansion of Vax2 is observed in mice with only 
one functional allele of Bmprlb and no Bmprla in the eye (Murali et al. 2005). 
Ventroptin can be downregulated by Bmp4 as retroviral mediated Bmp4 infection of 
eyes show an absence of Ventroptin expression (Sakuta et al 2001). It is not clear 
which transcriptional regulators mediate this reciprocal repression o f transcription of 
Bmp4 and Ventroptin, though it should be noted that this type o f interaction between 
two genes that are not normally coexpressed by misexpression studies could be due 
to the forced expression of these genes, and may not happen naturally
rhBMP4 bead implantation in the extra-ocular mesenchyme at 10.5 dpc did not 
induce the same consistent results as observed when beads were placed in the lens 
vesicle at 11.5 dpc, even though Noggin bead implantations in the same region at
10.5 dpc did alter T-box gene expression. Conversely, Noggin bead implantation in 
the lens vesicle at 11.5 dpc failed to induce changes in gene expression. These 
differences could arise due to the dramatic morphogenetic movements that take place 
at least at 10.5 dpc. Alternatively, at 11.5-12.5 dpc, Bmp4 signalling may no longer 
be required for maintaining the already induced domains of T-box gene expression 
and as a result, inhibition of endogenous Bmp4 signalling by Noggin has no effect on 
T-box gene or Vax2 expression. In support of this idea, endogenous Bmp4 transcripts 
appear downregulated in the neural retina at 12 dpc (Liu et al. 2003).
4.3.3 Role of Bmp4 signalling in controlling growth and shape of the 
mouse optic cup
Bmp4 haploinsufficiency has been reported to cause microphthalmia and 
anophthalmia in mice (Dunn et al. 1997), but the mechanism responsible for these 
severe phenotypes has not been investigated. Here, it was shown that cell division 
was reduced in rhBMP4 treated eyes compared to non-treated contralateral eyes. 
Regardless o f the between embryo variability in the number of mitotic cells detected, 
the mitotic index was lower in the treated eye in all embryos examined. While the 
pattern of cell death detected in control eyes correlated well with previous reports of
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cell death in the early optic cup (see Chapter 1.2.4), in rhBMP treated eyes beads 
soaked in 100 pg/|il, induced elevated cell death in the dorsal eye in particular. 
However, as the number o f apoptotic nuclei detected was small, it is most likely that 
rhBMP4 treated eyes were smaller than control eyes because o f a reduction in cell 
proliferation rather than elevated cell death. Eyes treated with beads soaked in a 
larger quantity o f rhBMP4, which has been reported as a way o f increasing the 
concentration o f protein on beads (Lee et al. 2001b), resulted in a dramatic increase 
in cell death, which interestingly was still primarily localised to the dorsal neural 
retina. This result also confirms that Bmp4 signalling in the eye can induce a 
different response depending on concentration. Increased levels of cell death in the 
eye was also reported in Bmprla/Ib compound mutants which lack Bmp signalling 
(Murali et al. 2005), suggesting that an optimal level o f Bmp4 signalling is essential 
for proper eye development as both increased (shown here) and decreased levels of 
Bmp4 signalling cause increased cell death and decreased cell proliferation.
Analysis o f regional differences in cell division, with the neural retina divided into 
dorsal and ventral regions with respect to the normal Vax2 expression domain, 
revealed a reduction in cell division in both regions o f rhBMP4 treated eyes. All 
three T-box genes are ectopically expressed in the dorsal region o f rhBMP4 treated 
eyes, with Tbx5 being most restricted, while the ventral eye has ectopic Tbx3 
expression and no Vax2 expression. All three T-box genes have been implicated in 
the control o f cell proliferation [see Chapter 1.3.5 and (He et al. 2002; Liberatore et 
al. 2000)] and without further experiments that investigate each gene specifically in 
the developing eye, it is not possible to pinpoint which downstream pathway of 
Bmp4 signalling is responsible for the reduction in cell proliferation.
The regional occurrence o f cell death in the dorsal neural retina o f rhBMP4 treated 
eyes seems unlikely to be caused by any o f the T-box genes. Tbx2 and Tbx3 alone or 
in combination are excluded on the basis that elevated cell death was not detected in 
the ventral neural retina where they were ectopically induced. It is however still 
possible that elevated expression o f either or all three T-box genes in the dorsal 
neural retina triggered apoptosis. Tbx5 in particular has been shown to induce cell 
death when misexpressed in vitro, while Tbx3 has been identified as an anti-apoptotic 
gene, also in vitro (He et al. 2002; Carlson et al. 2002). Taken together with the
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observation that the ectopic cell death occurred in the dorsal neural retina in response 
to rhBMP4 carrying beads, where Tbx5 was induced, it is possible that the observed 
apoptosis in treated eyes is mediated by Tbx5. However, it is also possible that it is 
induced by Msx2, a known mediator of the apoptotic effect o f Bmp4 during neural 
crest cell depletion in the rhombomeres (Graham et al 1994). As demonstrated in 
Chapter 3 and previously by Monaghan and colleagues (Monaghan et al. 1991), 
Msx2 is appropriately expressed in the dorsal neural retina to mediate this effect. The 
regulatory relationship between Msx2 and the T-box genes has not been elucidated.
The involvement o f the Bmp pathway in the control o f cell proliferation and cell 
death during nervous system development has been demonstrated in numerous in 
vitro and in vivo studies (Anderson et al. 2002; McMahon et al. 1998; Bachiller et al. 
2000; Furuta et al. 1997; Mehler et al. 1997). These studies highlight that the 
response to Bmp signalling is context dependent and therefore cannot be generalised.
In the context o f eye development in species other than the mouse, investigators have 
found that retroviral misexpression o f Noggin in the chick eye at HH 9-10 (ie 
reduced Bmp4 signalling), causes microphthalmia (Adler and Belecky-Adams 2002). 
Application o f rhBMP4 [lpg/ml] coated heparin beads to the extra-ocular 
mesenchyme dorsal to newly formed optic cups in the chick embryo increases dorsal 
apoptosis, which in the chick eye is the site o f relatively high levels o f naturally 
occurring apoptosis (Trousse et al. 2001). Application o f Noggin coated beads 
[1 mg/ml] abolishes the naturally occurring cell death and also reduces cell 
proliferation within the dorsal eye, whereas BMP4 treatment [40 ng/ml] o f retinal 
cell cultures from HH 18 chick embryos induces cell proliferation (Trousse et al. 
2001). In contrast to results presented here, the chick study suggests that addition of 
rhBMP4 induces both cell proliferation and cell death, while exogenous application 
of Noggin reduces both cell proliferation and cell death in the developing chick eye. 
However, with regards to the effect o f rhBMP4 treatment, as Trousse et al. did not 
analyse cell proliferation and cell death under similar experimental conditions (cell 
death was analysed in bead implantation study in vivo whereas cell proliferation was 
analysed in dissociated cells), it is hard to make comparisons of the effects in the 
chick embryo and those reported in this Chapter for the mouse embryo.
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As well as a reduction in overall eye size, the shape o f the optic cup appeared altered 
in rhBMP4 treated eyes. Measurements o f the P-Di axial length revealed that this 
most likely was due to the ventral region o f the optic cup being shorter or showing 
reduced bending than in BSA treated eyes. The P-Di axial length in more dorsal 
aspects were very similar between treatment groups. As mentioned in the 
introduction (Chapter 1.1.3), even slight changes in the axial length o f the mature eye 
can result in refractive errors, therefore identification o f genes and developmental 
mechanisms that may cause variation in eye shape is of interest.
Comparative studies o f the expression o f secreted signalling molecules in closely 
related species that show variation in organ size and shape have revealed that slight 
differences in the number o f cells that express these factors underlie the observed 
phenotypic variation between species. O f direct relevance is a study that reported the 
level and temporal onset o f Bmp4 expression in the craniofacial region of several 
closely related songbird species, to correlate with variations in upper beak 
morphology (Abzhanov et al. 2004). Misexpression o f Bmp4 in the craniofacial 
mesenchyme o f chick embryos can phenocopy the broad and deep beak morphology 
of songbird species that show the highest level and extent o f Bmp4 expression in 
their beak primordia during development and also in the duck, which expresses 
higher levels of Bmp4 and has a broader and longer beak than the chick (Abzhanov et 
al. 2004; Wu et al. 2004). Further evidence for Bmp signalling being implicated in 
regulating organ shape comes from misexpression studies of Bmp2 and Bmp4 in the 
developing chick limb, resulting in alteratior£in cartilage size and shape (Duprez et 
al. 1996), and o f dpp in the Drosophila wing, which results in alterations in wing 
size and shape (Zecca et al. 1995).
The development o f the shape o f the mature eye occurs during the period o f optic 
vesicle invagination into an optic cup. By 13.5 dpc in the mouse, the shape of the eye 
globe is complete with the optic disc being positioned in the central region of the cup 
and the optic fissure closed. Data presented here suggest that Bmp4 signalling during 
this period is one of the signals that ensures the formation o f a correctly sized and 
shaped eye in the mouse embryo.
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The initial pattern o f Bmp4 expression in the eye differs between chick and mouse 
embryos, as Bmp4 is expressed dorsally from optic vesicle stage in the mouse, but in 
the chick embryo, the dorsal expression only comes on after optic vesicle 
invagination has occurred, prior to which, Bmp4 is strongly expressed in the surface 
ectoderm (see Chapter 1.4.1). Given the differences also found in the pattern of 
dorsally restricted cell death, the observation shown here that in the mouse eye 
higher levels o f rhBMP4 treatment could induce dorsally localised cell death, which 
resembles that in the chick embryo, it is tempting to speculate that the difference in 
dorsally occurring cell death between the two species may be due to differences in 
Bmp4 expression. This in turn may be one o f the reasons why the chick eye differs so 
dramatically in size and shape from the mouse eye. Notably, the chick optic cup is 
relatively larger and rounder than the mouse optic cup. The thickness o f the neural 
retina also differs between the two, with the chick neural retina being thinner.
As a result o f the study presented here, the next step was to examine which of the 
effects of Bmp4 on eye development, which include the control o f D-V patterning 
and eye size and shape, were mediated by the T-box genes. The two next chapters are 
concerned with analysing D-V patterning and growth o f the eye when Tbx2, which 
showed a dramatic response to rhBMP4, is manipulated. Moreover, the possibility 
that Tbx2 may act by controlling regional cell proliferation or cell death was 
explored.
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CHAPTER 5 Analysis of early eye development in mouse 
embryos with a mutation in the Tbx2gene
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5.1 Introduction
The objective o f this Chapter was to directly investigate the role of Tbx2 in eye 
development, in particular to investigate whether Tbx2 regulates D-V patterning 
genes and eye morphogenesis, using mice that carry a targeted mutation in the Tbx2 
gene. Several functions have been identified for Tbx2 both at organ and cellular 
levels (see Chapter 1.3.3, 1.3.5). However, its role in mammalian eye development 
remains uncharacterised.
The starting point for this study was the knowledge that Tbx2 is expressed from the 
optic vesicle stage and hence is likely to have an early role in eye development, such 
as coordination o f optic cup formation or neural retina versus RPE specification. Its 
asymmetrical expression in the dorsal optic cup prompted the thinking that it may 
regulate molecular D-V patterning in the eye and perhaps be involved in mechanisms 
such as cell proliferation, which numerous studies have shown Tbx2 to be involved 
in as discussed in Chapter 1.3.5. Apart from the expression pattern o f Tbx2 in the eye 
as a basis for the formulation o f these hypotheses, they are supported by the findings 
in Chapter 4, where rhBMP4 treatment o f eyes resulted in the expansion of Tbx2 
expression and alterations in eye size and shape. Here, the role o f Tbx2 in mediating 
the effect o f Bmp4 in regulating D-V patterning and growth o f the eye was 
investigated.
The Tbx2 mutant allele, named Tbx2tmIPa and here forth referred to as Tbx2, was 
generated in Professor V.E Papaioannou’s laboratory (Columbia University) and has 
been described (Harrelson et al 2004). Briefly, a Tbx2 genomic clone isolated from a 
129/SvJ phage genomic library was used to generate a targeting construct containing 
a PGK-neo cassette flanked by LoxP sites and a 5’ 2.9 Kb homologous arm and a 3’
6.6 Kb homologous arm from the Tbx2 genomic sequence on either side o f the two 
LoxP sites. Homologous recombination in an ES cell line resulted in a 2.2 Kb 
deletion o f the Tbx2 sequence including 207 bp o f exon 1 and all of exon 2. The 
PGK-neo cassette was Cre-excised and correctly targeted ES cells were injected into 
C57BL/6N Tac host blastocysts, which were implanted into the uterus o f pseudo­
pregnant females. Progeny showing germ line transmission were eventually
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maintained on a mixed Sv/C57/ICR background as it was shown that the genetic 
background did not affect the phenotype (Harrelson et al. 2004).
In the time available for undertaking an analysis o f the Tbx2'f' eye phenotype, it was 
not possible to re-derive the Tbx2 mutation on a single genetic background devoid of 
the non-pigmented ICR strain. The RPE is the source o f Dopa production which is a 
precursor o f melanin. The lack o f synthesis o f melanin or reduced levels of melanin 
is thought to underlie the albino eye abnormalities including poorly developed 
central retinae, reduced ganglion cell density, crossing o f some ipsilateral axonal 
projections, and rod photoreceptor deficit (Jeffery 1997). Therefore the use of albino 
strains in eye research is not ideal. However, this Chapter aimed to study early 
aspects of eye development, so the great majority o f the analysis was performed at
10.5 dpc, when pigmentation o f the RPE has not yet initiated. All analysis beyond
10.5 dpc was performed on pigmented embryos. Therefore, it is unlikely that the 
possible future lack o f pigmentation in some embryos would have contributed to the 
defects identified.
The initial analysis o f the heart phenotype o f the Tbx2'/~ mice did not reveal a gene 
dosage effect as heterozygous embryos are developmentally normal (Harrelson et al. 
2004). Although heterozygotes are viable and fertile, homozygous embryos die 
prenatally. The first abnormalities manifest at 9.5 dpc in the developing heart in a 
subset of mutants, specifically in the atrioventricular canal (AVC), where the 
endocardial cushions, which normally form by 10.5 dpc and contribute to the 
septation o f the atrial and ventricular chambers are small or absent. This defect 
compromises the normal conduction o f the heart, which the authors propose is the 
cause of death in these embryos. The heart phenotype is expressed in only 26-35% of 
mutants at 9.5-10.5 dpc. At 10.5 dpc, a few o f the mutant embryos die and by 11.5 
dpc, roughly 50% o f the mutant embryos are dead. Occasionally homozygous 
embryos are recovered live at 12.5 dpc but never beyond 14.5 dpc (Harrelson et al. 
2004). Apart from the heart, other tissues in which Tbx2 is expressed were not 
examined in the initial study o f Tbx2~f~ mice. In this chapter I analyse the eye 
phenotype in Tbx2'f' embryos at early stages o f eye development.
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In agreement with the hypothesised role for Tbx2 in the regulation of eye growth, I 
present data which show an abnormally small eye size in mutants. Several 
mechanisms which could contribute to the small eye phenotype were therefore 
investigated.
Firstly, molecular analyses were performed. These included investigating the role of 
Tbx2 in controlling D-V patterning genes in the eye, which if abnormal could 
possibly lead to a small eye size as well as affecting other aspects of eye 
development. Asymmetrically expressed candidates included genes examined in 
Chapter 3 and genes with a previously known role in eye size regulation: the gap 
junction protein Cx43 and the homeobox gene Msx2. Downregulation of Cx43 in the 
chick embryo and gain o f function o f Msx2 in the mouse and Drosophila embryos 
respectively cause a small eye size (Becker and Mobbs 1999; Wu et al 2003; Mozer 
2001). Heterozygous mutations in humans, which are believed to cause loss of 
function or a dominant negative form of Cx43 result in oculo-dento-digital dysplasia, 
which is an autosomal dominant disorder characterised by defects affecting several 
organs including the limbs (syndactyly), craniofacial skeletal development, and the 
eye. The eye defects include microphthalmia, cataract, and abnormalities o f the iris 
(Paznekas et al. 2003; Kjaer et al. 2004; Vitiello et al. 2005). Furthermore, Tbx2 
expression was examined in a mouse model for microphthalmia, Chxl0orJ/orJ. These 
mice are homozygous for a natural mutation in the ChxlO transcription factor 
encoding gene, and are microphthalmic due to reduced proliferation of retinal 
progenitors and a progressive transdifferentiation of the neural retina into RPE 
(Burmeister et al. 1996; Rowan et al. 2004; Horsford et al. 2004). This experiment 
was performed to establish whether ChxlO is upstream of Tbx2 in a pathway that 
regulates eye size. Both genes are detected in the distal layer of the optic vesicle 
from 9.5 dpc (Liu et al. 1994; Holt 2003).
Secondly, cellular mechanisms that could limit the growth o f the neural retina were 
investigated including altered retinal cell proliferation, cell death, RPE specification, 
and premature differentiation of retinal progenitors. To examine whether initiation of 
differentiation occurs prematurely in Tbx2'/' embryos, hence contributing to the small 
eye phenotype, the RMO270 and VC 1.1 antibodies were used to label early 
differentiating neurons in 12.5 dpc mutant and wild-type embryos. RMO270 is an
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intermediate neurofilament marker that labels RGCs and their processes, while 
VC 1.1, as well as labelling fully differentiated amacrine cells, labels progenitors that 
later mainly differentiate into horizontal and amacrine cell fates (see Methods 
2.8.1.1). The temporal spread o f differentiation from the central to peripheral region 
of the developing eye (Drager 1985) allowed the comparison of timing of 
differentiation between mutant and wild-type eyes to be conducted at 12.5 dpc, when 
the central but not the peripheral neural retina has normally initiated the 
differentiation process.
Finally, since abnormalities outside o f the Tbx2 expressing region of the optic cup 
were identified, the expression o f Fgfl5 as a secreted factor that may convey some of 
the non-cell autonomous abnormalities was examined. In Chapter 3 it was 
established that Fgfl5 is not upstream o f Tbx2.
5.2 Results
For examination o f early eye development, embryos were dissected between 9.5-12.5 
dpc, with the majority o f the analysis focused at 10.5 dpc. Forty four pregnant 
females from heterozygous crosses yielded a total o f 351 embryos. Sixty nine live 
embryos were homozygous for the mutated Tbx2 allele and used in analyses here. 
Dying or dead embryos, which displayed pericardiac sac oedema and no heart beat or 
circulation at the time of dissection were discarded and not included in the analysis. 
Fig. 5.1 shows representative examples o f the results o f the genotyping PCR 
reactions.
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Fig. 5.1 Agarose gel electrophoresis of PCR products generated from 
genotyping reactions of Tbx2'/m and wild-type mice
(A) The Tbx2 wild-type coding region, depicting the seven exons of Tbx2 (top), and 
the Tbx2 mutant allele, showing the complete deletion of exon two (bottom). The 
primer sites used for genotyping are indicated below each allele. Primer 1 is specific 
for the wild-type allele, while primer 3 is specific for the mutant allele. (B) Both gels 
show representative 2% TAE agarose gels of genotyping PCR products. Gels are 
loaded with I fig of the 2-Log DNA Ladder and 10/xl (50% of the total reaction 
volume) of PCR reactions set up with DNA of previously known genotypes as 
controls and yolk sac DNA from various dissected embryos of unknown genotypes. 
The 180 bp product was detected in the wild-type (+/+) and mutant (+/-) controls 
only and indicates the existence of the wild-type allele. The 80 bp product was 
detected in the +/- and -/- controls only and indicates the existence of the mutant 
allele. In reactions where dFLO was substituted for the DNA template, only dNTPs 
and primer dimers were detected (red arrowhead). Genotypes are indicated below 
each lane. Figure in A adapted from Harrelson et al. 2004.
Abbreviations: bp, base pairs; dH^O, distilled H2O
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product size
5.2.1 Histological analysis of the developing eye in Tbx2A embryos
Eye morphology was first examined in whole lateral views o f eyes of homozygous 
and heterozygous embryos, which were compared to stage matched wild-type 
embryos. Heterozygous embryos, at all stages examined, possessed normal eye 
morphology, in agreement with the previously reported normal heart morphology 
and development in embryos with only one functional allele o f Tbx2.
Prior to optic vesicle invagination, the morphology o f the optic vesicle was 
indistinguishable between homozygotes and wild-type embryos (Fig. 5.2 A,B). The 
process o f invagination was found to initiate at around ss 28-30 (10.5 dpc) in wild- 
types on the genetic background o f the Tbx2'f~ mice. The same was observed in 
mutant littermates. However, occasionally some mutant embryos showed a delay in 
the invagination process compared to somite matched wild-type embryos at early
10.5 dpc. Desite this delay, the optic cup always formed in mutants examined at later 
stages o f 10.5 dpc and beyond (Fig. 5.2 C-H). Although the optic cup formed in late
10.5 dpc embryos, the delay in morphogenesis was also detected in some embryos at
11.5 dpc, with the ventral neural retina lagging in the invagination process. This 
together with a larger than normal subretinal space, which was often observed in 
dorsal and or naso-ventral regions o f mutant optic cups (demonstrated in later figures 
and Fig. 5.2 F) resulted in an increased exposure o f the optic stalk, which would 
normally be hidden behind the ventral neural retina in whole lateral views and 
manifested in a thicker than normal ventral neural retina in some mutants (Fig. 5.2 
E,F). At 11.5 dpc, pigmentation o f the RPE was also delayed in some mutants (Fig. 
5.2 E,F). Other morphological abnormalities apparent after optic cup invagination 
included smaller eye size (Fig. 5.2 C-H; quantified in Section 5.2.2) and abnormally 
dense distribution o f endothelial cells, which form the hyaloid vasculature, in the 
optic fissure region (analysed in more detail in Section 5.2.4.5). These abnormalities 
were never observed in wild-type littermates.
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Fig. 5.2 W hole m ount views o f Tbx2'1' and  wild type em bryos a t 9.5-12.5 
dpc
Images show lateral views of the head of embryos. (A) Wild-type (+/+) embryo at
9.5 dpc, showing the optic vesicle (arrows). (B) Mutant (-/-) littermate of embryo 
depicted in A, showing similar optic vesicle morphology as in A (arrows). Optic 
vesicles are highlighted in dashed circles. (C) Wild-type embryo at 11.5 dpc showing 
an optic cup. (D) Mutant littermate of embryo in C also possessing an optic cup. (E) 
Higher magnification of the optic cup in C showing initiation of pigmentation in the 
dorsal half of the eye and the presence of the optic fissure in the ventral optic cup. 
(F) Higher magnification of the optic cup in D showing pigmentation in the dorsal 
optic cup. The ventral region appears thicker than dorsal and a large naso-ventral 
subretinal space (arrow) is apparent, which exposes the optic stalk that normally 
would be hidden in a whole mount view of a wild-type eye. Note the smaller lens 
compared to E. (G) Wild-type embryo at 12.5 dpc. (H) Mutant littermate of embryo 
in G. Scale bars: 0.5 mm.
Abbreviations: D, dorsal; dpc, days post coitus; V, ventral
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Examination o f H&E stained wax sections o f homozygous and wild-type eyes 
confirmed that optic vesicle invagination was underway at 10.5 dpc in mutants and 
that the neural retina had started to thicken (Fig. 5.3 A-C).
At 11.5 dpc, the optic cup in mutant embryos possessed the same gross 
morphological features as those o f wild-type littermates, including a fully closed lens 
vesicle, a thick neural retina and initiated pigmentation o f the RPE, indicating that 
the an optic cup forms in the absence o f Tbx2. Figs. 5.3 D-E depict sections through 
the ventral region o f wild-type and mutant optic cups respectively and show that the 
ventral neural retina does not vary so much in thickness as it does in length along the 
P-Di axis o f the eye between the two genotypes. The hyaloid vasculature, which is 
normally first seen at this stage o f development within the optic cup, was observed in 
the ventral region o f the vitreous chamber (Fig. 5.3 D,E). However, it appeared 
unusually dense in the optic disc region in mutants compared to wild-type 
littermates, in agreement with observations made earlier in the optic fissure region of
10.5 dpc whole embryos.
At 12.5 dpc, eye size was small and the P-Di axial length considerably shorter in 
mutant eyes in comparison to wild-type littermates (Fig. 5.3 F,G). Moreover, the eye 
lid grooves, which can normally be distinguished at this stage in wild-types (Fig. 5.3 
I, arrows) had not formed in mutants (Fig. 5.3. J, arrows). This phenotype could 
either be directly linked to the shorter P-Di axial length o f the eye in mutants, or arise 
independently. Primary lens fibre elongation o f posterior lens cells was advanced in 
wild-types, but very primitive in mutant eyes (Fig. 5.3 F,G). The size o f the lens was 
also abnormally small in mutants (Fig. 5.3 F,G). In wild-type eyes, the nerve fibre 
layer was evident in the central region o f the neural retina, extending through the 
optic disc (Fig. 5.3 F). In mutant littermates a nerve fibre layer could not be easily 
distinguished and there were no indications o f nerve fibres extending through the 
optic disc (Fig. 5.3 G).
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Fig. 5.3 H & E stained sections o f eyes of Tbx2',m and  wild-type em bryos a t 
10.5-12.5 dpc
All images show paraffin midline sections of 7 /xm thickness cut in the transverse 
orientation and stained with H&E. (A) Initiation of optic vesicle invagination at ss 24 
in a wild-type embryo (+/+), evident by the presence of a lens placode (LP) and the 
thickening and invagination of the distal layer of the neuroepithelium (NE). (B,C) 
Two examples of histology of the developing eye in a Tbx2 mutant embryo (-/-) at ss 
26, showing initiation of invagination and thickening of the neuroepithelium. (D) 
Optic cup at 11.5 dpc in a wild-type embryo, revealing a fully formed lens vesicle 
(L) and the hyaloid vasculature extending into the vitreal chamber through the optic 
disc (arrows). (E) The optic cup in a mutant embryo at 11.5 dpc, with all expected 
structures present including the lens, but with the shape of the optic cup being 
stunted along the P-Di axis (dotted line) and the hyaloid vasculature being dense in 
the optic disc region (arrow). (F) Optic cup of a 12.5 dpc wild-type embryo. The 
dotted line along the P-Di axis highlights the protrusion of the cup distally (see also 
I). Arrowhead points to elongating posterior lens cells. Presence of a nerve fibre 
layer (NFL) indicates differentiation in the neural retina. The hyaloid vasculature is 
seen in the entire vitreal chamber. (G) An example of an abnormal optic cup in a
12.5 dpc mutant embryo. The growth along the P-Di axis is highlighted by the dotted 
line (see also J). The abnormal posterior lens cells in mutant are indicated by 
arrowhead and the extent of the spread of the hyaloid vasculature is shown by the 
arrows. The nerve fibre layer was absent. (H) An example of the histology of an eye 
of a 12.5 dpc mutant embryo with a mild phenotype. The reduced growth of the eye 
along the P-Di axis is highlighted by the dotted line (see also K). The nerve fibre 
layer (arrow) and the hyaloid vasculature appeared normal. (I-K) Show F-H at a 
lower magnification. The difference in the P-Di axial length between eyes is 
highlighted by the black stretch of the dotted lines. Protrusion of eyes are shown by 
perpendicular solid lines which were drawn in relation to the protrusion of the wild- 
type eye. Eye lid grooves are indicated by arrows.
Abbreviations: dpc, days post coitus; Di, distal; L, lens; LP, lens placode; N, nasal; 
NE, neuroepithelium; NFL, nerve fibre layer; NR, neural retina; P, proximal; T, 
temporal; Scale bars: 0.1 mm.
255
12.5 dpc Di
T—)— N
1 2 .5  d p c10.5 dpc
The occurrence o f these phenotypes was variable in mutant embryos. At 12.5 dpc, 
the above described phenotypes were observed in 8/12 examined eyes. 4/12 eyes 
manifested a mild phenotype and appeared normal apart from a slight decrease in the 
P-Di axial length resulting in less protrusion o f the eye compared to wild-type eyes 
o f littermates (Fig. 5.3 F,H,I,K; compare solid lines). Protrusion refers to the extent 
to which eyes ju t out externally beyond other facial tissue. Mutant eyes with the 
severe phenotype protruded much less than wild-type counterparts (Fig. 5.3 I,J).
Bearing in mind the variable expressivity o f phenotype, examination of whole 
embryos and H&E stained sections o f eyes through the period o f optic vesicle 
invagination and early optic cup development revealed that although Tbx2'A optic 
cups possessed all structural features expected at all stages examined, they were 
smaller in size than wild-type optic cups. As well as a size difference, the shape of 
the optic cup was abnormal with a shorter P-Di axial length, which made mutant 
optic cups protrude less than wild-type optic cups in littermates (Fig. 5.3 D,F,I versus 
E,G,J). Furthermore, the hyaloid vasculature was abnormally dense in the ventral 
aspect of the optic cup. This phenotype was most profound in 10.5-11.5 dpc 
embryos. At 12.5 dpc, the nerve fibre layer was poorly developed and there were no 
fibres extending beyond the optic disc in mutants. The lens vesicle was smaller in 
mutants and appeared less differentiated, while RPE differentiation was normal at
12.5 dc, although delayed in some embryos at 11.5 dpc.
These data indicate that targeted disruption o f Tbx2 affects normal ocular 
development. However, because o f the embryonic lethal nature o f the Tbx2 mutation, 
it was important to establish whether these observations were associated with a 
general developmental delay in mutant embryos.
5.2.2 Eye size
Soon after the initiation o f optic vesicle invagination (ss 28-30), mutant retinae were 
smaller in size than those o f somite matched wild-type littermates. To quantify the 
eye size phenotype and to address whether it was associated with a general 
developmental delay in mutants, the difference in retinal volume, estimated from 
measurements o f retinal area on vibratome sections as described in Chapter 2.11.1,
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was compared to the difference in head length between mutant and wild-type 
embryos at ss 33-35 (10.5 dpc). Head length was measured as an indicator of general 
growth retardation. Although like crown-rump length, head length does not show an 
exact linear trend with embryonic age, it is commonly used as a measure o f growth 
during embryogenesis and does show an increase with embryonic age (Brown 1990).
Head length measurements did not differ significantly between mutant and wild-type 
embryos (P= 0.352 by independent samples t-test, unequal variance; Fig. 5.4 A). 
However, measurements o f retinal volume showed that mutant retinae had a 
significantly smaller volume than wild-type retinae (P= 0.007 by independent 
samples t-test; Fig. 5.4 B; Table 5.1).
Table 5.1 Head length and retinal volume mean values ± l.s .d . in s s  33-35 Tbx2'/m mutant
and wild-type em bryos
n. Mean ± 1 s.d.
Head length wild-type 10 2.10 mm 0.07
Mutant 14 2 .14  mm 0.15
Retinal volume wild-type 7 6.14x1 O'3 mm3 0.48x1 O'3
Mutant 10 5.06x1 O'3 mm3 0.82x10 3
These data suggest that the small retinal volume in Tbx2'f' embryos is not associated 
with a general developmental delay and is likely to be occurring as a direct effect of 
the loss o f Tbx2 in the developing eye.
258
Fig. 5.4 Quantification of eye size and head size in mutant and wild-type 
embryos
(A) Bars represent the mean head length ± 1 s.d. in 10.5 dpc mutant and wild-type 
embryos (ss33-35). No significant difference was detected between the two 
genotypes analysed by the independent samples t-test, unequal variances (n= number 
of embryos). (B) Bars represent mean retinal volume ± 1 s.d. in 10.5 dpc mutant and 
wild-type embryos (ss33-35). Retinal volume was significantly smaller in mutant 
eyes compared to stage matched wild-types (independent samples t-test, n= number 
of eyes).
Abbreviations: ss, somite stage
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5.2.3 Molecular patterning along the D-V axis of the optic cup
As outlined earlier (Section 5.1), one of the main aims of this Chapter was to 
investigate whether Tbx2 regulates the expression of D-V patterning genes as a 
downstream mediator of Bmp4 signalling. Moreover, given the small eye phenotype 
identified in Tbx2'f' mice, disruption of D-V patterning was investigated as abnormal 
expression of asymmetrically expressed genes may cause a defect in the coordination 
of overall growth of the optic cup. This hypothesis is supported by evidence that 
regional growth in the developing heart is linked to regional gene expression (Cai et 
al. 2005). Evidence for the existence of regional growth in the eye was discussed in 
Chapter 1.
To examine the role of Tbx2 in molecular patterning along the D-V axis of the 
developing eye, the expression of several genes previously implicated in D-V 
patterning (described in Chapter 3) were examined by whole mount in situ 
hybridisation. Mutant and wild-type embryos were somite matched and processed 
simultaneously in the same tube to minimise variability of signal due to the 
experimental procedure. When possible and indicated in the text, littermates were 
used in both experimental groups. Control embryos possessing two normal copies of 
Tbx2 were used in the majority of experiments, but where stated, heterozygotes 
which are phenotypically normal were used as controls.
Apart from serving as dorsal or ventral retinal markers, other reasons also lay behind 
the choice of the panel of genes selected for the analysis presented in this section. 
The panel includes Bmp4, investigated for the possibility of a feed-back loop, in 
which Tbx2 exerts regulation on Bmp4 expression in the dorsal eye. Msx2 was also of 
interest as its overexpression in the mouse eye and likewise the misexpression of its 
homologue Msh in the Drosophila eye cause microphthalmia in mice and a small eye 
phenotype in Drosophila (Wu et al. 2003; Mozer 2001). EphrinB2 was also analysed 
due to its role in the regulation of RGC axonal projections from the dorsal eye in 
Xenopus and its regulation by Tbx5 in the developing chick eye (see Chapter 1.4.2). 
Analysis of Tbx3 and Tbx5 expression served to investigate whether the T-box genes 
of the eye regulate each other, while Vax2 was selected as a ventral neural retinal
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marker. Finally, Tbx2 mRNA expression was examined to trace cells that would have 
expressed Tbx2 in order to investigate their fate.
Bmp4
Expression of Bmp4 in the dorsal neural retina was similar in mutant and wild-type 
eyes at 10.5 dpc (n= 6 eyes per genotype) and 11.5 dpc (n= 2 -/- eyes, 6 +/+ eyes; 
Fig. 5.5 A-D). However, Bmp4 expression in the maxillary process of the first 
branchial arch and in the nasal process was much reduced in mutants at 10.5 dpc, and 
remained more restricted also at 11.5 dpc compared to wild-types (Fig. 5.5 A-D).
Msx2
No difference was observed in Msx2 expression between wild-type and mutant optic 
cups at 10.5 dpc (n= 4; Fig. 5.5 E,F), suggesting that Tbx2 is not upstream of Msx2 
expression during mouse eye development and that Bmp4 regulation of Msx2 is 
normal in Tbx2'/' eyes.
ephrinB2
The colourimetric reaction of the ephrinB2 whole mount in situ hybridisation 
experiment was stopped after two hours, at which point all embryos were 
photographed, and the reaction was re-started and allowed to proceed for a further 
three hours with half of the embryos, to ensure full detection of ephrinB2 expression. 
In this experiment embryos with normal and heterozygous genotypes were used as 
controls.
After two hours, ephrinB2 expression in wild-type eyes was restricted to the anterior 
edges of the invaginating lens epithelium and to the dorsal neural retina and RPE 
(Fig. 5.6 A,C). In mutants, ephrinB2 was still localised to the dorsal neural retina and 
RPE, but in comparison to wild-types, appeared broader. Moreover, it was detected 
in the entire invaginating lens epithelium (Fig. 5.6 B,D; n= 5/6). After longer 
development of the colour reaction, the signal detected in the invaginating lens 
epithelium appeared spatially similar in whole mount and section views of both 
genotypes (Fig. 5.6 E,F). The signal intensity in the neural retina of overdeveloped 
embryos was still higher and expression was broader in mutant retinae compared to 
wild-types (Fig. 5.6 E,F see arrowheads).
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Fig. 5.5 Bmp4 and Msx2 expression in Tbx2',m and wild-type eyes by whole 
mount in situ hybridisation
All images depict lateral views of the head of embryos. (A) 10.5 dpc wild-type (+/+) 
embryo at ss 35 showing the normal pattern of expression of Bmp4, including the 
dorsal optic cup expression (arrow). Other sites of expression in picture include the 
maxillary (MX) and nasal (NP) processes. (B) 10.5 dpc mutant (-/-) embryo at ss 34, 
showing similar Bmp4 expression to wild-type in the dorsal neural retina (arrow). In 
the maxillary and nasal processes, its expression was more restricted than normal. 
(C) Bmp4 expression in an 11.5 dpc wild-type embryo. Expression was detected in 
the dorsal neural retina (arrow), the maxillary and nasal processes. (D) 11.5 dpc 
mutant embryo showing spatially normal Bmp4 expression in the dorsal neural retina 
(arrow). (E) 10.5 dpc wild-type embryo at ss 37 hybridised with the Msx2 probe. 
Msx2 expression was detected in the dorsal neural retina (arrow) and dorsal anterior 
lens epithelium. (F) Mutant embryo at ss 38 showing normal Msx2 expression. Scale 
bars: 0.5 mm
Abbreviations: D, dorsal; MX, maxillary process of the first pharyngeal arch; NP, 
nasal process; OV, otic vesicle; ss, somite stage; V, ventral
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Fig. 5.6 ephrinB2 expression in Tbx2m/' and wild-type eyes a t 10.5 dpc by 
whole m ount in situ hybridisation
(A) Lateral view of a wild-type (+/+) embryo at ss 33. EphrinB2 expression was 
detected in the dorsal neural retina (arrow) and in the lens placode, where expression 
was confined to the anterior portion. (B) Lateral view of a mutant (-/-) embryo at ss 
33 showing elevated ephrinB2 expression in the dorsal neural retina (arrow) and lens 
epithelium. (C) Coronal vibratome section of the eye in A through the plane 
indicated by the arrow. EphrinB2 expression was detected in the anterior edges of the 
invaginating lens epithelium, the dorsal distal RPE (arrow), and the dorsal neural 
retina (arrowhead). (D) Coronal vibratome section of the eye in B through the plane 
of the arrow, showing elevated expression in the dorsal neural retina (arrowhead) and 
in the invaginating lens epithelium. (E) Coronal vibratome section through another 
wild-type eye at ss 33 showing ephrinB2 expression after a longer period of 
development of the NBT/BCIP colour reaction. The expression in the dorsal neural 
retina is marked by the arrowhead. Expression was detected throughout the lens 
epithelium. (F) Coronal vibratome section through a mutant eye at ss 33 treated and 
developed for the same length of time as the wild-type section in E. EphrinB2 was 
strongly and more broadly expressed in the dorsal neural retina (arrowhead) than 
seen in wild-type. (G-H) Show whole mount views of the eyes shown in E-F 
respectively, when these embryos had been developed for as long as embryos shown 
in A-B, prior to overdevelopment of the colour reaction. Scale bars: 0.5 mm in 
A,B,G,H and 0.1 mm in C-F
Abbreviations: D, dorsal; LE, lens epithelium; MN, mandibular process of the first 
pharyngeal arch; MX, maxillary process of the first pharyngeal arch; NP, nasal 
process; NR, neural retina; RPE, retinal pigment epithelium; ss, somite stage; V, 
ventral.
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These data suggest that ephrinB2 levels may be upregulated in the absence of Tbx2 
in both the neural retina and the invaginating lens epithelium.
Vax2
At 10.5 dpc, the expression of Vax2 was correctly confined to the ventral neural 
retina in mutants although slightly reduced in comparison to wild-type somite 
matched littermates (n= 6 eyes per genotype; Fig 5.7 A-D). Note the abnormally 
large space between the inner and outer layers of the naso-ventral optic cup, 
mentioned previously (asterisk in Fig. 5.7 B). As Vax2 induces ventral eye 
properties, this shows that the ventral neural retina is correctly specified in Tbx2'f' 
embryos but may gradually lose Vax2 expression in the absence of Tbx2. 
Alternatively, the smaller Vax2 expression domain may be due to the reduced size of 
the ventral neural retina.
Tbx5 and Tbx3
The expression domain of Tbx5 in the dorsal neural retina was smaller in mutants 
than in somite matched wild-type littermates at 10.5 dpc (n= 6 eyes per genotype Fig.
5.7 E-F). This is unlikely to be due to the overall small retinal volume as genes such 
as Msx2, and Bmp4 were normally expressed in the same region in mutant eyes. 
Moreover, Tbx3 expression in mutant eyes was unaltered compared to wild-types (n= 
4 eyes per genotype; Fig. 5.7 G-H).
Detection of cells destined to express Tbx2
Tracing of mutant cells, that lack functional Tbx2 due to incomplete transcription of 
Tbx2 mRNA, was performed using a full length Tbx2 RNA probe encompassing the 
entire cDNA, including the 5’ end. In the mutation carried by Tbx2'f~ mice, exon two 
and part of exon one were deleted, with the 5’ end of exon one remaining intact, 
which made detection of transcripts with the full length probe possible. This 
experiment revealed that the population of cells in the dorsal neural retina that would 
normally be expressing Tbx2 were present in their normal location and in an 
apparently normal quantity in 35-36 ss (10.5 dpc) embryos (n= 4; Fig. 5.7 I,J).
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This is a later stage than when Tbx5 expression was found to be reduced and further 
supports that a reduction in Tbx5 expression, rather than diminished cell numbers, is 
the cause of the difference seen between mutant and wild-type embryos hybridised 
with the Tbx5 probe.
5.2.4 Investigation of mechanisms responsible for the eye size 
phenotype in Tbx?' mice
5.2.4.1 Retinal cell proliferation and cell death
There are several mechanisms that if perturbed could result in a small eye phenotype 
(see Chapter 1.1.3). Two mechanisms that contribute to the determination of growth 
of a tissue are rates of cell division and cell death. In order to investigate whether the 
small eye phenotype in Tbx2A mice is caused by defects in any of these two 
mechanisms, cell division and cell death by apoptosis were analysed by pH3 
immuno-labelling and the TUNEL assay respectively as described in Sections 2.8.1.3 
and 2.9 of Chapter 2. As eye size and morphology appeared normal at optic vesicle 
stage but retinal volume was already significantly smaller at optic cup stage (ss 33- 
35) in mutant embryos, these experiments were carried out on embryos at ss 30-31. 
This is just after the initiation of optic vesicle invagination, which in these mice 
occurred at ss 28-30. Assuming that observable changes in morphology lag behind 
molecular changes in the cell, it was hoped that changes in cell proliferation and cell 
death were detected prior to morphological manifestation of the small eye phenotype. 
Embryos were somite matched in order to minimise between embryo variability.
Cell division and cell death were analysed on every third midline section (12 fim  
thick) in four wild-type and six mutant eyes. Comparisons of global pH3 cell counts, 
mitotic indices (pH3 cells divided by total cells), and pH3 cells/mm2 of the retinae 
showed a trend of increased cell division in mutants compared to wild-types (Table 
5.2; Fig. 5.8; total cells counted= 2189 in wild-types and 2990 in mutants).
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Fig. 5.8 Cell proliferation detected by im m unohistochem istry with an  M- 
phase m arker of the cell cycle
Pictures depict midline frozen sections cut in the coronal plane. (A,B) Wild-type eye 
labelled with anti phospho-histone H3 (pH3, green), showing dividing cells of the 
ventricular surface of the neural retina and counterstained with propidium iodide (PI, 
red). (C,D) Mutant eye labelled with anti-pH3 (green) and stained with PI (red) 
showing dividing cells at the ventricular surface also in the mutant retina. Dotted 
lines outline the ventral neural retina. Arrowheads highlight dividing cells (in mutant 
eye) in the ventral mesenchyme in which Tbx2 is normally expressed. The displaced 
RPE in pictures of the mutant eye is due to a sectioning artefact. (E) Scatter plot of 
the number of pH3 positive cells per section in mutant (n= 14) and wild-type (n= 8) 
eyes from 4 and 6 eyes respectively. (F) Scatter plot of the mitotic indices per 
section. Data was analysed with a One-Way ANOVA in E (P= 0.15) and with an 
ANCOVA in F (P= 0.1) with the total number of cells per section included as a 
covariate. Scale bars: 50 nm.
Abbreviations: D, dorsal; LE, lens epithelium; NR, neural retina; s, somite pairs; V, 
ventral
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Despite this trend the differences were not statistically significant (number of pH3 
positive cells P= 0.15, by One-Way ANOVA, Table 5.3; mitotic indices P= 0.10 by 
ANCOVA with the total cell number per section incorporated as a covariate to 
account for the effect of cell number on the number of mitotic cells, Table 5.4; P= 
0 .12).
Table 5.2 Mean counts of mitotic cells and indices in Tbx2*  mutant and wild-type retinae
at early 10.5 dpc.
Mean ± 1 s.d.
wild-type (8 sections) mutant (14 sections)
global pH3 positive cells 3.8 ± 2.4 6.1 ±3.9
global mitotic index 1.4 ±0.9 2.8 ±1.8
global pH3/mm2 197 ±131 302 ±179
dorsal pH3 positive cells 2 ±1.4 4 ±2.4
dorsal mitotic index 1.5 ± 1.2 2.9 ±1.8
dorsal pH3/mm2 1 8 1 ± 139 322 ±179
Cell division in the dorsal eye only was also compared between genotypes, as Tbx2 is 
expressed dorsally (Table 5.2; Fig. 5.9). For this purpose, the eye was divided as 
previously described for the analysis of cell division in Chapter 4 and shown in the 
schematic in Fig. 5.9 A. An increased trend of cell division was also apparent in the 
dorsal neural retina in mutants compared to wild-types (Fig 5.9 B,C), although 
comparisons of cell counts by One-Way ANOVA as well as comparisons of mitotic 
indices by incorporation of the effect of total cell number in the dorsal eye on the 
number of mitotic cells in the dorsal eye by ANCOVA gave P-values of 0.046 and 
0.05 respectively (Table 5.5 and 5.6).
These results suggest that cell division does occur in the absence of Tbx2 and 
contrary to expectations that cell division would be reduced as retinal volume is 
reduced in mutants, there appears to be an upward trend in cell division when Tbx2 
is lacking in the eye. Also note the increased number of pH3 positive cells in the 
mesenchyme between the ventral neural retina and the surface ectoderm (Fig. 5.8 
B,D arrowheads), where Tbx2 is normally expressed as shown in Chapter 3 (Fig. 3.5 
E).
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Fig. 5.9 Cell proliferation in the dorsal neural re tina  of Tbx2'/m and  wild- 
type eyes
(A) Schematic diagram of the developing eye at 10.5 dpc. The dorsal region of the 
neural retina was demarcated as depicted by dotted lines. (B,C) Scatter plots of the 
number of pH3 positive cells counted per section in the dorsal region of mutant (n= 
14) and wild-type (n= 8) retinae from 4 and 6 eyes respectively. Data was analysed 
with a One-Way ANOVA in B (P= 0.046) and with an ANCOVA in C (P= 0.05) 
with the total number of cells in the dorsal neural retina per section included as a 
covariate
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Table 5.3: One-Way ANOVA for the comparison of global pH3 labelled cells in Tbx2/' mutant
and wild-type retinae
Dependent Variable: n. pH3 labelled cells per section_________________________________________
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 27.435(a) 1 27.435 2.263 .148
Intercept 491.071 1 491.071 40.513 .000
genotype 27.435 1 27.435 2.263 .148
Error 242.429 20 12.121
Total 871.000 22
Corrected Total 269.864 21
a R Squared = 1 0 2  (Adjusted R Squared = .057)
Table 5.4 ANCOVA table for the comparison of global pH3 labelled cells in TbxZ'' mutant and
wild-type retinae, with Total cell number incorporated as a covariate 
Dependent Variable: n. pH3 labelled cells per section
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 38.750(a) 2 19.375 1.593 .229
Intercept .330 1 .330 .027 .871
Total cell num ber 11.315 1 11.315 .930 .347
genotype 37.146 1 37.146 3.054 .097
Error 231.114 19 12.164
Total 871.000 22
Corrected Total 269.864 21
a R Squared = .144 (Adjusted R Squared = .053)
Table 5.5: One-Way ANOVA for the comparison of dorsal pH3 labelled cells in TbxZ*’ mutant
and wild-type retinae
Dependent Variable: n. pH3 labelled cells in dorsal retina per section
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 20.364(a) 1 20.364 4.525 .046
Intercept 183.273 1 183.273 40.727 .000
genotype 20.364 1 20.364 4.525 .046
Error 90.000 20 4.500
Total 346.000 22
Corrected Total 110.364 21
a R Squared = 1 8 5  (Adjusted R Squared = .144)
Table 5.6 ANCOVA table for the comparison of dorsal pH3 labelled cells in TbxZ*' mutant and
wild-type retinae, with n.dorsal cell number incorporated as a covariate
Dependent Variable: n. pH3 labelled cells in dorsal retina per section___________ _______ —______
Source
Type III Sum 
of Squares df Mean Square F S '9-
Corrected Model 20.674(a) 2 10.337 2.190 .139
Intercept 2.605 1 2.605 .552 .467
Dorsal cell 310 1 .310 .066 .800num ber
genotype 20.608 1 20.608 4.366 .050
Error 89.690 19 4.721
Total 346.000 22
Corrected Total 110.364 21
a R Squared = 1 8 7  (Adjusted R Squared =102)
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Fig. 5.10 Analysis of cell death in Tbx2'/m and  wild-type eyes, using the 
TUNEL assay
Pictures depict midline frozen sections cut in the coronal plane. (A,B) Wild-type eye 
labelled with the TUNEL assay (green), showing the pattern of apoptosis in the eye. 
(C,D) Mutant eye labelled with the TUNEL assay (green) showing a similar pattern 
of apoptosis. Sections were counterstained with PI (red). Scale bars: 50 /an.
Abbreviations: D, dorsal; LE, lens epithelium; NR, neural retina; RPE, retinal 
pigmented epithelium; s, somite pairs; V, ventral.
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In the ventral extra-ocular mesenchyme however, where Tbx2, but none of the other 
T-box genes is expressed (Chapter 3, Fig. 3.4), dividing cells were more abundant in 
mutants compared to wild-types (Fig. 5.8 B,D, arrowheads). Examination of cell 
death by TUNEL labelling showed a similar pattern of cell death in mutant and wild- 
type eyes (Fig. 5.10; wild-type n= 18, mean TUNEL= 24 ± 22, mean TUNEL/mm2= 
1214 ± 1029; mutant: n= 11, mean TUNEL= 17 ± 15, mean TUNEL/mm2= 1126 ± 
912; P= 0.358 by independent samples t-test). This pattern was in agreement with 
previous descriptions of the pattern of cell death in the optic cup at 10.5 dpc (see 
Chapter 1.2.4), suggesting that, at this stage, apoptosis occurs normally in the mutant 
eye.
5.2.4.2 RPE specification
If the initial pool of retinal progenitor cells is smaller due to mis-specification of the 
RPE, one could expect this to result in an overall smaller retinal volume later in 
development even if there is normal progression of other growth limiting 
mechanisms.
Reciprocal antagonism between the transcription factors M itf and ChxlO, which after 
a period of co-expression in the distal optic vesicle, become exclusively expressed in 
the RPE and the neural retina respectively, has been shown to be required for the 
maintenance of neural retina versus RPE fates (Horsford et al. 2004; Rowan et al. 
2004). The pigment-cell specific gene Silver (Pmell7, gp87- Mouse Genome 
Informatics) encodes a transmembrane protein, which is detected in the presumptive 
RPE already at 9.5 dpc and is not expressed in M ilfni/mi mutants (Baxter and Pavan 
2003). It is therefore thought to be an early marker of the RPE under the regulation 
of Mitf. To investigate a possible role for Tbx2 in the formation of the dorsal 
boundary between the RPE and the neural retina, and to examine whether the RPE 
domain is expanded at the expense of the neural retina, thereby diminishing the 
neural retinal progenitor pool, expression of Silver was examined in Tbx2'A eyes. 
Furthermore, the expression of Tbx2 was examined in the C hxl0OrJ/OrJ mice that first 
display a small eye phenotype at 10.5 dpc, around the same developmental period as 
the observed eye size phenotype in Tbx2'A mice. The underlying cause of the small 
eye phenotype in Chxl(PrJ/0rJ mice has been assigned to a lower rate of retinal cell
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proliferation and a progressive transdifferentiation of the neural retina into RPE, 
which is apparent at 10.5 dpc with the ectopic expression of Mitf in the Chxl0OrJ/OrJ 
neural retina (Burmeister et al. 1996; Rowan et a l 2004; Horsford et al. 2004). 
Examination of Tbx2 expression in these mice served to clarify whether Tbx2 is 
downstream of ChxlO in the regulation of eye size and whether the phenotypes of 
these mice are caused by the same aberrant mechanisms.
Silver
Section in situ hybridisation with the Silver probe revealed expression in the RPE of 
wild-type embryos at 10.5 dpc in accordance with previous reports (Fig. 5.11 A). In 
6/6 mutant eyes, Silver expression was detected in the RPE (Fig. 5.11 B). This 
experiment showed that the RPE was correctly specified at 10.5 dpc as the 
expression of the M/(/'-dependent gene Silver was spatially normal and did not extend 
into the neural retina in Tbx2'f' embryos.
Tbx2 expression in Chxl0OrJ/OrJ embryos
Chxl0OrJOrJ embryos were obtained from homozygous Chxl0OrJ crosses on the 
Svl29 genetic background. Wild-type embryos, serving as controls, were collected 
from timed matings of Svl29 mice. Embryos were harvested at 10.5 dpc and somite 
matched between genotypes.
Tbx2 expression detected by whole mount in situ hybridisation at 10.5 dpc was 
restricted to the dorsal neural retina in mutant embryos and did not differ from the 
expression in wild-type somite matched controls (n= 6 eyes per genotype; Fig. 5.11 
C,D). These data therefore suggest that Tbx2 is not downstream of ChxlO and that 
Tbx2 expression is not dependent upon Mitf, which in 10.5 dpc Chxl0OrJ/OrJ embryos 
is ectopically expressed in the neural retina (Horsford et al. 2004). Together, these 
experiments provide evidence that the RPE is correctly specified in the absence of 
Tbx2.
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Fig. 5.11 Examination of RPE specification in Tbx2'/m mice and Tbx2 
expression in ChxlO°rJ/orJ mice
(A,B) Coronally cut frozen sections (15 /*m thick) showing Silver expression in the 
RPE of wild type (+/+) and mutant embryos at ss 34 respectively, detected by section 
in situ hybridisation. Note the distinct accumulation of cells in the ventral region of 
the mutant optic cup (arrowhead) and the lack of ventral optic cup invagination. (C) 
Lateral view of a 10.5 dpc wild-type embryo at ss 31 hybridised with the Tbx2 probe. 
(D) Tbx2 expression in a C hxl(frJ/orJ (-/-) embryo at ss 31. Expression was normal 
and is marked by arrows in C-D. Scale bars: 50 /Am in A,B and 0.5 mm in C,D.
Abbreviations: D, dorsal; LP, lens placode; MN, mandibular process of the first 
pharyngeal arch; MX, maxillary process of the first pharyngeal arch; NP, nasal 
process; NR, neural retina; RPE, retinal pigmented epithelium; ss, somite stage; V, 
ventral
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5.2.4.3 Expression of Cx43
Cx43 encodes a gap junction protein that is expressed in the RPE of developing and 
adult eyes of several vertebrate species, as well as many other parts of the body, as it 
is an important protein that facilitates cell to cell communication (Yancey et al. 
1992; Janssen-Bienhold et al. 1998). Its highly conserved expression in the 
embryonic and adult RPE among vertebrates is suggestive of an evolutionarily 
preserved role in pre- and postnatal eye development and homeostasis. Its promoter 
contains T-box binding sites and it has been shown to be suppressed by Tbx2 in co­
transfection assays of Tbx2 with Cx43-driven reporter constructs in an osteoblast-like 
cell line (Borke et al. 2003; Chen et al. 2004). Moreover, there is evidence that it is 
important for regulating eye size, as discussed in the introduction of this Chapter. To 
test whether repression of Cx43 by Tbx2 occurs in vivo in the developing neural 
retina, Cx43 protein expression was compared by immunohistochemistry in Tbx2'/' 
and wild-type eyes.
The spatial expression o f Cx43 in Tbx2'/' and somite matched wild-type eyes was 
equivalent at 10.5 dpc, with the characteristic punctuate Cx43 expression lining the 
apical surface (facing the neural retina) of the RPE in a dorsal-high, ventral-low 
gradient (Fig. 5.12 A-D, G, H; n= 6 eyes per genotype). The ventral presumptive 
RPE was not positive for Cx43 expression in either mutant or wild-type eyes. 
Specific Cx43 expression was also detected with an HRP-tagged secondary antibody, 
in the RPE, but not in control sections without a primary antibody incubation (Fig. 
5.12 I,J). As Cx43 expression, which is normally only confined to the RPE in the 
mouse optic cup, did not extend into the mutant neural retina, correct distinction 
between the neural retina and the RPE in the dorsal eye was again confirmed in 
mutants. However, the intensity of Cx43 labelling, reflective of levels of protein, 
differed between wild-type and mutant eyes. Intense Cx43 labelling was observed in 
the dorsal peripheral RPE in mutants and weaker labelling was detected in the 
equivalent region in wild-type eyes (Fig. 5.12 G, H; n= 6 eyes per genotype).
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Fig. 5.12 Connexin43 expression in midline sections in Tbx2m/' and wild-type 
eyes at 10.5 dpc detected by immunohistochemistry
All except I-J show pictures show coronally cut frozen sections of 15 pim thickness 
immuno-labelled with an antibody against Cx43 (green) and counterstained with 
propidium iodide (red). (A) Eye of a wild-type (+/+) embryo at ss 34, showing Cx43 
protein localisation to the RPE (arrow) in a dorsal-high, ventral-low gradient. (B) 
Same section as in A, but without the propidium iodide stain. The green fluorescence 
between the ventral neural retina and presumptive RPE layers and the randomly 
distributed green circles are non-specific trapping of secondary antibody, as they do 
not demonstrate the punctate labelling pattern that is characteristic of Cx43 
expression and also appear on negative control sections incubated without primary 
antibody. (C) Midline section of the eye of a mutant (-/-) embryo at ss 34. Strong 
Cx43 expression was detected in the RPE (arrow), in a dorsal-high, ventral-low 
gradient. The dorsal expression appeared stronger than in wild-type eyes. (D) Same 
section as in C, but without the propidium iodide stain. (E) A negative control (10.5 
dpc optic cup) showing the non-specific immuno-labelling of the secondary antibody 
in the absence of the Cx43 antibody. The RPE was completely void of signal. (F) 
Same section as in E without the propidium iodide stain. (G) Higher magnification of 
the dorsal region of the wild-type eye in A. (H) Higher magnification of the dorsal 
region of the mutant eye in C. (I) 12 jLim thick frozen section of a wild-type embryo 
at 10.5 dpc immuno-labelled with the same Cx43 antibody as used in A-H, but 
detected with an HRP-tagged secondary antibody and a colourimetric assay. Section 
is counterstained with 0.5% Methyl Green. Cx43 expression was detected in the 
dorsal RPE as in A-D. (J) Adjacent section to I treated equally except for the 
exclusion of the primary antibody. No labelling was seen in the RPE (arrow). Scale 
bars: A-H, 0.1 mm; I-J, 0.05 mm.
Abbreviations: D, dorsal; LP, lens epithelium; NR, neural retina; RPE, retinal 
pigmented epithelium; ss, somite stage; V, ventral.
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Fig. 5.13 Connexin43 expression in peripheral sections of Tbx2’/m and wild- 
type eyes a t 10.5 dpc detected by immunohistochem istry
Images depict coronally cut frozen sections of 15 /xm thickness immuno-labelled 
with an antibody against Cx43 (green) and counterstained with propidium iodide 
(red). (A) Section of the nasal region of a wild-type eye at ss 34, showing low levels 
of Cx43 expression in the nasal RPE. (B) Same section as A, without propidium 
iodide. (C) Section of the nasal region of a mutant eye at ss 34, showing abnormally 
high levels of Cx43 expression in the nasal edge of the RPE. (D) Same section as 
shown in C, but without the propidium iodide stain. Scale bars: 50 ixm
Abbreviations: D, dorsal; RPE, retinal pigmented epithelium; ss, somite stage; V, 
ventral.
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Labelling was also highly intense in nasal and temporal peripheral RPE of mutants 
but barely detectable in equivalent sections from wild-type eyes (Fig. 5.13 A-D)
The difference in Cx43 immuno-labelling intensity between mutant and wild-type 
eyes is suggestive of higher levels of expression of the protein in the absence of Tbx2 
in the dorsal, nasal, and temporal peripheries of the RPE. However, a quantitative 
approach that measures levels of protein expression would be needed to confirm 
these results.
5.2.4.4 Differentiation of the neural retina
A reduction in the number of cell divisions undertaken by retinal progenitor cells and 
early differentiation could cause a small eye size. For example, mice homozygous for 
a targeted mutation of Inhibitor o f  DNA binding 4 (Id4) have a small brain size partly 
due to premature onset o f differentiation during early development (Yun et al. 2004). 
To investigate this possibility in Tbx2'f' eyes, differentiation was analysed by 
immunohistochemistry at 12.5 dpc, when the central, but not the peripheral part of 
the neural retina has normally initiated the differentiation process.
Previous examination of H&E stained sections of mutant eyes at 12.5 dpc (Section 
5.2.1) suggested a lack of a nerve fibre layer and a lack of axons projecting through 
the optic disc in embryos that exhibited the severe phenotype (Fig. 5.3 G). Immuno- 
labelling with the RMO270 antibody, which labels RGC bodies and processes, 
revealed an organised nerve fibre layer in the central neural retina, dorsal to the optic 
disc, in wild-type eyes (Fig. 5.14 A). In mutant eyes, cell bodies and their axons were 
labelled in the same central region as observed in wild-types and the lack of labelling 
of axons projecting through the optic disc agreed with observations made previously 
on H&E sections (n= 2 eyes; Fig. 5.14 B). The absence of labelling in the peripheral 
neural retina suggests that premature differentiation does not occur at 12.5 dpc in 
mutants and can thus be excluded as a cause of the small eye phenotype at this stage.
RMO270 labelling also revealed that in mutant retinae, axons were extremely 
disorganised in comparison to the neat sheet of nerve fibre layer in wild-type retinae 
(Fig. 5.14 C-J).
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Fig. 5.14 Retinal nerve fibre layer genesis and organisation in Tbx2'/m and 
wild-type eyes detected by RMO270 immunohistochemistry
15 fim  thick coronal sections of 12.5 dpc eyes immuno-labelled with the RMO270 
antibody (green) against intermediate neurofilament-M (160 kDa), and 
counterstained with propidium iodide (red). (A) Midline section through the eye of a 
wild-type (+/+) embryo at ss 54 showing the existence of a nerve fibre layer on the 
vitreal surface of the neural retina. Labelling was confined to the central neural 
retina, dorsal to the optic disc. Arrow points to the optic disc. (B) Midline section 
through the eye of a mutant (-/-) embryo at ss 56 showing the existence of labelled 
axons in the same region as in the wild-type eye in A. Arrow points to the region 
where a poorly defined optic disc could be distinguished (see higher magnification in 
H). (C) High power confocal view of the dorsal region of the wild-type optic cup, 
roughly corresponding to the region highlighted by a solid box in A, although 
belonging to the adjacent section to A. The nerve fibre layer was orderly arranged on 
the vitreal surface of the neural retina. Arrow points towards the location of the optic 
disc, which is not shown in picture. (D) High power confocal picture of the dorsal 
region of the mutant optic cup roughly corresponding to the region highlighted by a 
solid box in B, although belonging to the adjacent section to B. The nerve fibre layer 
was disorganised and the axons were protruding into the vitreous chamber. The cells 
of the neural retina were rounder in appearance than in wild-type. Arrow points 
towards the optic disc (E,F) Same sections as in C and D respectively without the 
propidium iodide stain. (G) High power confocal view of the optic disc region of a 
wild-type eye (broken box in A). Optic nerve fibres make an orderly exit through the 
optic disc. (H) High power confocal view of the optic disc region of a mutant eye 
(broken box in B). The axons were disorganised and did not exit the optic cup. 
Arrow shows the poorly defined optic disc. (I-J) Show G-H respectively without the 
propidium iodide stain. Scale bars: 100 /*m in A-B, 20 fim  in C-J.
Abbreviations: D, dorsal; L, lens; NR, neural retina; OD, optic disc; RPE, retinal 
pigmented epithelium; ss, somite stage; V, ventral.
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Most axons in mutant eyes appeared to protrude into the vitreous chamber rather than 
following the vitreal surface o f the neural retina These disorganised axons were seen 
all along the differentiated region of the eye and were not specific to a particular 
region. The lack o f axons exiting the optic disc and a poorly defined optic disc were 
confirmed in high power views of that region (Fig. 5.14 H, arrow, compare to G).
The embryonic lethality caused by the Tbx2 mutation prevented further 
investigations of neurogenesis in Tbx2'/' retinae. However, at 12.5 dpc, progenitor 
cells that will adopt mainly amacrine and horizontal cell fates once postmitotic can 
be identified by immuno-labelling with the VC 1.1 antibody (Alexiades and Cepko 
1997). The VC 1.1 antibody was used to examine whether commitment to any other 
cell types apart from the RGC fate could occur in the absence of Tbx2. In both wild- 
type and mutant retinae, labelling of cell bodies and laminar processes were detected 
in the central neural retina, dorsal to the optic disc (n= 2 eyes; Fig. 5.15 A-O). In this 
experiment, it was not possible to distinguish between progenitors and differentiated 
amacrine/horizontal cells, which are also labelled with the VC 1.1 antibody and 
which start to differentiate at 12.5 dpc (Alexiades and Cepko 1997). The VC1.1 
antibody has not been reported to label RGCs and this experiment provides 
indications of the existence of a progenitor population that is distinct from that giving 
rise to the RGCs in Tbx2~/~ eyes.
Surprisingly, strong labelling was also detected in the vitreous chamber of mutant but 
not wild-type eyes with this antibody, which is raised against an epitope commonly 
occurring in cell adhesion molecules (see Chapter 2.8.1.1). This labelling site did not 
particularly coincide within or around cell nuclei and appeared as a fibrous mass that 
occupied the vitreous chamber (Fig. 5.15 H,K,N). This type of labelling was not seen 
in wild-type eyes or in the vitreous chamber in negative controls (Fig 5.15 G,J,M,R).
With no evidence for ectopic differentiation, it is concluded that premature 
differentiation does not cause the small eye phenotype in Tbx2/ embryos by 12.5 
dpc. The markers used showed that ganglion cell genesis is initiated in mutant eyes 
and that at least one other progenitor population exists, which may or may not give 
rise to amacrine and horizontal cells in the absence of Tbx2. This analysis also 
revealed a possible involvement for Tbx2 in intra-retinal axonal organisation.
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Fig. 5.15 VC1.1 labelling in Tbx2'/m eyes detected by immunohistochemistry
15 /xm thick coronal sections of 12.5 dpc eyes immuno-labelled with the VC 1.1 
antibody (green) against amacrine/horizontal cells and counterstained with 
propidium iodide (red). (A) Section through the eye of a wild-type (+/+) embryo at ss 
54, showing labelling within the central region of the neural retina. (B) Midline 
section through the eye of a mutant (-/-) embryo at ss 56, also showing labelling of 
cells in the central neural retina. Strong labelling was also detected within the 
vitreous chamber, surrounding the lens (dashed lines). (C) A more peripheral section 
of another mutant eye showing labelled cells within the central neural retina and 
some labelling in the vitreous surrounding the lens. (D-F) Show A-C without 
propidium iodide staining. (G) High power view equivalent to the boxed area in A 
but in an adjacent section to A. Dorsal is to the right, ventral to the left. VC 1.1 labels 
cell bodies (arrowhead) and laminar processes. (H,I) Magnified views of boxed 
regions in B-C respectively, with arrowhead indicating a labelled cell body. (J-L) 
Show G-I with the propidium iodide stain only. Dashed lines demarcate the region 
within the vitreous chamber where strong VC 1.1 labelling was detected in mutants 
(in H and K). (M-O) Show G-I without the propidium iodide stain. (P) Negative 
control incubated without the VC 1.1 antibody, but with the secondary antibody. (Q) 
Adjacent section to P incubated with both primary and secondary antibodies (positive 
control). (R) Another negative control on a section containing the vitreous chamber, 
showing absence of signal in the vitreous chamber when the VC 1.1 antibody was 
omitted. Scale bars: 50 /xm.
Abbreviations: D, dorsal; L, lens; NR, neural retina; ss, somite stage; V, ventral
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5.2.4.5 The hyaloid vasculature
Prior to genotyping of embryos, it was usually possible to identify mutants from 
wild-types by their abnormally small retinae, but also by a dense manifestation of the 
vasculature in the region of the optic fissure at 10.5 dpc. Furthermore, histological 
examination of mutant eyes, described in 5.3.1 also revealed an abnormal hyaloid 
vasculature in mutants. At 10.5 dpc, the development of the hyaloid vascular system, 
but not the retinal vasculature, is already underway (Chapter 1.1.1). Relatively little 
is known about the molecular regulation of hyaloid vasculature formation. At the 
cellular level however, its formation is pretty well characterised and it is known that 
mesenchymal cells that enter the optic cup through the optic fissure contribute to its 
formation. Tbx2 is expressed in a small number of mesenchymal cells in the ventral 
region of the optic cup prior to optic fissure closure and could possibly therefore be 
expressed in cells that later directly become part of the hyaloid vasculature (Fig. 5.16 
K).
To further examine the vasculature in mutant eyes, whole embryos were labelled 
with the endothelial cell specific antibody, Platelet Endothelial Cell Adhesion 
Molecule 1 (PECAM1; details in Chapter 2.8.1.1), by whole mount 
immunohistochemistry at 10.5 dpc. Compared to wild-types, PECAM1 immuno- 
labelling in mutant eyes was more dense in the region of the optic fissure when 
examined in whole mount view (Fig. 5.16 A,F blue signal; n= 6 eyes), confirming 
the previous observations of the existence of an abnormal endothelial network during 
dissections. Sectioning in the transverse plane through labelled eyes showed a larger 
number of endothelial cells accumulated in the opening of the optic fissure in mutant 
optic cups compared to wild-types (Fig. 5.16 E,J, yellowish-brown signal).
JaggedJ is also expressed in the same region of the ventral mesenchyme as Tbx2 
(Fig. 5.17 C, E). This site of expression suggested that Jaggedl may be dependent on 
Tbx2 and play a role in the development of the hyaloid vasculature. Together with its 
other sites of expression in the neural retina and lens, Jaggedl made an interesting 
gene to examine in Tbx2'/' embryos.
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Fig. 5.16 Com parison of the hyaloid vasculature in Tbx2'/m and wild-type 
eyes a t 10.5 dpc labelled by anti PEC A M I whole-mount immunohistochemistry
(A) Eye vasculature at 10.5 dpc in a wild-type embryo immuno-labelled with anti- 
PEC AMI. Endothelial cells were detected in the periphery of the optic cup, 
encircling the lens and appeared to occupy the optic fissure region (arrow, blue 
signal). (B-E) Complete set of transverse vibratome sections through the eye in A, 
starting from dorsal shown in B to the ventral most region of the eye shown in E. 
Endothelial cells were present between the fissure walls (arrow in E, brown signal). 
(F) PEC AMI immuno-labelling in a 10.5 dpc mutant (-/-) embryo somite matched to 
the embryo in A. Endothelial cells were detected in the periphery of the mutant optic 
cup but in abnormally clustered pattern, especially in the optic fissure region (arrow, 
blue signal) and also in the dorsal side of the lens (arrowhead, blue signal). (G-J) 
Complete set of transverse vibratome sections of the eye in F, starting from the 
dorsal most section shown in G to the ventral most section in J. J shows the large 
number of endothelial cells populating the fissure region in the mutant eye (arrow, 
brown signal). (K) Vibratome section, showing Tbx2 expression in mesenchyme 
ventral to the optic cup (arrowhead). Scale bars: 50 /-im.
Abbreviations: D, dorsal; HL, hyaloid vasculature; L, lens; NR, neural retina; OS, 
optic stalk; ss, somite stage; V, ventral
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Fig. 5.17 Jaggedl expression in Tbx2'/m and wild-type eyes by whole mount 
in situ hybridisation a t 10.5 dpc
(A) Lateral view of a wild-type (+/+) embryo at ss 35 showing expression of 
Jaggedl in the lens epithelium and in the neural retina, where it is excluded from the 
dorsal-most and ventral-most regions. (B) Lateral view of a mutant (-/-) embryo at ss 
34 showing similar expression to the embryo in A. (C) Coronal vibratome section 
through the plane of the dotted line in A. (D) Coronal vibratome section through the 
plane of the dotted line in B. Expression in the extra-ocular mesenchyme is indicated 
by arrowheads in C-D. (E,D) Higher magnifications of the ventral optic cups in C 
and D respectively showing the expression of Jaggedl in the extra-ocular 
mesenchyme (arrowhead), which was similar between wild-type and mutant 
embryos. Scale bars: 0.5 mm in A-B, 0.1 mm in C-F.
Abbreviations: D, dorsal; LE, lens epithelium; NR, neural retina; ss, somite stage; V, 
ventral
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At 10.5 dpc, somite matched mutant and wild-type embryos showed similar patterns 
o f expression o f Jagged 1 in the retina and in the invaginating lens (n= 6 eyes; Fig. 
5.17 A,B). Sectioning o f embryos further revealed that expression o f Jaggedl in the 
ventral mesenchyme was also normal in Tbxl eyes (Fig. 5.17 C-F). These results 
exclude Jaggedl as a downstream target o f Tbx2 in both the neural retina and the 
ventral mesenchyme.
5.2.5 Fgf15expression
In Chapter 3, the expression o f  Fgfl5 was described to be adjacent to the dorsal 
Bmp4 expression domain with some overlap, reminiscent o f the spatial pattern of 
expression o f Fgfs and Bmps in several other tissues where they are known to 
interact (see Chapter 1.4.4). The expression o f Bmp4 and Tbx2 in Fgfl5'f' eyes were 
found to be normal. Meanwhile, another study reported that Bmp4 is essential for the 
expression o f  Fgfl5 in the mouse eye (Murali et al. 2005). Evidence was presented 
in Chapter 4 o f this thesis for Tbx2 being downstream o f Bmp4 signalling in the eye 
and being involved in eye growth. I therefore tested whether Bmp4 could act through 
Tbx2 to regulate or modulate the expression o f Fgfl5 in the central region o f the 
optic cup. Moreover, several o f the identified abnormalities in the Tbx2'/' mice, such 
as the abnormal lens, the potentially increased levels o f Cx43 in the RPE, as well as 
the abnormal hyaloid vasculature are suggestive o f a non-cell autonomous effect. 
Therefore, investigation o f the expression o f an extra-cellular signalling molecule 
such as Fgfl5 was desired.
Fgfl5 expression was examined by in situ hybridisation in Tbx2~/~ embryos. At 10.5 
dpc, expression was completely absent in 4/6 eyes (Fig. 5.18 A-C) and the signal 
intensity was much reduced in the remaining two eyes compared to wild-type somite 
matched controls (Fig. 5.18 B,D). As in previous experiments, wild-type and mutant 
embryos were processed in the same tube and therefore treated in exactly the same 
manner. Fgfl5 expression at other sites in the developing head were similar in all 
embryos. The presence o f Fgfl5 expression in 2/6 mutant eyes, although at reduced 
signal intensity, suggests that Tbx2 is not essential for the induction o f Fgfl5 
expression, but may rather be required for the maintenance o f its expression after it 
has been switched on in the neural retina.
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Fig. 5.18 Fgfl5  expression in  Tbx2'/m an d  w ild-type em bryos by whole 
m ount in situ hybrid isa tion
Arrows indicate nasal and temporal limits of optic cups. (A) Lateral view of two 
wild-types (+/+) and one mutant (-/-) embryoic heads at ss 35 (10.5 dpc) hybridised 
with the Fgfl5 probe and treated in the same tube throughout the experiment. Fgfl5 
expression was evident in two stripes in the nasal and temporal retina in wild-type 
embryos but not in the mutant embryo (arrows). (B) Higher magnification of the 
head of a wild-type embryo at ss 35, showing normal FgflS expression (arrows). (C) 
Higher magnification o f the head o f a mutant embryo at ss 35, showing lack of 
expression in the eye (arrows) but not the midbrain. (D) Lateral view of the head of a 
mutant embryo at ss 35, showing low levels of Fgfl5 expression in the eye (arrows). 
This embryo was treated in the same tube as embryo shown in B. (E) Lateral view of 
the head of a mutant embryo at the optic vesicle stage (ss 28), showing Fgfl5 
expression in its characteristic two stripes in the nasal and temporal optic vesicle 
(arrows). Scale bars: 1 mm in A, 0.5 mm in B-E.
Abbreviations: D, dorsal; ss, somite stage; V, ventral
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Examination o f Fgfl5 expression at an earlier stage, prior to optic vesicle 
invagination, in Tbx2'/' eyes revealed normal expression (n= 2 eyes; Fig. 5.18 E). 
This supports the idea that Tbx2 is important for the maintenance o f Fgfl5 
expression but not for its induction in the developing mouse eye.
5.3 Discussion
5.3.1 Summary of findings
The aims o f this Chapter were to investigate whether the role o f the dorsally 
expressed Tbx2 in the optic cup is to regulate molecular patterning along the D-V 
axis of the eye, and whether Tbx2 is required for early eye morphogenesis and 
growth. The strategy employed was a loss o f function approach by analysing mice 
with a targeted mutation in Tbx2. The results obtained suggest the following:
1) Tbx2 is not essential for optic vesicle invagination, but is required for coordination 
of invagination on the basis that invagination o f the ventral eye is delayed.
2) In the absence o f Tbx2, retinal volume is significantly smaller than normal at 10.5 
dpc, suggestive o f an important role in the regulation o f eye size.
3) A shape change was observed at 12.5 dpc, with the optic cup appearing shorter 
along the P-Di axis, and protruding much less than in stage matched wild-type eyes.
4) Tbx2 is not essential for the induction o f dorsally expressed genes; there is no 
feed-back regulation o f  Bmp4 by Tbx2 and all genes examined were present. Neither 
is Tbx2 essential for the establishment o f the dorsal neural retina-RPE border. The 
expression o f several genes are however altered in the absence o f Tbx2 in a way 
which suggests that Tbx2 may be important for maintaining their correct expression 
patterns/levels. These include Tbx5, EphrinB2, Fgfl5, and Cx43.
5) Investigation o f several growth limiting mechanisms as potential causes o f the 
small eye phenotype excluded excessive cell death, precocious cell differentiation,
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and expansion o f the RPE domain at the expense o f the neural retina. Instead, a trend 
o f increased cell proliferation was detected in mutants.
6) A range o f other phenotypes were observed including failure o f /delayed eye lid 
groove formation, abnormal lens growth and lens fibre differentiation, disorganised 
intra-retinal axonal projections, and abnormalities within the vitreous including 
abnormal development o f  the hyaloid vasculature.
5.3.2 Tbx2 in eye morphogenesis, early growth, and differentiation of 
the eye
Analysis o f the number o f pH3 positive cells in the dorsal eye, revealed a higher 
number of mitotic cells in mutant eyes at ss 30-31 in comparison to somite matched 
wild-types. This is in spite o f a significant reduction in retinal volume 2-5 somite 
stages later (ss 33-35). There could be several explanations for this result. Firstly, as 
the number o f pH3 positive cells were low, it is possible that this increase has no 
significant effect on eye growth, at least not an effect that would be immediately 
obvious. Because ectopic apoptosis in the dorsal eye was not detected, the effect of 
increased cell death cannot have counteracted the increased proliferation to yield a 
small eye. In further support o f this conclusion, in situ hybridisation using a full- 
length Tbx2 RNA probe to detect cells that would have expressed Tbx2 in mutant 
embryos, confirmed the presence o f this population o f cells at apparently normal 
density in their usual region. Instead, other factors or mechanisms must be 
responsible for the small eye phenotype. Delayed invagination of the ventral optic 
cup, which was observed at early 10.5 dpc, when retinal volume measurements were 
taken, could indeed result in a small eye phenotype. This suggests that two different 
mechanisms are aberrant in the absence o f Tbx2 in the developing eye; one is 
proliferation o f the dorsal neural retina, the other, invagination o f the ventral region 
of the developing eye. An enlarged sub-retinal space in the naso-ventral (and 
sometimes in the dorsal) side o f the developing eye was consistently observed and 
may represent a true regionally restricted abnormality with a functional significance. 
Typical coloboma, the most frequent type o f coloboma, occurs in the inferio-nasal 
quadrant o f the human eye (Onwochei et al. 2000).
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An increase in cell proliferation in the absence o f Tbx2 correlates well with the role 
of Tbx2 elsewhere in embryogenesis. In the developing heart, the expression sites of 
Tbx2 in non-chamber myocardium including the A VC and the outflow tract are 
associated with lower proliferation than the Tbx2 negative chamber tissue (Cai et al. 
2005). The chamber tissue in the Tbx20 targeted mutant mouse, ectopically expresses 
Tbx2 and possesses a lower mitotic rate than detected in wild-types, resulting in the 
formation o f a hypoplastic heart. It has been suggested that the cardiac defect in 
Tbx20'/' mice is due to the ectopic expression o f Tbx2 in chamber tissue (Cai et al. 
2005; Singh et al. 2005). Furthermore, Tbx2 was shown to directly repress the 
expression o f the oncogene Nmycl, which was downregulated in Tbx20'/' chamber 
tissue (Cai et al. 2005). In Tbx2~f~ mice, chamber tissue differentiation occurs at the 
expense o f A VC formation, though when cell proliferation was analysed in whole 
hearts, no differences were found between mutants and wild-types (Harrelson et al. 
2004).
There are a lot o f reports that link Tbx2 to the control o f the cell cycle, via the 
inhibition o f various CDKIs, including p21 and p l S ^ 1". In vitro studies suggest that 
Tbx2 acts to promote cell cycle progression/cell division (see Chapter 1.3.5). These 
reports correlate with reports that TBX2 is amplified in a subset of primary breast 
tumours, breast tumour cell lines, and pancreatic cancer cell lines (Jacobs et al. 2000; 
Barlund et al. 2000; Sinclair et al. 2002; Mahlamaki et al. 2002; Vance et al. 2005). 
However, a similar repression o f CDKIs by Tbx2 during development has not been 
found. In fact the evidence from the developing heart, and results presented in this 
Chapter, point towards an opposite role, where Tbx2 expression is required to slow 
down proliferation. Analysis o f the expression levels o f p21, p l b ^ 43, p i 5 INK4b, and 
p i9 arf in the developing heart revealed that these genes are not affected by the lack 
of Tbx2 during heart development at least (Harrelson et al. 2004). Moreover, 
investigation o f a genetic interaction with p53, where the absence of Tbx2 was 
hypothesised to be compensated for by the absence o f p53 in mice doubly 
homozygous for Tbx2 and Trp52, revealed that these pathways are independent as 
there was no rescue o f the heart phenotype (Harrelson et al. 2004). It is still possible 
that Tbx2 directly regulates cell cycle genes also in development, although these may 
be a different set o f genes than those identified in adult cancer tissues/from adult 
studies. The identification o f NMycl as a target in heart development encourages
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future searches for other cell cycle genes that may be regulated by Tbx2 during 
embryogenesis.
If additional time and resources were available to me, analysis of more embryos 
combined with BromodeoxyUridine (BrdU) labelling, which allows tracing of 
several rounds o f cell divisions over a period o f time rather than a snap-shot of the 
state o f cell division offered by pH3 immuno-labelling, would be undertaken. This 
would give a better answer to the effect o f loss o f Tbx2 on cell proliferation. 
Alternatively or in combination, DNA flow cytometry would offer insight into the 
regulation o f the cell cycle in the absence o f Tbx2 by detecting the proportion of 
cells within each phase o f the cell cycle in mutant eyes in comparison to wild-types. 
Finally, pH3 immuno-labelling performed at a later stage would be helpful.
Other avenues responsible for the eye size phenotype were also investigated. 
Analysis o f the RPE specific gene Silver, served to address whether Tbx2 is 
important for setting the dorsal neural retina-RPE boundary. It was shown that this is 
not the case, as Silver was expressed in a normal spatial pattern. Moreover, this 
experiment together with correct localisation o f Cx43 protein to the RPE, showed 
that the small eye phenotype is unlikely to be due to the expansion of the RPE at the 
expense o f the neural retina, which has been reported to occur in Chxl0OrJ/OrJ mice 
(Horsford et al. 2004; Rowan et al. 2004). ChxlO, like Tbx2 is under the regulation 
of Bmp signalling in the eye as ChxlO expression is absent in Bmp receptor 
compound mutants (Murali et al. 2005). In situ hybridisation o f Tbx2 in Chxl0OrJ/OrJ 
showed that Tbx2 expression was normal in the absence o f ChxlO, positioning Tbx2 
in an independent pathway, or perhaps upstream o f ChxlO during mouse eye 
development. However, several pieces o f data presented here argue against the latter. 
In Tbx2'/‘ eyes, RPE specific genes do not extend into the neural retina, whereas in 
Chxl0OrJ/OrJ embryos, several RPE genes are ectopically expressed in the neural 
retina (Horsford et al. 2004; Rowan et al. 2004). Moreover, differentiation is delayed 
in Chxl0OrJ/OrJ eyes (Burmeister et al. 1996), whereas it was detected at 12.5 dpc in 
Tbx2'f' eyes. Together, these observations suggest that Tbx2 is likely to be regulating 
eye size via a different pathway than to ChxlO.
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Interestingly, in a recent study employing morpholino-mediated knockdown of 
Tbx2b, the zebrafish homologue o f the mouse Tbx2 gene, differentiation of all retinal 
cell types except the RGCs was transiently blocked in the dorsal, but not the ventral 
neural retina, although the expression o f all D-V patterning genes investigated was 
normal (Gross and Dowling 2005). In Tbx2~/~ mice it was not possible to examine 
differentiation past 12.5 dpc. Further analysis and the use o f conditional knockout 
technology to overcome the lethality o f the Tbx2' allele is needed to investigate 
whether this is also true in the mouse or whether it is species specific.
5.3.3 Role of Tbx2\n D-V patterning
Establishment o f molecular patterning o f the D-V axis o f the eye occurs properly in 
the absence o f Tbx2, as most asymmetrically expressed genes examined were present 
at 10.5 dpc. However, Tbx5 expression was reduced in Tbx2~f~ eyes. This reduction 
appeared independent o f the reduced eye phenotype o f Tbx2~f~ embryos, as Msx2, 
Bmp4, and Tbx3 expression in the dorsal neural retina were normal in mutants. At 9.5 
dpc, Tbx5 expression is identical in wild-type and mutant embryos (personal 
communication with Z. Harrelson, Columbia University, NY). These observations 
suggest that Tbx2 is not required for the initial expression o f Tbx5, but rather for its 
maintenance. Examination o f Tbx5 expression at a later developmental stage would 
test this hypothesis, because if  maintenance o f Tbx5 expression is dependent on 
Tbx2, the expected result would be a loss o f Tbx5 expression in an older embryo.
In Chapter 3 it was shown that Noggin treatment o f the optic cup at 11.5 dpc had no 
effect on D-V patterning including the expressions o f Tbx2 and Tbx5, whereas earlier 
treatment induced changes in these genes. One interpretation o f this outcome, as 
discussed in Chapter 4, is that T-box gene expression as well as overall D-V 
patterning is dependent on Bmp4 signalling for its induction, but not for its 
maintenance. In this Chapter, it was found that Tbx5 expression was reduced, in the 
absence o f a change in expression o f Bmp4 or Bmp signalling, as indicated by the 
normal expression o f the Bmp4 downstream target Msx2, suggesting that perhaps 
Bmp4 induces, while Tbx2 maintains Tbx5 expression. That maintenance o f Tbx5 
expression may be independent o f Bmp signalling and hence its induction, is 
supported by another study in which Tbx5 expression is spatially normal when
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Noggin is misexpressed in the chick eye at HH 15-18 (Adler and Belecky-Adams 
2002). This is one day after Tbx5 expression is first detected in the chick eye 
(Koshiba-Takeuchi et al. 2000) and a relatively late stage in optic cup 
morphogenesis; differentiation has already initiated (Martinez-Morales et al. 2005).
Vax2 expression in the ventral optic cup also appeared reduced in Tbx2'/' mutants. As 
optic cup formation is particularly delayed in the ventral region, this is likely to be a 
reflection o f the abnormal ventral eye morphogenesis. Analysis o f more markers of 
the ventral optic cup such as Pax2 or EphB3 could help to confirm this interpretation. 
However, it would be possible that Tbx2 affects the expression o f Vax2 in the ventral 
eye via a secreted factor.
Analysis o f ephrinB2 expression revealed that even though Tbx2 is not required for 
the induction o f ephrinB2, it appears to play a role in regulating its pattern of 
expression in both the lens and in the neural retina. Expression analysis at later stages 
combined with quantitative measurement o f transcripts are required to verify these 
data and to determine the quantity o f the change in levels o f ephrinB2 expression in 
Tbx2'/~ mice.
Although not possible to examine in the Tbx2~/~ mice, the altered expression of 
ephrinB2, Tbx5, and possibly that o f Vax2 is likely to have functional consequences 
for topographic mapping o f RGCs to the superior colliculus, as several studies have 
shown that these genes are critical for correct topographic mapping (Mann et al. 
2002; Koshiba-Takeuchi et al. 2000; Barbeiri et al. 2002). When wild-type ephrinB2 
is overexpressed into the dorsal Xenopus neural retina, which normally already 
expresses high levels o f ephrinB2 and projects axons to the lateral tectum, the 
dorsally derived axons project even more laterally than normal. Misexpression o f a 
truncated ephrinB2, which is thought to act in a dominant negative manner to dilute 
out the natural ephrinB2 signalling in that region, into the dorsal neural retina causes 
a medial shift o f dorsally derived axons (Mann et al. 2002). The incidence of ectopic 
projections o f ventro-temporally derived axons, which normally express high levels 
of EphB receptors, to more lateral regions o f the superior colliculus in EphB2+/~; 
EphB3'~ compound mutants is lower than the incidence observed in EphB27 / EphB3 
' mutants (Hindges et al. 2002). Therefore it appears that the ephrinB/EphB receptor
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ligands act in a dosage dependent manner to mediate topographic mapping o f RGC 
axons to the brain and that changes in the dosage or pattern o f these molecules has a 
direct functional translation in the form o f a shift in axonal projections to ectopic 
locations.
5.5.4 Cx43
Analysis o f the expression o f Cx43 in the developing mouse eye at 10.5 dpc, 
revealed that it is confined to the RPE. In Tbx2~/~ embryos, Cx43 expression appeared 
elevated in the RPE. This is indicative o f the action o f a secreted intermediary, as 
Tbx2 itself is never expressed in the RPE.
Cx43 is a gap junction protein which hexamerises to form a hemi-channel. Hemi- 
channels in neighbouring cells interact to form gap junctions. Gap junctional 
communication has been implicated in many developmental processes including the 
control o f cell proliferation in the eye (Pearson et al. 2005). Previous reports have 
suggested that gap junctional coupling mediated by Cx43 in the chick retina is 
positively correlated with retinal cell proliferation, as antisense 
oligodeoxynucleotide-mediated suppression o f Cx43 expression reduces cell 
proliferation (Becker and Mobbs 1999). The mechanism by which gap junctional 
communication may affect cell proliferation in the retina has been suggested to be 
related to the control o f interkinetic cell movement o f neural progenitor cells. Retinal 
progenitors migrate to and fro between the vitreal surface and the ventricular surface, 
which is the site o f mitosis (Sidman 1961). Electroporation o f dominant-negative 
Cx43 in chick retinal flat mounts reduces the speed o f interkinetic cell movements, 
while misexpression o f Cx43 has been shown to increase this speed compared to 
controls (Pearson et al. 2005). A change in the speed at which proliferating cells 
reach the ventricular surface, where they appear to receive the signal to undergo 
mitosis, may result in fewer or more cell divisions. Based on the study of Cx43 in the 
developing chick eye, if  Cx43 is upregulated, increased cell proliferation should 
occur. Although the difference in mitotic index in the dorsal neural retina between 
Tbx2'/‘ and wild-type embryos was statistically not significant, the number o f mitotic 
cells were on average doubled, in agreement with increased cell division upon 
upregulation o f Cx43. However, it should be noted that in the older chick retina,
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where Cx43 has been studied in relation to retinal cell division, Cx43 was expressed 
in the RPE but also in the neural retina, mediating coupling between retinal 
progenitors. At 10.5 dpc, in studies performed here, Cx43 was not detected in the 
neural retina, and the effect o f Cx43 in the RPE at this stage, on retinal cell division, 
is currently unknown.
Interestingly, during the analysis o f Cx43 expression, it was noted that its expression 
is asymmetrical and distributed in a dorsal-high ventral-low gradient at 10.5 dpc. At 
this stage the dorsal region o f the eye has invaginated and the outer layer is 
morphologically thinner than the inner layer, although it is not yet pigmented. The 
ventral portion o f the eye is lagging in invagination and the outer layer is still thicker 
than expected for the RPE.
5.5.5 Fgf15 as the downstream effector of the non-cell autonomous 
phenotypes Identified In Tbx2-/- embryos
The presence o f Fgfl5 expression in the optic vesicle but its absence in 4/6 eyes in 
the optic cup suggest that Tbx2 is required for the maintenance, but not induction, of 
Fgfl 5 expression in the neural retina. The variability in gene expression may reflect 
the variability in the expressivity o f  the phenotype, in which case only affected 
embryos showed the lack o f Fgfl5 expression. Tbx2 and Fgfl5 are not completely 
co-expressed at 10.5 dpc when Tbx2 appears to be required for the maintenance of 
Fgfl5, suggesting that this regulation is indirect and mediated via another secreted 
factor. The known secreted factors that are specifically expressed or synthesised in 
the dorsal optic cup include Bmp4 and RA. Bmp4 expression and the expression of 
its downstream target Msx2 were directly analysed and shown to be normal in Tbx2'f' 
eyes. On this basis, the most likely intermediary factor to maintain Fgfl5 expression 
in the eye is RA. Aldhlal, the gene encoding a RA synthesising enzyme, is 
expressed in the dorsal neural retina but synthesises RA with a lower efficiency than 
the ventrally expressed Aldhla2 (Griin et al. 2000), which synthesises RA with a 
high efficiency. This is thought to account for the lower levels o f RA being present 
in the dorsal eye in comparison to the ventral eye. Interestingly, a middle domain, 
which is just dorsal to the optic disc but ventral to the expression o f Tbx2 is kept free 
from RA by the presence o f cytochrome P450-linked oxidases encoded by Cyp26
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enzymes which degrade RA (Sakai et al. 2004). It would be interesting to analyse the 
expression o f RA synthesising and degrading enzymes in Tbxl'' embryos.
Interestingly, many o f the phenotypes observed in RA deprived/deficient embryos is 
similar to those observed n Tbx2'/' embryos. RA deficiency in zebrafish embryos 
results in lack o f ventral neural retina formation (Marsh-Armstrong et al. 1994). RA 
deprivation in mammals causes microphthalmia and anophthalmia (Kalter and 
Warkany 1959), while retroviral driven expression o f a dominant negative form of 
RARa, which is one o f the nuclear RA receptors that mediates the RA signal 
intracellularly, in the developing chick eye results in a small eye phenotype (Sen et 
al. 2005). Other similar abnormalities include shortening o f the ventral neural retina, 
expansion o f the ventral extra-ocular mesenchyme, failure o f eye lid groove 
formation, and hyperplasia o f  the hyaloid vasculature, which were detected in 
Aldhlal; Aldhla3 compound null mutants (Matt et al. 2005).
Fgfl 5 was identified relatively recently (McWhirter et al. 1997). The proposed 
receptor for Fgfl 5 is FgfR4 (Xie et al. 1999). There is evidence from 
over/misexpression studies that Fgfs/FgfRs play a role in lens development including 
induction, proliferation, and differentiation (Faber et al. 2001; Lovicu and Overbeek 
1998). However, the identity o f the Fgfs that convey these effects during normal 
development is currently unknown, as no mouse mutants have revealed a lens 
phenotype. Based on the fact that double targeted disruption o f the only two Fgfs that 
are endogenously expressed in the mouse lens vesicle, Fgfl and Fgf2, does not result 
in any ocular defects (Miller et al. 2000), it has been proposed that an Fgf secreted 
from the neural retina into the vitreous chamber may be important for lens 
development, and that it may be Fgfl 5 (Govindarajan and Overbeek 2001). The 
chick and human Fgfl 9 are the closest homologues o f the mouse Fgfl 5 (Xie et al. 
1999; Wright et al. 2004), exhibiting similar but not identical gene expression 
patterns in the eye (Kurose et al. 2004). Electroporation o f Fgfl9 in the surface 
ectoderm overlying the optic vesicle in the chick embryo does not result in any eye 
defects, although the authors state that perhaps this is due to insufficient levels o f 
overexpression or that Fgfl 9 may need a synergising partner to induce its effect 
(Kurose et al. 2005). Until more is known about the role o f Fgfl 5 in eye 
development, the significance o f the lack o f maintenance of Fgfl 5 expression is
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highly speculative. However, being one o f the few secreted factors expressed in the 
neural retina, it is a good candidate for causing the non-cell autonomous eye defects 
identified in Tbx2'f' embryos.
Fgfl 5 could also potentially be important for guidance o f  axons towards the optic 
disc. A proportion o f early axons within the rat retina (13.5 dpc) are severely 
misrouted when the retina is treated with an FGFR blocking antibody against the 
extracellular portion o f FGFR protein, indicating that FGFR signalling is implicated 
in intra-retinal organisation and guidance (Brittis et al. 1996). The creation of 
conditional alleles to disrupt Tbx2 specifically in the developing eye, hence 
bypassing the heart defect, would allow further characterisation o f the disorganised 
axonal projections observed in the absence o f Tbx2. Alternatively, the role of Tbx2 in 
intra-retinal axonal projections can be investigated with other in vivo manipulation 
strategies such as misexpression o f Tbx2 or knock-down o f Tbx2 using somatic cell 
gene delivery to the developing eye directly.
5.3.6 Variable expressivity of the phenotype and genetic compensation
The expressivity o f  the eye phenotype in Tbx2'f' mutants was variable. The same was 
reported for the heart phenotype (Harrelson et al. 2004). Two common explanations 
for such variability include the existence o f genetic modifiers, which if true, a more 
homogenous phenotype is expected on a defined inbred background. The other is 
stochastic developmental effects. The fact that the Tbx2 mice are on a mixed genetic 
background, strain-specific genetic modifiers could potentially explain the variable 
phenotype. However, Harrelson et al. concluded that the expressivity o f the 
phenotype did not change on an inbred background, although their study did not 
include an analysis o f the eye (Harrelson et al. 2004). Another explanation offered by 
Anderson and colleagues, which may be relevant here is natural variation in Bmp 
signalling (Anderson et al. 2002), which was also suggested by Chang and 
colleagues in their analysis o f adult mice heterozygous for Bmp4 (Chang et al. 2001). 
Downstream targets o f Bmp signalling other than Tbx2, including Tbx3 and Msx2 are 
normally expressed and could potentially convey the variability in Bmp signalling. If 
Tbx3 has the potential to compensate for the Tbx21 phenotype, then a variation in 
Bmp signalling between embryos could contribute to the severity o f the phenotype.
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Tbx2 and Tbx3 are highly related paralogous genes (Agulnik et al. 1996), and are 
expressed in overlapping or identical regions in the embryo (Chapman et al 1996). 
They are both implicated in cell cycle control (see Chapter 1.3.5). Therefore, it is 
likely that they mediate the same or similar effects and can compensate for each 
other. Furthermore, there is recent evidence o f a genetic interaction between Tbx2 
and Tbx3 in mammary gland development where they also overlap in expression; 
Tbx2 heterozygosity does not result in any defects although in combination with 
Tbx3 heterozygosity, which itself has an effect on the maintenance o f mammary 
placodes, the Tbx3 haploinsufficient phenotype o f mammary gland aplasia and 
hypoplasia is enhanced (Jerome-M ajewska et al. 2005). A similar study for eye 
development could be carried out once the loss o f function Tbx3 eye phenotype is 
characterised, which would shed light on the issue o f expressivity o f phenotype and 
possible compensation.
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CHAPTER 6 Analysis of eye size, retinal cell 
differentiation, and intra-retinal axonal projections after Tbx2 
misexpression in the developing chick eye
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6.1 Introduction
In Chapter 4, eye size was significantly reduced upon rhBMP4 coated bead 
implantation in the lens vesicle. Although the T-box genes were ectopically 
expressed in these eyes, the experimental approach was not suitable for addressing 
the question o f whether a particular T-box gene or a combination o f the T-box genes 
regulate eye size. The loss o f function approach used in Chapter 5 provided direct 
evidence that Tbx2 is indeed implicated in eye size regulation, as Tbx2'/' embryos 
possessed smaller retinal volume than wild-type littermates. My next aims were to 
directly misexpress Tbx2 and Tbx3 in the ventral neural retina in the mouse embryo, 
first individually and then in combination, during the same developmental period as 
when rhBMP4 coated bead implantations had been performed. This would allow the 
investigation o f the direct effect o f Tbx2 and Tbx3 misexpression on eye size. 
M isexpression studies provide a complementary approach for the analysis o f gene 
function and can be a useful strategy for genes that are co-expressed with their 
closely related homologues in a tissue, like Tbx2 and Tbx3. It allows the study o f the 
gene o f interest in a similar environment, i.e. the tissue o f interest, but in the absence 
o f its closely related family members. For example, the ectopic expression of Tbx2 in 
the ventral neural retina, where the other T-box genes are not expressed, would allow 
one to examine the role o f Tbx2 in the context o f eye development without the 
interference o f endogenous expression o f the other dorsally expressed T-box genes.
Analysis o f Tbx2" embryos also revealed disorganisation o f the intra-retinal axonal 
projections, but further analysis was prevented by the onset o f  embryonic lethality in 
these mice. The second aim o f this study was therefore to further investigate the role 
of Tbx2 in retinal cell differentiation and intra-retinal axonal organisation. RGCs 
require precise positional information in order to project their axons correctly to their 
targets in the brain (see Chapter 1.2.2.2). Not only do the RGCs need to know where 
they reside within the retina, but their axons require positional cues in order to 
navigate towards the optic disc and beyond after exiting the optic cup. The 
asymmetrical expression pattern o f Tbx2 along the D-V axis o f the neural retina 
makes it a potential candidate in either providing positional identity to the RGCs or 
directing the migration o f RGC axons from the dorsal neural retina towards the optic
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disc via a cell intrinsic or extrinsic mechanism. A role for Tbx2 in RGC axonal 
pathfmding has not previously been investigated.
To misexpress the T-box genes, a gene delivery method suitable for targeting the 
embryonic eye was needed. Current available methods for gene delivery to tissues 
involve inducing alterations to the property o f cell membranes by the application o f 
an electric current, which enables penetration o f molecules by opening transient 
pores through which they enter the cell. This is the method o f electroporation. 
Alternatively gene delivery methods rely on receptor mediated uptake by the cell, 
which is the basis for viral gene delivery. Other non-viral methods such as 
microparticle bombardment and lipofection have also been utilised, but 
electroporation yields the strongest reporter gene expression among non-viral gene 
delivery methods (M uramatsu et al. 1997).
In this Chapter, electroporation was tested for its suitability to deliver plasmid DNA 
to the embryonic eye. Because one o f  the aims o f the study was to examine eye size, 
it was important that the experimental procedure itself did not cause non-specific 
changes to eye morphology, which needed to be retained in an excellent condition. 
The technique also had to allow good levels o f exogenous gene expression in the 
developing eye. One o f  the main advantages o f electroporation over viral delivery 
methods is that exogenous gene expression can be detected relatively soon after 
electroporation (2-5 hrs depending on promoter; Davidson et al. 2003; Osumi and 
Inoue 2001) and that multiple constructs can be co-electroporated simultaneously. 
Furthermore, insert size is not a limiting factor (Morgan and Fekete 1996).
At the time when experiments described in this Chapter were undertaken, there had 
only been a few reports o f electroporation in the mouse embryo involving targeting 
o f cDNA or morpholinos to gastrula stage embryos, and in older embryos where the 
developing brain was targeted (Itasaki et al. 1999; Swartz et al. 2001; Osumi and 
Inoue 2001; Calegari et al. 2002; M ellitzer et al. 2002; Davidson et al. 2003). 
However, to date, there have been no reports o f gene delivery by electroporation to 
the embryonic mouse eye. This may partly be due to the existence o f other 
established, although more time consuming, means o f genetic manipulation in the 
mouse, such as targeted mutagenesis in ES cell lines from which genetically altered
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mice can be derived, or the creation o f  transgenic animals. Also other issues such as 
limited culture period ex utero (1-2 days in embryo culture from our own experience 
and (Martin and Cockroft 1999) or the difficulty o f  growing embryos in utero after 
manipulations, present technical challenges for the usage o f the mouse as a model 
system in combination with electroporation.
Since culturing o f  mouse embryos during the period o f optic cup formation was 
successfully performed in Chapter 4, electroporation as a means o f gene delivery to 
the optic cup was explored and different variables were tested in this chapter for the 
purpose o f achieving optimised m isexpression o f the T-box genes during optic cup 
formation. Due to difficulties encountered in gene delivery by electroporation to both 
the developing mouse and chick eyes, the RCASBP retroviral vector was used to 
misexpress the chick Tbx2 cDNA in the developing chick eye. Prior to undertaking 
the misexpression study, the onset o f Tbx2 expression in the chick presumptive 
ocular tissues and its continued expression in the developing eye until HH 25 was 
examined, as a detailed analysis had previously not been reported. After Tbx2 
misexpression, eye size, early retinal cell differentiation, and intra-retinal axonal 
projections were analysed.
6.2 Results
6.2.1 Electroporation as a gene delivery method for the developing eye
6.2.1.1 Mouse electroporation followed by whole embryo culture
The objective o f this part o f the study was to efficiently deliver and express the 
pIRES2-EGFP reporter construct in the mouse neural retina at 11.5 dpc without 
causing damage to the electroporated tissue. Furthermore, survival o f the embryo for 
another ~15-18 hours beyond electroporation was vital.
Previous studies employing electroporation in early post implantation to mid 
gestation mouse embryos had used currents at 10-40 Volts, which were delivered in 
up to 5 pulses o f 30-50 milliseconds (msec) duration at 1 second (sec) intervals
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(Swartz et al 2001; Calegari et a l 2002; Davidson et a l 2003). With this as a 
guideline, various experimental parameters were tested, including the strength o f the 
electric field and the number o f pulses, the type o f electrodes, and the site o f DNA 
injection (Table 6.1). The setup had to be modified depending on the type of 
electrodes used. These are described in Chapter 2.6.2.4. The level o f transfection was 
assessed by the strength and area o f  EGFP fluorescent cells in embryos that were 
successfully cultured overnight. The state o f health o f embryos pre- and post-culture 
was assessed as previously described in Chapter 4, and embryos were considered to 
have shown satisfactory growth if  their somite count was increased by six pairs or 
more after overnight culture (—15-18 hrs) and if  they were healthy without 
morphological deformities. From all experimental parameters that were altered, a 
change in voltage had the highest impact on EGFP expression and embryo survival.
Table 6.1 Reporter gene expression and embryo survival in m ouse electroporation
experiments
Electrodes Voltage Site of EGFP expression % showing % survived
injection
strong weak none
strong 
EGFP (n)
culture (n)
gold 20 vitreous 0 2 0 0% (0/2) 0% (0/2)
25 N/A* N/A* N/A* N/A* N/A* 50% (2/4)
30 N/A* N/A* N/A* N/A* N/A* 50% (2/4)
30 vitreous 0 1 1 0% (0/2) 100% (2/2)
gold/tungsten 30 vitreous 1 7 1 11% (1/9) 78% (7/9)
35 vitreous 0 3 0 0% (0/3) 0% (0/3)
silver 20 vitreous 0 3 0 0% (0/3) 100% (3/3)
30 vitreous 2 1 0 67% (2/3) 100% (3/3)
35 vitreous 4 1 1 67% (4/6) 83% (5/6)
35 SR space 1 4 5 10% (1/10) 70% (7/10)
40 vitreous 1 0 1 50% (1/2) 100% (2/2)
40 SR space 1 2 1 25% (1/4) 75% (3/4)
* embryos were electroporated but not injected with DNA.
[DNA]= 1.8 pg/pl- Current was delivered in five pulses of 50 msec duration with 1 sec intervals for all 
embryos shown in table. Embryos were considered to have grown during overnight culture if they 
showed an increase of at least 6 somite pairs compared to their pre-culture state. N/A, not applicable; 
SR space, sub-retinal space.
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Fig. 6.1 E G F P  expression in  11.5 dpc  m ouse em bryos e lectroporated  w ith 
pIR E S2-E G FP
Lateral views o f post-culture embryos (overnight) injected with 1.88 ng/fil DNA in 
the vitreous cham ber and electroporated using various conditions. (A) Embryo 
injected with 5 pulses at 30 V with the tungsten/gold electrode combination. Low 
levels of EGFP were expressed in the surface ectoderm surrounding the eye. (B) 
Image in A merged with a brightfield view to show the morphology of the head. (C) 
Embryo electroporated with 5 pulses at 30 V with silver electrodes. Low levels of 
EGFP expression were detected in the surface ectoderm. (D) A brightfield image 
merged with the picture in C. (E) Em bryo electroporated with 5 pulses at 35 V with 
silver electrodes. High levels o f EGFP expression were detected. (F) A brightfield 
image merged with the picture in E. EGFP expression was absent in the optic cup. 
Scale bars: 0.5 mm.
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Although good levels of EGFP expression were detected in the lens and in the extra­
ocular mesenchyme, especially with the silver electrodes, and embryo morphology 
and survival were good after electroporations, none of the electrodes or varying field 
strengths tested were successful in driving EGFP expression in the mouse neural 
retina (Fig. 6.1). Therefore, I decided to test electroporation in the chick embryo, 
where targeting of the neural retina had been reported in several studies.
6.2.1.2 ln-ovo chick electroporation
There are several advantages in using the chick embryo for misexpression studies. In 
ovo electroporation is technically much easier to perform than electroporation in the 
mouse embryo, as the chick embryo is held in place inside o f the egg. The little time 
it takes to prepare the embryo for electroporation also means that far more embryos 
can be manipulated in each experiment in comparison to an experiment involving 
mouse embryo culture. In addition, electroporation can be performed at an early 
embryonic stage and the embryo can be developed until hatching if required, whereas 
the mouse embryo can only be successfully cultured for 1-2 days in vitro as 
mentioned earlier. This makes the study of later events of eye development, such as 
retinal cell differentiation and RGC axonal projections, more feasible in the 
manipulated chick embryo. Furthermore, as well as growing outside of the yolk sac, 
the early chick embryo lies flat on the surface of the yolk, making it very accessible 
for manipulations and placement of electrodes.
The objective was to first optimise gene delivery to the chick neural retina by 
electroporation, in order to achieve high levels of transgene expression, high embryo 
survival, and no adverse effects on eye size or morphology. Electroporations were 
performed at HH 9-10, when the primary optic vesicles are first distinguished. These 
stages were chosen in order to target the eye prior to the stage when the T-box genes 
are expressed asymmetrically in the dorsal neural retina. Like the mouse 
electroporation experiments, various parameters were tested and changed, including 
the electrodes, the setups of which were described in Chapter 2.6.2.5. The reporter 
constructs used here were pIRES2-EGFP and RCAS-AP (see Chapter 2.6.21 for 
descriptions), which encodes the human placental alkaline phosphatase in a retroviral 
vector. After electroporation and a further two days in culture, the percentage
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survival of embryos was calculated and EGFP expression, as well as the occurrence 
of eye abnormalities were scored within survivors (Table. 6.2).
Table 6.2 Reporter gene expression and embryo survival in chick electroporation
experiments
Electrodes plRES2- Voltage %
EGFP expression
% showing
EGFP- survived* abnormal eye
fr/g//#l] <n) in
survivors 
% (n)
% strong 
(n)
% in eye 
(n)
morphology
(n)
Gold 0.88 20 39%(17/44)
82%
(14/17)
14%
(2/14)
64%
(9/14) 30% (5/17)
1.88 20 44%
(16/36)
88%
(14/16)
29%
(4/14)
21%
(3/14) 13% (2/16)
1.88 15 62%
(6/8)
50%
(3/6)
33%
(1/3)
0%
(0/3) not recorded
gold/tungsten 0.88 20 80%(12/15)
not
recorded
not
recorded
not
recorded 100% (12/12)
0.88 10 100%
(8/8)
50%
(4/8)
0%
(0/4)
0%
(0/4) 50% (4/8)
* % survival 2 days post electroporation.
Current was delivered in five pulses of 50 m sec duration with 1 sec intervals for all embryos shown in 
table.
Abnormal eye morphology included unilateral or bilateral small eye size, absence of optic cup, cyclopia, 
and in most severe cases, absence of entire forebrain.
These analyses showed that it was possible to deliver DNA at sufficient levels to the 
optic vesicle in the chick embryo, using the gold plated electrode setup (6.2 A-C). 
However due to the high incidence of eye and forebrain abnormalities induced by the 
electroporation procedure (Fig. 6.2 D-F, Table 6.2), this method was deemed 
inappropriate for the investigation of the effect of T-box gene misexpression on eye 
size. Instead, it was decided to use retroviral gene delivery, which only involves 
microinjection of the viral suspension.
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Fig. 6.2 M orphology and transgene expression in electroporated chick 
embryos
(A) Lateral view of an electroporated embryo one day post electroporation at ~HH 
17. The embryo is in ovo  and covered by vascularised membrane. It was injected 
with 0.88 /xg//xl of pIRES2-EGFP and 0.66 /xg//xl of RCAS-AP plasmid DNA into 
the optic vesicle lumen a t HH 10 and electroporated with gold plated electrodes at 20 
Volts, 5 pulses of 50 m sec duration, 1 sec intervals. EGFP expression was detected in 
the neural retina (arrow). (B) Same embryo as in A, two days after electroporation at 
HH 20. EGFP expression was widely detected in the optic cup (arrow). (C) Same 
embryo as in A-B after the development of the alkaline phosphatase (AP) enzymatic 
colour reaction. RCAS-AP was expressed in the optic cup, but also in parts of the 
forebrain. (D) Anterior view of the head of an embryo at HH 25 after electroporation 
with the gold/tungsten combination electrodes with 20 V, 5 pulses of 50 msec 
duration, 1 sec intervals at HH 9. The embryo appeared cyclopic without a forebrain 
and had two pigmented optic cups, one much smaller than the other, located at 
approximately midline (arrows). (E) Anterior view of the head of another embryo, 
treated in the same manner and of the same age as the embryo in D. This embryo had 
a diencephalon (DI) and one optic cup correctly positioned (arrow), but was 
completely lacking the second eye. (F) Anterior view of the head of another embryo 
treated in the same way as embryos in D,E. This embryo completely lacked forebrain 
tissue including eyes, bu t had two pigmented spots located at midline, presumably 
where the optic cup tissue should have arisen from (arrows). Scale bars: 0.5 mm.
Abbreviations: DI, diencephalon; FB, forebrain; FL, forelimb; HL, hindlimb; MB, 
midbrain.
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Gold electrodes Gold/tungsten electrodes
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6.2 .2  E xpression  of Tbx2 in th e  develop ing  chick ey e
Tbx2 expression in the developing chick eye was previously reported to be localised 
to the dorsal optic cup at HH 14 (Gibson-Brown et al. 1998). However, the onset of 
Tbx2 expression prior to this stage and its pattern of expression after this stage has 
not been reported. Knowledge about the onset of Tbx2 expression in the developing 
chick eye was required for the purpose of manipulation of Tbx2 expression during 
eye development in subsequent sections of this chapter. It also allowed the 
comparison of Tbx2 expression in the eye of the chick embryo to that in the mouse 
embryo. Spatio-temporal gene expression of Tbx2 was detected by whole mount in 
situ hybridisation in white Leghorn chick embryos harvested between HH 9-24 (n= 
3-4 embryos per stage).
In the chick embryo, the rudimentary optic vesicles form at HH 9 and the proximal 
regions start to constrict at HH 10, so that by HH 11 two vesicles are clearly distinct 
on either side of the forebrain, and by HH 12 the proximal regions have shaped into 
the optic stalks. At HH 9-10, Tbx2 transcripts were not detected in the presumptive 
eye region (Fig. 6.3 A,B). At HH 12, Tbx2 expression was detected in the distal 
neuroepithelium along the entire D-V axis of the optic vesicle and hence did not 
show an asymmetrical expression pattern (Fig. 6.3 C,D). At HH 14, the optic vesicles 
invaginate to form the optic cup, and Tbx2 expression was confined to the dorsal 
region of the neural retina (Fig. 6.3 E). At HH 16, Tbx2 expression continued to be 
restricted to the dorsal region of the optic cup (Fig. 6.3 F). By HH 24, the expression 
of Tbx2 in the optic cup itself appeared weaker but was still confined to the dorsal 
region (Fig. 6.3 G,H). At this stage, strong expression was detected in the 
mesenchyme in the ventral region of the optic cup, around the lens, and in a streak of 
cells in the dorsal region of the eye (arrowheads Fig. 6.3 G and arrow in H). Tbx2 
expression in the mesenchyme between the surface ectoderm and the optic cup was 
also observed in the mouse embryo, although in the ventral aspect of the eye only.
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Fig. 6.3 Expression of Tbx2 in the developing chick eye detected by in situ 
hybridisation
Images depict lateral views of embryos (A) At HH 9 (ss7), Tbx2 transcripts were 
absent in the rudimentary optic vesicle (arrow). Tbx2 was detected in the heart 
primordia at this stage (arrowhead). (B) At HH 10 (sslO) Tbx2 transcripts were 
absent from the optic vesicle (arrow), which at this stage had started to undergo 
constriction in the proximal region (presumptive optic stalk). Tbx2 expression in the 
developing heart was restricted to the posterior heart tube (arrowhead). (C) At HH 12 
(ssl6), Tbx2 was expressed in the entire optic vesicle (arrow). (D) Anterior view of 
the rostral region of the embryo in C. Tbx2 transcripts were present along the entire 
D-V axis of the distal region (presumptive neural retina) of the optic vesicle and 
absent from the overlying ectoderm. Arrows mark the boundaries of expression. 
Expression was also detected in the ventral midline of the forebrain (arrowhead). (E) 
At HH 14 (ss22), Tbx2 transcripts were restricted to the dorsal neural retina. Image 
also shows expression in the mandibular process of the first pharyngeal arch. (F) 
Embryo at HH 16 (ss27) showing Tbx2 expression in the dorsal optic cup (arrows). 
Image also shows expression in the nasal primordia, mandibular process, and the 
atrio-ventricular canal. (G) At HH 24, Tbx2 expression was detected in the dorsal 
region of the optic cup (arrows), transcripts were absent in the ventral region of the 
cup. Strong expression was detected in mesenchyme on the ventral surface of the 
optic cup including in the optic fissure region, and also around the lens and in a 
streak in the dorsal region of the eye (arrowheads). (H) Coronal frozen section of the 
eye at HH 24 showing Tbx2 expression, detected by section in situ hybridisation, in 
the dorsal neural retina and the mesenchyme between the ventral optic cup and the 
surface ectoderm (arrow). Scale bars: 0.5 mm in A-G, 0.1 mm in H
Abbreviations: AVC; atrio-ventricular canal, D, dorsal; Di, distal; H; heart, L; lens, 
MN; mandibular process, MX; maxillary process, NP; nasal process, P, proximal; 
Pre. NR; presumptive neural retina, Pre. RPE; presumptive retinal pigmented 
epithelium; V, ventral
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These data indicated that Tbx2 expression in the developing eye initiated soon after 
the constriction o f the proximal part o f the rudimentary optic vesicles, but before 
optic vesicle invagination. In the optic vesicle, Tbx2 was expressed throughout the 
distal neuroepithelium and not in the proximal neuroepithelium (the future RPE), or 
the optic stalk. After invagination, it became restricted to the dorsal neural retina. 
Expression in the mesenchyme was evident at HH 24, but not at HH 16. This pattern 
o f expression is analogous to Tbx2 expression in the developing mouse eye, 
suggesting that Tbx2 is likely to have a highly conserved function in eye 
development in both species.
6.2.3. Misexpression of Tbx2 in the developing chick eye using 
retroviral vector delivery
6.2.3.1 Examination of infection efficiency by the RCkS-cTbx2 virus 
in vivo
Injections of a replication competent vector containing the chick Tbx2 cDNA, 
RCAS-cTbx2, with a titre of 1 x 108 colony forming units (c.f.u)/ml, were performed 
at HH 9-10 in the primary left optic vesicle and embryos were further cultured to HH 
23-25. It has been reported that viral matrix protein, the protein in which the viral 
genome is encased and which is produced by the host cell after viral integration, is 
detected after 18 hrs, but not after 10 hrs post infection (Morgan and Fekete 1996). 
Viral RNA is detected after 12 hrs (personal communication, Dr C. Rallis, NIMR, 
London, UK). On this basis, misexpression of Tbx2 was estimated to initiate around 
HH 12 in optic vesicles injected at HH 10, with protein synthesis occurring shortly 
after. This would result in the disruption o f the asymmetrical expression of Tbx2, 
which is regionalised from HH 14 in the optic cup (Fig. 6.3).
Misexpression of Tbx2 was assessed in all embryos analysed in this Chapter. There 
are several methods by which viral infection can be assessed in a tissue. These 
include detection o f viral genes or the transgene itself by in situ hybridisation or 
detection of proteins encoded by the transgene or the virus, using 
immunohistochemistry. In this study, in situ hybridisation was employed using an
327
antisense probe for Tbx2 or an antisense probe specific to a 900 bp region of the 
RCASBP env gene called RSCH (see Fig. 2.2). Since endogenous Tbx2 expression is 
confined to the dorsal region of the developing chick eye after invagination, it was 
feasible to use the Tbx2 probe to monitor misexpression in the ventral neural retina.
To assess the level of infection, one of two methods were used, depending on the 
requirements of subsequent experiments. Either whole mount in situ hybridisation of 
isolated optic cups were carried out, which allowed assessment of infection in the 
whole retina, or section in situ hybridisation of every tenth section of the eye. The 
frozen sections prepared for the latter approach were of 20 pm thickness, hence 
examination of every tenth section resulted in a snapshot of the status of targeting in 
every 200 pm of the eye.
Out of 34 examined eyes at HH 23-25, 22 showed high levels of ectopic Tbx2 
expression, suggesting that infection was successfully achieved in 65% of injections. 
Fig. 6.4 shows representative examples of control and infected eyes after in situ 
hybridisation. In all 22 infected eyes, Tbx2 was ectopically expressed in the ventral 
neural retina (Table 6.3). In some eyes, infection was also confirmed by the detection 
of RSCH on sections adjacent to those hybridised with the Tbx2 probe (Fig. 6.4 B,C). 
In most embryos, the lens, surface ectoderm, RPE, and some regions of the brain 
were also infected, indicating a wide spread of infection from the site of injection, 
which is likely due to the rapid diffusion of the viral solution when injected into the 
optic vesicle lumen. In situ hybridisation with the Tbx2 and RSCH probes on 
adjacent sections revealed variable lens expression (Fig. 6.4 B,C). RSCH was 
detected in the dividing cell population in the anterior and equatorial regions of the 
lens, whereas Tbx2 was expressed more widely in both dividing and non-dividing 
(posterior lens) cell populations of the lens. The RSCH probe detects a distinct 
mRNA splice form to the one encoding the transgene (Logan and Tabin 1998). One 
possible explanation for this is that exogenous Tbx2 may be inducing ectopic 
expression of endogenous Tbx2, which is detected by the Tbx2 probe throughout the 
lens. That the lens is likely to be permissive to Tbx2 expression is supported by 
experiments in Chapter 4, where ectopic Tbx2 expression was induced in the lens 
vesicle of the mouse embryo implanted with an rhBMP4 coated bead (Fig. 4.4 D).
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Fig. 6.4 Examination of infection and morphology of retinae by RCAS- 
cTbx2 and RCAS-AP viruses using whole mount and section in situ 
hybridisation and colourimetric detection of alkaline phosphatase activity
A, B, C depict frozen sections cut in the coronal plane at 20/xm thickness, whereas D, 
E, F are retinal flat mounts. In situ hybridisation of control and infected samples 
were performed together under identical conditions. Images are representative of 
typical levels of infection obtained (A) Section of a control eye of a chick embryo at 
HH 25 showing the normal distribution of Tbx2 expression in an uninfected retina. 
Tbx2 transcripts were not present in the ventral neural retina (arrow). (B) Section of 
the eye of an embryo at HH 24 infected with RCAS-cTbx2 at HH 10 and hybridised 
with the Tbx2 probe. All morphological features expected at HH 24 were present. 
Ectopic Tbx2 expression was detected in the ventral neural retina as compared to the 
control (arrow), and in the lens vesicle. The intensity of Tbx2 expression was 
stronger in some areas of the neural retina (white arrowhead). Tbx2 was also 
ectopically detected in the diencephalon (grey arrowhead). (C) Adjacent section to B, 
hybridised with a probe specific for part of the viral env gene (RSCH), indicating 
infection of the ventral neural retina and lens, as well as the diencephalon (grey 
arrowhead). (D) Flat mounted control retina hybridised with the Tbx2 probe, showing 
endogenous Tbx2 expression at HH 25. Remnants of the extra-ocular mesenchyme 
account for the blue signal in the ventral region of the retina, which otherwise lacks 
Tbx2 expression (arrowhead). (E) RCAS~cTbx2 infected retina at HH 25 hybridised 
with the Tbx2 probe. Tbx2 transcripts were present in large patches of the retina 
including the ventral region. Areas of strong signal are indicative of higher levels of 
Tbx2 expression. (F) RCAS-AP infected retina at HH 23. Patchy infection, assayed 
by AP activity, was detected in all parts of the retina. Scale bars: 0.5 mm.
Abbreviations: D, dorsal; V, ventral.
329
control
RCAS-cTbx2
M k
330
□ 
»
Table 6.3: RCAS-cTbx2 infection in injected eyes
control virus
Tbx2 expressed in ventral neural retina 0 22
Total examined 10 34
% infected eyes 0% 65%
Assessment of infection in retinal flat mount preparations revealed that although 
complete infection of the entire neural retina was not achieved by HH 25, all regions 
of the optic cup were successfully targeted (Fig. 6.4 E,F). In comparison to 
electroporated embryos, the prevalence of morphological defects in RCAS-AP and 
control injected embryos was negligible. Injection itself did not induce the type of 
eye and head abnormalities observed in electroporation experiments. Therefore, this 
method was pursued further to study eye development in infected retinae.
6.2.3.2 Morphological analysis and eye size
Examination of sections (Fig. 6.4) and whole mount views of infected eyes (Fig. 6.5) 
revealed that optic vesicles invaginated properly and that the RPE differentiated 
normally in both the dorsal and ventral regions of the eye. The optic fissure formed 
in the correct ventral position, and its walls were at an appropriate distance from each 
other for the ages examined (HH 24-25, n= 22, Fig. 6.5 G,H). Though often infected 
with RCAS-cTbx2, the lens also appeared morphologically normal at HH 24-25 (Fig. 
6.4 A-C).
Data presented in Chapters 4 and 5 provided indirect and direct evidence that Tbx2 is 
important for the control of eye size. To investigate whether misexpression of Tbx2 
in the ventral eye recapitulates the small eye size caused by rhBMP4 treatment, 
which induced ectopic Tbx2 expression in the ventral mouse neural retina, retinal 
area was measured on flat mounted infected and control chick retinae as described in 
Chapter 2.11.2.
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Fig. 6.5 M orphology of RCAS-c77>jc2 infected and stage matched control 
embryos
Images depict lateral views of embryos unless stated otherwise. (A) Control embryo 
at HH 24. (B) RCAS-cTbx2 infected embryo at HH 24, showing healthy 
morphology. (C) Dorsal view of the head of the control embryo in A. (D) Dorsal 
view of the head of the RCAS-cTbx2 infected embryo in B. (E) Control embryo at 
HH 25. (F) RCAS-cTbx2 infected embryo at HH 25, showing similar overall 
morphology to the embryo in E. (G) Ventral view of the eyes of the embryo in E. (H) 
Ventral view of the eyes of the embryo in F, showing normal optic fissure 
development. Arrows in G-H show the optic fissure. Scale bars: 1 mm
3 3 2
control injected
HH24HH24
HH24HH24
HH25HH25
HH25HH25
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First, retinal area was compared between four groups of control embryos between 
stages HH 23-28, in order to be confident that the method of staging embryos, which 
was based on their morphological features according to Hamburger Hamilton 
descriptions, and dissection and flat mounting o f retinae were consistent and reliable. 
Data were Ln transformed to acquire normal distribution as described previously 
(Chapter 2.12.2). Comparison of retinal area between these age groups with the One- 
Way ANOVA test showed that retinal area increased significantly with 
developmental age as also suggested by the bar chart (Fig. 6.6; Table 6.4; PO.OOOl). 
Overall, the method used for estimation o f retinal area appeared reliable and retinal 
area increased with the age o f the embryo as expected.
Table 6.4 Mean retinal area ± s.d . in HH 23-28 em bryos
n. Mean (mm ) ± 1 s.d.
Retinal area HH 23 control 10 7.29 1.90
HH 24 control 5 13.60 1.62
HH 25 control 19 17.12 2.68
HH 28 control 4 22.14 2.85
To eliminate the possibility that the viral vector itself imposed an effect on eye size, 
retinal area of control (non-injected) and RCAS-AP injected eyes were compared at 
HH 23 and found to be similar (Fig. 6.7 A; P= 0.746 by the independent samples t- 
test; Table 6.5). By contrast, comparison of retinal area in RCAS-cTbx2 infected eyes 
to stage matched controls at HH 24 revealed a significant reduction in eye size as a 
result of ectopic Tbx2 expression (Fig. 6.7 B; P= 0.006 by independent samples t- 
test; Table 6.5). This trend was also observed at HH 23, but only two embryos were 
analysed at this stage. The reduction in eye size is in accordance with the previously 
described findings in the mouse embryo (Chapter 4), where ectopic Tbx2 expression 
in the ventral neural retina induced by rhBMP4 caused a small eye size.
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Fig. 6.6 Comparison of retinal area between control embryos at HH stages 
23-28
Bar chart shows Ln mean retinal area ± 1 s.d. for HH 23-28 control embryos. P-value 
calculated with the One-Way ANOVA test suggests that mean Ln retinal area differs 
significantly across the age groups. n= number of eyes per group
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Fig. 6.7 Com parison of re tinal a rea  between control, RCAS-AP, and 
RC \S~cTbx2  infected em bryos
Bar chart shows mean Ln retinal area ± 1 s.d. for (A) control (non-injected) and 
RCAS-AP infected eyes at HH 23 and (B) for control (non-injected) and RCAS- 
cTbx2 injected eyes at HH 24. P-values were calculated with the independent 
samples t-test. n= number of eyes per group.
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Table 6.5 Mean retinal area ± s.d. in RCAS-cTbx2 treated and control groups
n. Mean (mm2) ± 1 s.d.
HH 23 control 10 7.29 1.90
RCAS-AP 5 7.61 1.81
HH 24 control 5 13,60 1.62
RCAS -cTbx2 10 10,44 1,68
The outcome ol the experiments presented in this thesis support a role for Tbx2 in 
eye size regulation. It is possible that the early role o f  Tbx2 in eye development, 
during the period when it is expressed in retinal progenitors o f the dorsal eye, is to 
reduce dorsal eye growth in com parison to other regions o f  the eye in order for the 
eye to acquire the correct shape. To investigate this hypothesis further, the size o f the 
ventral eye in injected and control eyes were compared. The length o f  the optic 
fissure, measured from the optic disc to the peripheral most ventral edge o f the neural 
retina following the outline o f  the fissure wall exactly (see Chapter 2.11.3), was used 
as a measure o f  the size o f  the ventral neural retina. If Tbx2 slows growth o f the 
neural retina. K( , \^ -cThx2  infected eyes should have significantly smaller ventral 
retinae, in which Tbx2 has been ectopically expressed.
Comparison o f  the optic fissure length in control (non-injected) embryos at four 
different stages showed an overall trend o f  increase in the length o f  the ventral neural 
retina with developmental stage (Fig. 6.8; P< 0.0001 by One-Way ANOVA; Table
6 .6 ).
Table 6.6 Mean optic fissure length ± s.d. in HH 23-28 embryos
n. Mean (mm) ± 1 s.d.
Optic fissure length HH 23 8 1.23 0.27
HH 24 4 2.05 0.05
HH 25 17 2.18 0.35
HH 28 4 2.66 0.39
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Fig. 6.8 Comparison of the size of the ventral neural retina between 
control embryos across HH stages 23-28
Bar chart shows Ln transformed mean optic fissure length ± 1 s.d. in HH 23-28 
control embryos. P-value calculated with the One-Way ANOVA test suggests that 
optic fissure length is significantly different across different age groups. n= number 
of eyes per group.
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Comparison of control (non-injected) and RCAS-AP infected eyes at HH 23 revealed 
no significant difference in optic fissure length among groups, again confirming that 
viral infection alone does not perturb eye size (Fig. 6.9 A; P= 0.841 by independent 
samples t-test; Table 6.7). RCAS-c77uc2 infected eyes however, at HH 24, showed a 
significantly smaller ventral neural retina in comparison to stage matched non- 
injected controls (Fig. 6.9 B; P< 0.0001 by the independent samples t-test, non equal 
variances; Table 6.7).
Table 6.7 Mean optic fissure length ± s.d . in RCAS-cTbx2 treated and control eyes
n. Mean (mm) ± 1 s.d.
HH 23 Control 8 1.23 0.27
RCAS-AP 4 1.26 0.22
HH 24 Control 4 2.05 0.05
RCAS-cTbx2 8 1.43 0.27
In accordance with the hypothesised role of Tbx2 as a negative regulator of eye 
growth, disruption o f the asymmetrical expression of Tbx2 by misexpression in the 
embryonic chick eye, resulted in eye size that was smaller in infected eyes compared 
to stage matched controls. The significant decrease in growth of the ventral neural 
retina can be interpreted as the ventral neural retina adapting the growth rate of the 
dorsal neural retina, upon Tbx2 misexpression in this region.
6.2.3.3 Analysis of differentiation in RCAS-cTbx2 infected eyes
One of the mechanisms that can reduce the growth of a tissue is untimely 
differentiation of progenitor cells. Growth can be limited if progenitor cells exit the 
cell cycle prematurely on receiving cues that promote cell cycle exit. This possibility 
was investigated in RCAS-c77>x2 infected eyes by immunohistochemistry on frozen 
sections using the VC 1.1 and RMO270 antibodies, used in the previous Chapter, as 
well as the BHI-tubulin antibody, which labels early differentiating neurons and their 
axonal processes (see Chapter 2.8.1.1 for details of antibodies).
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Fig. 6.9 Com parison of the size of the ventral neural retina between 
control (non-injected), RCAS-AP, and  KCAS-cTbx2  infected embryos
Bar charts show mean optic fissure length ± 1 s.d. in (A) control (non-injected) and 
RCAS-AP infected eyes at HH 23 and in (B) control (non-injected) and RCAS- 
cTbx2 infected eyes at HH 24. P-values were calculated with the independent 
samples t-test assuming unequal variances in B. n= number of eyes per group.
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Immuno-labelling with the VC 1.1 and the RMO270 antibodies revealed no major 
differences in the pattern of differentiation between control and RCAS-cTbx2 
infected eyes at HH 24 (Fig. 6.10 A,B and Fig. 6.11 A). Labelling was seen in a 
continuous broad domain in the central neural retina in both infected and control 
eyes. As reported by others (McCabe et al. 1999), RMO270 labelled the cytoplasm 
of RGC bodies and their processes as soon as they became postmitotic on the 
ventricular edge of the neural retina, allowing visualisation of their laminar migration 
from the time when they exit the cell cycle until they settle on the vitreal surface of 
the neural retina (Fig. 6.11 C). Although, differentiation appeared largely normal, in 
infected eyes, a few RGCs were labelled in the ventral neural retina at a distance 
away from the continuous band of RGCs and the nerve fibre layer (6/8, 75%; Fig. 
6.11 A, arrow). In control eyes, scattered RGCs in the ventral neural retina were 
observed in 2/6 (33%) retinae. Since RCAS-cTbx2 infected eyes contained 
occasional labelled RGCs at a distance from the continuous band at a higher 
incidence than seen in control eyes, some further investigation was undertaken to 
examine whether misexpression of Tbx2 was inducing early cell cycle exit in ventral 
infected retinal progenitor cells.
Infected and control eyes were flat mounted, to exclude the possibility of falsely 
scoring differentiated cells as ectopic in oblique sections. Differentiated RGCs were 
labelled with the BHI-tubulin antibody, as the RMO270 antibody was unable to 
detect its antigen in tissues that had been exposed to in situ hybridisation, which was 
performed to confirm viral infection. This is likely to be due to the failure of 
preservation of the epitope, which the RMO270 antibody recognises, during the in 
situ hybridisation procedure.
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Fig. 6.10 VC1.1 im m unohistochem istry in control and  RCAS-c7ijc2
infected eyes a t H H  24
Images show coronally cut frozen sections (20/im) immuno-labelled with VC 1.1 
(green) and stained with propidium iodide in red. Insets show high power views of 
the boxed areas. Arrowheads indicate labelled cell bodies. (A) Control eye showing 
VC 1.1 labelling in the central (proximal) neural retina. Arrow shows the dorsal limit 
of differentiation. (B) VC 1.1 immuno-labelling in an RCAS-cTbx2  infected eye. 
Arrow shows the dorsal limit of differentiation. (C) Positive control for VC 1.1 
labelling in a section through the neural tube. (D) Negative control for labelling by 
the secondary antibody in the absence of the primary antibody. Scale bars: 0.1 mm
Abbreviations: D, dorsal; V, ventral
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Fig. 6.11 RGC differentiation in RCAS-c J2>jc2 infected eyes detected by
immunohistochemistry using the RMO270 antibody
A and B represent coronal 20 pim frozen sections through the midline of the eye. (A) 
RCAS-cTbx2 infected eye at HH stage 24 showing labelled RGCs (green) from the 
region of the dorsal curvature to the optic disc and a short distance beyond (ventral), 
as well as a few isolated RGCs located in the ventral neural retina. Arrows mark 
limits of RGC differentiation. (B) Adjacent section to A hybridised with the Tbx2 
probe, showing ectopic Tbx2 expression in the ventral neural retina (arrow). (C) 
High power view of the neural retina in A (boxed area) showing labelling of 
postmitotic RGCs (arrow) at the ventricular surface (facing RPE) of the neural retina 
and their projections to the vitreal surface (facing lens). Scale bars: 0.1 mm
Abbreviations: D, Dorsal; NR, neural retina; RPE, retinal pigmented epithelium; V, 
Ventral
348
\-
I
RPE
NR
* •
vitreal side
349
The distances between the ventral-most differentiated RGC bodies to the ventral 
periphery of the neural retina were measured as demonstrated in Fig. 6.12 (the 
distance of arrows). An average was calculated per retina based on five 
measurements in the naso-ventral and five measurements in the tempo-ventral 
regions resulting in an average value of ten measurements per eye. These values gave 
an indication of the size of the non-differentiated portion of the ventral neural retina, 
while an estimate for the differentiated (RGC) portion was calculated by subtraction 
of the non-differentiated average distance from the previously measured optic fissure 
length (Fig. 6.12, white broken lines). The bar chart in Fig. 6.13 clearly shows that 
the length of the non-differentiated part of the neural retina (cream) is similar in both 
infected and control retinae, while differentiated RGC domain (green) is much longer 
in control retinae (Table 6.8). Taking into account that the ventral neural retina, 
measured as the optic fissure length, is shorter in infected eyes, it appears that the 
differentiation front does not differ significantly between RCAS-cTbx2 infected and 
control eyes. Using the ANCOVA test to compare the non-differentiated length of 
the neural retina (cream portion of bar chart) between control and infected eyes, with 
the optic fissure length incorporated as a covariate, it appears that RCAS-cTbx2 
treatment has no significant effect on this distance (Fig. 6.13; Table 6.9; P= 0.226), 
which was also not affected by the difference in optic fissure length between 
treatment groups (P= 0.227).
Table 6.8 Mean length ± s.d. of the differentiated RGC and non-differentiated portions of
the ventral neural retina of RCAS-c7T?x2 treated and control eyes at HH 24
n. Mean (mm) ± 1 s.d.
RGC front to ventral periphery control 3 0.76 0.10
RCAS-cTbx2 6 0.73 0.11
Optic disc to ventral RGC front control 3 1.32 0.13
RCAS-cTbx2 6 0.58 0.19
In contrast to the non-differentiated length of the neural retina, when the distance of 
the ventral differentiation front (green portion of bar chart) was compared between 
RCAS-cTbx2 treated and control retinae using the ANCOVA test, it appeared that 
the optic fissure length did have a significant effect on this distance as expected 
(Table 6.10; P= 0.005). However, when this effect was taken into account, the 
ventral differentiation front was not significantly different between treatment groups 
(Fig. 6.13; Table 6.10; P= 0.226).
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Fig. 6.12 RG C netw ork in flat m ounted RCAS-c7^jc2 infected and control 
retinae a t H H  24 detected by im m unohistochem istry using the filll-tubulin  
antibody
(A) Tbx2 expression in a control (non-injected) flat mounted retina detected by 
whole mount in situ hybridisation. The optic disc is in the centre of the dashed circle. 
Broken black line indicates the length of the optic fissure in the ventral neural retina
(B) Same retina as in A after whole mount immuno-labelling with the BHI-tubulin 
antibody, which labels RGCs and their axonal processes within the retina. Dashed 
circle shows the optic disc. The arrow indicates the average distance, from 10 
measurements, of the ventral-most RGC bodies to the ventral retinal periphery. This 
is the non-differentiated part of the neural retina. The white broken line extends from 
the optic disc to the ventral RGC differentiation front, calculated as optic fissure 
length minus the average distance of the RGC front to the ventral periphery. (C) 
High power merged image of Tbx2 expression and RGC differentiation in the dorsal 
neural retina, showing overlap between their expressions. Inset shows a higher power 
view. (D) Tbx2 expression in an RCAS-c72?jc2 infected flat mounted retina detected 
by whole mount in situ hybridisation. (E) Same retina as shown in D after BIII- 
tubulin immuno-labelling. The circles, arrow, and dashed lines represent the same as 
in A and B. (F) Merged image of the boxed region in D and E, with inset showing a 
higher power view. Scale bars: 0.5 mm in A, B, D, E; 0.1 mm in C, F.
Abbreviations: D, dorsal; V, ventral
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Fig. 6.13 Progression of differentiation in RCAS-cJ2>jc2 infected and
control retinae
Stacked bar chart represents the mean distance (mm) from the optic disc to the RGC 
front ± 1 s.d. (green portion) and the mean distance (mm) from the ventral most RGC 
bodies to the ventral retinal periphery ± 1 s.d. (cream portion) in control and RCAS- 
cTbx2 infected eyes at HH 24. Together, the stacked bars represent the difference in 
optic fissure length between control and infected eyes
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Table 6.9: The ANCOVA table for the analysis o f the ventral RGC front to the ventral 
peripehry (cream portion) in R C A S -cTbx2  infected and control retinae
S o u r c e
T y p e  III S u m  
o f  S q u a r e s d f M e a n  S q u a r e F S ig .
C o r r e c t e d  M o d e l . 0 1 8 ( a ) 2 .0 0 9 .9 6 3 .4 3 4
I n t e r c e p t . 0 1 1 1 .0 1 1 1 . 2 2 5 .3 1 1
O p t i c  f i s s u r e  
l e n g t h . 0 1 7 1 . 0 1 7 1 . 8 1 0 .227
T r e a t m e n t . 0 1 7 1 . 0 1 7 1 . 8 1 7 .226
E r r o r .0 5 6 6 . 0 0 9
T o t a l 5 . 1 2 9 9
C o r r e c t e d  T o t a l . 0 7 4 8
a  R  S q u a r e d  =  2 4 3  ( A d j u s t e d  R  S q u a r e d  =  - . 0 0 9 )
Table 6.10: The ANCOVA table for the analysis of the distance of the optic disc to 
the RGC front (green portion) in R C A S -cTbx2  infected and control retinae
S o u r c e
T y p e  III S u m  
o f  S q u a r e s d f M e a n  S q u a r e F S kj
C o r r e c t e d  M o d e l
I n t e r c e p t
O p t i c  A s s u r e  
l e n g t h
1 . 2 7 2 ( a ) 2 . 6 3 6 6 8 . 2 6 0 .0 0 0
.0 1 1 1 .0 1 1 1 . 2 2 5 .3 1 1
. 1 6 7 1 .1 6 7 1 7 . 9 7 1 . 0 0 5
T r e a t m e n t . 0 1 7 1 . 0 1 7 1 . 8 1 7 . 2 2 6
E r r o r . 0 5 6 6 . 0 0 9
T o t a l 7 . 4 3 7 9
C o r r e c t e d  T o t a l 1 . 3 2 8 8
a  R  S q u a r e d  =  .9 5 8  ( A d j u s t e d  R  S q u a r e d  =  .9 4 4 )
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These data suggest that misexpression o f Tbx2 in the ventral neural retina is not 
inducing early differentiation o f retinal progenitor cells and therefore the mechanism 
by which Tbx2 misexpression reduces growth o f the developing eye is not by 
premature differentiation. Interestingly, the size o f the non-differentiated portion of 
the neural retina was constant regardless o f the size o f the retina.
6.2.3.4 Intra-retinal RGC axonal projections
If Tbx2 is involved in axonal routing towards the optic disc, intra-retinal axonal 
misrouting would be expected when Tbx2 is misexpressed in the ventral neural 
retina. To investigate this hypothesis, whole retinae infected with RCAS-c7£jc2 and 
immuno-labelled with the Blll-tubulin antibody after in situ hybridisation were 
analysed for irregularities in intra-retinal axonal projections.
In control retinae at HH 24-25, axons labelled with the Blll-tubulin antibody covered 
the vitreal surface o f the neural retina in radial arrays, which projected towards the 
optic disc from all areas o f the retina (see Fig. 6.12). No axons in dorsal, nasal or 
temporal regions were seen to migrate outside o f the ordered projections towards the 
optic disc. In the ventral aspect o f the neural retina however, mainly in close 
proximity to the optic fissure, occasionally solitary axons were found outside of the 
main projection path (Fig. 6.14). Some of these axons belonged to cell bodies 
positioned within the network, while others originated from cell bodies outside of the 
network. The number o f ectopic axons were however too small for analysis. A 
preliminary analysis was performed to assess whether the incidence of axonal 
migration errors was higher in infected eyes as compared to stage matched controls. 
This is included in Appendix A.
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Fig. 6.14 RG C axonal projections in the ven tral neural re tina  of control 
and  R C \S -c T b x 2  infected eyes a t H H  24
Images depict flat mounted retinae immuno-labelled with the Blll-tubulin antibody 
(green) to show RGC axonal projections in (A) control and (B-E) several RCAS- 
cTbx2 infected eyes. Arrowheads indicate misrouted axons away from the common 
route towards the optic disc. (F) Close-up of the deviated axon in D (arrow). (G) 
Close-up of the deviated axon in C (arrow). Scale bars: 0.1 mm
Abbreviations: OD, optic disc; OF, optic fissure.
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6.3 Discussion
6.3.1 Summary of findings
1) Two gene delivery methods were tested for their feasibility and efficiency in 
delivering exogenous DNA to the embryonic eye. Retroviral mediated gene delivery 
proved superior than electroporation in terms of success of targeting of the 
developing eye as well as preservation of eye morphology.
2) Tbx2 expression in the developing chick eye is first detected at HH 12 in the entire 
distal neuroepithelium of the optic vesicle but becomes restricted to the dorsal neural 
retina after optic vesicle invagination, where it persists until at least HH 25. 
Expression was also detected in the mesenchyme between the optic cup and the 
surface ectoderm.
3) Retroviral mediated misexpression of Tbx2 resulted in a small retinal area and 
particularly a significant decrease in the length of the ventral neural retina, where 
Tbx2 was misexpressed.
4) Tbx2 misexpression did not prevent RGC differentiation.
5) Although the length of the differentiated region of the ventral neural retina of 
infected eyes was smaller than controls, this decrease was linked to the reduction in 
the size of the ventral neural retina. The non-differentiated portion of the ventral 
neural retina however was similar between treatment groups regardless of the 
difference in eye size.
5) Some intra-retinal axonal misrouting was observed in the ventral region of 
infected eyes, though a larger analysis is required to establish the involvement of 
Tbx2 in this process.
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6.3.2 Electroporation as a tool for somatic gene manipulation in the 
developing eye
Since the first reports o f the use o f electroporation in in vivo systems (e.g. 
(Muramatsu et al. 1997)), this method has been employed by many researchers to 
address various questions, as it provided a new and promising tool for manipulating 
gene expression. It is quick, relatively cost-effective, easy to operate, and provides 
solutions to some o f the restrictions posed by earlier existing gene delivery methods, 
such as the low efficiency o f lipofection and microinjection, or the size and host 
restrictions imposed by viral vectors. Electroporation is now being extensively used 
in studies involving chick embryos, but its usage for studying mouse development is 
relatively unexplored. Gene delivery to the developing mouse eye by electroporation 
has previously not been reported. In this Chapter, I used electroporation to test the 
feasibility o f this method to deliver a reporter construct to the early mouse optic cup 
followed by whole mouse embryo culture. Various parameters were tested and 
although plasmid DNA uptake and satisfactory embryo survival were achieved, it 
was not possible to target the neural retina. DNA injections were performed in the 
vitreous chamber but also into the subretinal space, as better transfection of the retina 
was reported to be achieved from this region rather than the vitreal side o f the retina 
in neonatal mice and rats (Matsuda and Cepko 2004). However, in my experience, 
subretinal injections did not improve embryonic retinal transfection.
The biggest challenge with this method was the difficulty of retaining the DNA 
solution in the optic cup between injection and the delivery of current. This is 
because o f the small volume o f the embryonic eye. Although plasmid DNA was 
dissolved in sucrose to make the solution more viscous, a superior method appears to 
be required. Recently, pluronic gels have become available, which retain DNA at the 
site where they are implanted. DNA is dissolved in the gel, which is then allowed to 
set and then implanted into the tissue (Becker and Mobbs 1999). Experiments would 
have to be carried out to determine whether it is feasible to implant the gel within the 
vitreous or the subretinal space of the embryonic eye, where DNA can be transferred 
into the retina by the direction o f the current. Alternatively, DNA of a higher 
concentration than used here may improve transfection.
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Electroporation was also tested in the chick embryo, as several studies had 
previously reported successful targeting of the developing chick neural retina. 
However, as it induced morphological deformities in a high percentage of embryos 
and affected eye growth, this method was not pursued further. Although several 
laboratories report using this method successfully, there are mentions in the literature 
that transfections cannot be achieved based on published parameters. For example, 
Momose and colleagues could not target the neural retina with the method of 
Muramatsu and colleagues. Cepko and colleagues could not reproduce the results of 
Dezawa and colleagues in targeting the RGCs (Matsuda and Cepko 2004). Although 
it seems possible to optimise electroporation to perhaps achieve a high percentage of 
successfully targeted specimens, tissue damage in a proportion of the experimental 
group is unavoidable with this method, and electroporation may therefore not offer 
the level o f reproducibility desired in experiments.
6.3.3 Conservation of Tbx2 expression and function in vertebrate eye 
development
In both the mouse and the chick embryo, Tbx2 is expressed in the optic vesicle, and 
then in the dorsal optic cup after invagination of the vesicle. Later, both were also 
detected in mesenchymal cells between the surface ectoderm and the distal tip of the 
ventral neural retina (In Chapter 3 and here). It therefore appears that, at least during 
the formation of the optic cup, the spatial expression of Tbx2 is conserved in these 
two animal models. Dorsal restriction o f Tbx2 in the optic cup has also been reported 
in Xenopus (Takabatake et al. 2002), and zebrafish embryos (Dheen et al. 1999), 
suggesting that dorsal expression of Tbx2 in the eye serves a highly conserved role in 
vertebrate species. Despite the conservation o f expression in the dorsal optic cup, 
some differences do exist between Tbx2 expression in higher and lower vertebrates. 
In Zebrafish, Tbx2 (tbx2b\ tbxc) is expressed as early as in the eye field, unlike in the 
chick and the mouse. In Xenopus, ET, which is another member of the Tbx2 
subfamily and most closely related to the mouse Tbx3, is also expressed in the eye 
field. This site o f expression in lower vertebrates highlights some differences and 
suggests that perhaps Tbx2 serves additional early roles in eye development in lower 
vertebrates.
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During the course o f this thesis, two studies were reported which addressed the role 
of Tbx2 in Xenopus and zebrafish eye development, using gain of function and loss 
o f function approaches respectively. Misexpression of Tbx2 in Xenopus, by 
electroporation in the eye field, was reported to disrupt D-V patterning, by loss of 
Pax2 expression in the ventral eye (Takabatake et al. 2002). Moreover, pigmentation 
of the ventral optic cup was absent and the optic stalk appeared shorter than normal. 
The lack o f pigmentation phenotype, was not observed in RCAS-c7£;t2 infected 
chick eyes presented here. Interestingly and in agreement with results presented here, 
in the Xenopus study, the most severely affected part o f the eye was the ventral optic 
cup, which was absent in embryos with a severe phenotype. The cause of the absence 
of the ventral optic cup was not investigated. In RCAS-c7ftx2 infected eyes, eye size 
was reduced and particularly a reduction in the length o f the ventral neural retina was 
detected. Together, these data suggest that Tbx2, when misexpressed in the ventral 
aspects o f the developing eye, represses its growth and development.
6.3.4 Small eye size induced by Tbx2 misexpression in the chick eye 
provides further support of a role in eye size regulation by Tbx2
Quantification o f retinal area, as a measure o f eye size, in RCAS-cTbx2 infected 
retinae revealed that these were significantly smaller than eyes of stage matched 
controls. Furthermore, measurements o f the length o f the ventral neural retina 
showed that this reduction was even more marked in the length of the ventral eye. 
These observations corroborate the finding in the analysis of Tbx2'/' embryos that 
Tbx2 is indeed important for the regulation of eye size. Although opposite 
approaches were used in these two studies, the outcome of both was a small eye 
phenotype. There are several examples where loss of function and overexpression of 
genes, transcription factors in particular, cause the same phenotype. For example, 
submicroscopic duplications o f Xq27.1, containing the human SOX3 transcription 
factor gene, as well as mutations which reduce the DNA binding activity of SOX3 
result in infundibular hypoplasia and hypopituitarism (Woods et al. 2005). Loss of 
function mutations o f Pax6 as well as transgenic overexpression of multiple copies 
o f PAX6 cause similar eye phenotypes including a small eye and anterior segment 
defects (Hill et al. 1991; Schedl et al. 1996). It has been argued that overexpression
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may lead to inhibition o f transcriptional activation, in the case o f Pax6, and therefore 
result in the same phenotype as loss o f expression (Schedl et al. 1996).
However, the effect o f Tbx2 homozygosity in mice and Tbx2 misexpression in the 
developing chick eye is slightly different to a simple loss of function versus 
overexpression/increased activation effect o f Pax6 and SOX3 . This is because Tbx2 
is asymmetrically expressed in the developing eye, so it would be expected that in 
Tbx2'' eyes, the dorsal eye would be affected by the loss o f Tbx2, while in the chick 
eye, although it is probable that the dorsal eye was exposed to higher levels of Tbx2 
expression than normal, the ventral eye was exposed to ectopic Tbx2 expression, and 
it would be expected that ventral eye development be more affected. Therefore, the 
Tbx2 manipulation studies presented here are not a simple case of loss of/reduced 
function versus overexpression. Instead, it appears likely that Tbx2 is required for 
mediating several different mechanisms, both intrinsic and extrinsic, that affect eye 
size (see Chapter 7 for a final discussion) and that when the balance of these 
mechanisms is perturbed, growth o f the eye is impaired.
Due to time constraints, infected chick eyes could not be extensively analysed to 
study mechanisms such as cell death and cell proliferation or molecular changes in 
gene expression upon Tbx2 misexpression. Analysis o f cell differentiation and 
quantification o f the differentiation front did not reveal an increase in cell 
differentiation, which is what would be expected if premature cell differentiation was 
preventing the growth o f the eye.
6.3.5 The effect of Tbx2 misexpression on the differentiation front and 
intra-retinal axonal projections
A role in tissue specification and differentiation has been demonstrated for several 
members o f the T-box gene family, both during early development and later during 
organogenesis. For example, Tbx4 is required for allantois development; loss o f Tbx4 
results in failure o f expression o f allantois differentiation markers (Naiche and 
Papaioannou 2003).
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The effect of Tbx2 misexpression on RGC differentiation and axonal projections 
were investigated here for two reasons. Firstly, Tbx2 is one of the few dorsally 
expressed genes discovered so far and therefore a potential candidate for providing 
positional information and regulating genes which have been hypothesised to aid in 
topographic mapping of RGC axons to the brain (Sperry 1963). In support of this 
idea, misexpression of another dorsally expressed T-box gene, Tbx5, in the chick eye 
causes axonal misprojections to the tectum (Koshiba-Takeuchi et al. 2000). 
Moreover, in Tbx2'/' mutants, the RGC axons appeared severely disorganised. The 
second reason for analysing differentiation was due to a most reason report, in which 
morpholino-mediated knock-down of Tbx2b in zebrafish eyes was described to cause 
a transient arrest in cell differentiation of dorsal neurons only (Gross and Dowling 
2005), suggesting a profound effect on cell differentiation, and most interestingly 
localised to the dorsal eye.
Differentiation, examined by Blll-tubulin, VC 1.1, and RMO270 immuno-labelling 
after misexpression of Tbx2 in the ventral retina, appeared similar to non 
manipulated eyes at HH 24-25. The length of the differentiation front in the ventral 
neural retina was reduced in line with the reduction in ventral retinal growth in 
RCAS-cTbx2 infected eyes, while the non-differentiated portion of these eyes was 
similar to stage matched controls. A previous study has reported that the non- 
differentiated portion remains constant as the neural retina grows; in other words, 
retinal cell differentiation keeps pace with retinal growth (McCabe et al. 1999).
The incidence of ectopically projecting axons was slightly higher after Tbx2 
misexpression, suggesting that ectopic Tbx2 expression can cause a certain degree of 
axonal misrouting. Previous studies in which Tbx5, Ventroptin, and Bmp4 were 
misexpressed, or Bmprlb or EphB receptors were disrupted by targeted mutations 
also reported a low incidence of axonal misrouting, suggesting that perhaps RGC 
axons are guided by an array of signals and therefore, the addition of one or lack of 
one does not overtly affect their projections (Koshiba-Takeuchi et al. 2000; Sakuta et 
al. 2001; Birgbauer et al. 2000; Liu et al. 2003).
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CHAPTER 7 Final Discussion
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Experiments presented in this thesis aimed to investigate the role of dorsally 
expressed genes in eye development. Molecular patterning along the D-V axis of the 
developing eye is remarkably conserved in vertebrates, with Bmp4, and several 
members o f the T-box gene family expressed in the dorsal eye, while Vax2, Pax2, 
and the Bmp4 antagonist, Ventroptin are expressed ventrally (Barbeiri et al. 1999; 
Schulte et al. 1999; Mui et al. 2002; Barbeiri et al. 2002; Nomes et al. 1990; Furuta 
and Hogan 1998; Sakuta et al. 2001; Belecky-Adams and Adler 2001; Trousse et al. 
2001; Papaioannou 2001). In addition, RA signalling, shown by reporter gene 
expression driven by RA nuclear receptor promoters, is high ventrally and lower 
dorsally (McCaffery et al. 1999; Wagner et al. 2000). Members of the EphB/ephrinB 
families, implicated in topographic mapping of RGC axons to the brain, are also 
asymmetrically distributed along the D-V axis (Peters and Cepko 2002), and several 
lines of evidence suggest that these are downstream of the early transcription factors, 
as loss of function o f Vax2 and manipulation of Tbx5 result in alterations in the 
expression o f these molecules (Koshiba-Takeuchi et al. 2000; Schulte et al. 1999; 
Mui et al. 2002; Barbeiri et al. 2002). A regulatory hierarchy is starting to emerge 
where signalling factors induce the expression o f transcription factors, which in turn 
regulate molecules such as the ephrins/EphBs and undoubtedly numerous other cell 
adhesion, cell cycle, and signalling molecules. Although much remains to be 
elucidated regarding the role of these asymmetrically expressed genes in eye 
development and their functional significance, advances have been made in 
understanding the role of the ventral genes. Vax2, together with its closely related 
homologue Vaxl serve to establish ventral retina and optic stalk characteristics, and 
they do so by repressing Pax6 expression and expansion o f neural retinal fate in the 
optic stalk. This has been nicely demonstrated by analysis o f compound mutants for 
Vaxl;Vax2 and several in vitro assays which tested Pax6 binding and repression of 
activity by the Vax proteins (Mui et al. 2005). Pax2 is important for optic fissure 
closure and optic nerve development. The loss of both Pax2 and Vax2 result in 
coloboma (Barbeiri et al. 2002; Torres et al. 1996).
In contrast to the ventrally expressed genes, very little is known about the function of 
the dorsal genes. In Chapter 4, it was shown that in the developing mouse eye, Bmp4 
is upstream of the T-box genes, Tbx2, Tbx3, and Tbx5 (Fig. 7.1), regulating the 
expression of each in a unique manner. A role for Bmp4 signalling in regulating the
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spatial domains o f gene expression along the D-V axis o f the eye and in regulating 
eye size was demonstrated. The mechanisms by which Bmp4 regulates eye growth 
include the control o f cell proliferation and cell death. These mechanisms appear to 
require an optimal level of Bmp4 signalling as both increased levels (shown here) 
and decreased levels (shown by Bmpr conditional knockouts in the eye by Murali et 
al. 2005), result in decreased proliferation and increased cell death.
Although Bmp4 treatment o f the eye resulted in a global decrease in cell 
proliferation, the experimental strategy used in Chapter 4 did not fully resolve the 
question o f whether Bmp4 normally acts to control these cellular events regionally, 
within the dorsal eye, or whether it has a global effect on cell proliferation and cell 
death in eye development. In Chapters 5 and 6, the role of Tbx2 specifically was 
investigated and it was shown that manipulation o f Tbx2 causes a reduction in eye 
size, suggesting that a Bmp-Tbx2 pathway is important for the control of early 
growth of the developing eye. The Tbx2' ~ phenotype suggests that Tbx2 may have 
both intrinsic and extrinsic effects on eye morphogenesis and growth. Although not 
statistically significant (P= 0.05), a trend o f increased levels o f cell division was 
observed in the dorsal eye specifically, suggesting that Tbx2 may normally be acting 
to slow down cell proliferation in the dorsal eye (Fig. 7.1). This role is in agreement 
with the emerging role o f Tbx2 in negatively controlling growth of other tissues 
during development.
In the developing heart, the AVC where Tbx2 is expressed, has a lower rate of cell 
proliferation in comparison to the chamber tissue (Cai et al. 2005). It has been 
suggested that Tbx2 represses chamber differentiation in the presumptive AVC, 
where it acts regionally to induce lower rates of proliferation by repressing the 
expression of Nm ycl and chamber tissue markers (Harrelson et al. 2004; Cai et al. 
2005). The functional significance o f this regionalisation is that it allows the division 
of the atrial and ventricular compartments by the AVC cushion tissue, which form 
the valves. Moreover, the AVC has a lower conduction velocity in comparison to the 
chamber tissue, and imposes a delay, allowing contraction of the atria to be 
completed before ventricular filling (Stennard and Harvey 2005). Evidence for Tbx2 
as a repressor o f tissue growth has also come to light in an organ that is homologous 
to the vertebrate eye, namely the Drosophila compound eye. Omb, which is the
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orthologue o f mouse Tbx2 (Bollag et al. 1994), is expressed in the Drosophila eye 
disc (Pflugfelder et al. 1992a), where it appears to be repressing eye growth. Omb 
null mutants display an increase in ommatidial number, while a dominant gain of 
function allele o f omb results in a reduction o f ommatidial number (unpublished data 
presented at the 1st European T-box meeting, November 2005, by G. O. Pflugfelder, 
Mainz University, Germany).
Despite the increased trend in cell proliferation in the dorsal neural retinae of Tbx2'/' 
mutants, they displayed a small retinal volume. The question arises as to how a role 
for Tbx2 as a repressor o f eye growth is compatible with the small eye phenotype in 
the mutants. The abnormal morphogenesis of mutant eyes offers a plausible answer 
to this question. A delay in morphogenesis in the ventral neural retina was observed 
in mutants compared to wild-types at 10.5 dpc, with the ventral neural retina 
appearing smaller and less invaginated. Abnormal ventral invagination of the optic 
cup could lead to a smaller retinal volume despite an increase in dorsal cell division. 
An effect on ventral invagination by the lack o f a dorsally expressed transcription 
factor is suggestive o f misregulation o f signalling molecules, which could convey the 
signal to the ventral eye. The morphological analysis of Tbx2'f' eyes provided several 
indications that Tbx2 plays a cell extrinsic role in eye development. As well as 
delayed ventral optic cup morphogenesis, this was evident in the absence of lens 
fibre elongation at 12.5 dpc, and abnormal hyaloid vasculature development at 10.5 
dpc. Tbx2 misexpression in the developing chick eye, in Chapter 6, resulted in 
reduced eye size, which was more marked in the ventral neural retina, although the 
mechanisms by which this occurred were not investigated due to time constraints, it 
supports a role for Tbx2 as a negative regulator o f eye growth.
The proposed model is that a Bmp4 signalling gradient restricts Tbx2 expression in 
the dorsal eye, which slows the growth o f the dorsal neural retina, by an intrinsic 
mechanism (Fig. 7.1). Tbx2 also regulates morphogenesis of the ventral eye via 
a/multiple secreted factor(s). This would suggest that perhaps there is cross-talk 
between the dorsal and the ventral regions o f the eye, which act in a synchronous 
manner to direct eye morphogenesis and growth. During eye morphogenesis, the 
dorsal neural retina invaginates first followed by the ventral neural retina, so that 
initially, the dorsal part appears larger and the optic stalk is positioned ventrally.
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Therefore, for the eye to acquire the globe shape that is apparent from 13.5 dpc in the 
mouse, when the optic fissure has closed and the optic disc and nerve are positioned 
approximately in the centre of the globe as opposed to ventrally, the ventral neural 
retina must grow at a faster pace than the dorsal region between the onset of 
invagination and completion of optic cup formation (around 13.5 dpc in mouse). 
Analysis of cell proliferation in the dorsal versus the ventral neural retina in the chick 
embryo at HH 14, which is when the optic vesicle has just invaginated, supports this 
idea. In the chick, the mitotic index is higher in the ventral optic cup than in the 
dorsal optic cup at this stage and this trend continues until HH 17, although it is not 
as significant as at HH 14 (Calvente et al. 1988). This difference has also been 
detected in the mouse optic cup at 10.5 dpc (J.Morcillo; J.C. Sowden et al. 
manuscript submitted). The idea that Tbx2 may act to reduce growth in the eye is 
also supported by the expression pattern of Tbx2. In Chapter 6, it was demonstrated 
that at optic vesicle stage, Tbx2 is expressed along the entire D-V length of the distal 
neuroepithelium in the chick embryo, which is still thin in appearance. Upon 
invagination, the distal layer undergoes a concomitant increase in cell number and 
becomes thicker than the proximal layer which goes on to form the thin RPE. During 
this process, Tbx2 becomes localised to the dorsal optic cup, where it may continue 
to act to reduce growth so that the ventral optic cup can ‘catch up’. This 
interpretation would suggest that Tbx2 functions to slow down the neural retina- 
specified distal layer of the optic vesicle; upon invagination and restriction of Tbx2 to 
the dorsal optic cup, it continues to serve this function dorsally, allowing the rest of 
the cup to acquire a higher rate of division.
368
Fig. 7.1 Schematic diagram illustrating the proposed model for the role of 
Tbx2 in the regulation of gene expression and growth along the D-V axis of the 
eye
This schematic builds on the one presented in Chapter 1 (Fig. 1.4). Findings of this 
thesis are shown by red arrows and lines, hypotheses are marked by grey. A dorsal- 
high, ventral-low Bmp4 signalling gradient restricts the expression of the dorsal 
genes Tbx2, Tbx3, and Tbx5, in distinct yet overlapping domains, while repressing 
Vax2 (refer to Fig. 3.9 for illustration of the domains).
The role of Tbx2 in D-V patterning: Tbx2 positively maintains the expression of 
Tbx5, Fgfl5 , while negatively regulating Cx43 and ephrinB2.
The proposed role of Tbx2 in early growth and morphogenesis: Tbx2 has a dual 
role in regulation of eye growth and morphogenesis. 1) It acts intrinsically in the 
dorsal neural retina to negatively regulate cell division (see invaginating optic cup). 
Evidence supporting such a role was provided by the increase in the trend of cell 
division in Tbx2'/' embryos in the dorsal eye specifically. Moreover, growth of the 
ventral neural retina was reduced in rhBmp4 treated eyes in which Tbx2 was 
ectopically expressed, as well as in the ventral region of chick eyes infected with 
RCAS-cTbx2. 2) Tbx2 positively affects growth and morphogenesis of the ventral 
eye via secreted factors. Evidence for this was provided by the delayed invagination 
of the ventral optic cup in Tbx2'/' eyes. Tbx2 regulation of RA or Fgfl5 could 
potentially convey this effect. FgfJ5 was absent in Tbx2'/' eyes at 10.5 dpc. Based on 
reports regarding the role of Fgf signalling in lens development, Fgfl5 is a potential 
candidate for regulating the development of the lens, which was perturbed in Tbx2/ 
embryos.
Abbreviations: D, dorsal; V, ventral
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As described, the Tbx2 phenotype, suggests a dual mechanism of growth control in 
the eye, both o f which were affected by the loss of Tbx2. How is Tbx2 affecting 
ventral optic cup morphogenesis? In Chapter 5, it was shown that Fgfl5, encoding a 
secreted factor expressed in the neural retina, is not maintained in Tbx2'/' mice and 
could potentially be the signal that conveys this effect. As discussed in Chapter 5, 
another candidate is RA, which has previously been shown to affect ventral eye 
morphogenesis (Hyatt et al. 1996; Marsh-Armstrong et al. 1994). Specifically, the 
effect of RA deficiency appears compatible with the Tbx2'/' phenotype, where ventral 
optic cup formation is defective in zebrafish embryos. Apart from one other Fgf, 
Fgf9, the existence o f other secreted factors, specifically expressed in the neural 
retina, that may overlap in expression with Tbx2 are currently not known.
Investigation o f the role o f Tbx2 at later developmental time points was impeded by 
the embryonic lethality caused by the targeted allele. To fully appreciate the role of 
Tbx2 in eye development however, analysis of later time points is necessary. For 
example, a more comprehensive analysis o f cell proliferation at different time points 
and with other markers o f cell proliferation such as incorporation of the Thymidine 
analogue, BrdU, is desirable to better understand the role o f Tbx2 in the control of 
cell proliferation in the eye. This could include an analysis over time, during normal 
optic cup morphogenesis and early growth, o f cell proliferation in the Tbx2 
expression domain o f the neural retina, compared to cell proliferation in the ventral 
neural retina. This could be done by first marking the Tbx2 expressing region by 
whole mount in situ hybridisation followed by immunohistochemistry for a cell 
proliferation marker.
A morphological analysis at later time points would also address the question of 
whether these mutants eventually display an enlarged eye phenotype as the result o f a 
cumulative effect o f increased cell proliferation in the absence of Tbx2, like the omb 
null mutants, or whether other mechanisms still would prevent eye growth. It would 
also be interesting to find out if lens fibre elongation does eventually occur in 
mutants or remains abnormal. Other phenotypes that may be expected are anterior 
segment defects, because Tbx2 is expressed in the comeal ectoderm from 14.5 dpc in 
mouse (Sowden et al. 2001). Furthermore, as the lens is essential for the
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development of the anterior segment, an abnormal lens would likely also result in 
abnormalities in the anterior segment.
Although Tbx2 misexpression did not have a profound effect on intra-retinal RGC 
projections, the disorganisation of the axons in Tbx2'A mice was an interesting 
phenotype, and merits further investigation. It would be necessary to establish 
whether these persist in later development and if so, which molecules may be 
affected that are not expressed/over expressed and are responsible for this defect. 
Currently, it cannot be excluded that this phenotype occurs due to the cardiac 
problems o f these mutants, as it was detected at 12.5 dpc when the rate of lethality is 
high. Although it should be noted, that all embryos analysed were healthy with heart 
beat and circulation and did not reveal cardiac distress such as edema. The questions 
posed here can only be answered with the establishment o f other experimental 
strategies as mentioned before, such as the creation o f conditional mutants.
At the molecular level, analysis of the expression o f Tbx5, Vax2, and ephrinB2 at 
later developmental time points would answer the question o f whether Tbx2 is indeed 
needed to maintain their correct localisation. Analyses in Chapter 5 suggest that it 
does, as these were altered, but a complete lack o f Tbx5 expression and further 
expansion of ephr\nB2 would further corroborate these findings. Several other 
downstream candidates are also deserving o f analysis. These include Cyp26 
enzymes, to investigate the regulation of RA degradation and therefore signalling in 
the absence of Tbx2 for the reasons mentioned before. Analysis of additional 
markers o f the ventral neural retina such as Pax2 and EphB3 would clarify whether 
the reduction in Vax2 expression, detected at 10.5 dpc, is due to a reduction in gene 
expression or the smaller ventral neural retina in mutants.
With regards to the regulation of the T-box genes by Bmp4, there are several 
experiments that could be conducted to answer specific questions that have arisen as 
the result of the findings presented in Chapter 4. Firstly, the normal distribution of 
Bmp signalling, detected by an antibody against phosphorylated Smads, which 
convey the Bmp signal to the nucleus where they, in conjunction with other factors, 
activate or repress gene expression, could be analysed. This may help to determine 
the extent of Bmp signalling away from the source. Secondly, the direct/indirect
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effect of Bmp4 bead implantation on T-box gene expression could be determined by 
bead implantation into the lens vesicle o f mutant embryos that lack functional Bmprs 
in the neural retina followed by embryo culture. Conditional inactivation of these 
receptors in the neural retina has recently been reported (Murali et a l 2005). If bead 
implantation in the lens vesicle, which retains Bmpr expression and therefore is 
capable o f receiving the Bmp signal, still induces ectopic T-box gene expression in 
the neural retina, in which Bmprs have been inactivated, it would suggest that the 
effect is indirect and that intermediaries are involved. Conversely, if ectopic T-box 
gene expression is not induced, it indicates that the effect o f Bmp4 is mediated by its 
direct action on the neural retina. Alternatively, the method o f transgenic expression 
o f a modified Bmp4 hybrid protein, bearing a transmembrane motif, which targets 
and tethers Bmp4 to the plasma membrane in the lens vesicle, hence preventing it 
from diffusing, could be explored. This was discussed in Chapter 4. These methods 
may however be technically difficult and hampered by a number of issues, such as 
failure to tether the Bmp4 protein to the cell membrane, or the loss of functional 
activity with the Bmp fusion protein after the modification. The use of the 
conditional compound Bmpr mutants would be restricted to a small window of 
development, as the neural retina has been reported to degenerate in these mice 
(Murali et a l 2005). Although it would still be feasible to do the suggested 
experiment, with an overnight culture period. The effect of increased levels of Bmp 
signalling on the spatial distribution of D-V markers could be further tested using the 
bead implantation and whole embryo culture system, by varying the concentration of 
the protein on beads. Experiments in Chapter 4, showed that beads soaked in high 
levels of Bmp4, induced more cell death in the dorsal eye than beads soaked in less 
protein. Using beads with a high concentration o f Bmp4, it could be tested whether 
Tbx5y normally restricted to D l, could be expanded not only into D2, as observed in 
experiments presented in Chapter 4, but also in the ventral neural retina (V3 and V4).
The significance o f D-V patterning o f the eye by the early asymmetrical expression 
of various genes is not yet fully understood. The importance o f patterning along this 
axis for topographic mapping of RGC axons to the brain is well established 
(McLaughlin et al. 2003a). It is likely that D-V patterning is important for additional 
functions. Here, data was presented which suggests that an additional role for this 
asymmetry is to control the growth of the eye in order to sculpt the shape of the
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globe. This thesis has provided new insights into the role of Tbx2 in eye development 
and the regulation of T-box genes by Bmp4 signalling in the mammalian eye. A role 
for Tbx2 in eye morphogenesis and early growth has been identified. The research 
has also opened up several avenues to be further explored and new questions to be 
answered. It is hoped that subsequent studies will be able to build upon these 
findings and further characterise the role of Tbx2 but also those of Tbx3 and Tbx5 in 
eye development.
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Appendix A
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Analysis of intra-retinal RGC axonal projections in RCAS-cTbx2 
infected and control retinae
The analysis described here was performed on chick retinae infected at HH 9-10 with 
RCAS-c77>*2 virus and harvested at HH 24-25. Intra-retinal axonal projections were 
visualised with BHI-tubulin whole mount immunohistochemistry, after which retinae 
were flat mounted for analysis. Table A .l shows the number of eyes in which 
‘ectopic’ axons were detected in the ventral neural retina in infected and stage 
matched control eyes. The percentage o f eyes containing ‘ectopic’ axons was higher 
in the RCAS-cTbx2 infected group compared to the control group (60% versus 47% 
respectively).
Table A.1: Incidence of ectopic axons and projection errors in RCAS-cTbx2 infected and
control retinae at HH 24-25
Treatment
RCkS-cTbx2 infected Control
n. eyes with ectopic axons 6 14
without ectopic axons 4 16
Total 10 30
% 60% 47%
n. axons 0° deviation 5 3
s90° deviation 8 16
>90° deviation 3 1
Total 16 20
% 19% 5%
The angle at which the ectopic axons deviated from the common route taken by their 
neighbours was measured by assigning the common route of axons as the 0° 
horizontal axis, while the optic disc and fissure were assigned the 90° vertical axis. 
An axon perpendicular to the common route (0°), which extended parallel to the optic 
fissure towards the ventral periphery would be described as having a 90° deviation. 
An axon not following the common route, but still projecting towards the optic 
fissure would be described as having <90° deviation, while an axon projecting away 
from the common route and away from the optic fissure would have >90° deviation. 
Hence, three categories were created to describe these deviations. 0°, for axons
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outside o f the network but projecting in the same manner, <90°, for axons projecting 
away from the network but towards the optic fissure and never away from it 
including those perpendicular to the network, >90°, for axons projecting away from 
the network and away from the optic fissure. Fig. A l illustrates the criteria for 
assigning axon deviation angles.
Dorsal
Ventral
Fig. Al Schematic diagram of the categorisation of ‘ectopic’ axonal
projections
Picture illustrates a retinal flat mount (grey) with the area of the optic disc 
highlighted by a dashed circle. The three different types o f RGC axonal deviations 
observed are categorised into 0°, <90°, and >90°, with respect to the common route of 
axons (0°) in the ventral aspects of the retina and the optic fissure (90°).
In control retinae, which contained deviated axons, only 5% (1/20) of these axons 
deviated more than 90°. By contrast, in RCAS-cTbx2 infected eyes, 19% (3/16) of 
the ‘ectopic’ axons deviated more than 90° (Table A l). The incidence of axonal 
migration errors was slightly higher in RCAS-cTbx2 infected eyes and among axons 
that extended in the wrong direction, the percentage of axons deviating severely from 
the common route (>90°) was four times higher in infected eyes than observed in 
stage matched controls (19% versus 5%), suggesting that Tbx2 misexpression in the
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ventral retina may be causing higher than normal axonal misrouting. For these 
observations to be validated, a larger data set is required.
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